<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bdrx="http://biodexapharma.com/20251231"
  xmlns:currency="http://xbrl.sec.gov/currency/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bdrx-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ShareCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_SharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_MergerReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MergerReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_WarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ForeignExchangeReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ForeignExchangeReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ShareCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_SharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_MergerReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MergerReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_WarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ShareCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_SharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_MergerReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MergerReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_WarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ShareCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_SharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_MergerReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MergerReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ForeignExchangeReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ShareCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_SharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_MergerReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MergerReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ShareCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_SharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_MergerReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MergerReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ShareCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_SharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_MergerReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MergerReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_WarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForeignExchangeReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ForeignExchangeReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsplcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaPharmaceuticalsplcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaAustraliaPTYLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaAustraliaPTYLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaIrelandLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaIrelandLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaUSIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaUSIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_HaalandUKLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:HaalandUKLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PharMidaAGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:PharMidaAGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ADeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:ADeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:BDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:CDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:DDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FAPProjectsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">bdrx:FAPProjectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FAPProjectsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">bdrx:FAPProjectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ITAndWebsiteCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RightOfUseAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:RightOfUseAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MTX228TolimidoneAcquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">bdrx:MTX228TolimidoneAcquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MTX228TolimidoneAcquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">bdrx:MTX228TolimidoneAcquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MTX228TolimidoneAcquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">bdrx:MTX228TolimidoneAcquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MTX230ERapaacquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">bdrx:MTX230ERapaacquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MTX230ERapaacquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">bdrx:MTX230ERapaacquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BelgiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">bdrx:BelgiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BelgiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">bdrx:BelgiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BelgiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">bdrx:BelgiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CustomersAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">bdrx:CustomersAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AdministrativeCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:AdministrativeCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AdministrativeCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:AdministrativeCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AdministrativeCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:AdministrativeCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeneralAndAdministrativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:GeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeneralAndAdministrativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:GeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeneralAndAdministrativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:IncomeStatementLocation1Axis">bdrx:GeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RightofuseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RightofuseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">bdrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RightofuseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">bdrx:GrossGrossGrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ITAndWebsiteCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ITAndWebsiteCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ITAndWebsiteCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:ITAndWebsiteCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MTX228TolimidoneAcquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:MTX228TolimidoneAcquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_MTX228TolimidoneAcquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:MTX228TolimidoneAcquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MTX228TolimidoneAcquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:MTX228TolimidoneAcquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MTX230ERapaacquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:MTX230ERapaacquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_MTX230ERapaacquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:MTX230ERapaacquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MTX230ERapaacquiredIPRDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">bdrx:MTX230ERapaacquiredIPRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaAustraliaPTYLimited1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaAustraliaPTYLimited1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaLimited1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaLimited1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_HaalandUKLimited1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:HaalandUKLimited1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PharMidaAG1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">bdrx:PharMidaAG1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EmtoraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">bdrx:EmtoraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-12-012025-12-31_custom_SeriesLADSwarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesLADSwarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-07-31_custom_SeriesJADSWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesJADSWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-07-31_custom_SeriesKWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesKWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-05-31_custom_SeriesGADSWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesGADSWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-05-31_custom_SeriesHWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesHWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31_custom_SeriesEADSWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesEADSWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31_custom_SeriesFADSWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesFADSWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-06-30_custom_SeriesDADSWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesDADSWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2020-05-012020-05-31_custom_SeriesADSWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesADSWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="From2019-10-012019-10-31_custom_SeriesADSWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:SeriesADSWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:WarrantSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DARAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DARAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DARAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DARAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DARAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DARAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DARAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DARAOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DARAOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DARAOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DARAOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DARAOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DARAOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DARAOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:DARAOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:MonteCarloSimulationModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:MonteCarloSimulationModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:MonteCarloSimulationModelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:MonteCarloSimulationModelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">bdrx:BlackScholesOptionPricingModelFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForeignExchangeRiskMember_currency_GBP">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ForeignExchangeRiskMember_currency_GBP">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ForeignExchangeRiskMember_currency_GBP">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForeignExchangeRiskMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ForeignExchangeRiskMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ForeignExchangeRiskMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForeignExchangeRiskMember_srt_OtherCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">srt:OtherCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ForeignExchangeRiskMember_srt_OtherCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">srt:OtherCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ForeignExchangeRiskMember_srt_OtherCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">srt:OtherCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignExchangeRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">bdrx:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">bdrx:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">bdrx:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">bdrx:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">bdrx:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">bdrx:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">bdrx:ForeignCurrencySensitivityAnalysisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-05-012025-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_DeferredConsiderationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:DeferredConsiderationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_GovernmentAndResearchLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:GovernmentAndResearchLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_GovernmentAndResearchLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:GovernmentAndResearchLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_GovernmentAndResearchLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:GovernmentAndResearchLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_GovernmentAndResearchLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:GovernmentAndResearchLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_custom_GovernmentAndResearchLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">bdrx:GovernmentAndResearchLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ADeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:ADeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ADeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:ADeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:BDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:BDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:CDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:CDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:DDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:DDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ADeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:ADeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ADeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:ADeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:BDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:CDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:DDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ADeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:ADeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:BDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:CDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:DDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DDeferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">bdrx:DDeferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ReserveForMergerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">bdrx:ReserveForMergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_Grant12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_Grant12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant24Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant24Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant24Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant24Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant24Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant24Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_Grant25Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant25Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_Grant25Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant26Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant26Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant26Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant26Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant26Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant26Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant27Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant27Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant27Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant27Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant27Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant27Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant28Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant28Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant28Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant28Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant28Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant28Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant29Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant29Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant29Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant29Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant29Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant29Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant30Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant30Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant30Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant31Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant31Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant31Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant31Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant31Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant31Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant32Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant32Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant32Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant32Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant32Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant32Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant33Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant33Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant33Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant33Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant33Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant33Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant34Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant34Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant34Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant34Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant34Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant34Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant35Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant35Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant35Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant35Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant35Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant35Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant36Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant36Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant36Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant36Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant36Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant36Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Grant37Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant37Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_Grant37Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant37Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Grant37Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:Grant37Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="From2024-02-012024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantsGrant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantsGrant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantsGrant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantsGrant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantsGrant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantsGrant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantsGrant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantsGrant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantsGrant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantsGrant4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantsGrant4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantsGrant4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantsGrant5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantsGrant5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantsGrant5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WarrantsGrant6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_WarrantsGrant6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantsGrant6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantsGrant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantsGrant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantsGrant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantsGrant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantsGrant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantsGrant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantsGrant4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantsGrant4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WarrantsGrant5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantsGrant5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantsGrant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantsGrant1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantsGrant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantsGrant2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WarrantsGrant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantsGrant3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bdrx:DateOfGrantAxis">bdrx:WarrantsGrant3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012025-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-05-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-07-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-03-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <instant>2022-12-18</instant>
        </period>
    </context>
    <context id="AsOf2023-01-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001643918</identifier>
        </entity>
        <period>
            <instant>2023-01-23</instant>
        </period>
    </context>
    <unit id="GBP">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="GBPPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:GBP</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="N">
        <measure>bdrx:Number</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2025-01-01to2025-12-31" id="Fact000004">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-01-01to2025-12-31" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-12-31" id="Fact000006">0001643918</dei:EntityCentralIndexKey>
    <ifrs-full:Revenue
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0068"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0069"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ExchangeGainsArisingOnTranslationOfForeignOperations
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0117"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ExchangeGainsArisingOnTranslationOfForeignOperations
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0118"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0121"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0122"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationNonCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0202"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0204"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0222"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CurrentProvisions
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0228"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CurrentProvisions
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0229"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CurrentProvisions
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0230"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ForeignExchangeReserve
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0265"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ForeignExchangeReserve
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0266"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ImpairmentOfLoan
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0308"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ImpairmentOfLoan
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0309"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ImpairmentOfElocUpfrontFee
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0313"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ImpairmentOfElocUpfrontFee
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0314"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ForeignExchangeGainslosses
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0334"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0348"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0349"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ProceedsFromDisposalOfFixedAssets
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0373"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:LoanGranted
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0380"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:LoanGranted
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0381"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0397"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:RepaymentproceedsFromPromissoryNote
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0406"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0424"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0425"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0426"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0436"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0440"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0441"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0442"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0443"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0444"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ForeignExchangeTranslation
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0448"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ForeignExchangeTranslation
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0449"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ForeignExchangeTranslation
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0450"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ForeignExchangeTranslation
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0451"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ForeignExchangeTranslation
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0453"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0456"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0457"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0458"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0459"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssuedUnderElocAgreement
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0474"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssuedUnderElocAgreement
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0475"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssuedUnderElocAgreement
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0476"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssuedUnderElocAgreement
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0477"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithElocAgreement
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0482"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithElocAgreement
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0483"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithElocAgreement
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0484"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithElocAgreement
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0485"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued7
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0490"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued7
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0491"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued7
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0492"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued7
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0493"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue7
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0496"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue7
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0498"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue7
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0499"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue7
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0500"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue7
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0501"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued6
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0506"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued6
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0508"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued6
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0509"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue6
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0512"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue6
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0514"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue6
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0516"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue6
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0517"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:LapseWarrants
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0520"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:LapseWarrants
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0521"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:LapseWarrants
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0522"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:LapseWarrants
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0524"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:LapseWarrants
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0526"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0528"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0529"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0530"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0531"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      id="xdx2ixbrl0532"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0559"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0560"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0561"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0562"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0566"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0567"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0568"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0569"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued5
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0582"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued5
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0583"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued5
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0584"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue5
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0587"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue5
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0589"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue5
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0590"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue5
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0591"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued4
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0596"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued4
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0598"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue4
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0601"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue4
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0603"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue4
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0604"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0610"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0612"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0617"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0618"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0619"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0622"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0623"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0624"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0625"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ChangesInEquity
      contextRef="From2024-01-012024-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0631"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0650"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0651"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0652"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0653"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0657"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0658"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0659"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0660"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0671"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0672"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0673"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0674"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0675"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0676"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued3
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0680"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued3
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0681"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued3
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0682"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue3
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0685"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue3
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0687"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue3
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0688"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue3
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0689"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued2
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0693"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued2
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0694"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued2
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0695"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue2
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0699"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue2
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0700"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue2
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0701"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue2
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0702"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued1
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0707"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SharesIssued1
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0708"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue1
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0713"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue1
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0714"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue1
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0715"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CostsAssociatedWithShareIssue1
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0716"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0722"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      id="xdx2ixbrl0724"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      id="xdx2ixbrl0727"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      id="xdx2ixbrl0728"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0729"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      id="xdx2ixbrl0730"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ChangesInEquity
      contextRef="From2023-01-012023-12-31_ifrs-full_MergerReserveMember"
      id="xdx2ixbrl0736"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AccruedRevenue
      contextRef="AsOf2025-12-31_custom_FAPProjectsMember"
      id="xdx2ixbrl0816"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AccruedRevenue
      contextRef="AsOf2024-12-31_custom_FAPProjectsMember"
      id="xdx2ixbrl0818"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SalesRevenue
      contextRef="From2025-01-012025-12-31_custom_BelgiumMember"
      id="xdx2ixbrl0935"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SalesRevenue
      contextRef="From2024-01-012024-12-31_custom_BelgiumMember"
      id="xdx2ixbrl0937"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SalesRevenue
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0941"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:SalesRevenue
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0943"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ContractAssets
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0951"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ContractAssets
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0953"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0957"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:TransfersInPeriodFromContractAssetsToTradeReceivables
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0963"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:TransfersInPeriodFromContractAssetsToTradeReceivables
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0965"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0967"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0969"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0971"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0973"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0975"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0977"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0979"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0981"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0985"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0987"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0989"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0993"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0995"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ExcessOfRevenueRecognisedOverCash
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1001"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesExcessOfRevenueRecognisedOverCash
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl1003"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesExcessOfRevenueRecognisedOverCash
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1005"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesExcessOfRevenueRecognisedOverCash
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1007"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl1009"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1011"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1013"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1019"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualAssetsForeignExchange
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl1021"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualAssetsForeignExchange
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1023"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualAssetsForeignExchange
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1025"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesForeignExchange
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1029"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ContractualLiabilitiesForeignExchange
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1031"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ContractAssets
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1037"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1043"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AmortisationOfIntangibleAssetsSoftware
      contextRef="From2025-01-012025-12-31_custom_AdministrativeCostsMember"
      id="xdx2ixbrl1083"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AmortisationOfIntangibleAssetsSoftware
      contextRef="From2023-01-012023-12-31_custom_AdministrativeCostsMember"
      id="xdx2ixbrl1087"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ImpairmentOfFinancialAsset
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl1089"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ImpairmentOfFinancialAsset
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1090"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ImpairmentOfCommissionPaidInAdvance
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1094"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ImpairmentOfCommissionPaidInAdvance
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1095"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ProvisionAgainstFutureLossOnLoanAgreement
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1098"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ProvisionAgainstFutureLossOnLoanAgreement
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1099"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:FeePayableOtherServices
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1110"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:FeePayableOtherServices1
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1115"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:PostemploymentBenefits
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl1185"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:TerminationBenefits
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl1189"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:TerminationBenefits
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1191"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:PostemploymentBenefits
      contextRef="From2025-01-012025-12-31_srt_DirectorMember"
      id="xdx2ixbrl1207"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:PostemploymentBenefits
      contextRef="From2024-01-012024-12-31_srt_DirectorMember"
      id="xdx2ixbrl1208"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:PostemploymentBenefits
      contextRef="From2023-01-012023-12-31_srt_DirectorMember"
      id="xdx2ixbrl1209"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:InterestExpenseOnDeferredConsideration
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1249"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl1283"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl1284"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1285"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1383"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1385"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1387"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1391"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1395"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1397"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1399"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1405"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1407"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1409"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1415"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1431"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1433"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1435"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1439"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1443"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1445"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1451"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1467"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1469"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1473"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1475"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1481"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1487"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1
      contextRef="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1515"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1517"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1519"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1525"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposals
      contextRef="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1539"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposals
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1541"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposals
      contextRef="From2023-01-012023-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1547"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposals
      contextRef="From2024-01-012024-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1575"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposals
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1577"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposals
      contextRef="From2024-01-012024-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1583"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposals
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1613"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposals
      contextRef="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl1619"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_LaboratoryEquipmentMember"
      id="xdx2ixbrl1641"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1735"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1737"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1751"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1753"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1757"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1759"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1773"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1775"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2025-01-012025-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1777"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2025-01-012025-12-31_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1779"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1781"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      id="xdx2ixbrl1783"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1805"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1807"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposal
      contextRef="From2023-01-012023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1813"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposal
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1815"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposal
      contextRef="From2023-01-012023-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1817"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposal
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1819"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1829"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1831"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposal
      contextRef="From2024-01-012024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1837"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposal
      contextRef="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1839"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1853"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1855"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposal
      contextRef="From2025-01-012025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1861"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Disposal
      contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      id="xdx2ixbrl1863"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember"
      id="xdx2ixbrl1879"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_ITAndWebsiteCostsMember"
      id="xdx2ixbrl1881"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember"
      id="xdx2ixbrl1887"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember"
      id="xdx2ixbrl1895"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_MTX230ERapaacquiredIPRDMember"
      id="xdx2ixbrl1916"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1971"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1985"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl1986"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1987"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2031"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2037"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl2047"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:TransferToSharePremiumOnExerciseOfWarrants
      contextRef="From2025-01-012025-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2049"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:WarrantsIssued
      contextRef="From2025-01-012025-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2055"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2061"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2067"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2088"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2094"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl2104"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:PromissoryNoteIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2112"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:WarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2118"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:ExerciseOfWarrantsTransferToSharePremium
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2124"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2130"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2136"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2154"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2164"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:WarrantsIssued
      contextRef="From2023-01-012023-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2166"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2172"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LongtermBorrowingsMember"
      id="xdx2ixbrl2178"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredIncome1
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2220"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationOpeningProvision
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2231"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationOpeningProvision
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2232"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationOnAcquisitionOfLicence
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl2234"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationOnAcquisitionOfLicence
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2236"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationPayments
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2240"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationInterestExpense
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2244"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationForeignExchange
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2248"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsideration
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2254"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationNonCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2258"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsiderationCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2262"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2025-12-31_custom_PromissoryNoteMember"
      id="xdx2ixbrl2273"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2023-12-31_custom_PromissoryNoteMember"
      id="xdx2ixbrl2277"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2025-12-31_custom_FinanceLeaseMember"
      id="xdx2ixbrl2291"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl2297"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Provision
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2308"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Provision
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2310"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:UtilisationOfProvision
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl2314"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:UtilisationOfProvision
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl2316"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AdjustmentsForProvisions1
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl2320"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AdjustmentsForProvisions1
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl2322"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:AdjustmentsForProvisions1
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2324"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Provision
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl2326"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Provision
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl2328"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Provision
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2330"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:NoncurrentProvisions1
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl2332"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:NoncurrentProvisions1
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl2334"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:NoncurrentProvisions1
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2336"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CurrentProvisions
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl2338"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CurrentProvisions
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl2340"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CurrentProvisions
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2342"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:TransferToSharePremiumOnExerciseOfWarrants
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2365"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2404"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2406"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2408"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2410"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2412"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2024-01-012024-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2414"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2416"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2418"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2025-01-012025-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2420"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_WarrantOneMember"
      id="xdx2ixbrl2424"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_WarrantTwoMember"
      id="xdx2ixbrl2428"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_WarrantTwoMember"
      id="xdx2ixbrl2430"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_WarrantTwoMember"
      id="xdx2ixbrl2432"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_WarrantTwoMember"
      id="xdx2ixbrl2434"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_WarrantTwoMember"
      id="xdx2ixbrl2436"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_WarrantTwoMember"
      id="xdx2ixbrl2440"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_WarrantTwoMember"
      id="xdx2ixbrl2446"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_WarrantThreeMember"
      id="xdx2ixbrl2452"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_WarrantThreeMember"
      id="xdx2ixbrl2454"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_WarrantThreeMember"
      id="xdx2ixbrl2456"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_WarrantThreeMember"
      id="xdx2ixbrl2458"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_WarrantThreeMember"
      id="xdx2ixbrl2460"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_WarrantThreeMember"
      id="xdx2ixbrl2464"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_WarrantThreeMember"
      id="xdx2ixbrl2470"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_WarrantFourMember"
      id="xdx2ixbrl2476"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_WarrantFourMember"
      id="xdx2ixbrl2478"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_WarrantFourMember"
      id="xdx2ixbrl2492"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_WarrantFourMember"
      id="xdx2ixbrl2494"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_WarrantFiveMember"
      id="xdx2ixbrl2498"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_WarrantFiveMember"
      id="xdx2ixbrl2500"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_WarrantFiveMember"
      id="xdx2ixbrl2506"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2024-01-012024-12-31_custom_WarrantFiveMember"
      id="xdx2ixbrl2508"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_WarrantFiveMember"
      id="xdx2ixbrl2510"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_WarrantFiveMember"
      id="xdx2ixbrl2514"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_WarrantFiveMember"
      id="xdx2ixbrl2516"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_WarrantSixMember"
      id="xdx2ixbrl2522"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_WarrantSixMember"
      id="xdx2ixbrl2524"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_WarrantSixMember"
      id="xdx2ixbrl2528"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2024-01-012024-12-31_custom_WarrantSixMember"
      id="xdx2ixbrl2530"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_WarrantSixMember"
      id="xdx2ixbrl2532"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_WarrantSixMember"
      id="xdx2ixbrl2538"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_WarrantSixMember"
      id="xdx2ixbrl2540"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_WarrantSixMember"
      id="xdx2ixbrl2542"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_WarrantSevenMember"
      id="xdx2ixbrl2546"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_WarrantSevenMember"
      id="xdx2ixbrl2548"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_WarrantSevenMember"
      id="xdx2ixbrl2552"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2024-01-012024-12-31_custom_WarrantSevenMember"
      id="xdx2ixbrl2554"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_WarrantSevenMember"
      id="xdx2ixbrl2556"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_WarrantSevenMember"
      id="xdx2ixbrl2562"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_WarrantSevenMember"
      id="xdx2ixbrl2564"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_WarrantSevenMember"
      id="xdx2ixbrl2566"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2568"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2570"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2572"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2574"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2576"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2024-01-012024-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2578"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2580"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2582"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2584"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2586"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_DARAWarrantsMember"
      id="xdx2ixbrl2588"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_DARAOptionsMember"
      id="xdx2ixbrl2594"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2024-01-012024-12-31_custom_DARAOptionsMember"
      id="xdx2ixbrl2600"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_DARAOptionsMember"
      id="xdx2ixbrl2602"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_DARAOptionsMember"
      id="xdx2ixbrl2608"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_DARAOptionsMember"
      id="xdx2ixbrl2610"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_DARAOptionsMember"
      id="xdx2ixbrl2612"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2624"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:DeferredConsideration
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2648"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="xdx2ixbrl2701"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="xdx2ixbrl2716"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="xdx2ixbrl2731"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="xdx2ixbrl2751"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="xdx2ixbrl2782"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember"
      id="xdx2ixbrl2843"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember"
      id="xdx2ixbrl2858"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="xdx2ixbrl2924"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="xdx2ixbrl2939"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_ForeignExchangeRiskMember_srt_OtherCurrencyMember"
      id="xdx2ixbrl2979"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31_custom_ForeignExchangeRiskMember_srt_OtherCurrencyMember"
      id="xdx2ixbrl2981"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR"
      id="xdx2ixbrl2993"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember"
      id="xdx2ixbrl2995"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR"
      id="xdx2ixbrl2999"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember"
      id="xdx2ixbrl3001"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR"
      id="xdx2ixbrl3005"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR"
      id="xdx2ixbrl3011"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember"
      id="xdx2ixbrl3019"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember"
      id="xdx2ixbrl3025"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3060"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3062"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3064"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3066"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_DeferredConsiderationsMember"
      id="xdx2ixbrl3074"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_DeferredConsiderationsMember"
      id="xdx2ixbrl3076"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3078"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3080"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3082"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3084"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3086"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_FinanceLeaseMember"
      id="xdx2ixbrl3092"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_FinanceLeaseMember"
      id="xdx2ixbrl3094"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl3102"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3104"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3108"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3110"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3112"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3114"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_DeferredConsiderationsMember"
      id="xdx2ixbrl3124"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3126"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3130"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3132"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_PromissoryNoteMember"
      id="xdx2ixbrl3134"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_FinanceLeaseMember"
      id="xdx2ixbrl3142"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_FinanceLeaseMember"
      id="xdx2ixbrl3144"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3154"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3158"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3160"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3162"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_TradeAndOtherPayablesMember"
      id="xdx2ixbrl3164"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember_custom_FinanceLeaseMember"
      id="xdx2ixbrl3174"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_custom_GovernmentAndResearchLoansMember"
      id="xdx2ixbrl3184"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2023-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3263"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ValueOfShares
      contextRef="AsOf2023-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3265"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3271"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ValueOfShares
      contextRef="AsOf2024-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3273"
      unitRef="GBP"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2023-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3275"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ValueOfShares
      contextRef="AsOf2023-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3277"
      unitRef="GBP"
      xsi:nil="true"/>
    <bdrx:PrivatePlacements
      contextRef="From2023-01-012023-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3315"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:PrivatePlacements
      contextRef="From2023-01-012023-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3317"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:PrivatePlacements
      contextRef="From2023-01-012023-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3319"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:PrivatePlacements
      contextRef="From2023-01-012023-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3321"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3327"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3329"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3331"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3333"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2023-01-012023-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3337"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2023-01-012023-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3341"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2023-01-012023-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3343"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3347"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3349"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3351"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3353"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredOffering
      contextRef="From2023-01-012023-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3359"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredOffering
      contextRef="From2023-01-012023-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3361"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredOffering
      contextRef="From2023-01-012023-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3363"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredOffering
      contextRef="From2023-01-012023-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3365"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3379"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3381"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3383"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3385"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:WarrantInducement
      contextRef="From2024-01-012024-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3391"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:WarrantInducement
      contextRef="From2024-01-012024-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3393"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:WarrantInducement
      contextRef="From2024-01-012024-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3395"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:WarrantInducement
      contextRef="From2024-01-012024-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3397"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredDirectOffering
      contextRef="From2024-01-012024-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3403"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredDirectOffering
      contextRef="From2024-01-012024-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3405"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredDirectOffering
      contextRef="From2024-01-012024-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3407"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:RegisteredDirectOffering
      contextRef="From2024-01-012024-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3409"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ExercisePrefundedWarrants
      contextRef="From2024-01-012024-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3415"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ExercisePrefundedWarrants
      contextRef="From2024-01-012024-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3417"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ExercisePrefundedWarrants
      contextRef="From2024-01-012024-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3419"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ExercisePrefundedWarrants
      contextRef="From2024-01-012024-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3421"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ExerciseSeriesESeriesFWarrants
      contextRef="From2024-01-012024-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3427"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ExerciseSeriesESeriesFWarrants
      contextRef="From2024-01-012024-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3429"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ExerciseSeriesESeriesFWarrants
      contextRef="From2024-01-012024-12-31_custom_CDeferredSharesMember"
      id="xdx2ixbrl3431"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ExerciseSeriesESeriesFWarrants
      contextRef="From2024-01-012024-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3433"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2024-01-012024-12-31_custom_ADeferredSharesMember"
      id="xdx2ixbrl3437"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2024-01-012024-12-31_custom_BDeferredSharesMember"
      id="xdx2ixbrl3439"
      unitRef="Shares"
      xsi:nil="true"/>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2024-01-012024-12-31_custom_DDeferredSharesMember"
      id="xdx2ixbrl3443"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant1Member"
      id="xdx2ixbrl3512"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant1Member"
      id="xdx2ixbrl3514"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant1Member"
      id="xdx2ixbrl3516"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant2Member"
      id="xdx2ixbrl3526"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant2Member"
      id="xdx2ixbrl3528"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant2Member"
      id="xdx2ixbrl3530"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant3Member"
      id="xdx2ixbrl3540"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant3Member"
      id="xdx2ixbrl3542"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant3Member"
      id="xdx2ixbrl3544"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant4Member"
      id="xdx2ixbrl3554"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant4Member"
      id="xdx2ixbrl3556"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant4Member"
      id="xdx2ixbrl3558"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant5Member"
      id="xdx2ixbrl3568"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant5Member"
      id="xdx2ixbrl3570"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant5Member"
      id="xdx2ixbrl3572"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant6Member"
      id="xdx2ixbrl3582"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant6Member"
      id="xdx2ixbrl3584"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant6Member"
      id="xdx2ixbrl3586"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant7Member"
      id="xdx2ixbrl3596"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant7Member"
      id="xdx2ixbrl3598"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant8Member"
      id="xdx2ixbrl3610"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant8Member"
      id="xdx2ixbrl3612"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant8Member"
      id="xdx2ixbrl3614"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant9Member"
      id="xdx2ixbrl3624"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant9Member"
      id="xdx2ixbrl3626"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant9Member"
      id="xdx2ixbrl3628"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant10Member"
      id="xdx2ixbrl3638"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant10Member"
      id="xdx2ixbrl3640"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant10Member"
      id="xdx2ixbrl3642"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant11Member"
      id="xdx2ixbrl3652"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant11Member"
      id="xdx2ixbrl3654"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant12Member"
      id="xdx2ixbrl3666"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant12Member"
      id="xdx2ixbrl3668"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant12Member"
      id="xdx2ixbrl3670"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3678"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3680"
      unitRef="N"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfOptionsExercised
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3690"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsLapsed
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3692"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsGranted
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3696"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant13Member"
      id="xdx2ixbrl3708"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant13Member"
      id="xdx2ixbrl3712"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant13Member"
      id="xdx2ixbrl3714"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant14Member"
      id="xdx2ixbrl3722"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant14Member"
      id="xdx2ixbrl3724"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant14Member"
      id="xdx2ixbrl3726"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant15Member"
      id="xdx2ixbrl3736"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant15Member"
      id="xdx2ixbrl3738"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant16Member"
      id="xdx2ixbrl3750"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant16Member"
      id="xdx2ixbrl3752"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant17Member"
      id="xdx2ixbrl3764"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant17Member"
      id="xdx2ixbrl3766"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant17Member"
      id="xdx2ixbrl3768"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant18Member"
      id="xdx2ixbrl3778"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant18Member"
      id="xdx2ixbrl3780"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant18Member"
      id="xdx2ixbrl3782"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant19Member"
      id="xdx2ixbrl3792"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant20Member"
      id="xdx2ixbrl3804"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant20Member"
      id="xdx2ixbrl3806"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant21Member"
      id="xdx2ixbrl3818"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant22Member"
      id="xdx2ixbrl3828"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant22Member"
      id="xdx2ixbrl3830"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant22Member"
      id="xdx2ixbrl3832"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant23Member"
      id="xdx2ixbrl3840"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant23Member"
      id="xdx2ixbrl3844"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant23Member"
      id="xdx2ixbrl3846"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant24Member"
      id="xdx2ixbrl3854"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant24Member"
      id="xdx2ixbrl3858"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant25Member"
      id="xdx2ixbrl3868"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant25Member"
      id="xdx2ixbrl3872"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant25Member"
      id="xdx2ixbrl3874"
      unitRef="N"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfOptionsExercised
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl3894"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant26Member"
      id="xdx2ixbrl3912"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant26Member"
      id="xdx2ixbrl3914"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant26Member"
      id="xdx2ixbrl3916"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant27Member"
      id="xdx2ixbrl3926"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant27Member"
      id="xdx2ixbrl3928"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant27Member"
      id="xdx2ixbrl3930"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant28Member"
      id="xdx2ixbrl3940"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant28Member"
      id="xdx2ixbrl3942"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant28Member"
      id="xdx2ixbrl3944"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant29Member"
      id="xdx2ixbrl3954"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant29Member"
      id="xdx2ixbrl3956"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant29Member"
      id="xdx2ixbrl3958"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant30Member"
      id="xdx2ixbrl3968"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant30Member"
      id="xdx2ixbrl3970"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant30Member"
      id="xdx2ixbrl3972"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant31Member"
      id="xdx2ixbrl3982"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant31Member"
      id="xdx2ixbrl3984"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant31Member"
      id="xdx2ixbrl3986"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant32Member"
      id="xdx2ixbrl3996"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant32Member"
      id="xdx2ixbrl4000"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant33Member"
      id="xdx2ixbrl4010"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant33Member"
      id="xdx2ixbrl4012"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant34Member"
      id="xdx2ixbrl4024"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant34Member"
      id="xdx2ixbrl4026"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant34Member"
      id="xdx2ixbrl4030"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant35Member"
      id="xdx2ixbrl4038"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant35Member"
      id="xdx2ixbrl4040"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant35Member"
      id="xdx2ixbrl4042"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant36Member"
      id="xdx2ixbrl4052"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant36Member"
      id="xdx2ixbrl4054"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant37Member"
      id="xdx2ixbrl4066"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant37Member"
      id="xdx2ixbrl4068"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant37Member"
      id="xdx2ixbrl4072"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4078"
      unitRef="N"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfOptionsExercised
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4090"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsGranted
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4096"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4169"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4171"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4173"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4183"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4185"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4187"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4197"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4199"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4201"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant4Member"
      id="xdx2ixbrl4211"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant4Member"
      id="xdx2ixbrl4213"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant4Member"
      id="xdx2ixbrl4215"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant5Member"
      id="xdx2ixbrl4225"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant5Member"
      id="xdx2ixbrl4227"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant5Member"
      id="xdx2ixbrl4229"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant6Member"
      id="xdx2ixbrl4237"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant6Member"
      id="xdx2ixbrl4241"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant6Member"
      id="xdx2ixbrl4243"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4253"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4255"
      unitRef="N"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfOptionsExercised
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4263"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsLapsed
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4265"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4267"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4281"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4283"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4285"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4295"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4297"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4299"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4309"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4311"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4313"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_WarrantsGrant4Member"
      id="xdx2ixbrl4321"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant4Member"
      id="xdx2ixbrl4325"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant4Member"
      id="xdx2ixbrl4327"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_WarrantsGrant5Member"
      id="xdx2ixbrl4335"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant5Member"
      id="xdx2ixbrl4339"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant5Member"
      id="xdx2ixbrl4341"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4351"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4353"
      unitRef="N"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfOptionsExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4361"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsLapsed
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4363"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4365"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4373"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4377"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant1Member"
      id="xdx2ixbrl4379"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4387"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4391"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant2Member"
      id="xdx2ixbrl4393"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4401"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4405"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant3Member"
      id="xdx2ixbrl4407"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4413"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4417"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4419"
      unitRef="N"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfOptionsExercised
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4427"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsLapsed
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4429"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl4431"
      unitRef="GBPPShares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2025-01-01to2025-12-31" id="Fact000015">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="From2025-01-01to2025-12-31" id="Fact000016">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="From2025-01-01to2025-12-31" id="Fact000017">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-01-01to2025-12-31" id="Fact000018">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-01-01to2025-12-31" id="Fact000019">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2025-01-01to2025-12-31" id="Fact000020">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="From2025-01-01to2025-12-31" id="Fact000021">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="From2025-01-01to2025-12-31" id="Fact000022">001-37652</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-12-31" id="Fact000023">BIODEXA PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-01-01to2025-12-31" id="Fact000024">D5</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2025-01-01to2025-12-31" id="Fact000025">1 Caspian Point</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-01-01to2025-12-31" id="Fact000026">Caspian Way</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-01-01to2025-12-31" id="Fact000027">Cardiff</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="From2025-01-01to2025-12-31" id="Fact000028">CF10 4DQ</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="From2025-01-01to2025-12-31" id="Fact000029">GB</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000030">Stephen Stamp</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000032">1 Caspian Point</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000034">Caspian Way</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000036">Cardiff</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000038">CF10 4DQ</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000040">GB</dei:EntityAddressCountry>
    <dei:CountryRegion
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000042">+44</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000044">29</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000046">2048 0180</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2025-01-01to2025-12-31" id="Fact000047">American Depositary Shares, each representing 100,000 ordinary shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2025-01-01to2025-12-31" id="Fact000048">BDRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2025-01-01to2025-12-31" id="Fact000049">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000050"
      unitRef="Shares">225817808922</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2025-01-01to2025-12-31" id="Fact000051">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2025-01-01to2025-12-31" id="Fact000052">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2025-01-01to2025-12-31" id="Fact000053">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-01-01to2025-12-31" id="Fact000054">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-01-01to2025-12-31" id="Fact000055">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-01-01to2025-12-31" id="Fact000056">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2025-01-01to2025-12-31" id="Fact000057">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2025-01-01to2025-12-31" id="Fact000058">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="From2025-01-01to2025-12-31" id="Fact000059">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="From2025-01-01to2025-12-31" id="Fact000060">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="From2025-01-01to2025-12-31" id="Fact000061">2814</dei:AuditorFirmId>
    <dei:AuditorFirmId contextRef="From2024-01-012024-12-31" id="Fact000062">1401</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2025-01-01to2025-12-31" id="Fact000063">PKF Littlejohn LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2025-01-01to2025-12-31" id="Fact000064">London, England</dei:AuditorLocation>
    <dei:AuditorName contextRef="From2024-01-012024-12-31" id="Fact000065">Mazars LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2024-01-012024-12-31" id="Fact000066">London, England</dei:AuditorLocation>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000070"
      unitRef="GBP">381000</ifrs-full:Revenue>
    <ifrs-full:OtherIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000072"
      unitRef="GBP">152000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000073"
      unitRef="GBP">31000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000074"
      unitRef="GBP">14000</ifrs-full:OtherIncome>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000076"
      unitRef="GBP">3961000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000077"
      unitRef="GBP">5437000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000078"
      unitRef="GBP">4067000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000080"
      unitRef="GBP">4836000</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000081"
      unitRef="GBP">3793000</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000082"
      unitRef="GBP">4342000</ifrs-full:AdministrativeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000084"
      unitRef="GBP">-8645000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000085"
      unitRef="GBP">-9199000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000086"
      unitRef="GBP">-8014000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000088"
      unitRef="GBP">2385000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000089"
      unitRef="GBP">3385000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000090"
      unitRef="GBP">570000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000092"
      unitRef="GBP">229000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000093"
      unitRef="GBP">165000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000094"
      unitRef="GBP">41000</ifrs-full:FinanceCosts>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000096"
      unitRef="GBP">-6489000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000097"
      unitRef="GBP">-5979000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000098"
      unitRef="GBP">-7485000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000100"
      unitRef="GBP">-105000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000101"
      unitRef="GBP">-250000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000102"
      unitRef="GBP">-406000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000104"
      unitRef="GBP">-6384000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000105"
      unitRef="GBP">-5729000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000106"
      unitRef="GBP">-7079000</ifrs-full:ProfitLoss>
    <bdrx:ExchangeGainsArisingOnTranslationOfForeignOperations
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000116"
      unitRef="GBP">3000</bdrx:ExchangeGainsArisingOnTranslationOfForeignOperations>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000120"
      unitRef="GBP">3000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000124"
      unitRef="GBP">-6381000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000125"
      unitRef="GBP">-5729000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000126"
      unitRef="GBP">-7079000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000136"
      unitRef="GBPPShares">-0.0001</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000138"
      unitRef="GBPPShares">-0.0001</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000140"
      unitRef="GBPPShares">-0.001</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000142"
      unitRef="GBPPShares">-0.001</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000144"
      unitRef="GBPPShares">-0.02</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000146"
      unitRef="GBPPShares">-0.02</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000156"
      unitRef="GBP">91000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000157"
      unitRef="GBP">324000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000158"
      unitRef="GBP">571000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000160"
      unitRef="GBP">5645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000161"
      unitRef="GBP">5646000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000162"
      unitRef="GBP">2941000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000164"
      unitRef="GBP">5736000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000165"
      unitRef="GBP">5970000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000166"
      unitRef="GBP">3512000</ifrs-full:NoncurrentAssets>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000172"
      unitRef="GBP">3786000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000173"
      unitRef="GBP">6568000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000174"
      unitRef="GBP">637000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000176"
      unitRef="GBP">123000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000177"
      unitRef="GBP">573000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000178"
      unitRef="GBP">422000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000180"
      unitRef="GBP">8534000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000181"
      unitRef="GBP">1669000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000182"
      unitRef="GBP">5971000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000184"
      unitRef="GBP">12443000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000185"
      unitRef="GBP">8810000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000186"
      unitRef="GBP">7030000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000188"
      unitRef="GBP">18179000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000189"
      unitRef="GBP">14780000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000190"
      unitRef="GBP">10542000</ifrs-full:Assets>
    <bdrx:DeferredConsiderationNonCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000200"
      unitRef="GBP">645000</bdrx:DeferredConsiderationNonCurrent>
    <bdrx:DeferredConsiderationNonCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000201"
      unitRef="GBP">1306000</bdrx:DeferredConsiderationNonCurrent>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000205"
      unitRef="GBP">118000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000206"
      unitRef="GBP">295000</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000208"
      unitRef="GBP">645000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000209"
      unitRef="GBP">1424000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000210"
      unitRef="GBP">295000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000216"
      unitRef="GBP">2590000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000217"
      unitRef="GBP">3504000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000218"
      unitRef="GBP">1240000</ifrs-full:TradeAndOtherCurrentPayables>
    <bdrx:DeferredConsiderationCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000220"
      unitRef="GBP">563000</bdrx:DeferredConsiderationCurrent>
    <bdrx:DeferredConsiderationCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000221"
      unitRef="GBP">538000</bdrx:DeferredConsiderationCurrent>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000224"
      unitRef="GBP">61000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000225"
      unitRef="GBP">609000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000226"
      unitRef="GBP">169000</ifrs-full:Borrowings>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000232"
      unitRef="GBP">2915000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000233"
      unitRef="GBP">383000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000234"
      unitRef="GBP">4160000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000236"
      unitRef="GBP">6129000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000237"
      unitRef="GBP">5034000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000238"
      unitRef="GBP">5569000</ifrs-full:CurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000240"
      unitRef="GBP">6774000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000241"
      unitRef="GBP">6458000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000242"
      unitRef="GBP">5864000</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000248"
      unitRef="GBP">14099000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000249"
      unitRef="GBP">11725000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000250"
      unitRef="GBP">6253000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000252"
      unitRef="GBP">98923000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000253"
      unitRef="GBP">93124000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000254"
      unitRef="GBP">86732000</ifrs-full:SharePremium>
    <ifrs-full:MergerReserve
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000256"
      unitRef="GBP">53003000</ifrs-full:MergerReserve>
    <ifrs-full:MergerReserve
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000257"
      unitRef="GBP">53003000</ifrs-full:MergerReserve>
    <ifrs-full:MergerReserve
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000258"
      unitRef="GBP">53003000</ifrs-full:MergerReserve>
    <ifrs-full:WarrantReserve
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000260"
      unitRef="GBP">1185000</ifrs-full:WarrantReserve>
    <ifrs-full:WarrantReserve
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000261"
      unitRef="GBP">894000</ifrs-full:WarrantReserve>
    <ifrs-full:WarrantReserve
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000262"
      unitRef="GBP">3457000</ifrs-full:WarrantReserve>
    <bdrx:ForeignExchangeReserve
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000264"
      unitRef="GBP">3000</bdrx:ForeignExchangeReserve>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000268"
      unitRef="GBP">-155808000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000269"
      unitRef="GBP">-150424000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000270"
      unitRef="GBP">-144767000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000272"
      unitRef="GBP">11405000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000273"
      unitRef="GBP">8322000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000274"
      unitRef="GBP">4678000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000276"
      unitRef="GBP">18179000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000277"
      unitRef="GBP">14780000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000278"
      unitRef="GBP">10542000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000284"
      unitRef="GBP">-6384000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000285"
      unitRef="GBP">-5729000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000286"
      unitRef="GBP">-7079000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000292"
      unitRef="GBP">52000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000293"
      unitRef="GBP">117000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000294"
      unitRef="GBP">143000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000296"
      unitRef="GBP">136000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000297"
      unitRef="GBP">135000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000298"
      unitRef="GBP">137000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000300"
      unitRef="GBP">1000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000301"
      unitRef="GBP">2000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000302"
      unitRef="GBP">3000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000304"
      unitRef="GBP">-29000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000305"
      unitRef="GBP">-4000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000306"
      unitRef="GBP">-2000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <bdrx:ImpairmentOfLoan
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000310"
      unitRef="GBP">79000</bdrx:ImpairmentOfLoan>
    <bdrx:ImpairmentOfElocUpfrontFee
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000312"
      unitRef="GBP">373000</bdrx:ImpairmentOfElocUpfrontFee>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000316"
      unitRef="GBP">2385000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000317"
      unitRef="GBP">3385000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000318"
      unitRef="GBP">570000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000320"
      unitRef="GBP">229000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000321"
      unitRef="GBP">165000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000322"
      unitRef="GBP">41000</ifrs-full:FinanceCosts>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000324"
      unitRef="GBP">170000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000325"
      unitRef="GBP">283000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000326"
      unitRef="GBP">28000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000328"
      unitRef="GBP">-105000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000329"
      unitRef="GBP">-250000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000330"
      unitRef="GBP">-406000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <bdrx:ForeignExchangeGainslosses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000332"
      unitRef="GBP">-130000</bdrx:ForeignExchangeGainslosses>
    <bdrx:ForeignExchangeGainslosses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000333"
      unitRef="GBP">4000</bdrx:ForeignExchangeGainslosses>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000336"
      unitRef="GBP">-8014000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000337"
      unitRef="GBP">-8654000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000338"
      unitRef="GBP">-7622000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000340"
      unitRef="GBP">2629000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000341"
      unitRef="GBP">-5975000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000342"
      unitRef="GBP">365000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000344"
      unitRef="GBP">-913000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000345"
      unitRef="GBP">2239000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000346"
      unitRef="GBP">-207000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000350"
      unitRef="GBP">-207000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000352"
      unitRef="GBP">-6298000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000353"
      unitRef="GBP">-12390000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000354"
      unitRef="GBP">-7671000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000356"
      unitRef="GBP">-707000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000357"
      unitRef="GBP">-129000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000358"
      unitRef="GBP">-845000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000360"
      unitRef="GBP">-5591000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000361"
      unitRef="GBP">-12261000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000362"
      unitRef="GBP">-6826000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000368"
      unitRef="GBP">2000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000369"
      unitRef="GBP">9000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000370"
      unitRef="GBP">26000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <bdrx:ProceedsFromDisposalOfFixedAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000372"
      unitRef="GBP">18000</bdrx:ProceedsFromDisposalOfFixedAssets>
    <bdrx:ProceedsFromDisposalOfFixedAssets
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000374"
      unitRef="GBP">4000</bdrx:ProceedsFromDisposalOfFixedAssets>
    <bdrx:PurchaseOfIntangibleAssetdeferredConsideration
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000376"
      unitRef="GBP">689000</bdrx:PurchaseOfIntangibleAssetdeferredConsideration>
    <bdrx:PurchaseOfIntangibleAssetdeferredConsideration
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000377"
      unitRef="GBP">765000</bdrx:PurchaseOfIntangibleAssetdeferredConsideration>
    <bdrx:PurchaseOfIntangibleAssetdeferredConsideration
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000378"
      unitRef="GBP">237000</bdrx:PurchaseOfIntangibleAssetdeferredConsideration>
    <bdrx:LoanGranted
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000382"
      unitRef="GBP">79000</bdrx:LoanGranted>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000384"
      unitRef="GBP">90000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000385"
      unitRef="GBP">176000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000386"
      unitRef="GBP">73000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000388"
      unitRef="GBP">-583000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000389"
      unitRef="GBP">-598000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000390"
      unitRef="GBP">-265000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000396"
      unitRef="GBP">14000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000398"
      unitRef="GBP">13000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <bdrx:AmountsPaidOnLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000400"
      unitRef="GBP">-246000</bdrx:AmountsPaidOnLeaseLiabilities>
    <bdrx:AmountsPaidOnLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000401"
      unitRef="GBP">-186000</bdrx:AmountsPaidOnLeaseLiabilities>
    <bdrx:AmountsPaidOnLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000402"
      unitRef="GBP">-188000</bdrx:AmountsPaidOnLeaseLiabilities>
    <bdrx:RepaymentproceedsFromPromissoryNote
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000404"
      unitRef="GBP">-450000</bdrx:RepaymentproceedsFromPromissoryNote>
    <bdrx:RepaymentproceedsFromPromissoryNote
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000405"
      unitRef="GBP">431000</bdrx:RepaymentproceedsFromPromissoryNote>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000408"
      unitRef="GBP">13749000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000409"
      unitRef="GBP">8312000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000410"
      unitRef="GBP">10427000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000412"
      unitRef="GBP">13039000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000413"
      unitRef="GBP">8557000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000414"
      unitRef="GBP">10226000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000416"
      unitRef="GBP">6865000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000417"
      unitRef="GBP">-4302000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000418"
      unitRef="GBP">3135000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000420"
      unitRef="GBP">1669000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000421"
      unitRef="GBP">5971000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000422"
      unitRef="GBP">2836000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000428"
      unitRef="GBP">8534000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000429"
      unitRef="GBP">1669000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000430"
      unitRef="GBP">5971000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000432"
      unitRef="GBP">11725000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000433"
      unitRef="GBP">93124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_MergerReserveMember"
      decimals="-3"
      id="Fact000434"
      unitRef="GBP">53003000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000435"
      unitRef="GBP">894000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000437"
      unitRef="GBP">-150424000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000438"
      unitRef="GBP">8322000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000445"
      unitRef="GBP">-6384000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000446"
      unitRef="GBP">-6384000</ifrs-full:ProfitLoss>
    <bdrx:ForeignExchangeTranslation
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      decimals="-3"
      id="Fact000452"
      unitRef="GBP">3000</bdrx:ForeignExchangeTranslation>
    <bdrx:ForeignExchangeTranslation
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000454"
      unitRef="GBP">3000</bdrx:ForeignExchangeTranslation>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2025-01-012025-12-31_custom_ForeignExchangeReserveMember"
      decimals="-3"
      id="Fact000460"
      unitRef="GBP">3000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000461"
      unitRef="GBP">-6384000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000462"
      unitRef="GBP">-6381000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <bdrx:SharesIssuedUnderElocAgreement
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000472"
      unitRef="GBP">2030000</bdrx:SharesIssuedUnderElocAgreement>
    <bdrx:SharesIssuedUnderElocAgreement
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000473"
      unitRef="GBP">4817000</bdrx:SharesIssuedUnderElocAgreement>
    <bdrx:SharesIssuedUnderElocAgreement
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000478"
      unitRef="GBP">6847000</bdrx:SharesIssuedUnderElocAgreement>
    <bdrx:CostsAssociatedWithElocAgreement
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000480"
      unitRef="GBP">86000</bdrx:CostsAssociatedWithElocAgreement>
    <bdrx:CostsAssociatedWithElocAgreement
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000481"
      unitRef="GBP">-77000</bdrx:CostsAssociatedWithElocAgreement>
    <bdrx:CostsAssociatedWithElocAgreement
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000486"
      unitRef="GBP">9000</bdrx:CostsAssociatedWithElocAgreement>
    <bdrx:SharesIssued7
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000488"
      unitRef="GBP">100000</bdrx:SharesIssued7>
    <bdrx:SharesIssued7
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000489"
      unitRef="GBP">143000</bdrx:SharesIssued7>
    <bdrx:SharesIssued7
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000494"
      unitRef="GBP">243000</bdrx:SharesIssued7>
    <bdrx:CostsAssociatedWithShareIssue7
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000497"
      unitRef="GBP">-8000</bdrx:CostsAssociatedWithShareIssue7>
    <bdrx:CostsAssociatedWithShareIssue7
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000502"
      unitRef="GBP">-8000</bdrx:CostsAssociatedWithShareIssue7>
    <bdrx:SharesIssued6
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000504"
      unitRef="GBP">158000</bdrx:SharesIssued6>
    <bdrx:SharesIssued6
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000505"
      unitRef="GBP">1110000</bdrx:SharesIssued6>
    <bdrx:SharesIssued6
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000507"
      unitRef="GBP">1184000</bdrx:SharesIssued6>
    <bdrx:SharesIssued6
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000510"
      unitRef="GBP">2452000</bdrx:SharesIssued6>
    <bdrx:CostsAssociatedWithShareIssue6
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000513"
      unitRef="GBP">-186000</bdrx:CostsAssociatedWithShareIssue6>
    <bdrx:CostsAssociatedWithShareIssue6
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000515"
      unitRef="GBP">-173000</bdrx:CostsAssociatedWithShareIssue6>
    <bdrx:CostsAssociatedWithShareIssue6
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000518"
      unitRef="GBP">-359000</bdrx:CostsAssociatedWithShareIssue6>
    <bdrx:LapseWarrants
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000523"
      unitRef="GBP">-720000</bdrx:LapseWarrants>
    <bdrx:LapseWarrants
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000525"
      unitRef="GBP">720000</bdrx:LapseWarrants>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000533"
      unitRef="GBP">280000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000534"
      unitRef="GBP">280000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ChangesInEquity
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000536"
      unitRef="GBP">2374000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000537"
      unitRef="GBP">5799000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000539"
      unitRef="GBP">291000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000541"
      unitRef="GBP">1000000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000542"
      unitRef="GBP">9464000</ifrs-full:ChangesInEquity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000544"
      unitRef="GBP">14099000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000545"
      unitRef="GBP">98923000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_MergerReserveMember"
      decimals="-3"
      id="Fact000546"
      unitRef="GBP">53003000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000547"
      unitRef="GBP">1185000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_ForeignExchangeReserveMember"
      decimals="-3"
      id="Fact000548"
      unitRef="GBP">3000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000549"
      unitRef="GBP">-155674000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000550"
      unitRef="GBP">11405000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000552"
      unitRef="GBP">6253000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000553"
      unitRef="GBP">86732000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_MergerReserveMember"
      decimals="-3"
      id="Fact000554"
      unitRef="GBP">53003000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000555"
      unitRef="GBP">3457000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000556"
      unitRef="GBP">-144767000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000557"
      unitRef="GBP">4678000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000563"
      unitRef="GBP">-5729000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000564"
      unitRef="GBP">-5729000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000570"
      unitRef="GBP">-5729000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000571"
      unitRef="GBP">-5729000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <bdrx:SharesIssued5
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000580"
      unitRef="GBP">1614000</bdrx:SharesIssued5>
    <bdrx:SharesIssued5
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000581"
      unitRef="GBP">5048000</bdrx:SharesIssued5>
    <bdrx:SharesIssued5
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000585"
      unitRef="GBP">6662000</bdrx:SharesIssued5>
    <bdrx:CostsAssociatedWithShareIssue5
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000588"
      unitRef="GBP">-487000</bdrx:CostsAssociatedWithShareIssue5>
    <bdrx:CostsAssociatedWithShareIssue5
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000592"
      unitRef="GBP">-487000</bdrx:CostsAssociatedWithShareIssue5>
    <bdrx:SharesIssued4
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000594"
      unitRef="GBP">2105000</bdrx:SharesIssued4>
    <bdrx:SharesIssued4
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000595"
      unitRef="GBP">79000</bdrx:SharesIssued4>
    <bdrx:SharesIssued4
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000597"
      unitRef="GBP">2000</bdrx:SharesIssued4>
    <bdrx:SharesIssued4
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000599"
      unitRef="GBP">2186000</bdrx:SharesIssued4>
    <bdrx:CostsAssociatedWithShareIssue4
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000602"
      unitRef="GBP">-55000</bdrx:CostsAssociatedWithShareIssue4>
    <bdrx:CostsAssociatedWithShareIssue4
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000605"
      unitRef="GBP">-297000</bdrx:CostsAssociatedWithShareIssue4>
    <bdrx:CostsAssociatedWithShareIssue4
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000606"
      unitRef="GBP">-352000</bdrx:CostsAssociatedWithShareIssue4>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000608"
      unitRef="GBP">1602000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000609"
      unitRef="GBP">1739000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000611"
      unitRef="GBP">-2565000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000613"
      unitRef="GBP">776000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000615"
      unitRef="GBP">151000</bdrx:IssueOfSharesToPurchaseIntangibleAsset>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000616"
      unitRef="GBP">68000</bdrx:IssueOfSharesToPurchaseIntangibleAsset>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000620"
      unitRef="GBP">219000</bdrx:IssueOfSharesToPurchaseIntangibleAsset>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000626"
      unitRef="GBP">369000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000627"
      unitRef="GBP">369000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ChangesInEquity
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000629"
      unitRef="GBP">5472000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000630"
      unitRef="GBP">6392000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000632"
      unitRef="GBP">-2563000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000633"
      unitRef="GBP">72000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000634"
      unitRef="GBP">9373000</ifrs-full:ChangesInEquity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000636"
      unitRef="GBP">11725000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000637"
      unitRef="GBP">93124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_MergerReserveMember"
      decimals="-3"
      id="Fact000638"
      unitRef="GBP">53003000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000639"
      unitRef="GBP">894000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000640"
      unitRef="GBP">-150424000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000641"
      unitRef="GBP">8322000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000643"
      unitRef="GBP">1108000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000644"
      unitRef="GBP">83667000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_MergerReserveMember"
      decimals="-3"
      id="Fact000645"
      unitRef="GBP">53003000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000646"
      unitRef="GBP">720000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000647"
      unitRef="GBP">-135336000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000648"
      unitRef="GBP">3162000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000654"
      unitRef="GBP">-7079000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000655"
      unitRef="GBP">-7079000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000661"
      unitRef="GBP">-7079000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000662"
      unitRef="GBP">-7079000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <bdrx:SharesIssued3
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000678"
      unitRef="GBP">1956000</bdrx:SharesIssued3>
    <bdrx:SharesIssued3
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000679"
      unitRef="GBP">3013000</bdrx:SharesIssued3>
    <bdrx:SharesIssued3
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000683"
      unitRef="GBP">4969000</bdrx:SharesIssued3>
    <bdrx:CostsAssociatedWithShareIssue3
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000686"
      unitRef="GBP">-903000</bdrx:CostsAssociatedWithShareIssue3>
    <bdrx:CostsAssociatedWithShareIssue3
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000690"
      unitRef="GBP">-903000</bdrx:CostsAssociatedWithShareIssue3>
    <bdrx:SharesIssued2
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000692"
      unitRef="GBP">2380000</bdrx:SharesIssued2>
    <bdrx:SharesIssued2
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000696"
      unitRef="GBP">-355000</bdrx:SharesIssued2>
    <bdrx:SharesIssued2
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000697"
      unitRef="GBP">2025000</bdrx:SharesIssued2>
    <bdrx:CostsAssociatedWithShareIssue2
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000703"
      unitRef="GBP">-527000</bdrx:CostsAssociatedWithShareIssue2>
    <bdrx:CostsAssociatedWithShareIssue2
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000704"
      unitRef="GBP">-527000</bdrx:CostsAssociatedWithShareIssue2>
    <bdrx:SharesIssued1
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000706"
      unitRef="GBP">485000</bdrx:SharesIssued1>
    <bdrx:SharesIssued1
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000709"
      unitRef="GBP">1315000</bdrx:SharesIssued1>
    <bdrx:SharesIssued1
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000710"
      unitRef="GBP">-1273000</bdrx:SharesIssued1>
    <bdrx:SharesIssued1
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000711"
      unitRef="GBP">527000</bdrx:SharesIssued1>
    <bdrx:CostsAssociatedWithShareIssue1
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000717"
      unitRef="GBP">-441000</bdrx:CostsAssociatedWithShareIssue1>
    <bdrx:CostsAssociatedWithShareIssue1
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000718"
      unitRef="GBP">-441000</bdrx:CostsAssociatedWithShareIssue1>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000720"
      unitRef="GBP">324000</bdrx:IssueOfSharesToPurchaseIntangibleAsset>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000721"
      unitRef="GBP">955000</bdrx:IssueOfSharesToPurchaseIntangibleAsset>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000723"
      unitRef="GBP">1422000</bdrx:IssueOfSharesToPurchaseIntangibleAsset>
    <bdrx:IssueOfSharesToPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000725"
      unitRef="GBP">2701000</bdrx:IssueOfSharesToPurchaseIntangibleAsset>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000731"
      unitRef="GBP">244000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000732"
      unitRef="GBP">244000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ChangesInEquity
      contextRef="From2023-01-012023-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000734"
      unitRef="GBP">5145000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2023-01-012023-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000735"
      unitRef="GBP">3065000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000737"
      unitRef="GBP">2737000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000738"
      unitRef="GBP">-2352000</ifrs-full:ChangesInEquity>
    <ifrs-full:ChangesInEquity
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000739"
      unitRef="GBP">8595000</ifrs-full:ChangesInEquity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_ShareCapitalMember"
      decimals="-3"
      id="Fact000741"
      unitRef="GBP">6253000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_SharePremiumMember"
      decimals="-3"
      id="Fact000742"
      unitRef="GBP">86732000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_MergerReserveMember"
      decimals="-3"
      id="Fact000743"
      unitRef="GBP">53003000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_WarrantReserveMember"
      decimals="-3"
      id="Fact000744"
      unitRef="GBP">3457000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"
      decimals="-3"
      id="Fact000745"
      unitRef="GBP">-144767000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000746"
      unitRef="GBP">4678000</ifrs-full:Equity>
    <ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000748">&lt;p id="xdx_803_eifrs-full--DisclosureOfChangesInAccountingPoliciesExplanatory_zHsI8gTu69V6" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;1&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82C_z2511PC4ePJ6"&gt;Accounting policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0 0pt 27pt; text-indent: -27pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;General information&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Biodexa Pharmaceuticals PLC (the &#x2018;Company&#x2019;) is a company registered and
domiciled in England and Wales. The Company was incorporated on 12 September 2014.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Company is a public limited company, whose ordinary shares were admitted to trading
on AIM (&#x2018;AIM&#x2019;), which is a submarket of the London Stock Exchange, on 8 December 2014 until admission of the Company&#x2019;s
ordinary shares to trading on AIM was cancelled 26 April 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;In addition, since 4 December 2015 the Company has American Depository Receipts (&#x2018;ADRs&#x2019;)
registered with the US Securities and Exchange Commission (&#x2018;SEC&#x2019;) and is listed on the NASDAQ Capital Market.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The financial statements were approved and authorised
for issue by the Board of Directors on 27 March 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Basis of preparation&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group was formed on 31 October 2014 when the Company entered into an agreement
to acquire the entire share capital of Biodexa Limited and its wholly owned subsidiaries through the issue equivalent of shares in the
Company which took place on 13 November 2014.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;These financial statements have been prepared in accordance with International Financial
Reporting Standards as issued by the International Accounting Standards Board (IASB).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The principal accounting policies adopted in the preparation of the financial statements
are set out below. The policies have been consistently applied to all the periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The consolidated financial statements have been prepared on a historical cost basis,
except for the following item (refer to individual accounting policies for details):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;- Certain financial instruments &#x2013; fair value through profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Adoption of new and revised standards&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;New standards, interpretations and amendments effective from 1 January 2025&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group reviewed the new standards, interpretations and amendments effective from
1 January 2025 and deemed none were applicable to the annual financial statements for the year ended 31 December 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;New standards, interpretations and amendments
not yet effective &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0; color: #595959"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;There are a number of standards, amendments to
standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the group has decided
not to adopt early.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Group reviewed the new standards, interpretations
and amendments effective from 1 January 2026 and 1 January 2027 and deemed none have a material impact on the group.&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;





&lt;p id="xdx_84F_ecustom--DescriptionOfAccountingPolicyForBasisForConsolidationExplanatory_zlPaw8h7jj0h" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_864_zrEtWgvj4h82"&gt;Basis for consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Group financial statements consolidate those
of the parent company and all of its subsidiaries. The parent controls a subsidiary if it has power over the investee to significantly
direct the activities, exposure, or rights to variable returns from its involvement with the investee, and the ability to use its power
over the investee to affect the amount of the investor&#x2019;s returns. All subsidiaries have a reporting date of 31 December.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;All transactions and balances between Group companies are eliminated on consolidation,
including unrealised gains and losses on transactions between Group companies. Where unrealised losses on intra-Group asset sales are
reversed on consolidation, the underlying asset is also tested for impairment from a Group perspective. Amounts reported in the financial
statements of subsidiaries have been adjusted where necessary to ensure consistency with the accounting policies adopted by the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The consolidated financial statements consist of the results of the following entities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfCompositionOfGroupExplanatory_pn3n3_z6evUhwhoQ6a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounting policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zdkCM8r0Pvz9" style="display: none"&gt;Schedule of entities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 69%; font-weight: bold"&gt;Entity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 30%; font-weight: bold; text-align: left"&gt;Summary description&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_907_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsplcMember_zGtD7ZENOhF9" title="Entity"&gt;Biodexa Pharmaceuticals PLC&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsplcMember" title="Summary description"&gt;Ultimate holding company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimitedMember" title="Entity"&gt;Biodexa Australia PTY Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_903_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimitedMember" title="Entity"&gt;Biodexa Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember" title="Entity"&gt;Biodexa Ireland Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember" title="Entity"&gt;Biodexa Pharmaceuticals (Wales) Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember" title="Entity"&gt;Biodexa US, Inc&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimitedMember" title="Entity"&gt;Haaland UK Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimitedMember" title="Summary description"&gt;Dormant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAGMember" title="Entity"&gt;PharMida AG&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAGMember" title="Summary description"&gt;Dormant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zEOOq9hys7nb" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--DescriptionOfAccountingPolicyForGoingConcernExplanatory_zJBJXtPHcsY3" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zYKVN1ig7KX2"&gt;Going concern &#x2013; material uncertainty&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;We have experienced net losses and significant cash outflows from cash used in operating
activities over the past years as it develops its portfolio. For the year ended 31 December 2025, the Group incurred a consolidated loss
for the year of &#xa3;&lt;span id="xdx_906_ecustom--LossFromOperations_pn3n3_dm_c20250101__20251231_zAd3arZefYSl" title="Loss from operations"&gt;6.38&lt;/span&gt; million and negative cash flows from operations of &#xa3;&lt;span id="xdx_905_ecustom--NegativeCashFlowsFromOperations_pn3n3_dm_c20250101__20251231_z5cAMZTTV4vf" title="Negative cash flows from operating activities"&gt;5.59&lt;/span&gt; million. As of 31 December 2025, the Group
had an accumulated deficit of &#xa3;&lt;span id="xdx_901_ecustom--AccumulatedDeficit_iI_pn3n3_dm_c20251231_zORTLtTBxAEi" title="Accumulated deficit"&gt;155.81&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Our future viability is dependent on our ability to raise cash from financing activities
to finance its development plans until milestones and/or royalties can be secured from partnering the Company&#x2019;s assets. Our failure
to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;We believe there are adequate options and time available to secure additional financing
for the Company and after considering the uncertainties, we consider it is appropriate to continue to adopt the going concern basis in
preparing these financial statements. The Group's consolidated financial statements have therefore been presented on a going concern basis,
which contemplates the realisation of assets and the satisfaction of liabilities in the normal course of business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;As at 31 December 2025, we had cash and cash equivalents of &#xa3;&lt;span id="xdx_900_eifrs-full--Cash_iI_pn3n3_dm_c20251231_zLIxi8o3EFok" title="Cash and cash equivalents"&gt;8.53&lt;/span&gt;
million. We have prepared cash flow forecasts and considered the cash flow requirement for the Group for the next three years
including the period 12 months from the date of approval of the consolidated financial statements. These forecasts show that further
financing will be required in Q3 2026 assuming, inter alia, that certain development programs and other operating activities
continue as currently planned. Pursuant to its $&lt;span id="xdx_90A_ecustom--EquityLineOfCredit_iI_pn3n3_dm_uUSD_c20251231_zxkut7auT7Zf" title="Equity Line of Credit"&gt;35&lt;/span&gt;
million Equity Line of Credit, or ELOC, as described in the Finance Review, the Company may direct C/M to purchase ADSs (subject to
certain limitations) and receive proceeds in accordance with a formula price There is no guarantee that the Company will be able to
use the ELOC or raise from other financing to the extent necessary to finance the Company&#x2019;s operations. As at 31 December 2025
$&lt;span id="xdx_90E_ecustom--EquityLineOfCreditUndraw_iI_pn3n3_dm_uUSD_c20251231_zz1AS2LsweP3" title="Equity Line of Credit undraw"&gt;26.08&lt;/span&gt;
million remains undrawn from the ELOC. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;In our opinion, the environment for financing of small and micro-cap biotech companies
remains challenging. While this may present acquisition and/or merger opportunities with other companies with limited or no access to
financing, as noted above, any attendant financings by Biodexa are likely to be dilutive. We continue to evaluate financing options, including
those connected to acquisitions and/or mergers, potentially available to the Group. Any alternatives considered are contingent upon the
agreement of counterparties and accordingly, there can be no assurance that any alternative courses of action to finance the Company would
be successful.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;This requirement for additional financing in the short term represents a material
uncertainty that may cast significant doubt upon the Group and Parent Company&#x2019;s ability to continue as a going concern. Should it
become evident in the future that there are no realistic financing options available to the Company which are actionable before its cash
resources run out then the Company will no longer be a going concern. In such circumstances, we would no longer be able to prepare financial
statements under paragraph 25 of IAS 1. Instead, the financial statements would be prepared on a liquidation basis and assets would be
stated at net realizable value and all liabilities would be accelerated to current liabilities.&lt;/p&gt;









&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zWoMWr0bCcal" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_znUaKXOkcB11"&gt;Revenue&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Revenue is accounted for in line with principles of IFRS 15 &#x2018;Revenue from contracts
with customers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;Supply of Research and Development Services&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Revenue from the supply of services is subject to specific agreement. This is recognised
over the contract term, proportionate to the progress in overall satisfaction of the performance obligations (the services performed by
the Group), measured by cost incurred to date out of total estimate of costs. The primary input of substantially all work performed under
these arrangements is labour. There is normally a direct relationship between costs incurred and the proportion of the contract performed
to date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Where the Group supplies services to a client it generally bills an agreed percentage
in advance of the commencement of any work and the balance on completion. Invoices to clients are payable under normal commercial terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;Grant revenue&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Where grant income is received, which is not a direct re-imbursement of related costs,
revenue is recognised at the point at which the conditions have been met, this has been recognised within grant revenue. Where grants
are received as a re-imbursement of directly related costs they are credited to research and development expense in the same period as
the expenditure towards which they are intended to contribute.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--AccountingForRrapaAndCpritGrantPolicyTextBlock_zMv1t9nXOIa8" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86F_zIQHYZsmRQx"&gt;Accounting for rRapa and CPRIT grant&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"&gt;On 25 April 2024 the Company entered into a License and Collaboration
Agreement (LCA) with Rapamycin Holdings, Inc. (d/b/a Emtora Biosciences). The LCA entered into with Emtora meets the definition of a Joint
Arrangement under IFRS 11, specifically related to the FAP program.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"&gt;A jointly controlled escrow account was established on completion
of the LCA. FAP program transactions eligible to be allocated against the CPRIT grant and match funding are processed through the escrow
account, including the Company&#x2019;s deposits of matching funds, as set out in the agreement, the receipt of grant funding from CPRIT
and the payment of eligible R&amp;amp;D expenses. Although the CPRIT grant and R&amp;amp;D supplier contracts are with Emtora, the joint arrangement
nature of the LCA results in Emtora being deemed to be acting as the Company&#x2019;s agent. Accordingly, the Company recognises 100% of
the grant and 100% of the R&amp;amp;D expenditure. The CPRIT grant recognised is on a 1 for 2 match basis for the first $17 million, the final
$3 million is recognised on a 1 for 1 basis. In accordance with the Company&#x2019;s accounting policy, the grant, as it is the re-imbursement
of directly related costs, is credited to R&amp;amp;D costs in the same period in the Statements of Comprehensive Income. The escrow account
is recognised within prepayments, CPRIT grant received in advance is recognised within deferred revenue and any grant not yet received
is recognised in accrued income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;The balances as at 31 December were as follows in relation to the
FAP project:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfFapProjectTableTextBlock_pn3n3_zLtrYnb5OaDg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounting policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zQpk0XCjrFC7" style="display: none"&gt;Schedule of FAP project&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;31 December &lt;br/&gt; 2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;31 December &lt;br/&gt; 2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Prepayments&lt;span&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--Prepayments_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_fKg_____zMygvOZSZgg7" title="Prepayments"&gt;2,842&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--Prepayments_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_fKg_____z89ninqxSFnj" title="Prepayments"&gt;6,114&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccruedRevenue_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zWJSDUqawPM6" title="Accrued revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccruedRevenue_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_z92vHeTSPmL5" title="Accrued revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0818"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DeferredTaxLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zci1S4l6zyUb" title="Deferred revenue"&gt;571&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DeferredTaxLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zgGMRJqGvgzg" title="Deferred revenue"&gt;1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td id="xdx_F00_zEXcRnS5onLa" style="width: 9pt; text-align: left"&gt;*&lt;/td&gt;&lt;td id="xdx_F1F_zftXwf2ed62j"&gt;prepayment reflects only the escrow account balance&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A4_z9TOHF6dqlKc" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;









&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zsXpmIaouhne" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zQ2nQkJcZh57"&gt;Business combinations and externally acquired intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Business combinations are accounted for using the acquisition method at the acquisition
date, which is the date at which the Group obtains control over the entity. The cost of an acquisition is measured as the amount of the
consideration transferred to the seller, measured at the acquisition date fair value, and the amount of any non-controlling interest in
the acquiree. The Group measures goodwill initially at cost at the acquisition date, being:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the fair value of the consideration transferred to the seller, plus;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the amount of any non-controlling interest in the acquiree, plus;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;if the business combination is achieved in stages, the fair value of the existing equity interest in the acquiree re-measured at the
acquisition date, less;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the fair value of the net identifiable assets acquired and assumed liabilities.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Acquisition costs incurred are expensed and included in administrative costs. Any
contingent consideration to be transferred by the acquirer is recognised at fair value at the acquisition date. Subsequent changes to
the fair value of the contingent consideration, whether it is an asset or liability, will be recognised through the consolidated statement
of comprehensive income. If the contingent consideration is classified as equity, it is not re-measured.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;An intangible asset, which is an identifiable non-monetary asset without physical
substance, is recognised to the extent that it is probable that the expected future economic benefits attributable to the asset will flow
to the Group and that its cost can be measured reliably. The asset is deemed to be identifiable when it is separable or when it arises
from contractual or other legal rights. Further contingent payments due on the purchase of the intangible asset are only recognised when
it is probable that payments are due.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Externally acquired intangible assets other than goodwill are initially recognised
at cost and subsequently amortised on a straight-line basis over their useful economic lives where they are in use. Goodwill is stated
at cost less any accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The amounts ascribed to intangibles recognised on business combinations are arrived
at by using appropriate valuation techniques. In-process research and development (&#x2018;IPRD&#x2019;) programmes acquired in business
combinations are recognised as assets even if subsequent expenditure is written off because the criteria specified in the policy for development
costs below are not met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;IPRD is subject to annual impairment testing until the completion or abandonment
of the related project. No further costs are capitalised in respect of this IPRD unless they meet the criteria for research and development
capitalisation as set out below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;As per IFRS 3, once the research and development of each defined project is completed,
the carrying value of the acquired IPRD is reclassified as a finite-lived asset and amortised over its useful life.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The significant intangibles recognised by the Group and their useful economic lives
are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory_pn3n3_zkHjCrh1cPj3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Accounting policies (Details 2)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;span id="xdx_8BD_z9zqRaNtMxPa" style="display: none"&gt;Schedule of intangibles assets useful economic lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20%; color: #4D4D4C"&gt;Goodwill&lt;/td&gt;
    &lt;td style="width: 80%; color: #4D4D4C"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember" title="Useful economic lives"&gt;&#x2013; Indefinite life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;IPRD&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember" title="Useful economic lives"&gt;&#x2013; In process, not yet amortising&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;IT and website costs&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember" title="Useful economic lives"&gt;&#x2013; 4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zY85nosDJ4W" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The useful economic life of IPRD will be determined when the in-process research
projects are completed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zRvrdDAmD178" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_861_zWOicvW42ofa"&gt;Internally generated intangible assets (development costs)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Expenditure on the research phase of an internal project is recognised as an expense
in the period in which it is incurred. Development costs incurred on specific projects are capitalised when all the following conditions
are&#160;satisfied:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;completion of the asset is technically feasible so that it will be available for use or sale;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the Group intends to complete the asset and use or sell it;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the Group has the ability to use or sell the asset and the asset will generate probable future economic benefits (over and above cost);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;there are adequate technical, financial and other resources to complete the development and to use or sell the asset; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the expenditure attributable to the asset during its development can be measured reliably.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;






&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;All internal activities related to the research and development of new projects are
continuously monitored by the Directors. The Directors consider that the criteria to capitalise development expenditure are not met for
a product prior to that product receiving regulatory approval in at least one country.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Development expenditure not satisfying the above criteria, and expenditure on the
research phase of internal projects are included in research and development costs recognised in the Consolidated Statement of Comprehensive
Income as incurred. No projects have yet reached the point of capitalisation.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;





&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zDvN2vQcGwEj" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_860_zRMSAbW2tdZ1"&gt;Impairment of non-financial assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Assets that have an indefinite useful life, for example goodwill, or intangible assets
not ready for use, such as IPRD, are not subject to amortisation and are tested annually for impairment. Assets that are subject to amortisation
are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment
loss is recognised for the amount by which the asset&#x2019;s carrying amount exceeds its recoverable amount. The recoverable amount is
the higher of an asset&#x2019;s fair value less costs to sell and value in use. The reversal of any impairment charge is limited to the
carrying amount of the asset that would have been determined (net of amortisation or depreciation) had no impairment charge been recognised
for the asset in prior periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;For the purposes of assessing impairment, assets are grouped at the lowest levels
for which there are separately identifiable cash flows (cash-generating units). The Group at 31 December 2025 had two cash generating
units(2024: two, 2023: one) as disclosed in note 11. Non-financial assets other than goodwill
that suffered impairment are reviewed for possible reversal of impairment at each reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForPatentsAndTrademarksExplanatory_zTSovYOcri1e" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_863_zeq5BNm3PRpa"&gt;Patents and trademarks&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The costs incurred in establishing patents and trademarks are either expensed in
accordance with the corresponding treatment of the development expenditure for the product to which they relate or capitalised if the
development expenditure to which they relate has reached the point of capitalisation as an intangible asset.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zma66B3kD3t2" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zchAGohGseUa"&gt;Foreign currency&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Transactions entered into by Group entities in a currency other than the currency
of the primary economic environment, in which they operate, are recorded at the rates ruling when the transactions occur. Foreign currency
monetary assets and liabilities are translated at the rates ruling at the reporting date. Exchange differences arising on the retranslation
of unsettled monetary assets and liabilities are recognised immediately in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The presentational currency of the Group is Pounds Sterling. Foreign subsidiaries
use the local currencies of the country where they operate. On consolidation, the results of overseas operations are translated into Pounds
Sterling at rates approximating to those ruling when the transactions took place. All assets and liabilities of overseas operations, including
goodwill arising on the acquisition of those operations, are translated at the rate ruling at the reporting date. Exchange differences
arising on translating the opening net assets at opening rate and the results of overseas operations at actual rate are recognised in
other comprehensive income and accumulated in the foreign exchange reserve.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Exchange differences recognised in the profit or loss of Group entities on the translation
of long-term monetary items forming part of the Group&#x2019;s net investment in the overseas operation concerned are reclassified to other
comprehensive income and accumulated in the foreign exchange reserve on consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;On disposal of a foreign operation, the cumulative exchange differences recognised
in the foreign exchange reserve relating to that operation up to the date of disposal are transferred to the consolidated statement of
comprehensive income as part of the gain or loss on disposal.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_zuCQZdNVOmZ2" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_868_zasSmb4SSlyi"&gt;Financial assets and liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Assets at amortised cost&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group does not have any financial assets which it would classify as fair value
through profit or loss. Therefore, all financial assets are classed as assets at amortised cost as defined below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;These assets are non-derivative financial assets with fixed or determinable payments
that are not quoted in an active market. They arise principally through the provision of goods and services to customers (e.g., trade
receivables), but also incorporate other types of contractual monetary asset. They are initially recognised at fair value plus transaction
costs that are directly attributable to their acquisition or issue and are subsequently carried at amortised cost using the effective
interest rate method, less provision for impairment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;For impairment provisions, the Group applies the IFRS 9 simplified approach to measure
expected credit losses using a lifetime expected credit loss provision for trade receivables to measure expected credit losses on a collective
basis. Trade receivables are grouped based on a similar credit risk and ageing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The expected loss rates are based on the Group&#x2019;s historic credit losses experienced
over the three-year period prior to the period end. The historic loss rates are then adjusted for current and forward-looking information
on macroeconomic factors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group&#x2019;s assets at amortised costs comprise trade and other receivables
and cash and cash equivalents in the consolidated statement of financial position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Cash and cash equivalents include cash in hand, deposits held at call with original
maturities of three months or less.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Financial liabilities&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group classifies its financial liabilities into one of two categories, depending
on the purpose for which the liability was acquired.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Fair value through profit and loss (&#x2018;FVTPL&#x2019;)&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group has outstanding warrants in the ordinary share capital of the company.
The number of ordinary shares to be issued when exercised is fixed, however the exercise price is denominated in US Dollars being different
to the functional currency of the parent company. Therefore, the warrants are classified as equity settled derivative financial liabilities
recognised at fair value through the profit and loss account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The financial liability is valued using the either the Monte Carlo model or the Black-Scholes
option pricing model. Financial liabilities at FVTPL are stated at fair value, with any gains or losses arising on re-measurement recognised
in profit or loss. The net gain or loss recognised in profit or loss incorporates any interest paid on the financial liability and is
included in the &#x2018;finance income&#x2019; or &#x2018;finance expense&#x2019; lines item in the income statement. Fair value is determined
in the manner described in note 19.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Other financial liabilities include the following items:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Borrowings are initially recognised at fair value net of any transaction costs directly attributable to the issue of the instrument.
Such interest-bearing liabilities are subsequently measured at amortised cost using the effective interest rate method, which ensures
that any interest expense over the period to repayment is at a constant rate on the balance of the liability carried in the consolidated
statement of financial position. Interest expense in this context includes initial transaction costs and premium payable on redemption,
as well as any interest or coupon payable while the liability is outstanding.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Trade payables and other short-term monetary liabilities are initially recognised at fair value and subsequently carried at amortised
cost using the effective interest method.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_zkRFga4R7Ht1" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86E_zQh6Jr9XPl14"&gt;Share capital&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Financial instruments issued by the Group are classified as equity only to the extent
that they do not meet the definition of a financial liability or financial asset. The Group has three classes of share in existence:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;ordinary shares of &#xa3;&lt;span id="xdx_905_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zir5pcmYp189" title="Share par value (in dollars per share)"&gt;0.00005&lt;/span&gt; each are classified as equity instruments;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#x2018;A&#x2019; deferred shares of &#xa3;&lt;span id="xdx_90D_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zuMLD8rEsw74" title="Share par value (in dollars per share)"&gt;1&lt;/span&gt; each are classified as equity instruments;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#x2018;B&#x2019; deferred shares of &#xa3;&lt;span id="xdx_906_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zRFarMAyHv54" title="Share par value (in dollars per share)"&gt;0.001&lt;/span&gt; each are classified as equity instruments;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#x2018;C&#x2019; deferred shares of &#xa3;&lt;span id="xdx_904_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zvI44ECRDeR6" title="Share par value (in dollars per share)"&gt;0.00005&lt;/span&gt; each are classified as equity instruments;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#x2018;D&#x2019; deferred shares of &#xa3;&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_z9kCuTvUfC21" title="Share par value (in dollars per share)"&gt;0.000001&lt;/span&gt; each are classified as equity instruments.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_zkZltpJVjTY1" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_868_zDyMayQAA2M2"&gt;Retirement benefits: defined contribution schemes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Contributions to defined contribution pension schemes are charged to the consolidated
statement of comprehensive income in the year to which they relate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_ztWswBxTLXVk" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zzXGSQgmbIK4"&gt;Provisions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Provisions are recognised when the Group has a present obligation (legal or constructive)
as a result of a past event; it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation
and a reliable estimate can be made of the amount of the obligation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zixS5xUnCyV3" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zSDxwK1Ntnv5"&gt;Share-based payments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group operates a number of equity-settled, share-based compensation plans, under
which the entity receives services from Directors and employees as consideration for equity instruments (options) of the Group. The fair
value of the Directors and employee services received in exchange for the grant of the options is recognised as an expense. The total
amount to be expensed is determined by reference to the fair value of the options granted:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;including any market performance conditions (including the share price);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;excluding the impact of any service and non-market performance vesting conditions (for example, remaining an employee of the entity
over a specified time period); and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;including the impact of any non-vesting conditions (for example, the requirement for employees to save).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Non-market performance and service conditions are included in assumptions about
the number of options that are expected to vest. The total expense is recognised over the vesting period, which is the period over which
all of the specified vesting conditions are to be satisfied. Where vesting conditions are accelerated on the occurrence of a specified
event, such as a change in control or initial public offering, such remaining unvested charge is accelerated to the income statement.&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;In addition, in some circumstances employees may provide services in advance of the
grant date and therefore the grant date fair value is estimated for the purposes of recognising the expense during the period between
service commencement period and grant date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;At the end of each reporting period, the Group revises its estimates of the number
of options that are expected to vest based on the non-market vesting conditions. It recognises the impact of the revision to original
estimates, if any, in the income statement, with a corresponding adjustment to equity. When the options are exercised, the Company issues
new shares. The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and
share premium.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group also issues warrants over ADSs to certain professional advisors in connection
with equity transactions that fall within the scope of IFRS2 and are accounted for as share based payments. The fair value of the services
received in exchange for the grant of the warrant is recognised as an expense of the equity transaction. The total expense is recognised
immediately.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z2VcG96qvHqe" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86C_zzNMziugyCCe"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;Identifying Leases &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Group accounts for a contract, or a portion
of a contract, as a lease when it conveys the right to use an asset for a period of time in exchange for consideration. Leases are those
contracts that satisfy the following criteria: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;(a) There is an identified asset; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;(b) The Group obtains substantially all the economic
benefits from use of the asset; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;(c) The Group has the right to direct use of the
asset. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Group considers whether the supplier has substantive
substitution rights. If the supplier does have those rights, the contract is not identified as giving rise to a lease. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;In determining whether the Group obtains substantially
all the economic benefits from use of the asset, the Group considers only the economic benefits that arise from the use of the asset,
not those incidental to legal ownership or other potential benefits. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;In determining whether the Group has the right
to direct use of the asset, the Group considers whether it directs how and for what purpose the asset is used throughout the period of
use. If there are no significant decisions to be made because they are pre-determined due to the nature of the asset, the Group considers
whether it was involved in the design of the asset in a way that predetermines how and for what purpose the asset will be used throughout
the period of use. If the contract or portion of a contract does not satisfy these criteria, the Group applies other applicable IFRSs
rather than IFRS 16. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;All leases are accounted for by recognising a right-of-use
asset and a lease liability except for: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol; font-weight: normal"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-weight: normal"&gt;Leases of low value assets; and &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol; font-weight: normal"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-weight: normal"&gt;Leases with a duration of 12 months or less. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;Lease liabilities are measured at the present value
of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the group&#x2019;s
incremental borrowing rate on commencement of the lease. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;Right of use assets are initially measured at the
amount of the lease liability, reduced for any lease incentives received, and increased for lease payments made at or before commencement
of the lease. The Group has taken advantage of the practical expedient to ignore the requirement to separate non-lease components and
instead account for the entire contract as a single lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;Subsequent to initial measurement lease liabilities
increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Right-of-use
assets are amortised on a straight-line basis over the remaining term of the lease. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;When the group revises its estimate of the term
of any lease (because, for example, it re-assesses the probability of a lessee extension or termination option being exercised), it adjusts
the carrying amount of the lease liability to reflect the payments to make over the revised term, which are discounted using a revised
discount rate. An equivalent adjustment is made to the carrying value of the right-of-use asset, with the revised carrying amount being
amortised over the remaining (revised) lease term. If the carrying amount of the right-of-use asset is adjusted to zero, any further reduction
is recognised in profit or loss. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;Nature of leasing activities (in the capacity
as lessee) &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;As at 31 December 2025 the Group had one property
lease in place in the UK. &lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;





&lt;p id="xdx_848_ecustom--DescriptionOfAccountingPolicyTextBlock_zbii9uK6T78j" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_869_zhRtF1bUiymc"&gt;Taxation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;Tax is recognised in the Comprehensive Statement
of Income, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised
directly in equity is also recognised in other comprehensive income or directly in equity respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The current income tax credit is calculated on
the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the country where the Company
operates. Current tax includes credits for qualifying research and development expenditure under the UK&#x2019;s Merged R&amp;amp;D Expenditure
Credit scheme.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory_zB5GFMAdy3Xe" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86A_zh1cXD3rhEt7"&gt;Deferred taxation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Deferred tax assets and liabilities are recognised where the carrying amount of an
asset or liability in the consolidated statement of financial position differs from its tax base, except for differences arising on:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the initial recognition of goodwill;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the initial recognition of an asset or liability in a transaction which is not a business combination and at the time&lt;br/&gt;
of the transaction affects neither accounting or taxable profit or loss; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;investments in subsidiaries and jointly controlled entities where the Group is able to control the timing of the reversal of the difference
and it is probable that the difference will not reverse in the foreseeable future.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Recognition of deferred tax assets is restricted to those instances where it is probable
that taxable profit will be available against which the difference can be utilised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The amount of the asset or liability is determined using tax rates that have been
enacted or substantively enacted by the reporting date and are expected to apply when the deferred tax assets or liabilities are recovered
or settled.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zBhHSIoIs6J3" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86C_zZKXCWvvSkMg"&gt;Property, plant and equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Property, plant and equipment is stated at cost, net of accumulated depreciation
and accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Depreciation is provided on all items of property, plant and equipment so as to write
off their carrying value over their expected useful economic lives. It is provided at the following rates:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfDepreciationRatesOfPropertyPlantAndEquipmentTableExplanatory_pn3n3_z30182a1gMOh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Accounting policies (Details 3)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;span id="xdx_8B9_zMYoAfaFglIe" style="display: none"&gt;Schedule of depreciation rates of property, plant and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20%; color: #4D4D4C"&gt;Fixtures and fittings&lt;/td&gt;
    &lt;td style="width: 80%; color: #4D4D4C"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 20%- 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Leasehold improvements&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; the shorter of 10% per annum straight line or over the lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Computer equipment&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Laboratory equipment&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 15% &#x2013; 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Right of use asset&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--RightOfUseAssetMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; Economic life of contractual relationship&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zEJ3DDbTaLC8" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory>
    <bdrx:DescriptionOfAccountingPolicyForBasisForConsolidationExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000753">&lt;p id="xdx_84F_ecustom--DescriptionOfAccountingPolicyForBasisForConsolidationExplanatory_zlPaw8h7jj0h" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_864_zrEtWgvj4h82"&gt;Basis for consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Group financial statements consolidate those
of the parent company and all of its subsidiaries. The parent controls a subsidiary if it has power over the investee to significantly
direct the activities, exposure, or rights to variable returns from its involvement with the investee, and the ability to use its power
over the investee to affect the amount of the investor&#x2019;s returns. All subsidiaries have a reporting date of 31 December.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;All transactions and balances between Group companies are eliminated on consolidation,
including unrealised gains and losses on transactions between Group companies. Where unrealised losses on intra-Group asset sales are
reversed on consolidation, the underlying asset is also tested for impairment from a Group perspective. Amounts reported in the financial
statements of subsidiaries have been adjusted where necessary to ensure consistency with the accounting policies adopted by the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The consolidated financial statements consist of the results of the following entities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfCompositionOfGroupExplanatory_pn3n3_z6evUhwhoQ6a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounting policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zdkCM8r0Pvz9" style="display: none"&gt;Schedule of entities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 69%; font-weight: bold"&gt;Entity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 30%; font-weight: bold; text-align: left"&gt;Summary description&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_907_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsplcMember_zGtD7ZENOhF9" title="Entity"&gt;Biodexa Pharmaceuticals PLC&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsplcMember" title="Summary description"&gt;Ultimate holding company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimitedMember" title="Entity"&gt;Biodexa Australia PTY Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_903_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimitedMember" title="Entity"&gt;Biodexa Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember" title="Entity"&gt;Biodexa Ireland Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember" title="Entity"&gt;Biodexa Pharmaceuticals (Wales) Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember" title="Entity"&gt;Biodexa US, Inc&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimitedMember" title="Entity"&gt;Haaland UK Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimitedMember" title="Summary description"&gt;Dormant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAGMember" title="Entity"&gt;PharMida AG&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAGMember" title="Summary description"&gt;Dormant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zEOOq9hys7nb" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</bdrx:DescriptionOfAccountingPolicyForBasisForConsolidationExplanatory>
    <ifrs-full:DisclosureOfCompositionOfGroupExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000755">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfCompositionOfGroupExplanatory_pn3n3_z6evUhwhoQ6a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounting policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zdkCM8r0Pvz9" style="display: none"&gt;Schedule of entities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 69%; font-weight: bold"&gt;Entity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 30%; font-weight: bold; text-align: left"&gt;Summary description&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_907_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsplcMember_zGtD7ZENOhF9" title="Entity"&gt;Biodexa Pharmaceuticals PLC&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsplcMember" title="Summary description"&gt;Ultimate holding company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimitedMember" title="Entity"&gt;Biodexa Australia PTY Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_903_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimitedMember" title="Entity"&gt;Biodexa Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember" title="Entity"&gt;Biodexa Ireland Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember" title="Entity"&gt;Biodexa Pharmaceuticals (Wales) Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember" title="Entity"&gt;Biodexa US, Inc&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember" title="Summary description"&gt;Trading company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimitedMember" title="Entity"&gt;Haaland UK Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimitedMember" title="Summary description"&gt;Dormant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAGMember" title="Entity"&gt;PharMida AG&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAGMember" title="Summary description"&gt;Dormant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfCompositionOfGroupExplanatory>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsplcMember"
      id="Fact000757">Biodexa Pharmaceuticals PLC</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsplcMember"
      id="Fact000759">Ultimate holding company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaAustraliaPTYLimitedMember"
      id="Fact000761">Biodexa Australia PTY Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaAustraliaPTYLimitedMember"
      id="Fact000763">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaLimitedMember"
      id="Fact000765">Biodexa Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaLimitedMember"
      id="Fact000767">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaIrelandLimitedMember"
      id="Fact000769">Biodexa Ireland Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaIrelandLimitedMember"
      id="Fact000771">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember"
      id="Fact000773">Biodexa Pharmaceuticals (Wales) Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWaleLimitedMember"
      id="Fact000775">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaUSIncMember"
      id="Fact000777">Biodexa US, Inc</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaUSIncMember"
      id="Fact000779">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_HaalandUKLimitedMember"
      id="Fact000781">Haaland UK Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_HaalandUKLimitedMember"
      id="Fact000783">Dormant</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_PharMidaAGMember"
      id="Fact000785">PharMida AG</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_PharMidaAGMember"
      id="Fact000787">Dormant</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <bdrx:DescriptionOfAccountingPolicyForGoingConcernExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000789">&lt;p id="xdx_844_ecustom--DescriptionOfAccountingPolicyForGoingConcernExplanatory_zJBJXtPHcsY3" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zYKVN1ig7KX2"&gt;Going concern &#x2013; material uncertainty&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;We have experienced net losses and significant cash outflows from cash used in operating
activities over the past years as it develops its portfolio. For the year ended 31 December 2025, the Group incurred a consolidated loss
for the year of &#xa3;&lt;span id="xdx_906_ecustom--LossFromOperations_pn3n3_dm_c20250101__20251231_zAd3arZefYSl" title="Loss from operations"&gt;6.38&lt;/span&gt; million and negative cash flows from operations of &#xa3;&lt;span id="xdx_905_ecustom--NegativeCashFlowsFromOperations_pn3n3_dm_c20250101__20251231_z5cAMZTTV4vf" title="Negative cash flows from operating activities"&gt;5.59&lt;/span&gt; million. As of 31 December 2025, the Group
had an accumulated deficit of &#xa3;&lt;span id="xdx_901_ecustom--AccumulatedDeficit_iI_pn3n3_dm_c20251231_zORTLtTBxAEi" title="Accumulated deficit"&gt;155.81&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Our future viability is dependent on our ability to raise cash from financing activities
to finance its development plans until milestones and/or royalties can be secured from partnering the Company&#x2019;s assets. Our failure
to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;We believe there are adequate options and time available to secure additional financing
for the Company and after considering the uncertainties, we consider it is appropriate to continue to adopt the going concern basis in
preparing these financial statements. The Group's consolidated financial statements have therefore been presented on a going concern basis,
which contemplates the realisation of assets and the satisfaction of liabilities in the normal course of business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;As at 31 December 2025, we had cash and cash equivalents of &#xa3;&lt;span id="xdx_900_eifrs-full--Cash_iI_pn3n3_dm_c20251231_zLIxi8o3EFok" title="Cash and cash equivalents"&gt;8.53&lt;/span&gt;
million. We have prepared cash flow forecasts and considered the cash flow requirement for the Group for the next three years
including the period 12 months from the date of approval of the consolidated financial statements. These forecasts show that further
financing will be required in Q3 2026 assuming, inter alia, that certain development programs and other operating activities
continue as currently planned. Pursuant to its $&lt;span id="xdx_90A_ecustom--EquityLineOfCredit_iI_pn3n3_dm_uUSD_c20251231_zxkut7auT7Zf" title="Equity Line of Credit"&gt;35&lt;/span&gt;
million Equity Line of Credit, or ELOC, as described in the Finance Review, the Company may direct C/M to purchase ADSs (subject to
certain limitations) and receive proceeds in accordance with a formula price There is no guarantee that the Company will be able to
use the ELOC or raise from other financing to the extent necessary to finance the Company&#x2019;s operations. As at 31 December 2025
$&lt;span id="xdx_90E_ecustom--EquityLineOfCreditUndraw_iI_pn3n3_dm_uUSD_c20251231_zz1AS2LsweP3" title="Equity Line of Credit undraw"&gt;26.08&lt;/span&gt;
million remains undrawn from the ELOC. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;In our opinion, the environment for financing of small and micro-cap biotech companies
remains challenging. While this may present acquisition and/or merger opportunities with other companies with limited or no access to
financing, as noted above, any attendant financings by Biodexa are likely to be dilutive. We continue to evaluate financing options, including
those connected to acquisitions and/or mergers, potentially available to the Group. Any alternatives considered are contingent upon the
agreement of counterparties and accordingly, there can be no assurance that any alternative courses of action to finance the Company would
be successful.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;This requirement for additional financing in the short term represents a material
uncertainty that may cast significant doubt upon the Group and Parent Company&#x2019;s ability to continue as a going concern. Should it
become evident in the future that there are no realistic financing options available to the Company which are actionable before its cash
resources run out then the Company will no longer be a going concern. In such circumstances, we would no longer be able to prepare financial
statements under paragraph 25 of IAS 1. Instead, the financial statements would be prepared on a liquidation basis and assets would be
stated at net realizable value and all liabilities would be accelerated to current liabilities.&lt;/p&gt;









&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</bdrx:DescriptionOfAccountingPolicyForGoingConcernExplanatory>
    <bdrx:LossFromOperations
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000791"
      unitRef="GBP">6380000</bdrx:LossFromOperations>
    <bdrx:NegativeCashFlowsFromOperations
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000793"
      unitRef="GBP">5590000</bdrx:NegativeCashFlowsFromOperations>
    <bdrx:AccumulatedDeficit
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000795"
      unitRef="GBP">155810000</bdrx:AccumulatedDeficit>
    <ifrs-full:Cash
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000797"
      unitRef="GBP">8530000</ifrs-full:Cash>
    <bdrx:EquityLineOfCredit
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000799"
      unitRef="USD">35000000</bdrx:EquityLineOfCredit>
    <bdrx:EquityLineOfCreditUndraw
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000801"
      unitRef="USD">26080000.00</bdrx:EquityLineOfCreditUndraw>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="From2025-01-01to2025-12-31" id="Fact000806">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zWoMWr0bCcal" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_znUaKXOkcB11"&gt;Revenue&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Revenue is accounted for in line with principles of IFRS 15 &#x2018;Revenue from contracts
with customers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;Supply of Research and Development Services&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Revenue from the supply of services is subject to specific agreement. This is recognised
over the contract term, proportionate to the progress in overall satisfaction of the performance obligations (the services performed by
the Group), measured by cost incurred to date out of total estimate of costs. The primary input of substantially all work performed under
these arrangements is labour. There is normally a direct relationship between costs incurred and the proportion of the contract performed
to date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Where the Group supplies services to a client it generally bills an agreed percentage
in advance of the commencement of any work and the balance on completion. Invoices to clients are payable under normal commercial terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;Grant revenue&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Where grant income is received, which is not a direct re-imbursement of related costs,
revenue is recognised at the point at which the conditions have been met, this has been recognised within grant revenue. Where grants
are received as a re-imbursement of directly related costs they are credited to research and development expense in the same period as
the expenditure towards which they are intended to contribute.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <bdrx:AccountingForRrapaAndCpritGrantPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000808">&lt;p id="xdx_84C_ecustom--AccountingForRrapaAndCpritGrantPolicyTextBlock_zMv1t9nXOIa8" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86F_zIQHYZsmRQx"&gt;Accounting for rRapa and CPRIT grant&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"&gt;On 25 April 2024 the Company entered into a License and Collaboration
Agreement (LCA) with Rapamycin Holdings, Inc. (d/b/a Emtora Biosciences). The LCA entered into with Emtora meets the definition of a Joint
Arrangement under IFRS 11, specifically related to the FAP program.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"&gt;A jointly controlled escrow account was established on completion
of the LCA. FAP program transactions eligible to be allocated against the CPRIT grant and match funding are processed through the escrow
account, including the Company&#x2019;s deposits of matching funds, as set out in the agreement, the receipt of grant funding from CPRIT
and the payment of eligible R&amp;amp;D expenses. Although the CPRIT grant and R&amp;amp;D supplier contracts are with Emtora, the joint arrangement
nature of the LCA results in Emtora being deemed to be acting as the Company&#x2019;s agent. Accordingly, the Company recognises 100% of
the grant and 100% of the R&amp;amp;D expenditure. The CPRIT grant recognised is on a 1 for 2 match basis for the first $17 million, the final
$3 million is recognised on a 1 for 1 basis. In accordance with the Company&#x2019;s accounting policy, the grant, as it is the re-imbursement
of directly related costs, is credited to R&amp;amp;D costs in the same period in the Statements of Comprehensive Income. The escrow account
is recognised within prepayments, CPRIT grant received in advance is recognised within deferred revenue and any grant not yet received
is recognised in accrued income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;The balances as at 31 December were as follows in relation to the
FAP project:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfFapProjectTableTextBlock_pn3n3_zLtrYnb5OaDg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounting policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zQpk0XCjrFC7" style="display: none"&gt;Schedule of FAP project&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;31 December &lt;br/&gt; 2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;31 December &lt;br/&gt; 2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Prepayments&lt;span&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--Prepayments_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_fKg_____zMygvOZSZgg7" title="Prepayments"&gt;2,842&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--Prepayments_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_fKg_____z89ninqxSFnj" title="Prepayments"&gt;6,114&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccruedRevenue_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zWJSDUqawPM6" title="Accrued revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccruedRevenue_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_z92vHeTSPmL5" title="Accrued revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0818"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DeferredTaxLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zci1S4l6zyUb" title="Deferred revenue"&gt;571&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DeferredTaxLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zgGMRJqGvgzg" title="Deferred revenue"&gt;1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td id="xdx_F00_zEXcRnS5onLa" style="width: 9pt; text-align: left"&gt;*&lt;/td&gt;&lt;td id="xdx_F1F_zftXwf2ed62j"&gt;prepayment reflects only the escrow account balance&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A4_z9TOHF6dqlKc" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;









</bdrx:AccountingForRrapaAndCpritGrantPolicyTextBlock>
    <bdrx:ScheduleOfFapProjectTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000810">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfFapProjectTableTextBlock_pn3n3_zLtrYnb5OaDg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounting policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zQpk0XCjrFC7" style="display: none"&gt;Schedule of FAP project&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;31 December &lt;br/&gt; 2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;31 December &lt;br/&gt; 2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Prepayments&lt;span&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--Prepayments_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_fKg_____zMygvOZSZgg7" title="Prepayments"&gt;2,842&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--Prepayments_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_fKg_____z89ninqxSFnj" title="Prepayments"&gt;6,114&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccruedRevenue_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zWJSDUqawPM6" title="Accrued revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccruedRevenue_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_z92vHeTSPmL5" title="Accrued revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0818"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DeferredTaxLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zci1S4l6zyUb" title="Deferred revenue"&gt;571&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DeferredTaxLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FAPProjectsMember_zgGMRJqGvgzg" title="Deferred revenue"&gt;1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td id="xdx_F00_zEXcRnS5onLa" style="width: 9pt; text-align: left"&gt;*&lt;/td&gt;&lt;td id="xdx_F1F_zftXwf2ed62j"&gt;prepayment reflects only the escrow account balance&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</bdrx:ScheduleOfFapProjectTableTextBlock>
    <ifrs-full:Prepayments
      contextRef="AsOf2025-12-31_custom_FAPProjectsMember"
      decimals="-3"
      id="Fact000812"
      unitRef="GBP">2842000</ifrs-full:Prepayments>
    <ifrs-full:Prepayments
      contextRef="AsOf2024-12-31_custom_FAPProjectsMember"
      decimals="-3"
      id="Fact000814"
      unitRef="GBP">6114000</ifrs-full:Prepayments>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-12-31_custom_FAPProjectsMember"
      decimals="-3"
      id="Fact000820"
      unitRef="GBP">571000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2024-12-31_custom_FAPProjectsMember"
      decimals="-3"
      id="Fact000822"
      unitRef="GBP">1468000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000828">&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zsXpmIaouhne" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zQ2nQkJcZh57"&gt;Business combinations and externally acquired intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Business combinations are accounted for using the acquisition method at the acquisition
date, which is the date at which the Group obtains control over the entity. The cost of an acquisition is measured as the amount of the
consideration transferred to the seller, measured at the acquisition date fair value, and the amount of any non-controlling interest in
the acquiree. The Group measures goodwill initially at cost at the acquisition date, being:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the fair value of the consideration transferred to the seller, plus;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the amount of any non-controlling interest in the acquiree, plus;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;if the business combination is achieved in stages, the fair value of the existing equity interest in the acquiree re-measured at the
acquisition date, less;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the fair value of the net identifiable assets acquired and assumed liabilities.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Acquisition costs incurred are expensed and included in administrative costs. Any
contingent consideration to be transferred by the acquirer is recognised at fair value at the acquisition date. Subsequent changes to
the fair value of the contingent consideration, whether it is an asset or liability, will be recognised through the consolidated statement
of comprehensive income. If the contingent consideration is classified as equity, it is not re-measured.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;An intangible asset, which is an identifiable non-monetary asset without physical
substance, is recognised to the extent that it is probable that the expected future economic benefits attributable to the asset will flow
to the Group and that its cost can be measured reliably. The asset is deemed to be identifiable when it is separable or when it arises
from contractual or other legal rights. Further contingent payments due on the purchase of the intangible asset are only recognised when
it is probable that payments are due.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Externally acquired intangible assets other than goodwill are initially recognised
at cost and subsequently amortised on a straight-line basis over their useful economic lives where they are in use. Goodwill is stated
at cost less any accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The amounts ascribed to intangibles recognised on business combinations are arrived
at by using appropriate valuation techniques. In-process research and development (&#x2018;IPRD&#x2019;) programmes acquired in business
combinations are recognised as assets even if subsequent expenditure is written off because the criteria specified in the policy for development
costs below are not met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;IPRD is subject to annual impairment testing until the completion or abandonment
of the related project. No further costs are capitalised in respect of this IPRD unless they meet the criteria for research and development
capitalisation as set out below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;As per IFRS 3, once the research and development of each defined project is completed,
the carrying value of the acquired IPRD is reclassified as a finite-lived asset and amortised over its useful life.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The significant intangibles recognised by the Group and their useful economic lives
are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory_pn3n3_zkHjCrh1cPj3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Accounting policies (Details 2)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;span id="xdx_8BD_z9zqRaNtMxPa" style="display: none"&gt;Schedule of intangibles assets useful economic lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20%; color: #4D4D4C"&gt;Goodwill&lt;/td&gt;
    &lt;td style="width: 80%; color: #4D4D4C"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember" title="Useful economic lives"&gt;&#x2013; Indefinite life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;IPRD&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember" title="Useful economic lives"&gt;&#x2013; In process, not yet amortising&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;IT and website costs&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember" title="Useful economic lives"&gt;&#x2013; 4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zY85nosDJ4W" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The useful economic life of IPRD will be determined when the in-process research
projects are completed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;




</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
    <ifrs-full:DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000830">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory_pn3n3_zkHjCrh1cPj3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Accounting policies (Details 2)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;span id="xdx_8BD_z9zqRaNtMxPa" style="display: none"&gt;Schedule of intangibles assets useful economic lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20%; color: #4D4D4C"&gt;Goodwill&lt;/td&gt;
    &lt;td style="width: 80%; color: #4D4D4C"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember" title="Useful economic lives"&gt;&#x2013; Indefinite life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;IPRD&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember" title="Useful economic lives"&gt;&#x2013; In process, not yet amortising&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;IT and website costs&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember" title="Useful economic lives"&gt;&#x2013; 4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ifrs-full:DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory>
    <ifrs-full:DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife
      contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember"
      id="Fact000832">&#x2013; Indefinite life</ifrs-full:DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife
      contextRef="From2025-01-012025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember"
      id="Fact000834">&#x2013; In process, not yet amortising</ifrs-full:DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife
      contextRef="From2025-01-012025-12-31_custom_ITAndWebsiteCostsMember"
      id="Fact000836">&#x2013; 4 years</ifrs-full:DescriptionAndCarryingAmountOfIntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000838">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zRvrdDAmD178" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_861_zWOicvW42ofa"&gt;Internally generated intangible assets (development costs)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Expenditure on the research phase of an internal project is recognised as an expense
in the period in which it is incurred. Development costs incurred on specific projects are capitalised when all the following conditions
are&#160;satisfied:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;completion of the asset is technically feasible so that it will be available for use or sale;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the Group intends to complete the asset and use or sell it;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the Group has the ability to use or sell the asset and the asset will generate probable future economic benefits (over and above cost);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;there are adequate technical, financial and other resources to complete the development and to use or sell the asset; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the expenditure attributable to the asset during its development can be measured reliably.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;






&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;All internal activities related to the research and development of new projects are
continuously monitored by the Directors. The Directors consider that the criteria to capitalise development expenditure are not met for
a product prior to that product receiving regulatory approval in at least one country.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Development expenditure not satisfying the above criteria, and expenditure on the
research phase of internal projects are included in research and development costs recognised in the Consolidated Statement of Comprehensive
Income as incurred. No projects have yet reached the point of capitalisation.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;





</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000844">&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zDvN2vQcGwEj" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_860_zRMSAbW2tdZ1"&gt;Impairment of non-financial assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Assets that have an indefinite useful life, for example goodwill, or intangible assets
not ready for use, such as IPRD, are not subject to amortisation and are tested annually for impairment. Assets that are subject to amortisation
are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment
loss is recognised for the amount by which the asset&#x2019;s carrying amount exceeds its recoverable amount. The recoverable amount is
the higher of an asset&#x2019;s fair value less costs to sell and value in use. The reversal of any impairment charge is limited to the
carrying amount of the asset that would have been determined (net of amortisation or depreciation) had no impairment charge been recognised
for the asset in prior periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;For the purposes of assessing impairment, assets are grouped at the lowest levels
for which there are separately identifiable cash flows (cash-generating units). The Group at 31 December 2025 had two cash generating
units(2024: two, 2023: one) as disclosed in note 11. Non-financial assets other than goodwill
that suffered impairment are reviewed for possible reversal of impairment at each reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory>
    <bdrx:DescriptionOfAccountingPolicyForPatentsAndTrademarksExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000846">&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForPatentsAndTrademarksExplanatory_zTSovYOcri1e" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_863_zeq5BNm3PRpa"&gt;Patents and trademarks&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The costs incurred in establishing patents and trademarks are either expensed in
accordance with the corresponding treatment of the development expenditure for the product to which they relate or capitalised if the
development expenditure to which they relate has reached the point of capitalisation as an intangible asset.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</bdrx:DescriptionOfAccountingPolicyForPatentsAndTrademarksExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000848">&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zma66B3kD3t2" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zchAGohGseUa"&gt;Foreign currency&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Transactions entered into by Group entities in a currency other than the currency
of the primary economic environment, in which they operate, are recorded at the rates ruling when the transactions occur. Foreign currency
monetary assets and liabilities are translated at the rates ruling at the reporting date. Exchange differences arising on the retranslation
of unsettled monetary assets and liabilities are recognised immediately in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The presentational currency of the Group is Pounds Sterling. Foreign subsidiaries
use the local currencies of the country where they operate. On consolidation, the results of overseas operations are translated into Pounds
Sterling at rates approximating to those ruling when the transactions took place. All assets and liabilities of overseas operations, including
goodwill arising on the acquisition of those operations, are translated at the rate ruling at the reporting date. Exchange differences
arising on translating the opening net assets at opening rate and the results of overseas operations at actual rate are recognised in
other comprehensive income and accumulated in the foreign exchange reserve.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Exchange differences recognised in the profit or loss of Group entities on the translation
of long-term monetary items forming part of the Group&#x2019;s net investment in the overseas operation concerned are reclassified to other
comprehensive income and accumulated in the foreign exchange reserve on consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;On disposal of a foreign operation, the cumulative exchange differences recognised
in the foreign exchange reserve relating to that operation up to the date of disposal are transferred to the consolidated statement of
comprehensive income as part of the gain or loss on disposal.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000850">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_zuCQZdNVOmZ2" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_868_zasSmb4SSlyi"&gt;Financial assets and liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Assets at amortised cost&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group does not have any financial assets which it would classify as fair value
through profit or loss. Therefore, all financial assets are classed as assets at amortised cost as defined below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;These assets are non-derivative financial assets with fixed or determinable payments
that are not quoted in an active market. They arise principally through the provision of goods and services to customers (e.g., trade
receivables), but also incorporate other types of contractual monetary asset. They are initially recognised at fair value plus transaction
costs that are directly attributable to their acquisition or issue and are subsequently carried at amortised cost using the effective
interest rate method, less provision for impairment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;For impairment provisions, the Group applies the IFRS 9 simplified approach to measure
expected credit losses using a lifetime expected credit loss provision for trade receivables to measure expected credit losses on a collective
basis. Trade receivables are grouped based on a similar credit risk and ageing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The expected loss rates are based on the Group&#x2019;s historic credit losses experienced
over the three-year period prior to the period end. The historic loss rates are then adjusted for current and forward-looking information
on macroeconomic factors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group&#x2019;s assets at amortised costs comprise trade and other receivables
and cash and cash equivalents in the consolidated statement of financial position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Cash and cash equivalents include cash in hand, deposits held at call with original
maturities of three months or less.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Financial liabilities&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group classifies its financial liabilities into one of two categories, depending
on the purpose for which the liability was acquired.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Fair value through profit and loss (&#x2018;FVTPL&#x2019;)&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group has outstanding warrants in the ordinary share capital of the company.
The number of ordinary shares to be issued when exercised is fixed, however the exercise price is denominated in US Dollars being different
to the functional currency of the parent company. Therefore, the warrants are classified as equity settled derivative financial liabilities
recognised at fair value through the profit and loss account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The financial liability is valued using the either the Monte Carlo model or the Black-Scholes
option pricing model. Financial liabilities at FVTPL are stated at fair value, with any gains or losses arising on re-measurement recognised
in profit or loss. The net gain or loss recognised in profit or loss incorporates any interest paid on the financial liability and is
included in the &#x2018;finance income&#x2019; or &#x2018;finance expense&#x2019; lines item in the income statement. Fair value is determined
in the manner described in note 19.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Other financial liabilities include the following items:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Borrowings are initially recognised at fair value net of any transaction costs directly attributable to the issue of the instrument.
Such interest-bearing liabilities are subsequently measured at amortised cost using the effective interest rate method, which ensures
that any interest expense over the period to repayment is at a constant rate on the balance of the liability carried in the consolidated
statement of financial position. Interest expense in this context includes initial transaction costs and premium payable on redemption,
as well as any interest or coupon payable while the liability is outstanding.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Trade payables and other short-term monetary liabilities are initially recognised at fair value and subsequently carried at amortised
cost using the effective interest method.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000855">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_zkRFga4R7Ht1" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86E_zQh6Jr9XPl14"&gt;Share capital&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Financial instruments issued by the Group are classified as equity only to the extent
that they do not meet the definition of a financial liability or financial asset. The Group has three classes of share in existence:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;ordinary shares of &#xa3;&lt;span id="xdx_905_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zir5pcmYp189" title="Share par value (in dollars per share)"&gt;0.00005&lt;/span&gt; each are classified as equity instruments;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#x2018;A&#x2019; deferred shares of &#xa3;&lt;span id="xdx_90D_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zuMLD8rEsw74" title="Share par value (in dollars per share)"&gt;1&lt;/span&gt; each are classified as equity instruments;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#x2018;B&#x2019; deferred shares of &#xa3;&lt;span id="xdx_906_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zRFarMAyHv54" title="Share par value (in dollars per share)"&gt;0.001&lt;/span&gt; each are classified as equity instruments;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#x2018;C&#x2019; deferred shares of &#xa3;&lt;span id="xdx_904_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zvI44ECRDeR6" title="Share par value (in dollars per share)"&gt;0.00005&lt;/span&gt; each are classified as equity instruments;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#x2018;D&#x2019; deferred shares of &#xa3;&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_z9kCuTvUfC21" title="Share par value (in dollars per share)"&gt;0.000001&lt;/span&gt; each are classified as equity instruments.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000857"
      unitRef="GBPPShares">0.00005</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_ADeferredSharesMember"
      decimals="INF"
      id="Fact000859"
      unitRef="GBPPShares">1</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_BDeferredSharesMember"
      decimals="INF"
      id="Fact000861"
      unitRef="GBPPShares">0.001</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_CDeferredSharesMember"
      decimals="INF"
      id="Fact000863"
      unitRef="GBPPShares">0.00005</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_DDeferredSharesMember"
      decimals="INF"
      id="Fact000865"
      unitRef="GBPPShares">0.000001</ifrs-full:ParValuePerShare>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000867">&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_zkZltpJVjTY1" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_868_zDyMayQAA2M2"&gt;Retirement benefits: defined contribution schemes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Contributions to defined contribution pension schemes are charged to the consolidated
statement of comprehensive income in the year to which they relate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000869">&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_ztWswBxTLXVk" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zzXGSQgmbIK4"&gt;Provisions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Provisions are recognised when the Group has a present obligation (legal or constructive)
as a result of a past event; it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation
and a reliable estimate can be made of the amount of the obligation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000871">&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zixS5xUnCyV3" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_867_zSDxwK1Ntnv5"&gt;Share-based payments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group operates a number of equity-settled, share-based compensation plans, under
which the entity receives services from Directors and employees as consideration for equity instruments (options) of the Group. The fair
value of the Directors and employee services received in exchange for the grant of the options is recognised as an expense. The total
amount to be expensed is determined by reference to the fair value of the options granted:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;including any market performance conditions (including the share price);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;excluding the impact of any service and non-market performance vesting conditions (for example, remaining an employee of the entity
over a specified time period); and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;including the impact of any non-vesting conditions (for example, the requirement for employees to save).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Non-market performance and service conditions are included in assumptions about
the number of options that are expected to vest. The total expense is recognised over the vesting period, which is the period over which
all of the specified vesting conditions are to be satisfied. Where vesting conditions are accelerated on the occurrence of a specified
event, such as a change in control or initial public offering, such remaining unvested charge is accelerated to the income statement.&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;In addition, in some circumstances employees may provide services in advance of the
grant date and therefore the grant date fair value is estimated for the purposes of recognising the expense during the period between
service commencement period and grant date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;At the end of each reporting period, the Group revises its estimates of the number
of options that are expected to vest based on the non-market vesting conditions. It recognises the impact of the revision to original
estimates, if any, in the income statement, with a corresponding adjustment to equity. When the options are exercised, the Company issues
new shares. The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and
share premium.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group also issues warrants over ADSs to certain professional advisors in connection
with equity transactions that fall within the scope of IFRS2 and are accounted for as share based payments. The fair value of the services
received in exchange for the grant of the warrant is recognised as an expense of the equity transaction. The total expense is recognised
immediately.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000879">&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z2VcG96qvHqe" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86C_zzNMziugyCCe"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;Identifying Leases &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Group accounts for a contract, or a portion
of a contract, as a lease when it conveys the right to use an asset for a period of time in exchange for consideration. Leases are those
contracts that satisfy the following criteria: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;(a) There is an identified asset; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;(b) The Group obtains substantially all the economic
benefits from use of the asset; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;(c) The Group has the right to direct use of the
asset. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Group considers whether the supplier has substantive
substitution rights. If the supplier does have those rights, the contract is not identified as giving rise to a lease. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;In determining whether the Group obtains substantially
all the economic benefits from use of the asset, the Group considers only the economic benefits that arise from the use of the asset,
not those incidental to legal ownership or other potential benefits. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;In determining whether the Group has the right
to direct use of the asset, the Group considers whether it directs how and for what purpose the asset is used throughout the period of
use. If there are no significant decisions to be made because they are pre-determined due to the nature of the asset, the Group considers
whether it was involved in the design of the asset in a way that predetermines how and for what purpose the asset will be used throughout
the period of use. If the contract or portion of a contract does not satisfy these criteria, the Group applies other applicable IFRSs
rather than IFRS 16. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;All leases are accounted for by recognising a right-of-use
asset and a lease liability except for: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol; font-weight: normal"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-weight: normal"&gt;Leases of low value assets; and &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol; font-weight: normal"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-weight: normal"&gt;Leases with a duration of 12 months or less. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;Lease liabilities are measured at the present value
of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the group&#x2019;s
incremental borrowing rate on commencement of the lease. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;Right of use assets are initially measured at the
amount of the lease liability, reduced for any lease incentives received, and increased for lease payments made at or before commencement
of the lease. The Group has taken advantage of the practical expedient to ignore the requirement to separate non-lease components and
instead account for the entire contract as a single lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;Subsequent to initial measurement lease liabilities
increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Right-of-use
assets are amortised on a straight-line basis over the remaining term of the lease. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;When the group revises its estimate of the term
of any lease (because, for example, it re-assesses the probability of a lessee extension or termination option being exercised), it adjusts
the carrying amount of the lease liability to reflect the payments to make over the revised term, which are discounted using a revised
discount rate. An equivalent adjustment is made to the carrying value of the right-of-use asset, with the revised carrying amount being
amortised over the remaining (revised) lease term. If the carrying amount of the right-of-use asset is adjusted to zero, any further reduction
is recognised in profit or loss. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;Nature of leasing activities (in the capacity
as lessee) &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;As at 31 December 2025 the Group had one property
lease in place in the UK. &lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;





</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <bdrx:DescriptionOfAccountingPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000884">&lt;p id="xdx_848_ecustom--DescriptionOfAccountingPolicyTextBlock_zbii9uK6T78j" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_869_zhRtF1bUiymc"&gt;Taxation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;Tax is recognised in the Comprehensive Statement
of Income, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised
directly in equity is also recognised in other comprehensive income or directly in equity respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The current income tax credit is calculated on
the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the country where the Company
operates. Current tax includes credits for qualifying research and development expenditure under the UK&#x2019;s Merged R&amp;amp;D Expenditure
Credit scheme.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</bdrx:DescriptionOfAccountingPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000886">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory_zB5GFMAdy3Xe" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86A_zh1cXD3rhEt7"&gt;Deferred taxation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Deferred tax assets and liabilities are recognised where the carrying amount of an
asset or liability in the consolidated statement of financial position differs from its tax base, except for differences arising on:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the initial recognition of goodwill;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the initial recognition of an asset or liability in a transaction which is not a business combination and at the time&lt;br/&gt;
of the transaction affects neither accounting or taxable profit or loss; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;investments in subsidiaries and jointly controlled entities where the Group is able to control the timing of the reversal of the difference
and it is probable that the difference will not reverse in the foreseeable future.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Recognition of deferred tax assets is restricted to those instances where it is probable
that taxable profit will be available against which the difference can be utilised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The amount of the asset or liability is determined using tax rates that have been
enacted or substantively enacted by the reporting date and are expected to apply when the deferred tax assets or liabilities are recovered
or settled.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000888">&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zBhHSIoIs6J3" style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_86C_zZKXCWvvSkMg"&gt;Property, plant and equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Property, plant and equipment is stated at cost, net of accumulated depreciation
and accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Depreciation is provided on all items of property, plant and equipment so as to write
off their carrying value over their expected useful economic lives. It is provided at the following rates:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfDepreciationRatesOfPropertyPlantAndEquipmentTableExplanatory_pn3n3_z30182a1gMOh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Accounting policies (Details 3)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;span id="xdx_8B9_zMYoAfaFglIe" style="display: none"&gt;Schedule of depreciation rates of property, plant and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20%; color: #4D4D4C"&gt;Fixtures and fittings&lt;/td&gt;
    &lt;td style="width: 80%; color: #4D4D4C"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 20%- 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Leasehold improvements&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; the shorter of 10% per annum straight line or over the lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Computer equipment&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Laboratory equipment&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 15% &#x2013; 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Right of use asset&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--RightOfUseAssetMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; Economic life of contractual relationship&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zEJ3DDbTaLC8" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <bdrx:DisclosureOfDepreciationRatesOfPropertyPlantAndEquipmentTableExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000890">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfDepreciationRatesOfPropertyPlantAndEquipmentTableExplanatory_pn3n3_z30182a1gMOh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Accounting policies (Details 3)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;span id="xdx_8B9_zMYoAfaFglIe" style="display: none"&gt;Schedule of depreciation rates of property, plant and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20%; color: #4D4D4C"&gt;Fixtures and fittings&lt;/td&gt;
    &lt;td style="width: 80%; color: #4D4D4C"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 20%- 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Leasehold improvements&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; the shorter of 10% per annum straight line or over the lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Computer equipment&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Laboratory equipment&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; 15% &#x2013; 25% per annum straight line&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="color: #4D4D4C"&gt;Right of use asset&lt;/td&gt;
    &lt;td style="color: #4D4D4C"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--RightOfUseAssetMember" title="Description of useful life, property, plant and equipment"&gt;&#x2013; Economic life of contractual relationship&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfDepreciationRatesOfPropertyPlantAndEquipmentTableExplanatory>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember"
      id="Fact000892">&#x2013; 20%- 25% per annum straight line</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember"
      id="Fact000894">&#x2013; the shorter of 10% per annum straight line or over the lease term</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember"
      id="Fact000896">&#x2013; 25% per annum straight line</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_LaboratoryEquipmentMember"
      id="Fact000898">&#x2013; 15% &#x2013; 25% per annum straight line</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_RightOfUseAssetMember"
      id="Fact000900">&#x2013; Economic life of contractual relationship</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <bdrx:DisclosureOfCriticalAccountingEstimatesAndJudgements contextRef="From2025-01-01to2025-12-31" id="Fact000902">&lt;p id="xdx_80F_ecustom--DisclosureOfCriticalAccountingEstimatesAndJudgements_z3Hv3UzNVVzj" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;2&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_zkRWdnfOIerk"&gt;Critical accounting estimates and judgements&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The preparation of these consolidated financial statements requires the Group to
make estimates, assumptions and judgments that can have a significant impact on the reported amounts of assets and liabilities, revenue
and expenses and related disclosure of contingent assets and liabilities, at the respective dates of our financial statements. The Group
bases its estimates, assumptions and judgments on historical experience and various other factors that we believe to be reasonable under
the circumstances. Actual results may differ from these estimates under different assumptions or conditions. Management evaluates estimates,
assumptions and judgments on a regular basis and makes changes accordingly and discusses critical accounting estimates with the board
of Directors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The following are considered to be critical accounting estimates:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Impairment of intangible assets not yet ready for use&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Intangible assets not yet ready for use are tested for impairment at the cash generating
unit level on an annual basis at the year end and between annual tests if an event occurs or circumstances change that would more likely
than not reduce the fair value of a cash generating unit below its carrying value. Impairment indications include events causing significant
changes in any of the underlying assumptions used in valuing intangibles not ready for use. The key assumptions are the probability of
success, the discount factor, the timing of future revenue flows, market penetration and peak sales assumptions, and expenditure required
to complete development.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The fair value of each cash generating unit or asset is estimated using the income
approach, on a discounted cash flow methodology. This analysis requires significant judgments, including estimation of future cash flows,
which is dependent on internal forecasts, including for revenues and development costs, estimation of the long-term rate of growth for
the business, estimation of the useful life over which cash flows will occur and determination of our weighted-average cost of&#160;capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The carrying value of intangibles not yet ready for use was &#xa3;&lt;span id="xdx_90B_ecustom--CarryingValueOfIntangiblesNotYetReadyForUse_iI_pn3n3_dm_c20251231_zCp6UQbxTZWe" title="Carrying value of intangibles not yet ready for use"&gt;5.6&lt;/span&gt; million (2024:
&#xa3;&lt;span id="xdx_90A_ecustom--CarryingValueOfIntangiblesNotYetReadyForUse_iI_pn3n3_dm_c20241231_z6hhEtoHUdd1" title="Carrying value of intangibles not yet ready for use"&gt;5.6&lt;/span&gt; million; 2023: &#xa3;&lt;span id="xdx_904_ecustom--CarryingValueOfIntangiblesNotYetReadyForUse_iI_pn3n3_dm_c20231231_zvdMZFKfBlTj" title="Carrying value of intangibles not yet ready for use"&gt;2.9&lt;/span&gt; million) as at 31 December 2025 (note 11).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Management apply a further 20% sensitivity to the probability of success, this resulted
in the following change in the fair value of the asset:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfFairValueOfPlanAssetsExplanatory_pn3n3_zhG6X13ESyzi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Critical accounting estimates and judgements (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zVkTD7lTpGH2" style="display: none"&gt;Schedule of fair value of the asset&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;% change in fair value&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;MTX228 tolimidone acquired IPRD*&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--PercentageChangeInFairValue_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zapPGdhrIApg" title="% change in fair value"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--PercentageChangeInFairValue_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zZJtIFumdp1c" title="% change in fair value"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--PercentageChangeInFairValue_pid_dp_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zPPo7nATNe62" title="% change in fair value"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;MTX230 eRapa acquired IPRD*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--PercentageChangeInFairValue_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____z2d1sNFnar48" title="% change in fair value"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--PercentageChangeInFairValue_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____zcRq2GPvEzI2" title="% change in fair value"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Share-based payments&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group accounts for share-based payment transactions
for Directors and employees in accordance with IFRS 2 Share-based Payment, which requires the measurement of the cost of Director and
employee services received in exchange for the options on our ordinary shares, based on the fair value of the award on the grant date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Directors selected the Black-Scholes-Merton option
pricing model as the most appropriate method for determining the estimated fair value of our share-based awards without market conditions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The resulting cost of an equity incentive award is
recognised as an expense over the requisite service period of the award, which is usually the vesting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The assumptions used for estimating fair value for
share-based payment transactions are disclosed in note 25 to our consolidated financial
statements and are estimated as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;volatility is estimated based on the average annualised volatility of a number of publicly traded peer companies in the biotech sector;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the estimated life of the option is estimated to be until the first exercise period, which is typically the month after the option
vests; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the dividend return is estimated by reference to our historical dividend payments. Currently, this is estimated to be zero as no dividend
has been paid in the prior periods.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;









&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;&lt;i&gt;Fair value through profit and
loss (&#x2018;FVTPL&#x2019;)&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group has outstanding warrants in the ordinary
share capital of the Company. The number of ordinary shares to be issued when exercised is fixed, however the exercise price is denominated
in US Dollars being different to the functional currency of the parent company. Therefore, the warrants are classified as equity settled
derivative financial liabilities recognised at fair value through the profit and loss account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The financial liability is valued using the either
the Monte Carlo model or the Black-Scholes option pricing model. Financial liabilities at FVTPL are stated at fair value, with any gains
or losses arising on re-measurement recognised in profit or loss. The net gain or loss recognised in profit or loss incorporates any interest
paid on the financial liability and is included in the &#x2018;finance income&#x2019; or &#x2018;finance expense&#x2019; lines item in the
income statement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The assumptions used for estimating fair value for
warrants transactions as disclosed in note 19 to our consolidated financial statements and are estimated as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;volatility is estimated based on the average annualised volatility of a number of publicly traded peer companies in the biotech sector;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the dilutive impact of the exercise of the warrants; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;the dividend return is estimated by reference to our historical dividend payments. Currently, this is estimated to be zero as no dividend
has been paid in the prior periods.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The following are
considered to be critical accounting judgments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Income taxes&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Deferred tax assets are recognised for unused tax
losses to the extent that it is probable that taxable profit will be available against which the losses can be utilised. Judgment is required
to determine the amount of deferred tax assets that can be recognised based upon the likely timing and the level of future taxable profits
together with future tax planning strategies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;In 2025, there were approximately &#xa3;&lt;span id="xdx_902_ecustom--UnutilisedTaxLosses_iI_pn3n3_dm_c20251231_zXVsJUOJeHQl" title="Unutilised tax losses"&gt;82.2&lt;/span&gt; million
of gross unutilised tax losses carried forward (2024: &#xa3;&lt;span id="xdx_90C_ecustom--UnutilisedTaxLosses_iI_pn3n3_dm_c20241231_ztAImyObN106" title="Unutilised tax losses"&gt;79.7&lt;/span&gt; million; 2023: &#xa3;&lt;span id="xdx_90F_ecustom--UnutilisedTaxLosses_iI_pn3n3_dm_c20231231_zH7z4PmguPN6" title="Unutilised tax losses"&gt;75.5&lt;/span&gt; million). No deferred tax asset has been
provided in respect of these losses as there was insufficient evidence to support their recoverability in future periods. The losses do
not have an expiry date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;b&gt;Going Concern &#x2013; material uncertainty&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The director&#x2019;s considerations and judgement
on going concern are set out in note 1.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</bdrx:DisclosureOfCriticalAccountingEstimatesAndJudgements>
    <bdrx:CarryingValueOfIntangiblesNotYetReadyForUse
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000904"
      unitRef="GBP">5600000</bdrx:CarryingValueOfIntangiblesNotYetReadyForUse>
    <bdrx:CarryingValueOfIntangiblesNotYetReadyForUse
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000906"
      unitRef="GBP">5600000</bdrx:CarryingValueOfIntangiblesNotYetReadyForUse>
    <bdrx:CarryingValueOfIntangiblesNotYetReadyForUse
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000908"
      unitRef="GBP">2900000</bdrx:CarryingValueOfIntangiblesNotYetReadyForUse>
    <ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000910">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfFairValueOfPlanAssetsExplanatory_pn3n3_zhG6X13ESyzi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Critical accounting estimates and judgements (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zVkTD7lTpGH2" style="display: none"&gt;Schedule of fair value of the asset&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;% change in fair value&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;MTX228 tolimidone acquired IPRD*&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--PercentageChangeInFairValue_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zapPGdhrIApg" title="% change in fair value"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--PercentageChangeInFairValue_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zZJtIFumdp1c" title="% change in fair value"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--PercentageChangeInFairValue_pid_dp_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zPPo7nATNe62" title="% change in fair value"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;MTX230 eRapa acquired IPRD*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--PercentageChangeInFairValue_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____z2d1sNFnar48" title="% change in fair value"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--PercentageChangeInFairValue_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____zcRq2GPvEzI2" title="% change in fair value"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory>
    <bdrx:PercentageChangeInFairValue
      contextRef="From2025-01-012025-12-31_custom_MTX228TolimidoneAcquiredIPRDMember"
      decimals="INF"
      id="Fact000912"
      unitRef="Pure">0.40</bdrx:PercentageChangeInFairValue>
    <bdrx:PercentageChangeInFairValue
      contextRef="From2024-01-012024-12-31_custom_MTX228TolimidoneAcquiredIPRDMember"
      decimals="INF"
      id="Fact000914"
      unitRef="Pure">0.41</bdrx:PercentageChangeInFairValue>
    <bdrx:PercentageChangeInFairValue
      contextRef="From2023-01-012023-12-31_custom_MTX228TolimidoneAcquiredIPRDMember"
      decimals="INF"
      id="Fact000916"
      unitRef="Pure">0.18</bdrx:PercentageChangeInFairValue>
    <bdrx:PercentageChangeInFairValue
      contextRef="From2025-01-012025-12-31_custom_MTX230ERapaacquiredIPRDMember"
      decimals="INF"
      id="Fact000918"
      unitRef="Pure">0.20</bdrx:PercentageChangeInFairValue>
    <bdrx:PercentageChangeInFairValue
      contextRef="From2024-01-012024-12-31_custom_MTX230ERapaacquiredIPRDMember"
      decimals="INF"
      id="Fact000920"
      unitRef="Pure">0.19</bdrx:PercentageChangeInFairValue>
    <bdrx:UnutilisedTaxLosses
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000925"
      unitRef="GBP">82200000</bdrx:UnutilisedTaxLosses>
    <bdrx:UnutilisedTaxLosses
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000927"
      unitRef="GBP">79700000</bdrx:UnutilisedTaxLosses>
    <bdrx:UnutilisedTaxLosses
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000929"
      unitRef="GBP">75500000</bdrx:UnutilisedTaxLosses>
    <ifrs-full:DisclosureOfRevenueExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000931">&lt;p id="xdx_80F_eifrs-full--DisclosureOfRevenueExplanatory_z15SsHmUOxa" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;3&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_823_zZIWftsVAnQb"&gt;Revenue&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Revenue from contracts with customers&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Geographical analysis of revenue by destination
of customer&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eifrs-full--DisclosureOfGeographicalAreasExplanatory_pn3n3_zPjq9jprJLda" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_znumrU2iQGM1" style="display: none"&gt;Schedule of revenue by geographical analysis&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Revenue:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%"&gt;Belgium&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--SalesRevenue_pn3n3_c20250101__20251231__ifrs-full--GeographicalAreasAxis__custom--BelgiumMember_z34rqtQxMqvj" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SalesRevenue_pn3n3_c20240101__20241231__ifrs-full--GeographicalAreasAxis__custom--BelgiumMember_zkP4NA7GhVf8" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0937"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SalesRevenue_pn3n3_c20230101__20231231__ifrs-full--GeographicalAreasAxis__custom--BelgiumMember_zrVEPOtf46P5" title="Revenue"&gt;381&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_ecustom--SalesRevenue_pn3n3_c20250101__20251231_zq4QVBt90C0f" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0941"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SalesRevenue_pn3n3_c20240101__20241231_zF4pRcuzaQYc" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0943"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SalesRevenue_pn3n3_c20230101__20231231_zvlIm5G5nb23" title="Revenue"&gt;381&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zzk3G7HDV59h" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;All revenue came from the sale of services in 2023.
It is derived entirely from the Group&#x2019;s R&amp;amp;D collaboration agreements. It is recognised over the contract term proportionate
to the progress in overall satisfaction of the performance obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--PerformanceObligationsTableTextBlock_pn3n3_z4bVf43oq4vd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Revenue (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zct0ybpCq01d" style="display: none"&gt;Schedule of performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: center"&gt;Contractual Assets&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: center"&gt;Contractual Liabilities&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; font-weight: bold"&gt;At 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ContractAssets_iS_pn3n3_c20250101__20251231_z4pIZQs4hg75" title="Contractual assets, beginning"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ContractAssets_iS_pn3n3_c20240101__20241231_zgQiqkwUnXu2" title="Contractual assets, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ContractAssets_iS_pn3n3_c20230101__20231231_ziDAjy2UInT1" title="Contractual assets, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0953"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ContractLiabilities_iS_pn3n3_c20250101__20251231_zv5kthVB1285" title="Contractual liabilities, beginning"&gt;(1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--ContractLiabilities_iS_pn3n3_c20240101__20241231_zBgiuDtc6gAj" title="Contractual liabilities, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ContractLiabilities_iS_pn3n3_c20230101__20231231_zzbAgeE4bWQi" title="Contractual liabilities, beginning"&gt;(197&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Transfers in the period from contract assets to trade receivables&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--TransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20250101__20251231_zHlcoMZlT6Xc" title="Contractual assets, Transfers in the period from contract assets to trade receivables"&gt;(47&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--TransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20240101__20241231_zT8pwc2kpm9k" title="Contractual assets, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--TransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20230101__20231231_z3fF4wxPFrl8" title="Contractual assets, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0965"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20250101__20251231_zVG0lPbAaDx1" title="Contractual liabilities, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0967"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20240101__20241231_zZZbLMQ5IAb1" title="Contractual liabilities, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20230101__20231231_zmtXPTAlgNk7" title="Contractual liabilities, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0971"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Amounts included in contract liabilities that was recognised as revenue during the period&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20250101__20251231_zVfQDu5kLr1g" title="Contractual assets, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0973"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20240101__20241231_zIfg8xUmqYP" title="Contractual assets, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0975"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20230101__20231231_zZ2f7IFrJVig" title="Contractual assets, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20250101__20251231_zMQ7fSMtZ3xb" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0979"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20240101__20241231_z5wwYUO0d588" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0981"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20230101__20231231_zHWM6ZNgTin5" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20250101__20251231_zDQ9LYQ8g2Qg" title="Contractual assets, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0985"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20240101__20241231_zBD9edlj2Zjk" title="Contractual assets, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0987"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20230101__20231231_zxM8iEOcj1sg" title="Contractual assets, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0989"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20250101__20251231_zwmxoTUO3c47" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;4,458&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20240101__20241231_zIjI5AV1MxNk" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0993"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20230101__20231231_z5a1cUvVMKel" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Excess of revenue recognised over cash&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ExcessOfRevenueRecognisedOverCash_pn3n3_c20250101__20251231_zzRk2KJAsdJ1" title="Contractual assets, Excess of revenue recognised over cash"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExcessOfRevenueRecognisedOverCash_pn3n3_c20240101__20241231_zPutQ3DqD0Fc" title="Contractual assets, Excess of revenue recognised over cash"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ExcessOfRevenueRecognisedOverCash_pn3n3_c20230101__20231231_znNhZN3IbHjk" title="Contractual assets, Excess of revenue recognised over cash"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1001"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ContractualLiabilitiesExcessOfRevenueRecognisedOverCash_pn3n3_c20250101__20251231_zd5pgOHMIRi8" title="Contractual liabilities, Excess of revenue recognised over cash"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1003"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ContractualLiabilitiesExcessOfRevenueRecognisedOverCash_pn3n3_c20240101__20241231_zLAc2u0MKWo8" title="Contractual liabilities, Excess of revenue recognised over cash"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1005"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ContractualLiabilitiesExcessOfRevenueRecognisedOverCash_pn3n3_c20230101__20231231_zIPZsjbDO2pg" title="Contractual liabilities, Excess of revenue recognised over cash"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1007"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash received in advance of performance and not recognised as revenue during the period&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20250101__20251231_zHODXiTBX6Gb" title="Contractual assets, Cash received in advance of performance and not recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1009"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20240101__20241231_zCBrgP08WdYi" title="Contractual assets, Cash received in advance of performance and not recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1011"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20230101__20231231_zB4cSEP0RzZ8" title="Contractual assets, Cash received in advance of performance and not recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1013"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20250101__20251231_znqbkHkyjZr7" title="Contractual liabilities, Cash received in advance of performance and not recognised as revenue during the period"&gt;(3,645&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20240101__20241231_zoEd1FBNR9pe" title="Contractual liabilities, Cash received in advance of performance and not recognised as revenue during the period"&gt;(1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20230101__20231231_zFoMSIcA6EQi" title="Contractual liabilities, Cash received in advance of performance and not recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1019"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ContractualAssetsForeignExchange_pn3n3_c20250101__20251231_zJ8fpiOqqZ7h" title="Contractual assets, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1021"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ContractualAssetsForeignExchange_pn3n3_c20240101__20241231_zZW3Ci0i0eP4" title="Contractual assets, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1023"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ContractualAssetsForeignExchange_pn3n3_c20230101__20231231_zDFDyyPOQ66g" title="Contractual assets, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ContractualLiabilitiesForeignExchange_pn3n3_c20250101__20251231_zTIHqCwYsoX5" title="Contractual liabilities, Foreign exchange"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ContractualLiabilitiesForeignExchange_pn3n3_c20240101__20241231_zJrRdHZDKzf5" title="Contractual liabilities, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1029"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ContractualLiabilitiesForeignExchange_pn3n3_c20230101__20231231_zIHEEGtRwvF7" title="Contractual liabilities, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1031"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ContractAssets_iE_pn3n3_c20250101__20251231_z9kUQ3K3aRXe" title="Contractual assets, ending"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ContractAssets_iE_pn3n3_c20241231_z82tMJ0rRKB4" title="Contractual assets, ending"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ContractAssets_iE_pn3n3_c20230101__20231231_zsiMR6K85hWj" title="Contractual assets, ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1037"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ContractLiabilities_iE_pn3n3_c20250101__20251231_zy7GOXXmSIQf" title="Contractual liabilities, ending"&gt;(571&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ContractLiabilities_iE_pn3n3_c20240101__20241231_zPY0ByneU1zi" title="Contractual liabilities, ending"&gt;(1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ContractLiabilities_iE_pn3n3_c20230101__20231231_zdFygGJe42Y6" title="Contractual liabilities, ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1043"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zIzGWGEhghh5" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group&#x2019;s R&amp;amp;D collaboration agreements
are the delivery of services within the next 12 months for which the practical expedient in paragraph 121 (a) of IFRS15 applies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;In 2025, no revenue from customers (2024: no revenue;
2023: 1 customer).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfCommercialSegmentsTableTextBlock_pn3n3_zSrSKyMV7Zni" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Revenue (Details 2)"&gt;
  &lt;tr style="color: White; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; text-align: left"&gt;&lt;span id="xdx_8B1_zkft3h69k7he" style="display: none"&gt;Schedule of commercial segment&lt;/span&gt;&lt;/td&gt;&lt;td style="color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: White; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: White; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: White; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: White; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: White; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Customer A&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20230101__20231231__ifrs-full--MajorCustomersAxis__custom--CustomersAMember_zXdE2PiT6yqc" title="Percentage of revenue in excess of 10%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zGcYWdg4XIrj" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group contains one reportable operating segment,
Pipeline Research and Development (&#x2018;Pipeline R&amp;amp;D&#x2019;). This segment seeks to develop products using the Group&#x2019;s nanomedicine
and sustained release technology platforms. All the reconciliations required for segmental reporting can be found in the primary statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The accounting policies of the reportable segments
are consistent with the Group&#x2019;s accounting policies described in note 1.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfRevenueExplanatory>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000933">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eifrs-full--DisclosureOfGeographicalAreasExplanatory_pn3n3_zPjq9jprJLda" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_znumrU2iQGM1" style="display: none"&gt;Schedule of revenue by geographical analysis&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Revenue:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%"&gt;Belgium&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--SalesRevenue_pn3n3_c20250101__20251231__ifrs-full--GeographicalAreasAxis__custom--BelgiumMember_z34rqtQxMqvj" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SalesRevenue_pn3n3_c20240101__20241231__ifrs-full--GeographicalAreasAxis__custom--BelgiumMember_zkP4NA7GhVf8" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0937"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SalesRevenue_pn3n3_c20230101__20231231__ifrs-full--GeographicalAreasAxis__custom--BelgiumMember_zrVEPOtf46P5" title="Revenue"&gt;381&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_ecustom--SalesRevenue_pn3n3_c20250101__20251231_zq4QVBt90C0f" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0941"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SalesRevenue_pn3n3_c20240101__20241231_zF4pRcuzaQYc" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0943"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SalesRevenue_pn3n3_c20230101__20231231_zvlIm5G5nb23" title="Revenue"&gt;381&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <bdrx:SalesRevenue
      contextRef="From2023-01-012023-12-31_custom_BelgiumMember"
      decimals="-3"
      id="Fact000939"
      unitRef="GBP">381000</bdrx:SalesRevenue>
    <bdrx:SalesRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000945"
      unitRef="GBP">381000</bdrx:SalesRevenue>
    <bdrx:PerformanceObligationsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000947">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--PerformanceObligationsTableTextBlock_pn3n3_z4bVf43oq4vd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Revenue (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zct0ybpCq01d" style="display: none"&gt;Schedule of performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: center"&gt;Contractual Assets&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: center"&gt;Contractual Liabilities&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; font-weight: bold"&gt;At 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ContractAssets_iS_pn3n3_c20250101__20251231_z4pIZQs4hg75" title="Contractual assets, beginning"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ContractAssets_iS_pn3n3_c20240101__20241231_zgQiqkwUnXu2" title="Contractual assets, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ContractAssets_iS_pn3n3_c20230101__20231231_ziDAjy2UInT1" title="Contractual assets, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0953"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ContractLiabilities_iS_pn3n3_c20250101__20251231_zv5kthVB1285" title="Contractual liabilities, beginning"&gt;(1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--ContractLiabilities_iS_pn3n3_c20240101__20241231_zBgiuDtc6gAj" title="Contractual liabilities, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ContractLiabilities_iS_pn3n3_c20230101__20231231_zzbAgeE4bWQi" title="Contractual liabilities, beginning"&gt;(197&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Transfers in the period from contract assets to trade receivables&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--TransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20250101__20251231_zHlcoMZlT6Xc" title="Contractual assets, Transfers in the period from contract assets to trade receivables"&gt;(47&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--TransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20240101__20241231_zT8pwc2kpm9k" title="Contractual assets, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--TransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20230101__20231231_z3fF4wxPFrl8" title="Contractual assets, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0965"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20250101__20251231_zVG0lPbAaDx1" title="Contractual liabilities, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0967"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20240101__20241231_zZZbLMQ5IAb1" title="Contractual liabilities, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ContractualLiabilitiesTransfersInPeriodFromContractAssetsToTradeReceivables_pn3n3_c20230101__20231231_zmtXPTAlgNk7" title="Contractual liabilities, Transfers in the period from contract assets to trade receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0971"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Amounts included in contract liabilities that was recognised as revenue during the period&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20250101__20251231_zVfQDu5kLr1g" title="Contractual assets, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0973"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20240101__20241231_zIfg8xUmqYP" title="Contractual assets, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0975"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20230101__20231231_zZ2f7IFrJVig" title="Contractual assets, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20250101__20251231_zMQ7fSMtZ3xb" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0979"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20240101__20241231_z5wwYUO0d588" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0981"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod_pn3n3_c20230101__20231231_zHWM6ZNgTin5" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as revenue during the period"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20250101__20251231_zDQ9LYQ8g2Qg" title="Contractual assets, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0985"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20240101__20241231_zBD9edlj2Zjk" title="Contractual assets, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0987"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ContractualAssetsAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20230101__20231231_zxM8iEOcj1sg" title="Contractual assets, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0989"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20250101__20251231_zwmxoTUO3c47" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;4,458&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20240101__20241231_zIjI5AV1MxNk" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0993"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod_pn3n3_c20230101__20231231_z5a1cUvVMKel" title="Contractual liabilities, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Excess of revenue recognised over cash&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ExcessOfRevenueRecognisedOverCash_pn3n3_c20250101__20251231_zzRk2KJAsdJ1" title="Contractual assets, Excess of revenue recognised over cash"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExcessOfRevenueRecognisedOverCash_pn3n3_c20240101__20241231_zPutQ3DqD0Fc" title="Contractual assets, Excess of revenue recognised over cash"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ExcessOfRevenueRecognisedOverCash_pn3n3_c20230101__20231231_znNhZN3IbHjk" title="Contractual assets, Excess of revenue recognised over cash"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1001"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ContractualLiabilitiesExcessOfRevenueRecognisedOverCash_pn3n3_c20250101__20251231_zd5pgOHMIRi8" title="Contractual liabilities, Excess of revenue recognised over cash"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1003"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ContractualLiabilitiesExcessOfRevenueRecognisedOverCash_pn3n3_c20240101__20241231_zLAc2u0MKWo8" title="Contractual liabilities, Excess of revenue recognised over cash"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1005"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ContractualLiabilitiesExcessOfRevenueRecognisedOverCash_pn3n3_c20230101__20231231_zIPZsjbDO2pg" title="Contractual liabilities, Excess of revenue recognised over cash"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1007"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash received in advance of performance and not recognised as revenue during the period&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20250101__20251231_zHODXiTBX6Gb" title="Contractual assets, Cash received in advance of performance and not recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1009"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20240101__20241231_zCBrgP08WdYi" title="Contractual assets, Cash received in advance of performance and not recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1011"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--CashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20230101__20231231_zB4cSEP0RzZ8" title="Contractual assets, Cash received in advance of performance and not recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1013"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20250101__20251231_znqbkHkyjZr7" title="Contractual liabilities, Cash received in advance of performance and not recognised as revenue during the period"&gt;(3,645&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20240101__20241231_zoEd1FBNR9pe" title="Contractual liabilities, Cash received in advance of performance and not recognised as revenue during the period"&gt;(1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod_pn3n3_c20230101__20231231_zFoMSIcA6EQi" title="Contractual liabilities, Cash received in advance of performance and not recognised as revenue during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1019"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ContractualAssetsForeignExchange_pn3n3_c20250101__20251231_zJ8fpiOqqZ7h" title="Contractual assets, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1021"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ContractualAssetsForeignExchange_pn3n3_c20240101__20241231_zZW3Ci0i0eP4" title="Contractual assets, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1023"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ContractualAssetsForeignExchange_pn3n3_c20230101__20231231_zDFDyyPOQ66g" title="Contractual assets, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ContractualLiabilitiesForeignExchange_pn3n3_c20250101__20251231_zTIHqCwYsoX5" title="Contractual liabilities, Foreign exchange"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ContractualLiabilitiesForeignExchange_pn3n3_c20240101__20241231_zJrRdHZDKzf5" title="Contractual liabilities, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1029"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ContractualLiabilitiesForeignExchange_pn3n3_c20230101__20231231_zIHEEGtRwvF7" title="Contractual liabilities, Foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1031"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ContractAssets_iE_pn3n3_c20250101__20251231_z9kUQ3K3aRXe" title="Contractual assets, ending"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ContractAssets_iE_pn3n3_c20241231_z82tMJ0rRKB4" title="Contractual assets, ending"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ContractAssets_iE_pn3n3_c20230101__20231231_zsiMR6K85hWj" title="Contractual assets, ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1037"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ContractLiabilities_iE_pn3n3_c20250101__20251231_zy7GOXXmSIQf" title="Contractual liabilities, ending"&gt;(571&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ContractLiabilities_iE_pn3n3_c20240101__20241231_zPY0ByneU1zi" title="Contractual liabilities, ending"&gt;(1,468&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ContractLiabilities_iE_pn3n3_c20230101__20231231_zdFygGJe42Y6" title="Contractual liabilities, ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1043"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:PerformanceObligationsTableTextBlock>
    <ifrs-full:ContractAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000949"
      unitRef="GBP">47000</ifrs-full:ContractAssets>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000955"
      unitRef="GBP">-1468000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000959"
      unitRef="GBP">-197000</ifrs-full:ContractLiabilities>
    <bdrx:TransfersInPeriodFromContractAssetsToTradeReceivables
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000961"
      unitRef="GBP">-47000</bdrx:TransfersInPeriodFromContractAssetsToTradeReceivables>
    <bdrx:ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000983"
      unitRef="GBP">197000</bdrx:ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsRevenueDuringPeriod>
    <bdrx:ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000991"
      unitRef="GBP">4458000</bdrx:ContractualLiabilitiesAmountsIncludedInContractLiabilitiesThatWasRecognisedAsGrantIncomeAndNettedAgainstRelevantExpensesInPeriod>
    <bdrx:ExcessOfRevenueRecognisedOverCash
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000997"
      unitRef="GBP">39000</bdrx:ExcessOfRevenueRecognisedOverCash>
    <bdrx:ExcessOfRevenueRecognisedOverCash
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000999"
      unitRef="GBP">47000</bdrx:ExcessOfRevenueRecognisedOverCash>
    <bdrx:ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001015"
      unitRef="GBP">-3645000</bdrx:ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod>
    <bdrx:ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001017"
      unitRef="GBP">-1468000</bdrx:ContractualLiabilitiesCashReceivedInAdvanceOfPerformanceAndNotRecognisedAsRevenueDuringPeriod>
    <bdrx:ContractualLiabilitiesForeignExchange
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001027"
      unitRef="GBP">85000</bdrx:ContractualLiabilitiesForeignExchange>
    <ifrs-full:ContractAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001033"
      unitRef="GBP">39000</ifrs-full:ContractAssets>
    <ifrs-full:ContractAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001035"
      unitRef="GBP">47000</ifrs-full:ContractAssets>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001039"
      unitRef="GBP">-571000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001041"
      unitRef="GBP">-1468000</ifrs-full:ContractLiabilities>
    <bdrx:ScheduleOfCommercialSegmentsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001045">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfCommercialSegmentsTableTextBlock_pn3n3_zSrSKyMV7Zni" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Revenue (Details 2)"&gt;
  &lt;tr style="color: White; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; text-align: left"&gt;&lt;span id="xdx_8B1_zkft3h69k7he" style="display: none"&gt;Schedule of commercial segment&lt;/span&gt;&lt;/td&gt;&lt;td style="color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: White; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: White; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: White; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: White; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: White; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Customer A&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20230101__20231231__ifrs-full--MajorCustomersAxis__custom--CustomersAMember_zXdE2PiT6yqc" title="Percentage of revenue in excess of 10%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:ScheduleOfCommercialSegmentsTableTextBlock>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2023-01-012023-12-31_custom_CustomersAMember"
      decimals="INF"
      id="Fact001047"
      unitRef="Pure">1</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001049">&lt;p id="xdx_80C_eifrs-full--DisclosureOfProfitLossFromOperatingActivitiesExplanatory_zxFDd78p1gta" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;4&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_827_z9gxGZgBKZtf"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfScheduleProfitLossFromOperatingActivitiesExplanatory_pn3n3_zTCHd4gW7a1l" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss from operations (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_zoaWpj81O19h" style="display: none"&gt;Schedule of loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20250101__20251231_zx6mSiTJAghi" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20240101__20241231_z3f2OgHnB3wj" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20230101__20231231_zfvcsqwv2uVb" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Note&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Loss from operations is stated after charging/(crediting):&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left"&gt;- Research and development costs&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zFEcqSxPHFLg" title="Depreciation of property, plant and equipment"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zCxP39YCZ8fd" title="Depreciation of property, plant and equipment"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_za7McokW9Pic" title="Depreciation of property, plant and equipment"&gt;135&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;- Administrative costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zu0iTpma8obc" title="Depreciation of property, plant and equipment"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zKbOM7GOmXul" title="Depreciation of property, plant and equipment"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zdsd1dqDqGIk" title="Depreciation of property, plant and equipment"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation of right of use asset&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;- Research and development costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zz8U1kFPll6d" title="Depreciation of right of use asset"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zLaUWewSlSPk" title="Depreciation of right of use asset"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_z53rsKVx9hrb" title="Depreciation of right of use asset"&gt;113&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;- Administrative costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_z5CEAmL8GlYb" title="Depreciation of right of use asset"&gt;34&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zkwfNnZPCFKe" title="Depreciation of right of use asset"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zREzrBOEA2Sa" title="Depreciation of right of use asset"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortisation of intangible assets &#x2013; software&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;- Research and development costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;11&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zl3wXsE6IZz2" title="Amortisation of intangible assets - software"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zxXboqhPuzk7" title="Amortisation of intangible assets - software"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_z8hkG4pIjzd3" title="Amortisation of intangible assets - software"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;- Administrative costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;11&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_ztHgOzlwdd13" title="Amortisation of intangible assets - software"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1083"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_z7J4wj6juVC2" title="Amortisation of intangible assets - software"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_ztXQ4NcM5mkj" title="Amortisation of intangible assets - software"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1087"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ImpairmentOfFinancialAsset_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Impairment of financial asset&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;13&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1089"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1090"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;79&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ImpairmentOfCommissionPaidInAdvance_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Impairment of commission paid in advance on ELOC&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;373&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1094"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1095"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProvisionAgainstFutureLossOnLoanAgreement_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Provision against future loss on loan agreement&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;18&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1098"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--FeeAndCommissionIncomeExpense_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fees payable to the Company&#x2019;s auditor for the audit of the parent Company financial statements&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;80&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;90&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;127&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--FeeAndCommissionIncomeExpense1_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fees payable to the Company&#x2019;s auditor for the audits of the subsidiary financial statements&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;60&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;60&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;58&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fees payable to the Company&#x2019;s auditor for:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FeePayableOtherServices_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;- Audit related services&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;35&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1110"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;131&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fees payable to the Company&#x2019;s previous auditor for:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--FeePayableOtherServices1_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;-&#160;&#160;Audit&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;16&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;21&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FeesPayableToCompanysPreviousAuditorForAudit_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;-&#160;&#160;Audit related services&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;69&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;110&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;32&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AdjustmentsForUnrealisedForeignExchangeLossesGains_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign exchange (gain)/loss&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;343&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(93&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;164&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment1_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loss on disposal of property, plant and equipment&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;29&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;4&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;2&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdjustmentsForSharebasedPayments_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Equity settled share-based payment &#x2013; employee schemes&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;170&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;283&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory>
    <bdrx:DisclosureOfScheduleProfitLossFromOperatingActivitiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001051">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfScheduleProfitLossFromOperatingActivitiesExplanatory_pn3n3_zTCHd4gW7a1l" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss from operations (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_zoaWpj81O19h" style="display: none"&gt;Schedule of loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20250101__20251231_zx6mSiTJAghi" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20240101__20241231_z3f2OgHnB3wj" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20230101__20231231_zfvcsqwv2uVb" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Note&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Loss from operations is stated after charging/(crediting):&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left"&gt;- Research and development costs&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zFEcqSxPHFLg" title="Depreciation of property, plant and equipment"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zCxP39YCZ8fd" title="Depreciation of property, plant and equipment"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_za7McokW9Pic" title="Depreciation of property, plant and equipment"&gt;135&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;- Administrative costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zu0iTpma8obc" title="Depreciation of property, plant and equipment"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zKbOM7GOmXul" title="Depreciation of property, plant and equipment"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--DepreciationOfPropertyPlantAndEquipment_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zdsd1dqDqGIk" title="Depreciation of property, plant and equipment"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation of right of use asset&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;- Research and development costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zz8U1kFPll6d" title="Depreciation of right of use asset"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zLaUWewSlSPk" title="Depreciation of right of use asset"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_z53rsKVx9hrb" title="Depreciation of right of use asset"&gt;113&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;- Administrative costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_z5CEAmL8GlYb" title="Depreciation of right of use asset"&gt;34&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zkwfNnZPCFKe" title="Depreciation of right of use asset"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--DepreciationOfRightOfUseAsset_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_zREzrBOEA2Sa" title="Depreciation of right of use asset"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortisation of intangible assets &#x2013; software&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;- Research and development costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;11&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zl3wXsE6IZz2" title="Amortisation of intangible assets - software"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_zxXboqhPuzk7" title="Amortisation of intangible assets - software"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_z8hkG4pIjzd3" title="Amortisation of intangible assets - software"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;- Administrative costs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;11&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_ztHgOzlwdd13" title="Amortisation of intangible assets - software"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1083"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_z7J4wj6juVC2" title="Amortisation of intangible assets - software"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AmortisationOfIntangibleAssetsSoftware_pn3n3_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--AdministrativeCostsMember_ztXQ4NcM5mkj" title="Amortisation of intangible assets - software"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1087"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ImpairmentOfFinancialAsset_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Impairment of financial asset&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;13&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1089"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1090"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;79&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ImpairmentOfCommissionPaidInAdvance_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Impairment of commission paid in advance on ELOC&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;373&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1094"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1095"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProvisionAgainstFutureLossOnLoanAgreement_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Provision against future loss on loan agreement&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;18&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1098"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--FeeAndCommissionIncomeExpense_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fees payable to the Company&#x2019;s auditor for the audit of the parent Company financial statements&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;80&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;90&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;127&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--FeeAndCommissionIncomeExpense1_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fees payable to the Company&#x2019;s auditor for the audits of the subsidiary financial statements&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;60&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;60&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;58&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fees payable to the Company&#x2019;s auditor for:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FeePayableOtherServices_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;- Audit related services&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;35&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1110"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;131&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fees payable to the Company&#x2019;s previous auditor for:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--FeePayableOtherServices1_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;-&#160;&#160;Audit&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;16&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;21&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FeesPayableToCompanysPreviousAuditorForAudit_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;-&#160;&#160;Audit related services&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;69&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;110&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;32&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AdjustmentsForUnrealisedForeignExchangeLossesGains_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign exchange (gain)/loss&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;343&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(93&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;164&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment1_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loss on disposal of property, plant and equipment&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;29&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;4&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;2&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdjustmentsForSharebasedPayments_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Equity settled share-based payment &#x2013; employee schemes&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;170&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;283&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:DisclosureOfScheduleProfitLossFromOperatingActivitiesExplanatory>
    <bdrx:DepreciationOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001053"
      unitRef="GBP">44000</bdrx:DepreciationOfPropertyPlantAndEquipment>
    <bdrx:DepreciationOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001055"
      unitRef="GBP">110000</bdrx:DepreciationOfPropertyPlantAndEquipment>
    <bdrx:DepreciationOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001057"
      unitRef="GBP">135000</bdrx:DepreciationOfPropertyPlantAndEquipment>
    <bdrx:DepreciationOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_AdministrativeCostsMember"
      decimals="-3"
      id="Fact001059"
      unitRef="GBP">8000</bdrx:DepreciationOfPropertyPlantAndEquipment>
    <bdrx:DepreciationOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_AdministrativeCostsMember"
      decimals="-3"
      id="Fact001061"
      unitRef="GBP">7000</bdrx:DepreciationOfPropertyPlantAndEquipment>
    <bdrx:DepreciationOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_AdministrativeCostsMember"
      decimals="-3"
      id="Fact001063"
      unitRef="GBP">8000</bdrx:DepreciationOfPropertyPlantAndEquipment>
    <bdrx:DepreciationOfRightOfUseAsset
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001065"
      unitRef="GBP">102000</bdrx:DepreciationOfRightOfUseAsset>
    <bdrx:DepreciationOfRightOfUseAsset
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001067"
      unitRef="GBP">99000</bdrx:DepreciationOfRightOfUseAsset>
    <bdrx:DepreciationOfRightOfUseAsset
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001069"
      unitRef="GBP">113000</bdrx:DepreciationOfRightOfUseAsset>
    <bdrx:DepreciationOfRightOfUseAsset
      contextRef="From2025-01-012025-12-31_custom_AdministrativeCostsMember"
      decimals="-3"
      id="Fact001071"
      unitRef="GBP">34000</bdrx:DepreciationOfRightOfUseAsset>
    <bdrx:DepreciationOfRightOfUseAsset
      contextRef="From2024-01-012024-12-31_custom_AdministrativeCostsMember"
      decimals="-3"
      id="Fact001073"
      unitRef="GBP">36000</bdrx:DepreciationOfRightOfUseAsset>
    <bdrx:DepreciationOfRightOfUseAsset
      contextRef="From2023-01-012023-12-31_custom_AdministrativeCostsMember"
      decimals="-3"
      id="Fact001075"
      unitRef="GBP">24000</bdrx:DepreciationOfRightOfUseAsset>
    <bdrx:AmortisationOfIntangibleAssetsSoftware
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001077"
      unitRef="GBP">1000</bdrx:AmortisationOfIntangibleAssetsSoftware>
    <bdrx:AmortisationOfIntangibleAssetsSoftware
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001079"
      unitRef="GBP">1000</bdrx:AmortisationOfIntangibleAssetsSoftware>
    <bdrx:AmortisationOfIntangibleAssetsSoftware
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentMember"
      decimals="-3"
      id="Fact001081"
      unitRef="GBP">3000</bdrx:AmortisationOfIntangibleAssetsSoftware>
    <bdrx:AmortisationOfIntangibleAssetsSoftware
      contextRef="From2024-01-012024-12-31_custom_AdministrativeCostsMember"
      decimals="-3"
      id="Fact001085"
      unitRef="GBP">1000</bdrx:AmortisationOfIntangibleAssetsSoftware>
    <bdrx:ImpairmentOfFinancialAsset
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001091"
      unitRef="GBP">79000</bdrx:ImpairmentOfFinancialAsset>
    <bdrx:ImpairmentOfCommissionPaidInAdvance
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001093"
      unitRef="GBP">373000</bdrx:ImpairmentOfCommissionPaidInAdvance>
    <ifrs-full:FeeAndCommissionIncomeExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001101"
      unitRef="GBP">80000</ifrs-full:FeeAndCommissionIncomeExpense>
    <ifrs-full:FeeAndCommissionIncomeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001102"
      unitRef="GBP">90000</ifrs-full:FeeAndCommissionIncomeExpense>
    <ifrs-full:FeeAndCommissionIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001103"
      unitRef="GBP">127000</ifrs-full:FeeAndCommissionIncomeExpense>
    <bdrx:FeeAndCommissionIncomeExpense1
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001105"
      unitRef="GBP">60000</bdrx:FeeAndCommissionIncomeExpense1>
    <bdrx:FeeAndCommissionIncomeExpense1
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001106"
      unitRef="GBP">60000</bdrx:FeeAndCommissionIncomeExpense1>
    <bdrx:FeeAndCommissionIncomeExpense1
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001107"
      unitRef="GBP">58000</bdrx:FeeAndCommissionIncomeExpense1>
    <bdrx:FeePayableOtherServices
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001109"
      unitRef="GBP">35000</bdrx:FeePayableOtherServices>
    <bdrx:FeePayableOtherServices
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001111"
      unitRef="GBP">131000</bdrx:FeePayableOtherServices>
    <bdrx:FeePayableOtherServices1
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001113"
      unitRef="GBP">16000</bdrx:FeePayableOtherServices1>
    <bdrx:FeePayableOtherServices1
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001114"
      unitRef="GBP">21000</bdrx:FeePayableOtherServices1>
    <bdrx:FeesPayableToCompanysPreviousAuditorForAudit
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001117"
      unitRef="GBP">69000</bdrx:FeesPayableToCompanysPreviousAuditorForAudit>
    <bdrx:FeesPayableToCompanysPreviousAuditorForAudit
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001118"
      unitRef="GBP">110000</bdrx:FeesPayableToCompanysPreviousAuditorForAudit>
    <bdrx:FeesPayableToCompanysPreviousAuditorForAudit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001119"
      unitRef="GBP">32000</bdrx:FeesPayableToCompanysPreviousAuditorForAudit>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001121"
      unitRef="GBP">343000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001122"
      unitRef="GBP">-93000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001123"
      unitRef="GBP">164000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <bdrx:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment1
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001125"
      unitRef="GBP">29000</bdrx:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment1>
    <bdrx:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment1
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001126"
      unitRef="GBP">4000</bdrx:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment1>
    <bdrx:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment1
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001127"
      unitRef="GBP">2000</bdrx:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment1>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001129"
      unitRef="GBP">170000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001130"
      unitRef="GBP">283000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001131"
      unitRef="GBP">28000</ifrs-full:AdjustmentsForSharebasedPayments>
    <bdrx:DisclosureOfStaffCostsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001133">&lt;p id="xdx_808_ecustom--DisclosureOfStaffCostsExplanatory_z4QRMfWuwVpb" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;5&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82C_znYRSUqjpbhf"&gt;Staff costs&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Staff costs (including Directors) comprise:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutStaffCostsExplanatory_pn3n3_zZKcFgPkaQka" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Staff costs (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zNPYMqenOWgg" style="display: none"&gt;Schedule of staff costs&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20250101__20251231_zzP5x8YOHpR6" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20240101__20241231_zPO6GE3ZBHF9" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20230101__20231231_zn2YzJKrU0Cb" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--WagesAndSalaries_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Wages and salaries&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;1,710&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;1,597&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;1,708&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--PostemploymentBenefitExpenseDefinedContributionPlans_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Defined contribution pension cost (note 24)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;69&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;67&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;86&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--SocialSecurityContributions_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Social security contributions and similar taxes&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;192&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;201&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;233&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AdjustmentsForSharebasedPayments_z9Zl3BzuHA81" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Share-based payment charge&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;170&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;283&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--StaffCostsGross_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: rgb(204,238,255)"&gt;Staff costs gross&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2,141&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2,148&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2,055&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zCBl9dDc424e" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Employee numbers&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The average number of staff employed by the Group
during the financial year amounted to:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfAverageNumberOfStaffEmployeeExplanatory_pn3n3_zKCfr65nTR53" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Staff costs (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_zAow6xCAKaa4" style="display: none"&gt;Schedule for average number of employed staff&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AverageNumberOfEmployees_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_pd" title="Average number of staff employee"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AverageNumberOfEmployees_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_pd" title="Average number of staff employee"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AverageNumberOfEmployees_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_pd" title="Average number of staff employee"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;General and administration&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AverageNumberOfEmployees_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--GeneralAndAdministrativeMember_pd" title="Average number of staff employee"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AverageNumberOfEmployees_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--GeneralAndAdministrativeMember_pd" title="Average number of staff employee"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AverageNumberOfEmployees_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--GeneralAndAdministrativeMember_pd" title="Average number of staff employee"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AverageNumberOfEmployees_c20250101__20251231_pd" title="Average number of staff employee"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AverageNumberOfEmployees_c20240101__20241231_pd" title="Average number of staff employee"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--AverageNumberOfEmployees_c20230101__20231231_pd" title="Average number of staff employee"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zS0pjuo4OgP6" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman; margin: 0pt 0"&gt;Key management personnel compensation&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span id="xdx_90F_ecustom--DisclosureOfInformationAboutKeyManagementPersonnel_c20250101__20251231_zfSCoccJKoae" title="Disclosure of information about key management personnel"&gt;Key management personnel are those persons having
authority and responsibility for planning, directing and controlling the activities of the Group, including the Directors of the Company,
including the Chief Executive Officer and Chief Scientific Officer&lt;/span&gt; for 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfManagementPersonalCompensationTableTextBlock_pn3n3_zihz1ehI9p8d" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Staff costs (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B0_zy2vWCkNPVP7" style="display: none"&gt;Schedule of Management Personnel Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20250101__20251231_zcZYCcIYyEE1" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240101__20241231_zuXO88FrNDd5" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20230101__20231231_zY4CEw4nFI4" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ShortTermEmployeeBenefits_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Short term employee benefits&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;563&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;782&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;677&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--PostemploymentBenefits_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Post-employment benefits&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1185"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;11&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;21&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TerminationBenefits_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Termination benefits&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1189"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;30&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1191"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SharebasedPayment_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Share-based payment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;138&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;201&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;22&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ManagementPersonnalCompensation_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: rgb(204,238,255)"&gt;Management Personnal Compensation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;701&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;1,024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;720&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_znW7XfV5gRIk" style="font: 10pt Times New Roman; margin: 0pt 7.1pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;During the year no Directors (2024:0; 2023: 0) participated
in a defined contribution pension scheme. Pension contributions in the above note include those of the Chief Scientific Officer for 2024
and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 7.1pt 0pt 0"&gt;Emoluments disclosed above include the following
amounts in respect of the highest paid Director.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 7.1pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleofEmolumentsDisclosedTableTextBlock_pn3n3_zM3LfENBwTD7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Staff costs (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zBJmGMFwTkg" style="display: none"&gt;Schedule of emoluments disclosed&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20250101__20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zdg3A3Dd6yyc" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20240101__20241231__srt--TitleOfIndividualAxis__srt--DirectorMember_z7cejlG0zEc3" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20230101__20231231__srt--TitleOfIndividualAxis__srt--DirectorMember_zcfVbRHhUTT3" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ShortTermEmployeeBenefits_z9NdNbJRvs1a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Short term employee benefits&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;303&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;287&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;252&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PostemploymentBenefits_z9RZ8vQBqOR4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Post-employment benefits&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1208"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1209"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ManagementPersonnalCompensation_zN4bakbvVb9l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: rgb(204,238,255)"&gt;Management Personnal Compensation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;250&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;287&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;252&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zeK0sP40cXAc" style="font: 10pt Times New Roman; margin: 0pt 7.1pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;None of the Directors have exercised share options
during the year (2024: nil, 2023: nil).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</bdrx:DisclosureOfStaffCostsExplanatory>
    <bdrx:DisclosureOfDetailedInformationAboutStaffCostsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001135">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutStaffCostsExplanatory_pn3n3_zZKcFgPkaQka" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Staff costs (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zNPYMqenOWgg" style="display: none"&gt;Schedule of staff costs&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20250101__20251231_zzP5x8YOHpR6" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20240101__20241231_zPO6GE3ZBHF9" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20230101__20231231_zn2YzJKrU0Cb" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--WagesAndSalaries_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Wages and salaries&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;1,710&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;1,597&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;1,708&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--PostemploymentBenefitExpenseDefinedContributionPlans_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Defined contribution pension cost (note 24)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;69&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;67&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;86&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--SocialSecurityContributions_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Social security contributions and similar taxes&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;192&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;201&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;233&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AdjustmentsForSharebasedPayments_z9Zl3BzuHA81" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Share-based payment charge&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;170&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;283&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--StaffCostsGross_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: rgb(204,238,255)"&gt;Staff costs gross&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2,141&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2,148&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2,055&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfDetailedInformationAboutStaffCostsExplanatory>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001137"
      unitRef="GBP">1710000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001138"
      unitRef="GBP">1597000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001139"
      unitRef="GBP">1708000</ifrs-full:WagesAndSalaries>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001141"
      unitRef="GBP">69000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001142"
      unitRef="GBP">67000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001143"
      unitRef="GBP">86000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:SocialSecurityContributions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001145"
      unitRef="GBP">192000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001146"
      unitRef="GBP">201000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001147"
      unitRef="GBP">233000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001149"
      unitRef="GBP">170000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001150"
      unitRef="GBP">283000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001151"
      unitRef="GBP">28000</ifrs-full:AdjustmentsForSharebasedPayments>
    <bdrx:StaffCostsGross
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001153"
      unitRef="GBP">2141000</bdrx:StaffCostsGross>
    <bdrx:StaffCostsGross
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001154"
      unitRef="GBP">2148000</bdrx:StaffCostsGross>
    <bdrx:StaffCostsGross
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001155"
      unitRef="GBP">2055000</bdrx:StaffCostsGross>
    <bdrx:DisclosureOfAverageNumberOfStaffEmployeeExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001157">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfAverageNumberOfStaffEmployeeExplanatory_pn3n3_zKCfr65nTR53" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Staff costs (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_zAow6xCAKaa4" style="display: none"&gt;Schedule for average number of employed staff&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AverageNumberOfEmployees_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_pd" title="Average number of staff employee"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AverageNumberOfEmployees_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_pd" title="Average number of staff employee"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AverageNumberOfEmployees_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--ResearchAndDevelopmentMember_pd" title="Average number of staff employee"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;General and administration&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AverageNumberOfEmployees_c20250101__20251231__custom--IncomeStatementLocation1Axis__custom--GeneralAndAdministrativeMember_pd" title="Average number of staff employee"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AverageNumberOfEmployees_c20240101__20241231__custom--IncomeStatementLocation1Axis__custom--GeneralAndAdministrativeMember_pd" title="Average number of staff employee"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AverageNumberOfEmployees_c20230101__20231231__custom--IncomeStatementLocation1Axis__custom--GeneralAndAdministrativeMember_pd" title="Average number of staff employee"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AverageNumberOfEmployees_c20250101__20251231_pd" title="Average number of staff employee"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AverageNumberOfEmployees_c20240101__20241231_pd" title="Average number of staff employee"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--AverageNumberOfEmployees_c20230101__20231231_pd" title="Average number of staff employee"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfAverageNumberOfStaffEmployeeExplanatory>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2025-01-012025-12-31_custom_ResearchAndDevelopmentMember"
      decimals="INF"
      id="Fact001159"
      unitRef="N">7</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2024-01-012024-12-31_custom_ResearchAndDevelopmentMember"
      decimals="INF"
      id="Fact001161"
      unitRef="N">8</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2023-01-012023-12-31_custom_ResearchAndDevelopmentMember"
      decimals="INF"
      id="Fact001163"
      unitRef="N">16</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2025-01-012025-12-31_custom_GeneralAndAdministrativeMember"
      decimals="INF"
      id="Fact001165"
      unitRef="N">4</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2024-01-012024-12-31_custom_GeneralAndAdministrativeMember"
      decimals="INF"
      id="Fact001167"
      unitRef="N">5</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2023-01-012023-12-31_custom_GeneralAndAdministrativeMember"
      decimals="INF"
      id="Fact001169"
      unitRef="N">5</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001171"
      unitRef="N">11</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001173"
      unitRef="N">13</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001175"
      unitRef="N">21</ifrs-full:AverageNumberOfEmployees>
    <bdrx:DisclosureOfInformationAboutKeyManagementPersonnel contextRef="From2025-01-01to2025-12-31" id="Fact001177">Key management personnel are those persons having
authority and responsibility for planning, directing and controlling the activities of the Group, including the Directors of the Company,
including the Chief Executive Officer and Chief Scientific Officer</bdrx:DisclosureOfInformationAboutKeyManagementPersonnel>
    <bdrx:ScheduleOfManagementPersonalCompensationTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001179">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfManagementPersonalCompensationTableTextBlock_pn3n3_zihz1ehI9p8d" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Staff costs (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B0_zy2vWCkNPVP7" style="display: none"&gt;Schedule of Management Personnel Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20250101__20251231_zcZYCcIYyEE1" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240101__20241231_zuXO88FrNDd5" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20230101__20231231_zY4CEw4nFI4" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ShortTermEmployeeBenefits_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Short term employee benefits&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;563&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;782&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;677&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--PostemploymentBenefits_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Post-employment benefits&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1185"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;11&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;21&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TerminationBenefits_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Termination benefits&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1189"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;30&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1191"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SharebasedPayment_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Share-based payment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;138&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;201&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;22&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ManagementPersonnalCompensation_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: rgb(204,238,255)"&gt;Management Personnal Compensation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;701&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;1,024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;720&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:ScheduleOfManagementPersonalCompensationTableTextBlock>
    <bdrx:ShortTermEmployeeBenefits
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001181"
      unitRef="GBP">563000</bdrx:ShortTermEmployeeBenefits>
    <bdrx:ShortTermEmployeeBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001182"
      unitRef="GBP">782000</bdrx:ShortTermEmployeeBenefits>
    <bdrx:ShortTermEmployeeBenefits
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001183"
      unitRef="GBP">677000</bdrx:ShortTermEmployeeBenefits>
    <bdrx:PostemploymentBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001186"
      unitRef="GBP">11000</bdrx:PostemploymentBenefits>
    <bdrx:PostemploymentBenefits
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001187"
      unitRef="GBP">21000</bdrx:PostemploymentBenefits>
    <bdrx:TerminationBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001190"
      unitRef="GBP">30000</bdrx:TerminationBenefits>
    <bdrx:SharebasedPayment
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001193"
      unitRef="GBP">138000</bdrx:SharebasedPayment>
    <bdrx:SharebasedPayment
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001194"
      unitRef="GBP">201000</bdrx:SharebasedPayment>
    <bdrx:SharebasedPayment
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001195"
      unitRef="GBP">22000</bdrx:SharebasedPayment>
    <bdrx:ManagementPersonnalCompensation
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001197"
      unitRef="GBP">701000</bdrx:ManagementPersonnalCompensation>
    <bdrx:ManagementPersonnalCompensation
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001198"
      unitRef="GBP">1024000</bdrx:ManagementPersonnalCompensation>
    <bdrx:ManagementPersonnalCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001199"
      unitRef="GBP">720000</bdrx:ManagementPersonnalCompensation>
    <bdrx:ScheduleofEmolumentsDisclosedTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001201">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleofEmolumentsDisclosedTableTextBlock_pn3n3_zM3LfENBwTD7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Staff costs (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zBJmGMFwTkg" style="display: none"&gt;Schedule of emoluments disclosed&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20250101__20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zdg3A3Dd6yyc" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20240101__20241231__srt--TitleOfIndividualAxis__srt--DirectorMember_z7cejlG0zEc3" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20230101__20231231__srt--TitleOfIndividualAxis__srt--DirectorMember_zcfVbRHhUTT3" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ShortTermEmployeeBenefits_z9NdNbJRvs1a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Short term employee benefits&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;303&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;287&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;252&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PostemploymentBenefits_z9RZ8vQBqOR4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Post-employment benefits&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1208"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1209"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ManagementPersonnalCompensation_zN4bakbvVb9l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: rgb(204,238,255)"&gt;Management Personnal Compensation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;250&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;287&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;252&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:ScheduleofEmolumentsDisclosedTableTextBlock>
    <bdrx:ShortTermEmployeeBenefits
      contextRef="From2025-01-012025-12-31_srt_DirectorMember"
      decimals="-3"
      id="Fact001203"
      unitRef="GBP">303000</bdrx:ShortTermEmployeeBenefits>
    <bdrx:ShortTermEmployeeBenefits
      contextRef="From2024-01-012024-12-31_srt_DirectorMember"
      decimals="-3"
      id="Fact001204"
      unitRef="GBP">287000</bdrx:ShortTermEmployeeBenefits>
    <bdrx:ShortTermEmployeeBenefits
      contextRef="From2023-01-012023-12-31_srt_DirectorMember"
      decimals="-3"
      id="Fact001205"
      unitRef="GBP">252000</bdrx:ShortTermEmployeeBenefits>
    <bdrx:ManagementPersonnalCompensation
      contextRef="From2025-01-012025-12-31_srt_DirectorMember"
      decimals="-3"
      id="Fact001211"
      unitRef="GBP">250000</bdrx:ManagementPersonnalCompensation>
    <bdrx:ManagementPersonnalCompensation
      contextRef="From2024-01-012024-12-31_srt_DirectorMember"
      decimals="-3"
      id="Fact001212"
      unitRef="GBP">287000</bdrx:ManagementPersonnalCompensation>
    <bdrx:ManagementPersonnalCompensation
      contextRef="From2023-01-012023-12-31_srt_DirectorMember"
      decimals="-3"
      id="Fact001213"
      unitRef="GBP">252000</bdrx:ManagementPersonnalCompensation>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001215">&lt;p id="xdx_808_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_z72yVX48ZxNj" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;6&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_821_z1cPsSe8rbt2"&gt;Finance income and expense&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory_pn3n3_zeyDVQ38YVO9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Finance income and expense (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zsvHoO9ncV3a" style="display: none"&gt;Schedule of finance income&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20250101__20251231_zuB8yptGBQna" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240101__20241231_zOIio4HNtYs1" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20230101__20231231_zq8oIxOf2hm1" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FinanceIncomeAbstract_iB_zFZE9m6Enu17" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Finance income&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--InterestIncomeOnDeposits_i01_pn3n3_maFIzC4V_zKbpNQm0hVKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Interest received on bank deposits&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;166&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;73&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--OtherInterestReceivable_i01_pn3n3_maFIzC4V_zWDfgFt2uz87" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other interest receivable&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;6&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;10&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--GainsOnChangeInFairValueOfDerivatives_i01_pn3n3_maFIzC4V_zTLG86objwel" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Gain on equity settled derivative financial liability&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2,296&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;3,218&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;487&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--FinanceIncome_i01T_pn3n3_mtFIzC4V_zwL2unsc7Rl2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Total finance income&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2,385&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;3,385&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;570&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--InterestCostsAbstract_iB_zqhl3keG09a8" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Finance expense&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--InterestExpenseOnLeaseLiabilities_i01_pn3n3_maFCz4Ip_zKVl4ekNPt8d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Interest expense on lease liabilities&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;10&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;19&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;28&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestExpenseOnDeferredConsideration_i01_pn3n3_maFCz4Ip_zUBSWqCO1dE1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest expense on deferred consideration&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;159&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;144&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1249"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--InterestExpenseOnOtherFinancialLiabilities_i01_pn3n3_maFCz4Ip_zZUGV3KGfvv1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other loans&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;60&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;13&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinanceCosts_i01T_pn3n3_mtFCz4Ip_zcUmBHIKsm9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Total finance expense&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;229&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;165&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;41&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zbQAZpapq3H1" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The gain on the equity settled derivative financial
liability in 2025, 2024 and 2023 arose as a result of the movement in share price (note 19).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <bdrx:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001217">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory_pn3n3_zeyDVQ38YVO9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Finance income and expense (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zsvHoO9ncV3a" style="display: none"&gt;Schedule of finance income&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20250101__20251231_zuB8yptGBQna" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240101__20241231_zOIio4HNtYs1" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20230101__20231231_zq8oIxOf2hm1" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FinanceIncomeAbstract_iB_zFZE9m6Enu17" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Finance income&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--InterestIncomeOnDeposits_i01_pn3n3_maFIzC4V_zKbpNQm0hVKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Interest received on bank deposits&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;166&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;73&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--OtherInterestReceivable_i01_pn3n3_maFIzC4V_zWDfgFt2uz87" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other interest receivable&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;6&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;10&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--GainsOnChangeInFairValueOfDerivatives_i01_pn3n3_maFIzC4V_zTLG86objwel" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Gain on equity settled derivative financial liability&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2,296&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;3,218&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;487&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--FinanceIncome_i01T_pn3n3_mtFIzC4V_zwL2unsc7Rl2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Total finance income&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2,385&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;3,385&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;570&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--InterestCostsAbstract_iB_zqhl3keG09a8" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Finance expense&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--InterestExpenseOnLeaseLiabilities_i01_pn3n3_maFCz4Ip_zKVl4ekNPt8d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Interest expense on lease liabilities&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;10&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;19&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;28&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestExpenseOnDeferredConsideration_i01_pn3n3_maFCz4Ip_zUBSWqCO1dE1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest expense on deferred consideration&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;159&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;144&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1249"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--InterestExpenseOnOtherFinancialLiabilities_i01_pn3n3_maFCz4Ip_zZUGV3KGfvv1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other loans&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;60&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;13&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinanceCosts_i01T_pn3n3_mtFCz4Ip_zcUmBHIKsm9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Total finance expense&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;229&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;165&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;41&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory>
    <ifrs-full:InterestIncomeOnDeposits
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001223"
      unitRef="GBP">83000</ifrs-full:InterestIncomeOnDeposits>
    <ifrs-full:InterestIncomeOnDeposits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001224"
      unitRef="GBP">166000</ifrs-full:InterestIncomeOnDeposits>
    <ifrs-full:InterestIncomeOnDeposits
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001225"
      unitRef="GBP">73000</ifrs-full:InterestIncomeOnDeposits>
    <bdrx:OtherInterestReceivable
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001227"
      unitRef="GBP">6000</bdrx:OtherInterestReceivable>
    <bdrx:OtherInterestReceivable
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001228"
      unitRef="GBP">1000</bdrx:OtherInterestReceivable>
    <bdrx:OtherInterestReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001229"
      unitRef="GBP">10000</bdrx:OtherInterestReceivable>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001231"
      unitRef="GBP">2296000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001232"
      unitRef="GBP">3218000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnChangeInFairValueOfDerivatives
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001233"
      unitRef="GBP">487000</ifrs-full:GainsOnChangeInFairValueOfDerivatives>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001235"
      unitRef="GBP">2385000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001236"
      unitRef="GBP">3385000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001237"
      unitRef="GBP">570000</ifrs-full:FinanceIncome>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001243"
      unitRef="GBP">10000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001244"
      unitRef="GBP">19000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001245"
      unitRef="GBP">28000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <bdrx:InterestExpenseOnDeferredConsideration
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001247"
      unitRef="GBP">159000</bdrx:InterestExpenseOnDeferredConsideration>
    <bdrx:InterestExpenseOnDeferredConsideration
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001248"
      unitRef="GBP">144000</bdrx:InterestExpenseOnDeferredConsideration>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001251"
      unitRef="GBP">60000</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001252"
      unitRef="GBP">2000</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001253"
      unitRef="GBP">13000</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001255"
      unitRef="GBP">229000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001256"
      unitRef="GBP">165000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001257"
      unitRef="GBP">41000</ifrs-full:FinanceCosts>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001259">&lt;p id="xdx_80F_eifrs-full--DisclosureOfIncomeTaxExplanatory_zEMVpsGmJqeb" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;7&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_821_z3RVZy7BOTs8"&gt;Taxation&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseBenefitExplanatory_pn3n3_zDc75Gjst6bd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Taxation (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span id="xdx_8B2_zL4Q03KVMTE4" style="display: none"&gt;Schedule of components of income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250101__20251231_zBU3wTcZAoV3" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240101__20241231_zfEWCF15eDSa" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20230101__20231231_z5Ae3zVo8NM5" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_iB_zhP0h1hM4d49" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Current tax credit&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--CurrentTaxCreditedToIncomeStatement_i01_pn3n3_zsZkkgI2COY6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Current tax (charged)/credited to the income statement&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;(21&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;241&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;407&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AdjustmentInRespectOfPriorYear_i01_pn3n3_zq8B7TXt5vUc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Adjustment in respect of prior year&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;126&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--CurrentTaxCredit_i01_pn3n3_zLsxwHBvXW3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&#160;Current tax credit&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;105&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;250&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;406&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DeferredTaxExpenseIncomeAbstract_iB_zZLcMUjj1m54" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax credit&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_i01N_pn3n3_di_zEvJvODm8Lbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Reversal of temporary differences&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1283"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1284"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1285"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--IncomeTaxExpenseContinuingOperations_i01N_pn3n3_di_zkSnKPb05qkb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Total tax credit&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;105&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;250&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;406&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zXxNfdp6HEcb" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The reasons for the difference between the actual
tax credit for the year and the standard rate of corporation tax in the United Kingdom applied to losses for the year are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutDifferenceBetweenActualTaxChargeAndStandardTateOfCorporationTaxExplanatory_pn3n3_zy7guIZK7vnh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Taxation (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_zG7N9ORJtnXg" style="display: none"&gt;Schedule of difference between actual tax charge and the standard rate of corporation tax&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250101__20251231_zJ9WpoKVS1yi" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240101__20241231_z2l0rIAsIzKc" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20230101__20231231_z5CuTbgFFu4f" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--LossBeforeTax_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Loss before tax&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(6,489&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(5,979&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(7,485&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected tax credit based on the standard rate of United Kingdom corporation tax at the domestic rate of 25% (2024: 25%; 2023: 25.52%)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(1,555&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(1,495&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(1,764&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expenses not deductible for tax purposes&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;726&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;1,069&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;408&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--IncomeNotTaxable_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income not taxable&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(212&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(809&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(5&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AdjustmentsToBroughtForwardValues_iN_pn3n3_zaCNHIwrpMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustment in respect of prior period&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(126&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(9&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--EffectOfRdRelief_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Effect of R&amp;amp;D relief&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;38&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;100&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;26&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredTaxNotRecognised_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Deferred tax not recognised&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;1,024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;894&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;928&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TotalTaxCreditedToIncomeStatement_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Total tax credited to the income statement&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;(105&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;(250&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;(406&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zwYFrTv0fGA3" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The taxation credit arises on the enhanced research
and development tax credits accrued for the respective periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <bdrx:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseBenefitExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001261">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseBenefitExplanatory_pn3n3_zDc75Gjst6bd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Taxation (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span id="xdx_8B2_zL4Q03KVMTE4" style="display: none"&gt;Schedule of components of income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250101__20251231_zBU3wTcZAoV3" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240101__20241231_zfEWCF15eDSa" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20230101__20231231_z5Ae3zVo8NM5" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_iB_zhP0h1hM4d49" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Current tax credit&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--CurrentTaxCreditedToIncomeStatement_i01_pn3n3_zsZkkgI2COY6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Current tax (charged)/credited to the income statement&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;(21&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;241&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;407&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AdjustmentInRespectOfPriorYear_i01_pn3n3_zq8B7TXt5vUc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Adjustment in respect of prior year&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;126&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--CurrentTaxCredit_i01_pn3n3_zLsxwHBvXW3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&#160;Current tax credit&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;105&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;250&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;406&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DeferredTaxExpenseIncomeAbstract_iB_zZLcMUjj1m54" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax credit&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_i01N_pn3n3_di_zEvJvODm8Lbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Reversal of temporary differences&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1283"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1284"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1285"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--IncomeTaxExpenseContinuingOperations_i01N_pn3n3_di_zkSnKPb05qkb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Total tax credit&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;105&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;250&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;406&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseBenefitExplanatory>
    <bdrx:CurrentTaxCreditedToIncomeStatement
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001267"
      unitRef="GBP">-21000</bdrx:CurrentTaxCreditedToIncomeStatement>
    <bdrx:CurrentTaxCreditedToIncomeStatement
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001268"
      unitRef="GBP">241000</bdrx:CurrentTaxCreditedToIncomeStatement>
    <bdrx:CurrentTaxCreditedToIncomeStatement
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001269"
      unitRef="GBP">407000</bdrx:CurrentTaxCreditedToIncomeStatement>
    <bdrx:AdjustmentInRespectOfPriorYear
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001271"
      unitRef="GBP">126000</bdrx:AdjustmentInRespectOfPriorYear>
    <bdrx:AdjustmentInRespectOfPriorYear
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001272"
      unitRef="GBP">9000</bdrx:AdjustmentInRespectOfPriorYear>
    <bdrx:AdjustmentInRespectOfPriorYear
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001273"
      unitRef="GBP">-1000</bdrx:AdjustmentInRespectOfPriorYear>
    <bdrx:CurrentTaxCredit
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001275"
      unitRef="GBP">105000</bdrx:CurrentTaxCredit>
    <bdrx:CurrentTaxCredit
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001276"
      unitRef="GBP">250000</bdrx:CurrentTaxCredit>
    <bdrx:CurrentTaxCredit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001277"
      unitRef="GBP">406000</bdrx:CurrentTaxCredit>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001287"
      unitRef="GBP">-105000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001288"
      unitRef="GBP">-250000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001289"
      unitRef="GBP">-406000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <bdrx:DisclosureOfDetailedInformationAboutDifferenceBetweenActualTaxChargeAndStandardTateOfCorporationTaxExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001291">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutDifferenceBetweenActualTaxChargeAndStandardTateOfCorporationTaxExplanatory_pn3n3_zy7guIZK7vnh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Taxation (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_zG7N9ORJtnXg" style="display: none"&gt;Schedule of difference between actual tax charge and the standard rate of corporation tax&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250101__20251231_zJ9WpoKVS1yi" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240101__20241231_z2l0rIAsIzKc" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20230101__20231231_z5CuTbgFFu4f" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--LossBeforeTax_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Loss before tax&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(6,489&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(5,979&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(7,485&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected tax credit based on the standard rate of United Kingdom corporation tax at the domestic rate of 25% (2024: 25%; 2023: 25.52%)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(1,555&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(1,495&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(1,764&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expenses not deductible for tax purposes&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;726&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;1,069&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;408&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--IncomeNotTaxable_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income not taxable&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(212&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(809&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(5&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AdjustmentsToBroughtForwardValues_iN_pn3n3_zaCNHIwrpMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustment in respect of prior period&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(126&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;(9&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--EffectOfRdRelief_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Effect of R&amp;amp;D relief&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;38&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;100&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;26&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredTaxNotRecognised_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Deferred tax not recognised&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;1,024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;894&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;928&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TotalTaxCreditedToIncomeStatement_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Total tax credited to the income statement&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;(105&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;(250&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;(406&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfDetailedInformationAboutDifferenceBetweenActualTaxChargeAndStandardTateOfCorporationTaxExplanatory>
    <bdrx:LossBeforeTax
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001293"
      unitRef="GBP">-6489000</bdrx:LossBeforeTax>
    <bdrx:LossBeforeTax
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001294"
      unitRef="GBP">-5979000</bdrx:LossBeforeTax>
    <bdrx:LossBeforeTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001295"
      unitRef="GBP">-7485000</bdrx:LossBeforeTax>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001297"
      unitRef="GBP">-1555000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001298"
      unitRef="GBP">-1495000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001299"
      unitRef="GBP">-1764000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001301"
      unitRef="GBP">726000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001302"
      unitRef="GBP">1069000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001303"
      unitRef="GBP">408000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <bdrx:IncomeNotTaxable
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001305"
      unitRef="GBP">-212000</bdrx:IncomeNotTaxable>
    <bdrx:IncomeNotTaxable
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001306"
      unitRef="GBP">-809000</bdrx:IncomeNotTaxable>
    <bdrx:IncomeNotTaxable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001307"
      unitRef="GBP">-5000</bdrx:IncomeNotTaxable>
    <bdrx:AdjustmentsToBroughtForwardValues
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001309"
      unitRef="GBP">-126000</bdrx:AdjustmentsToBroughtForwardValues>
    <bdrx:AdjustmentsToBroughtForwardValues
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001310"
      unitRef="GBP">-9000</bdrx:AdjustmentsToBroughtForwardValues>
    <bdrx:AdjustmentsToBroughtForwardValues
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001311"
      unitRef="GBP">1000</bdrx:AdjustmentsToBroughtForwardValues>
    <bdrx:EffectOfRdRelief
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001313"
      unitRef="GBP">38000</bdrx:EffectOfRdRelief>
    <bdrx:EffectOfRdRelief
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001314"
      unitRef="GBP">100000</bdrx:EffectOfRdRelief>
    <bdrx:EffectOfRdRelief
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001315"
      unitRef="GBP">26000</bdrx:EffectOfRdRelief>
    <bdrx:DeferredTaxNotRecognised
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001317"
      unitRef="GBP">1024000</bdrx:DeferredTaxNotRecognised>
    <bdrx:DeferredTaxNotRecognised
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001318"
      unitRef="GBP">894000</bdrx:DeferredTaxNotRecognised>
    <bdrx:DeferredTaxNotRecognised
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001319"
      unitRef="GBP">928000</bdrx:DeferredTaxNotRecognised>
    <bdrx:TotalTaxCreditedToIncomeStatement
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001321"
      unitRef="GBP">-105000</bdrx:TotalTaxCreditedToIncomeStatement>
    <bdrx:TotalTaxCreditedToIncomeStatement
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001322"
      unitRef="GBP">-250000</bdrx:TotalTaxCreditedToIncomeStatement>
    <bdrx:TotalTaxCreditedToIncomeStatement
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001323"
      unitRef="GBP">-406000</bdrx:TotalTaxCreditedToIncomeStatement>
    <bdrx:DisclosureOfEarningsPerSharesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001325">&lt;p id="xdx_80E_ecustom--DisclosureOfEarningsPerSharesExplanatory_z6WKOCOTiJC2" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;8&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_z5YCOhaYcfF8"&gt;Loss per share&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DisclosureOfDetailedInformationAboutEarningsPerShareExplanatory_pn3n3_zD28oWycHHof" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Loss per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BE_zjxOaXXZoPl3" style="display: none"&gt;Schedule of loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250101__20251231_zwlTIk7I5U87" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240101__20241231_z624TL1EnTs2" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20230101__20231231_zVurkw5jSXVl" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_iB_zCdvjxL0cA6h" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Numerator&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ProfitLossAbstract_i01B_zKhnH3kznU19" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Loss used in basic EPS and diluted EPS:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ProfitLossFromContinuingOperations_i02_pn3n3_zdTiraOm9Zkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Continuing operations&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(6,384&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(5,729&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(7,079&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Denominator&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--WeightedAverageShares_i01_pid_zrIS4h8juUhd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average number of ordinary shares used in basic EPS:&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;54,861,066,264&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;4,952,784,179&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;315,849,600&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--BasicAndDilutedEarningsLossPerShareAbstract_i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Basic and diluted loss per share:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Continuing operations &lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--BasicEarningsLossPerShare_pid_c20250101__20251231_zf0o4q6waKSi" title="Basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20250101__20251231_zmp9ngfHBgg6" title="Diluted loss per share"&gt;(0.0001&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--BasicEarningsLossPerShare_pid_c20240101__20241231_zeCik38utKfg" title="Basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20240101__20241231_zI118WYHi3Ng" title="Diluted loss per share"&gt;(0.001&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20231231_z3T9o33n6Y6" title="Basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20231231_zOX86C8dHAif" title="Diluted loss per share"&gt;(0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;At a General Meeting on 1 June 2025, shareholders
approved the subdivision and redesignation of the &lt;span id="xdx_90D_ecustom--DescriptionOStockholdersEquityNoteStockSplit_c20250101__20251231_z6pw4G1OnnLe" title="Description of stock split"&gt;Company&#x2019;s Issued Ordinary Shares of &#xa3;0.00005 each into to one Ordinary Share
of &#xa3;0.000001 each and 49 &#x2018;D&#x2019; Deferred Shares of &#xa3;0.000001 each. The &#x2018;D&#x2019; Deferred Shares have limited
rights and are effectively valueless.&lt;/span&gt; The share sub-division and redesignation did not impact the calculation of the denominator as the
number of Issued Ordinary Shares did not change.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;During the year the Company issued warrants that were
accounted through the Warrant Reserve as detailed in note 22.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Company has considered the guidance set out in
IAS 33 in calculating the denominator in connection with the issuance of Pre-Funded warrants as disclosed in note 22. Management have
recognised the warrants from the date of grant rather than the date of issue of the corresponding Ordinary Shares when calculating the
denominator.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group has made a loss in the current and previous
periods presented, and therefore the options and warrants are anti-dilutive. As a result, diluted loss per share is presented on the same
basis as basic loss per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</bdrx:DisclosureOfEarningsPerSharesExplanatory>
    <bdrx:DisclosureOfDetailedInformationAboutEarningsPerShareExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001327">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DisclosureOfDetailedInformationAboutEarningsPerShareExplanatory_pn3n3_zD28oWycHHof" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Loss per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BE_zjxOaXXZoPl3" style="display: none"&gt;Schedule of loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250101__20251231_zwlTIk7I5U87" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240101__20241231_z624TL1EnTs2" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20230101__20231231_zVurkw5jSXVl" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_iB_zCdvjxL0cA6h" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Numerator&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ProfitLossAbstract_i01B_zKhnH3kznU19" style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;Loss used in basic EPS and diluted EPS:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ProfitLossFromContinuingOperations_i02_pn3n3_zdTiraOm9Zkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Continuing operations&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(6,384&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(5,729&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;(7,079&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Denominator&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--WeightedAverageShares_i01_pid_zrIS4h8juUhd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average number of ordinary shares used in basic EPS:&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;54,861,066,264&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;4,952,784,179&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;315,849,600&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--BasicAndDilutedEarningsLossPerShareAbstract_i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Basic and diluted loss per share:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Continuing operations &lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--BasicEarningsLossPerShare_pid_c20250101__20251231_zf0o4q6waKSi" title="Basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20250101__20251231_zmp9ngfHBgg6" title="Diluted loss per share"&gt;(0.0001&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--BasicEarningsLossPerShare_pid_c20240101__20241231_zeCik38utKfg" title="Basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20240101__20241231_zI118WYHi3Ng" title="Diluted loss per share"&gt;(0.001&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20231231_z3T9o33n6Y6" title="Basic loss per share"&gt;&lt;span id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20231231_zOX86C8dHAif" title="Diluted loss per share"&gt;(0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:DisclosureOfDetailedInformationAboutEarningsPerShareExplanatory>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001337"
      unitRef="GBP">-6384000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001338"
      unitRef="GBP">-5729000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001339"
      unitRef="GBP">-7079000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001345"
      unitRef="Shares">54861066264</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001346"
      unitRef="Shares">4952784179</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001347"
      unitRef="Shares">315849600</ifrs-full:WeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001353"
      unitRef="GBPPShares">-0.0001</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001355"
      unitRef="GBPPShares">-0.0001</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001357"
      unitRef="GBPPShares">-0.001</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001359"
      unitRef="GBPPShares">-0.001</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001361"
      unitRef="GBPPShares">-0.02</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001363"
      unitRef="GBPPShares">-0.02</ifrs-full:DilutedEarningsLossPerShare>
    <bdrx:DescriptionOStockholdersEquityNoteStockSplit contextRef="From2025-01-01to2025-12-31" id="Fact001365">Company&#x2019;s Issued Ordinary Shares of &#xa3;0.00005 each into to one Ordinary Share
of &#xa3;0.000001 each and 49 &#x2018;D&#x2019; Deferred Shares of &#xa3;0.000001 each. The &#x2018;D&#x2019; Deferred Shares have limited
rights and are effectively valueless.</bdrx:DescriptionOStockholdersEquityNoteStockSplit>
    <bdrx:DisclosureOfPropertyPlantAndEquipmentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001367">&lt;p id="xdx_80E_ecustom--DisclosureOfPropertyPlantAndEquipmentsExplanatory_za4JdfaTyPi8" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;9&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_826_zZhXIIHnCYMd"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_zGnOlMUlcbil" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property, plant and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BA_zS1GmHjk4B9k" style="display: none"&gt;Schedule of detailed information about property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Fixtures&lt;br/&gt; and fittings&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Leasehold&lt;br/&gt; improvements&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Computer&lt;br/&gt; equipment&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Laboratory&lt;br/&gt; equipment&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Right of use&lt;br/&gt; &#160;asset&lt;br/&gt; &#160;&#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zT7SC5XQ6qkl" title="Balance at beginning"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zaw7wL28yQBi" title="Balance at beginning"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zkOBU2T1mPL9" title="Balance at beginning"&gt;88&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zu2jwdBkoLY2" title="Balance at beginning"&gt;1,434&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zjJPV8uKSMM1" title="Balance at beginning"&gt;824&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zY7qlfS1fVzc" title="Balance at beginning"&gt;2,462&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zoNJSFEzNQQd" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1383"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zSGt5ZvporV6" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1385"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zOSlQmndvVw2" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1387"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zhQKZX4RvbZf" title="Additions"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUVuKQAQ9y4e" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1391"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zGP99041hQec" title="Additions"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Transfers&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zQX5io4AuVqf" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1395"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zqzFLP85sc4h" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1397"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zFu7xdGNiH83" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1399"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zblRjuCOCcnf" title="Transfer"&gt;103&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zu1UDDhs3v3j" title="Transfer"&gt;(103&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zzhNLsEDtk2f" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1405"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zBx7P0cuo2U9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1407"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zxWeN20IdPF9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1409"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ziJwxuopUiH9" title="Disposals"&gt;(38&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z142V5oOJLL6" title="Disposals"&gt;(152&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zfr8ilTJums9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1415"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zayTL0pGagV6" title="Disposals"&gt;(190&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zJ48gLZCXfy2" title="Balance at beginning"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zWyiOVwptXrb" title="Balance at beginning"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAwLdev8cxVb" title="Balance at beginning"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zMSvRbBMtaal" title="Balance at beginning"&gt;1,411&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zGLNo2fq7bde" title="Balance at beginning"&gt;721&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zGc15KMyqtS7" title="Balance at beginning"&gt;2,298&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zK1PyQRKKLY4" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1431"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zDI2rWEgHRw" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1433"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zH3NAjFLXRA2" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1435"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z26LoAZKzCF4" title="Additions"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zY1PxKMWTDOi" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1439"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zCFF3uYoXtub" title="Additions"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUjUoCon97V9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1443"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zvBQMPx4Iwx1" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1445"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zX6ngLZg64Zk" title="Disposals"&gt;(25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z0mS8SRlQ1Gc" title="Disposals"&gt;(740&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zMpJ2WFyNYpe" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1451"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zm9G4c0I38u5" title="Disposals"&gt;(765&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zFc7HX5MGY76" title="Balance at beginning"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zJoos1pz2k8b" title="Balance at beginning"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAuMuWUzNdJh" title="Balance at beginning"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zLgoa3ZRvF91" title="Balance at beginning"&gt;680&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z4LjuQM4YGa9" title="Balance at beginning"&gt;721&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z63kyhS6mj0c" title="Balance at beginning"&gt;1,542&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ziDPg5GXqgR2" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1467"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zFSRdCA5RPP8" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1469"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zTjZQamGEgi9" title="Additions"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zZ50vIFqYyFc" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1473"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zdNJzwaQw7A6" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z27nN13cuZwd" title="Additions"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zSgvQz23d719" title="Disposals"&gt;(28&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zG5fCyhf8QRk" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1481"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z72GdVRLb9Wh" title="Disposals"&gt;(5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zPkppB8PYEeh" title="Disposals"&gt;(575&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUYNVJQoih7j" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1487"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUEff9h9EXr5" title="Disposals"&gt;(608&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z5heaZKl2pE7" title="Balance at ending"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAt0x3hmnrLl" title="Balance at ending"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zKlvga9Qu403" title="Balance at ending"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zbK7hmzUWK52" title="Balance at ending"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zmIcFomnr1u1" title="Balance at ending"&gt;721&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ziQEnG9QfmBb" title="Balance at ending"&gt;936&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Fixtures&lt;br/&gt; and fittings&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Leasehold&lt;br/&gt; improvements&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Computer&lt;br/&gt; equipment&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Laboratory &lt;br/&gt; equipment&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Right of use&lt;br/&gt; &#160;asset&lt;br/&gt; &#160;&#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ztzBmXAzQdQ7" title="Balance at beginning"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z7m7nV9Cgcpl" title="Balance at beginning"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ze0hmrngGiV7" title="Balance at beginning"&gt;71&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUCz6NFNU0Jl" title="Balance at beginning"&gt;1,189&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zpZuxG7D9gd" title="Balance at beginning"&gt;337&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zxZSXgUpu5t3" title="Balance at beginning"&gt;1,631&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Transfers&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z5rvCeu21Kk5" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1515"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8d116g4aOK" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1517"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0y3uE05ULYe" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1519"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zeOXBFZL5Mw9" title="Transfer"&gt;103&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zc7F7ENDM0rh" title="Transfer"&gt;(103&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3MSPqHKvFo8" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1525"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmQXbFPpqH03" title="Charge for the year"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zU0Q2fhOwGj8" title="Charge for the year"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBN4jvpxS7O3" title="Charge for the year"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVBSVr8K8L44" title="Charge for the year"&gt;113&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLMyVqGEIVsd" title="Charge for the year"&gt;137&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zF8wi6nhTVVg" title="Charge for the year"&gt;280&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAY3x3Tz6Bie" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1539"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPTUFTFXHYp9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1541"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zb4QEfBkeIt7" title="Disposals"&gt;(38&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxkGluRs6CR8" title="Disposals"&gt;(146&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3H4sjJ2bAPj" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1547"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbYM7kByt4Nc" title="Disposals"&gt;(184&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zPYNVKTAVlb3" title="Balance at beginning"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z7D1WNioB047" title="Balance at beginning"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zCK02LaUkBf6" title="Balance at beginning"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z3kkgrSmqtvc" title="Balance at beginning"&gt;1,259&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z9ngMxw0Kjb8" title="Balance at beginning"&gt;371&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zTWpxXUlJDW2" title="Balance at beginning"&gt;1,727&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zn7i1u7Zv9Hc" title="Charge for the year"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUGEP4OSbKK8" title="Charge for the year"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkBJdIOzZJN6" title="Charge for the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zGdAK2kH6cb3" title="Charge for the year"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zS7aLGqdodJg" title="Charge for the year"&gt;135&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zALLLBjp6x14" title="Charge for the year"&gt;252&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zENqF6ESnP0e" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1575"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNBKHo3K46kc" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1577"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z621awzEjkAk" title="Disposals"&gt;(25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z16YkmpDfvk1" title="Disposals"&gt;(736&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlJCvMxu5Ib7" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1583"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIKgb5z1rhm5" title="Disposals"&gt;(761&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zqa0EbmmXBUf" title="Balance at beginning"&gt;43&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z8MezqwtvFmj" title="Balance at beginning"&gt;37&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z1TLUCfA6Rg2" title="Balance at beginning"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zKc7HsOKe5Ja" title="Balance at beginning"&gt;612&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zeldyIjRO4C3" title="Balance at beginning"&gt;506&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zOi1VAttiPui" title="Balance at beginning"&gt;1,218&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQ4Phm6hlCFl" title="Charge for the year"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlHzlJKlIQ4k" title="Charge for the year"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvIIrPV9vGo" title="Charge for the year"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf7gY0p3cOJb" title="Charge for the year"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zeXzo4bLwBM8" title="Charge for the year"&gt;136&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zMNksnCOUMMg" title="Charge for the year"&gt;188&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsOoolbwnUSl" title="Disposals"&gt;(23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCtAUfmFb9vi" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1613"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHrf5wN0WwCi" title="Disposals"&gt;(5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z23SxkA4AWa2" title="Disposals"&gt;(533&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRwELYQsdVii" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1619"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_znqvCd0uUMrj" title="Disposals"&gt;(561&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zqGRNsrBteD6" title="Balance at ending"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z8cNXtVhzp8f" title="Balance at ending"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zvuWrAvfD974" title="Balance at ending"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zl3F7mo47tfl" title="Balance at ending"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zakEcc4E7FA4" title="Balance at ending"&gt;642&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ztt8MSae4yQ7" title="Balance at ending"&gt;845&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Net book value&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zJ50ZK6gpSn1" title="Net book value"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zfrQlvBEEU22" title="Net book value"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4obvxmjBFT4" title="Net book value"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember_zChkH6nP1CYg" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1641"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_zk0tbQUgtr7d" title="Net book value"&gt;79&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231_zrK5EQ0vR203" title="Net book value"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;At 31 December 2024&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zTZZrRfeNGna" title="Net book value"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zHqaTVlSnlxb" title="Net book value"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zOJ7LeSHsBre" title="Net book value"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember_zTKEu9h9igif" title="Net book value"&gt;68&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_z119lCbb4PV8" title="Net book value"&gt;215&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231_ztrpYgoUk4f8" title="Net book value"&gt;324&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zDYzsCWR9av1" title="Net book value"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zC5orHNLH225" title="Net book value"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhbtzlhbKx0g" title="Net book value"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember_z6st9BnFD8Li" title="Net book value"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_z7SZ14ynWeRa" title="Net book value"&gt;350&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231_zgwSp4HgGbs8" title="Net book value"&gt;571&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z84nGVgUKq5h" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;As at 31 December the right of use
asset consisted of leasehold improvements of net book value &#xa3;&lt;span id="xdx_909_eifrs-full--RightofuseAssets_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3p" title="Right of use asset"&gt;79,000&lt;/span&gt; (2024: &#xa3;&lt;span id="xdx_90A_eifrs-full--RightofuseAssets_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3p" title="Right of use asset"&gt;215,000&lt;/span&gt;; 2023: &#xa3;&lt;span id="xdx_90B_eifrs-full--RightofuseAssets_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3p" title="Right of use asset"&gt;350,000&lt;/span&gt;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;On 1 February 2023 laboratory equipment
previously disclosed within right of use assets was transferred to laboratory equipment when the final payment on the finance lease was
made.&lt;br/&gt;
&#160;&lt;/p&gt;





</bdrx:DisclosureOfPropertyPlantAndEquipmentsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001369">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_zGnOlMUlcbil" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property, plant and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BA_zS1GmHjk4B9k" style="display: none"&gt;Schedule of detailed information about property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Fixtures&lt;br/&gt; and fittings&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Leasehold&lt;br/&gt; improvements&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Computer&lt;br/&gt; equipment&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Laboratory&lt;br/&gt; equipment&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Right of use&lt;br/&gt; &#160;asset&lt;br/&gt; &#160;&#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zT7SC5XQ6qkl" title="Balance at beginning"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zaw7wL28yQBi" title="Balance at beginning"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zkOBU2T1mPL9" title="Balance at beginning"&gt;88&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zu2jwdBkoLY2" title="Balance at beginning"&gt;1,434&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zjJPV8uKSMM1" title="Balance at beginning"&gt;824&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zY7qlfS1fVzc" title="Balance at beginning"&gt;2,462&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zoNJSFEzNQQd" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1383"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zSGt5ZvporV6" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1385"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zOSlQmndvVw2" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1387"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zhQKZX4RvbZf" title="Additions"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUVuKQAQ9y4e" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1391"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zGP99041hQec" title="Additions"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Transfers&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zQX5io4AuVqf" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1395"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zqzFLP85sc4h" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1397"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zFu7xdGNiH83" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1399"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zblRjuCOCcnf" title="Transfer"&gt;103&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zu1UDDhs3v3j" title="Transfer"&gt;(103&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zzhNLsEDtk2f" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1405"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zBx7P0cuo2U9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1407"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zxWeN20IdPF9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1409"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ziJwxuopUiH9" title="Disposals"&gt;(38&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z142V5oOJLL6" title="Disposals"&gt;(152&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zfr8ilTJums9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1415"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zayTL0pGagV6" title="Disposals"&gt;(190&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zJ48gLZCXfy2" title="Balance at beginning"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zWyiOVwptXrb" title="Balance at beginning"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAwLdev8cxVb" title="Balance at beginning"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zMSvRbBMtaal" title="Balance at beginning"&gt;1,411&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zGLNo2fq7bde" title="Balance at beginning"&gt;721&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zGc15KMyqtS7" title="Balance at beginning"&gt;2,298&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zK1PyQRKKLY4" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1431"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zDI2rWEgHRw" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1433"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zH3NAjFLXRA2" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1435"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z26LoAZKzCF4" title="Additions"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zY1PxKMWTDOi" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1439"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zCFF3uYoXtub" title="Additions"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUjUoCon97V9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1443"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zvBQMPx4Iwx1" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1445"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zX6ngLZg64Zk" title="Disposals"&gt;(25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z0mS8SRlQ1Gc" title="Disposals"&gt;(740&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zMpJ2WFyNYpe" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1451"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zm9G4c0I38u5" title="Disposals"&gt;(765&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zFc7HX5MGY76" title="Balance at beginning"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zJoos1pz2k8b" title="Balance at beginning"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAuMuWUzNdJh" title="Balance at beginning"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zLgoa3ZRvF91" title="Balance at beginning"&gt;680&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z4LjuQM4YGa9" title="Balance at beginning"&gt;721&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z63kyhS6mj0c" title="Balance at beginning"&gt;1,542&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ziDPg5GXqgR2" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1467"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zFSRdCA5RPP8" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1469"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zTjZQamGEgi9" title="Additions"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zZ50vIFqYyFc" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1473"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zdNJzwaQw7A6" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z27nN13cuZwd" title="Additions"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zSgvQz23d719" title="Disposals"&gt;(28&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zG5fCyhf8QRk" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1481"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z72GdVRLb9Wh" title="Disposals"&gt;(5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zPkppB8PYEeh" title="Disposals"&gt;(575&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUYNVJQoih7j" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1487"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DisposalsPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUEff9h9EXr5" title="Disposals"&gt;(608&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z5heaZKl2pE7" title="Balance at ending"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAt0x3hmnrLl" title="Balance at ending"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zKlvga9Qu403" title="Balance at ending"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zbK7hmzUWK52" title="Balance at ending"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zmIcFomnr1u1" title="Balance at ending"&gt;721&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ziQEnG9QfmBb" title="Balance at ending"&gt;936&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Fixtures&lt;br/&gt; and fittings&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Leasehold&lt;br/&gt; improvements&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Computer&lt;br/&gt; equipment&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Laboratory &lt;br/&gt; equipment&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Right of use&lt;br/&gt; &#160;asset&lt;br/&gt; &#160;&#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ztzBmXAzQdQ7" title="Balance at beginning"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z7m7nV9Cgcpl" title="Balance at beginning"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ze0hmrngGiV7" title="Balance at beginning"&gt;71&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zUCz6NFNU0Jl" title="Balance at beginning"&gt;1,189&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zpZuxG7D9gd" title="Balance at beginning"&gt;337&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zxZSXgUpu5t3" title="Balance at beginning"&gt;1,631&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Transfers&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z5rvCeu21Kk5" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1515"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8d116g4aOK" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1517"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0y3uE05ULYe" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1519"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zeOXBFZL5Mw9" title="Transfer"&gt;103&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zc7F7ENDM0rh" title="Transfer"&gt;(103&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3MSPqHKvFo8" title="Transfer"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1525"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmQXbFPpqH03" title="Charge for the year"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zU0Q2fhOwGj8" title="Charge for the year"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBN4jvpxS7O3" title="Charge for the year"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVBSVr8K8L44" title="Charge for the year"&gt;113&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLMyVqGEIVsd" title="Charge for the year"&gt;137&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zF8wi6nhTVVg" title="Charge for the year"&gt;280&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAY3x3Tz6Bie" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1539"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPTUFTFXHYp9" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1541"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zb4QEfBkeIt7" title="Disposals"&gt;(38&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxkGluRs6CR8" title="Disposals"&gt;(146&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3H4sjJ2bAPj" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1547"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Disposals_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbYM7kByt4Nc" title="Disposals"&gt;(184&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zPYNVKTAVlb3" title="Balance at beginning"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z7D1WNioB047" title="Balance at beginning"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zCK02LaUkBf6" title="Balance at beginning"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z3kkgrSmqtvc" title="Balance at beginning"&gt;1,259&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z9ngMxw0Kjb8" title="Balance at beginning"&gt;371&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zTWpxXUlJDW2" title="Balance at beginning"&gt;1,727&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zn7i1u7Zv9Hc" title="Charge for the year"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUGEP4OSbKK8" title="Charge for the year"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkBJdIOzZJN6" title="Charge for the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zGdAK2kH6cb3" title="Charge for the year"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zS7aLGqdodJg" title="Charge for the year"&gt;135&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zALLLBjp6x14" title="Charge for the year"&gt;252&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zENqF6ESnP0e" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1575"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNBKHo3K46kc" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1577"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z621awzEjkAk" title="Disposals"&gt;(25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z16YkmpDfvk1" title="Disposals"&gt;(736&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlJCvMxu5Ib7" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1583"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Disposals_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIKgb5z1rhm5" title="Disposals"&gt;(761&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zqa0EbmmXBUf" title="Balance at beginning"&gt;43&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z8MezqwtvFmj" title="Balance at beginning"&gt;37&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z1TLUCfA6Rg2" title="Balance at beginning"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zKc7HsOKe5Ja" title="Balance at beginning"&gt;612&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zeldyIjRO4C3" title="Balance at beginning"&gt;506&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--AccumulatedDepreciationAndAmortisation_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zOi1VAttiPui" title="Balance at beginning"&gt;1,218&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQ4Phm6hlCFl" title="Charge for the year"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlHzlJKlIQ4k" title="Charge for the year"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvIIrPV9vGo" title="Charge for the year"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf7gY0p3cOJb" title="Charge for the year"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zeXzo4bLwBM8" title="Charge for the year"&gt;136&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zMNksnCOUMMg" title="Charge for the year"&gt;188&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsOoolbwnUSl" title="Disposals"&gt;(23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCtAUfmFb9vi" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1613"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHrf5wN0WwCi" title="Disposals"&gt;(5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z23SxkA4AWa2" title="Disposals"&gt;(533&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRwELYQsdVii" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1619"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Disposals_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_znqvCd0uUMrj" title="Disposals"&gt;(561&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zqGRNsrBteD6" title="Balance at ending"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z8cNXtVhzp8f" title="Balance at ending"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zvuWrAvfD974" title="Balance at ending"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zl3F7mo47tfl" title="Balance at ending"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zakEcc4E7FA4" title="Balance at ending"&gt;642&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedDepreciationAndAmortisation_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_ztt8MSae4yQ7" title="Balance at ending"&gt;845&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Net book value&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zJ50ZK6gpSn1" title="Net book value"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zfrQlvBEEU22" title="Net book value"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4obvxmjBFT4" title="Net book value"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember_zChkH6nP1CYg" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1641"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_zk0tbQUgtr7d" title="Net book value"&gt;79&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231_zrK5EQ0vR203" title="Net book value"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;At 31 December 2024&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zTZZrRfeNGna" title="Net book value"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zHqaTVlSnlxb" title="Net book value"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zOJ7LeSHsBre" title="Net book value"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember_zTKEu9h9igif" title="Net book value"&gt;68&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_z119lCbb4PV8" title="Net book value"&gt;215&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231_ztrpYgoUk4f8" title="Net book value"&gt;324&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zDYzsCWR9av1" title="Net book value"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zC5orHNLH225" title="Net book value"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhbtzlhbKx0g" title="Net book value"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoryEquipmentMember_z6st9BnFD8Li" title="Net book value"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_z7SZ14ynWeRa" title="Net book value"&gt;350&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20231231_zgwSp4HgGbs8" title="Net book value"&gt;571&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001371"
      unitRef="GBP">63000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001373"
      unitRef="GBP">53000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001375"
      unitRef="GBP">88000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001377"
      unitRef="GBP">1434000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001379"
      unitRef="GBP">824000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001381"
      unitRef="GBP">2462000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001389"
      unitRef="GBP">26000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001393"
      unitRef="GBP">26000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001401"
      unitRef="GBP">103000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001403"
      unitRef="GBP">-103000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001411"
      unitRef="GBP">-38000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001413"
      unitRef="GBP">-152000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001417"
      unitRef="GBP">-190000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001419"
      unitRef="GBP">63000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001421"
      unitRef="GBP">53000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001423"
      unitRef="GBP">50000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001425"
      unitRef="GBP">1411000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001427"
      unitRef="GBP">721000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001429"
      unitRef="GBP">2298000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001437"
      unitRef="GBP">9000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001441"
      unitRef="GBP">9000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001447"
      unitRef="GBP">-25000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001449"
      unitRef="GBP">-740000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001453"
      unitRef="GBP">-765000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001455"
      unitRef="GBP">63000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001457"
      unitRef="GBP">53000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001459"
      unitRef="GBP">25000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001461"
      unitRef="GBP">680000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001463"
      unitRef="GBP">721000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001465"
      unitRef="GBP">1542000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001471"
      unitRef="GBP">2000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001477"
      unitRef="GBP">2000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001479"
      unitRef="GBP">-28000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001483"
      unitRef="GBP">-5000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001485"
      unitRef="GBP">-575000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001489"
      unitRef="GBP">-608000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001491"
      unitRef="GBP">35000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001493"
      unitRef="GBP">53000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001495"
      unitRef="GBP">22000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001497"
      unitRef="GBP">105000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001499"
      unitRef="GBP">721000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001501"
      unitRef="GBP">936000</ifrs-full:PropertyPlantAndEquipment>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2022-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001503"
      unitRef="GBP">19000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2022-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001505"
      unitRef="GBP">15000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2022-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001507"
      unitRef="GBP">71000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2022-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001509"
      unitRef="GBP">1189000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2022-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001511"
      unitRef="GBP">337000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2022-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001513"
      unitRef="GBP">1631000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1
      contextRef="From2023-01-012023-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001521"
      unitRef="GBP">103000</bdrx:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1>
    <bdrx:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1
      contextRef="From2023-01-012023-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001523"
      unitRef="GBP">-103000</bdrx:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001527"
      unitRef="GBP">12000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001529"
      unitRef="GBP">11000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001531"
      unitRef="GBP">7000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001533"
      unitRef="GBP">113000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001535"
      unitRef="GBP">137000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001537"
      unitRef="GBP">280000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <bdrx:Disposals
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001543"
      unitRef="GBP">-38000</bdrx:Disposals>
    <bdrx:Disposals
      contextRef="From2023-01-012023-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001545"
      unitRef="GBP">-146000</bdrx:Disposals>
    <bdrx:Disposals
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001549"
      unitRef="GBP">-184000</bdrx:Disposals>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001551"
      unitRef="GBP">31000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001553"
      unitRef="GBP">26000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001555"
      unitRef="GBP">40000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2023-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001557"
      unitRef="GBP">1259000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2023-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001559"
      unitRef="GBP">371000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2023-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001561"
      unitRef="GBP">1727000</bdrx:AccumulatedDepreciationAndAmortisation>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001563"
      unitRef="GBP">12000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001565"
      unitRef="GBP">11000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001567"
      unitRef="GBP">5000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001569"
      unitRef="GBP">89000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001571"
      unitRef="GBP">135000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001573"
      unitRef="GBP">252000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <bdrx:Disposals
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001579"
      unitRef="GBP">-25000</bdrx:Disposals>
    <bdrx:Disposals
      contextRef="From2024-01-012024-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001581"
      unitRef="GBP">-736000</bdrx:Disposals>
    <bdrx:Disposals
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001585"
      unitRef="GBP">-761000</bdrx:Disposals>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001587"
      unitRef="GBP">43000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001589"
      unitRef="GBP">37000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001591"
      unitRef="GBP">20000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2024-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001593"
      unitRef="GBP">612000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2024-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001595"
      unitRef="GBP">506000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2024-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001597"
      unitRef="GBP">1218000</bdrx:AccumulatedDepreciationAndAmortisation>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001599"
      unitRef="GBP">11000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001601"
      unitRef="GBP">11000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001603"
      unitRef="GBP">4000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001605"
      unitRef="GBP">26000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001607"
      unitRef="GBP">136000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001609"
      unitRef="GBP">188000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <bdrx:Disposals
      contextRef="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001611"
      unitRef="GBP">-23000</bdrx:Disposals>
    <bdrx:Disposals
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001615"
      unitRef="GBP">-5000</bdrx:Disposals>
    <bdrx:Disposals
      contextRef="From2025-01-012025-12-31_custom_LaboratoryEquipmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001617"
      unitRef="GBP">-533000</bdrx:Disposals>
    <bdrx:Disposals
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact001621"
      unitRef="GBP">-561000</bdrx:Disposals>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001623"
      unitRef="GBP">31000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001625"
      unitRef="GBP">48000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001627"
      unitRef="GBP">19000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2025-12-31_custom_LaboratoryEquipmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001629"
      unitRef="GBP">105000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2025-12-31_ifrs-full_RightofuseAssetsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001631"
      unitRef="GBP">642000</bdrx:AccumulatedDepreciationAndAmortisation>
    <bdrx:AccumulatedDepreciationAndAmortisation
      contextRef="AsOf2025-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001633"
      unitRef="GBP">845000</bdrx:AccumulatedDepreciationAndAmortisation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact001635"
      unitRef="GBP">4000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact001637"
      unitRef="GBP">5000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_ComputerEquipmentMember"
      decimals="-3"
      id="Fact001639"
      unitRef="GBP">3000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_RightofuseAssetsMember"
      decimals="-3"
      id="Fact001643"
      unitRef="GBP">79000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001645"
      unitRef="GBP">91000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact001647"
      unitRef="GBP">20000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact001649"
      unitRef="GBP">16000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_ComputerEquipmentMember"
      decimals="-3"
      id="Fact001651"
      unitRef="GBP">5000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_LaboratoryEquipmentMember"
      decimals="-3"
      id="Fact001653"
      unitRef="GBP">68000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_RightofuseAssetsMember"
      decimals="-3"
      id="Fact001655"
      unitRef="GBP">215000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001657"
      unitRef="GBP">324000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact001659"
      unitRef="GBP">32000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact001661"
      unitRef="GBP">27000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember"
      decimals="-3"
      id="Fact001663"
      unitRef="GBP">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_LaboratoryEquipmentMember"
      decimals="-3"
      id="Fact001665"
      unitRef="GBP">152000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_RightofuseAssetsMember"
      decimals="-3"
      id="Fact001667"
      unitRef="GBP">350000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001669"
      unitRef="GBP">571000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact001671"
      unitRef="GBP">79000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact001673"
      unitRef="GBP">215000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact001675"
      unitRef="GBP">350000</ifrs-full:RightofuseAssets>
    <bdrx:DisclosureOfLeaseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001677">&lt;p id="xdx_809_ecustom--DisclosureOfLeaseExplanatory_z1Y1FAAEISPb" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;10&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82D_zUYDPwtmZQ0e"&gt;Leases&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutMarketRentalRatesExplanatory_pn3n3_zEUbL9rMaPT5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Leases (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B7_z6AtyutTZwnh" style="display: none"&gt;Schedule of market rental rates&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Lease Liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;At 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zbMrjwzHa668" title="At 1 January"&gt;297&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zlWyQaJBU7K6" title="At 1 January"&gt;464&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zRhaIuEWLi4c" title="At 1 January"&gt;624&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest expenses&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z4tuNKL43zTg" title="Interest expenses"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z483BHo23bel" title="Interest expenses"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zlVplAehKlO4" title="Interest expenses"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Lease payments&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zSKHvzgFqaxd" title="Lease payments"&gt;(246&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z6Nk6EN3JuAg" title="Lease payments"&gt;(186&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zDY31hAtOXR5" title="Lease payments"&gt;(188&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z6ajSQsDMRV7" title="At 31 December"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z62f8f101F9b" title="At 31 December"&gt;297&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zONPeNAgylf3" title="At 31 December"&gt;464&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zUMS7TZ7G4F4" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The right of use
assets is disclosed in note 9.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"&gt;In April 2021 the Group signed
an agreement to lease new premises in Cardiff, Wales, to house its corporate offices and laboratories. The agreement to lease allowed
the Group to carry out the Cat A works and fit out prior to completion of the lease and its occupation in August 2021. The lease agreed
was for a 5 year period with no break clause. The lease was recognised as a right of use asset in 2021. The recognition in 2021 of the
right of use asset and corresponding lease liability were a non cash investing and financing transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;b&gt;Low value leases expensed in year:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfLowValueLeasesExpensed_pn3n3_zIUPkfPhFZZa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Leases (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B8_zY2EBnGwq7s2" style="display: none"&gt;Low value leases expensed in year&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20250101__20251231_z8K8OrZ1A0a6" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20240101__20241231_znrjsXWhmwq6" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20230101__20231231_zaIChU7m7V7f" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LowValueLeasesExpensed_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Low value leases expensed&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--Total_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: White"&gt;&#160;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_z7MclGNiVc0e" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;Total cash outflow for leases in
2025 was &#xa3;&lt;span id="xdx_90D_ecustom--TotalCashOutflowForLeases_c20250101__20251231_pn3p" title="Total cash outflow for leases"&gt;246,000&lt;/span&gt; (2024: &#xa3;&lt;span id="xdx_90B_ecustom--TotalCashOutflowForLeases_c20240101__20241231_pn3p" title="Total cash outflow for leases"&gt;187,000&lt;/span&gt;; 2023: &#xa3;&lt;span id="xdx_909_ecustom--TotalCashOutflowForLeases_c20230101__20231231_pn3p" title="Total cash outflow for leases"&gt;190,000&lt;/span&gt;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</bdrx:DisclosureOfLeaseExplanatory>
    <bdrx:DisclosureOfDetailedInformationAboutMarketRentalRatesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001679">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutMarketRentalRatesExplanatory_pn3n3_zEUbL9rMaPT5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Leases (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B7_z6AtyutTZwnh" style="display: none"&gt;Schedule of market rental rates&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Lease Liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;At 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zbMrjwzHa668" title="At 1 January"&gt;297&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zlWyQaJBU7K6" title="At 1 January"&gt;464&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zRhaIuEWLi4c" title="At 1 January"&gt;624&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest expenses&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z4tuNKL43zTg" title="Interest expenses"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z483BHo23bel" title="Interest expenses"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zlVplAehKlO4" title="Interest expenses"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Lease payments&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zSKHvzgFqaxd" title="Lease payments"&gt;(246&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z6Nk6EN3JuAg" title="Lease payments"&gt;(186&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zDY31hAtOXR5" title="Lease payments"&gt;(188&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z6ajSQsDMRV7" title="At 31 December"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_z62f8f101F9b" title="At 31 December"&gt;297&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--LandAndBuildingsMember_zONPeNAgylf3" title="At 31 December"&gt;464&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfDetailedInformationAboutMarketRentalRatesExplanatory>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001681"
      unitRef="GBP">297000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001683"
      unitRef="GBP">464000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001685"
      unitRef="GBP">624000</ifrs-full:LeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2025-01-012025-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001687"
      unitRef="GBP">10000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2024-01-012024-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001689"
      unitRef="GBP">19000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2023-01-012023-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001691"
      unitRef="GBP">28000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001693"
      unitRef="GBP">-246000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001695"
      unitRef="GBP">-186000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001697"
      unitRef="GBP">-188000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001699"
      unitRef="GBP">61000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001701"
      unitRef="GBP">297000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LandAndBuildingsMember"
      decimals="-3"
      id="Fact001703"
      unitRef="GBP">464000</ifrs-full:LeaseLiabilities>
    <bdrx:DisclosureOfLowValueLeasesExpensed contextRef="From2025-01-01to2025-12-31" id="Fact001705">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfLowValueLeasesExpensed_pn3n3_zIUPkfPhFZZa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Leases (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B8_zY2EBnGwq7s2" style="display: none"&gt;Low value leases expensed in year&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20250101__20251231_z8K8OrZ1A0a6" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20240101__20241231_znrjsXWhmwq6" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20230101__20231231_zaIChU7m7V7f" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LowValueLeasesExpensed_i_pn3n" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Low value leases expensed&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; color: #4D4D4C; text-align: right"&gt;2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--Total_i_pn3n" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: White"&gt;&#160;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfLowValueLeasesExpensed>
    <bdrx:LowValueLeasesExpensed
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001707"
      unitRef="GBP">1000</bdrx:LowValueLeasesExpensed>
    <bdrx:LowValueLeasesExpensed
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001708"
      unitRef="GBP">1000</bdrx:LowValueLeasesExpensed>
    <bdrx:LowValueLeasesExpensed
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001709"
      unitRef="GBP">2000</bdrx:LowValueLeasesExpensed>
    <bdrx:Total
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001711"
      unitRef="GBP">1000</bdrx:Total>
    <bdrx:Total
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001712"
      unitRef="GBP">1000</bdrx:Total>
    <bdrx:Total
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001713"
      unitRef="GBP">2000</bdrx:Total>
    <bdrx:TotalCashOutflowForLeases
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001715"
      unitRef="GBP">246000</bdrx:TotalCashOutflowForLeases>
    <bdrx:TotalCashOutflowForLeases
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001717"
      unitRef="GBP">187000</bdrx:TotalCashOutflowForLeases>
    <bdrx:TotalCashOutflowForLeases
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001719"
      unitRef="GBP">190000</bdrx:TotalCashOutflowForLeases>
    <bdrx:DisclosureOfIntangibleAssetExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001721">&lt;p id="xdx_800_ecustom--DisclosureOfIntangibleAssetExplanatory_zpR6akYEHdma" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;11&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_829_zXuFPbjHHnrf"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eifrs-full--DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_pn3n3_zYzaU1L9pkw5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B8_zIFZOpCec99f" style="display: none"&gt;Schedule of reconciliation of changes in intangible assets and goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;In-process &lt;br/&gt; research and &lt;br/&gt; development&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Goodwill&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;IT/Website &lt;br/&gt; costs&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Cost&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zm9lWUwmsged" title="Balance at beginning"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z2rKu2R3Gr8l" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z2dIZytdSI2j" title="Balance at beginning"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAInc4QsKt85" title="Balance at beginning"&gt;15,779&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Acquisition&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zR1DOvvrbpA5" title="Acquisition"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zyDz2ObD5HP" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1735"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zJhZIyBbJEC3" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1737"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zBxmFVG5d1Af" title="Acquisition"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zbk3bWCNrsRh" title="Balance at beginning"&gt;16,316&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zorYb2zbng76" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zVs27ED11Wra" title="Balance at beginning"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zm7LbEeQCVif" title="Balance at beginning"&gt;18,717&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Acquisition&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zbOe9VQdccqb" title="Acquisition"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAO1NWEIvDD5" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1751"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zr98H0NWsj0f" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zpWxaYaigHv7" title="Acquisition"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zglUo8MWevs4" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1757"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zfb3sVc7C7n2" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1759"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zr3Jx7DhBN92" title="Disposal"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zZeQtCRkvdHl" title="Disposal"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z2nAw17d63n2" title="Balance at beginning"&gt;19,023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z10i0cp2WFx6" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zITdYtmcooyc" title="Balance at beginning"&gt;88&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zojllFE9aqOj" title="Balance at beginning"&gt;21,402&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Acquisition&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zuXyxYu9Nccj" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1773"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z0jURJ2S054i" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1775"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zviY5retN6Je" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1777"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zOlCkpEbZjR6" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1779"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z3Bm56pIBOOb" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1781"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zA0JGKVxwA45" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1783"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z3xckKrLhq35" title="Disposal"&gt;(19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zNwCaOD5rCn2" title="Disposal"&gt;(19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zz1WX8EWJfub" title="Balance at end"&gt;19,023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zDYUUGpSTHJ2" title="Balance at end"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z89dRHOKBbF" title="Balance at end"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zPP1G5p4HQg7" title="Balance at end"&gt;21,383&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;In-process&lt;br/&gt; research and&lt;br/&gt; development&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Goodwill&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;IT/Website&lt;br/&gt; Costs&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Accumulated amortisation and impairment&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zLpZyjRRMFRh" title="Balance at beginning"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zBZ3SQPHxrOh" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z6BsO3zAkLRh" title="Balance at beginning"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z340LyjN7xW6" title="Balance at beginning"&gt;15,773&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortisation charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_ztOR8VWKlyik" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1805"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z0THU3IghrSf" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1807"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zp7u3klmvtee" title="Amortisation charge for the year"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z66AvAkhipui" title="Amortisation charge for the year"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Disposal_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zjSjdAyvDBn6" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1813"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Disposal_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z3Znstd5YLNc" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1815"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Disposal_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zmV3g5ytfSM8" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1817"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Disposal_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z8I0zQUj3wvi" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1819"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zfn3cl56iUv4" title="Balance at beginning"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zOZZCo0uBV45" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zwsGQM9J3QUa" title="Balance at beginning"&gt;107&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z65g2SsmGtel" title="Balance at beginning"&gt;15,776&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Amortisation charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zSspyHcZSOva" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1829"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zYYFfxOsthO3" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1831"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zPNN99w8Gghg" title="Amortisation charge for the year"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zN934ER126ec" title="Amortisation charge for the year"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Disposal_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z9KAPu6IsZHf" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1837"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Disposal_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z8f6ufaE9e8b" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1839"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposal_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z0ABLakh1Yic" title="Disposal"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposal_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z5mO2Djcz3Pe" title="Disposal"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zjYTEnrs11Ic" title="Balance at beginning"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z0ic6Osouumj" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zzwjCsMPqJAc" title="Balance at beginning"&gt;87&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zyDcmhUtDia" title="Balance at beginning"&gt;15,756&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortisation charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zazA73ic4yc1" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1853"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z24PxUd8Rt36" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1855"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zwcaRZjkv6o8" title="Amortisation charge for the year"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zMEd43lFadtf" title="Amortisation charge for the year"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Disposal_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zxoRMBbjSEAi" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1861"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Disposal_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zo01rE7VxDl8" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1863"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Disposal_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zUnuZfzJXtUc" title="Disposal"&gt;(19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Disposal_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zwWzx8859r4i" title="Disposal"&gt;(19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedAmortisationAndImpairment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zEanS2F4yjwi" title="Balance at end"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccumulatedAmortisationAndImpairment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zegJGheUCcUk" title="Balance at end"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccumulatedAmortisationAndImpairment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zMu5YjNnqu17" title="Balance at end"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AccumulatedAmortisationAndImpairment_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zbbv1lFO6O46" title="Balance at end"&gt;15,738&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Net book value&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zHIZrRQseiJ4" title="Net book value"&gt;5,645&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zaCNSPLzIsA6" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1879"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember_z4INyjWIv1Hk" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1881"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20251231_zS3UmKLrvEmb" title="Net book value"&gt;5,645&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;At 31 December 2024&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zGAO8x6i92La" title="Net book value"&gt;5,645&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_znL7Rjsgn6dl" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1887"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember_zeeEPm83c2Od" title="Net book value"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20241231_zKHh25mGFBbe" title="Net book value"&gt;5,646&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_z3EGVrt1rATi" title="Net book value"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zqQzih8Q2TOc" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1895"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember_zvD6FOOC7bp7" title="Net book value"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20231231_zcqMWcRXYHwd" title="Net book value"&gt;2,941&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zChmatnZ06N9" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The individual intangible asset which is material
to the financial statements is as follows:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOffCondensedFinancialStatementsTableTextBlock_pn3n3_zABhsTAnXqc4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Intangible assets (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_zQdGNuC25MD1" style="display: none"&gt;Schedule of condensed financial statements&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Carrying amount&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Remaining amortisation &lt;br/&gt; period&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; (years)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; (years)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; (years)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;MTX228 tolimidone acquired IPRD*&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zG3zUky8Fd47" title="Carrying amount"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zVPjyRakZTWb" title="Carrying amount"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zOTq9yiWP7g4" title="Carrying amount"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;MTX230 eRapa acquired IPRD*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____zciRlDiibdse" title="Carrying amount"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____zfTtmNCNaEF6" title="Carrying amount"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____zjCVXI3rURuk" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1916"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td id="xdx_F0E_zBO0PvK6EGKe" style="width: 9pt; text-align: left"&gt;*&lt;/td&gt;&lt;td id="xdx_F10_zMESEH8Njh6g"&gt;asset is not yet in use and has not started amortising&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A1_zL6aRIuSszx2" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</bdrx:DisclosureOfIntangibleAssetExplanatory>
    <ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001723">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eifrs-full--DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_pn3n3_zYzaU1L9pkw5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B8_zIFZOpCec99f" style="display: none"&gt;Schedule of reconciliation of changes in intangible assets and goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;In-process &lt;br/&gt; research and &lt;br/&gt; development&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Goodwill&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;IT/Website &lt;br/&gt; costs&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Cost&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zm9lWUwmsged" title="Balance at beginning"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z2rKu2R3Gr8l" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z2dIZytdSI2j" title="Balance at beginning"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAInc4QsKt85" title="Balance at beginning"&gt;15,779&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Acquisition&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zR1DOvvrbpA5" title="Acquisition"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zyDz2ObD5HP" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1735"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zJhZIyBbJEC3" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1737"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zBxmFVG5d1Af" title="Acquisition"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zbk3bWCNrsRh" title="Balance at beginning"&gt;16,316&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zorYb2zbng76" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zVs27ED11Wra" title="Balance at beginning"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zm7LbEeQCVif" title="Balance at beginning"&gt;18,717&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Acquisition&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zbOe9VQdccqb" title="Acquisition"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zAO1NWEIvDD5" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1751"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zr98H0NWsj0f" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zpWxaYaigHv7" title="Acquisition"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zglUo8MWevs4" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1757"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zfb3sVc7C7n2" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1759"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zr3Jx7DhBN92" title="Disposal"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zZeQtCRkvdHl" title="Disposal"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z2nAw17d63n2" title="Balance at beginning"&gt;19,023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z10i0cp2WFx6" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zITdYtmcooyc" title="Balance at beginning"&gt;88&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zojllFE9aqOj" title="Balance at beginning"&gt;21,402&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Acquisition&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zuXyxYu9Nccj" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1773"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z0jURJ2S054i" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1775"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zviY5retN6Je" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1777"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zOlCkpEbZjR6" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1779"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z3Bm56pIBOOb" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1781"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zA0JGKVxwA45" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1783"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z3xckKrLhq35" title="Disposal"&gt;(19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zNwCaOD5rCn2" title="Disposal"&gt;(19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zz1WX8EWJfub" title="Balance at end"&gt;19,023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zDYUUGpSTHJ2" title="Balance at end"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_z89dRHOKBbF" title="Balance at end"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--GrossGrossGrossCarryingAmountMember_zPP1G5p4HQg7" title="Balance at end"&gt;21,383&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;In-process&lt;br/&gt; research and&lt;br/&gt; development&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Goodwill&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;IT/Website&lt;br/&gt; Costs&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold"&gt;Accumulated amortisation and impairment&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zLpZyjRRMFRh" title="Balance at beginning"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zBZ3SQPHxrOh" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z6BsO3zAkLRh" title="Balance at beginning"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z340LyjN7xW6" title="Balance at beginning"&gt;15,773&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortisation charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_ztOR8VWKlyik" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1805"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z0THU3IghrSf" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1807"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zp7u3klmvtee" title="Amortisation charge for the year"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z66AvAkhipui" title="Amortisation charge for the year"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Disposal_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zjSjdAyvDBn6" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1813"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Disposal_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z3Znstd5YLNc" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1815"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Disposal_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zmV3g5ytfSM8" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1817"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Disposal_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z8I0zQUj3wvi" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1819"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zfn3cl56iUv4" title="Balance at beginning"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zOZZCo0uBV45" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zwsGQM9J3QUa" title="Balance at beginning"&gt;107&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z65g2SsmGtel" title="Balance at beginning"&gt;15,776&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Amortisation charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zSspyHcZSOva" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1829"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zYYFfxOsthO3" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1831"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zPNN99w8Gghg" title="Amortisation charge for the year"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zN934ER126ec" title="Amortisation charge for the year"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Disposal_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z9KAPu6IsZHf" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1837"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Disposal_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z8f6ufaE9e8b" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1839"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposal_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z0ABLakh1Yic" title="Disposal"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Disposal_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z5mO2Djcz3Pe" title="Disposal"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zjYTEnrs11Ic" title="Balance at beginning"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z0ic6Osouumj" title="Balance at beginning"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zzwjCsMPqJAc" title="Balance at beginning"&gt;87&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedAmortisationAndImpairment_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zyDcmhUtDia" title="Balance at beginning"&gt;15,756&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortisation charge for the year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zazA73ic4yc1" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1853"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z24PxUd8Rt36" title="Amortisation charge for the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1855"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zwcaRZjkv6o8" title="Amortisation charge for the year"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zMEd43lFadtf" title="Amortisation charge for the year"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Disposal&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Disposal_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zxoRMBbjSEAi" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1861"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Disposal_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zo01rE7VxDl8" title="Disposal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1863"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Disposal_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zUnuZfzJXtUc" title="Disposal"&gt;(19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Disposal_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zwWzx8859r4i" title="Disposal"&gt;(19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedAmortisationAndImpairment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zEanS2F4yjwi" title="Balance at end"&gt;13,378&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccumulatedAmortisationAndImpairment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zegJGheUCcUk" title="Balance at end"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccumulatedAmortisationAndImpairment_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zMu5YjNnqu17" title="Balance at end"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AccumulatedAmortisationAndImpairment_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zbbv1lFO6O46" title="Balance at end"&gt;15,738&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Net book value&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zHIZrRQseiJ4" title="Net book value"&gt;5,645&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zaCNSPLzIsA6" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1879"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember_z4INyjWIv1Hk" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1881"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20251231_zS3UmKLrvEmb" title="Net book value"&gt;5,645&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;At 31 December 2024&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zGAO8x6i92La" title="Net book value"&gt;5,645&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_znL7Rjsgn6dl" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1887"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember_zeeEPm83c2Od" title="Net book value"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20241231_zKHh25mGFBbe" title="Net book value"&gt;5,646&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_z3EGVrt1rATi" title="Net book value"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zqQzih8Q2TOc" title="Net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1895"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--ITAndWebsiteCostsMember_zvD6FOOC7bp7" title="Net book value"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsAndGoodwill_iI_pn3n3_c20231231_zcqMWcRXYHwd" title="Net book value"&gt;2,941&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001725"
      unitRef="GBP">13378000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001727"
      unitRef="GBP">2291000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001729"
      unitRef="GBP">110000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001731"
      unitRef="GBP">15779000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001733"
      unitRef="GBP">2938000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001739"
      unitRef="GBP">2938000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001741"
      unitRef="GBP">16316000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001743"
      unitRef="GBP">2291000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001745"
      unitRef="GBP">110000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001747"
      unitRef="GBP">18717000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001749"
      unitRef="GBP">2707000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001755"
      unitRef="GBP">2707000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001761"
      unitRef="GBP">-22000</ifrs-full:DisposalsIntangibleAssetsAndGoodwill>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001763"
      unitRef="GBP">-22000</ifrs-full:DisposalsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001765"
      unitRef="GBP">19023000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001767"
      unitRef="GBP">2291000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001769"
      unitRef="GBP">88000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001771"
      unitRef="GBP">21402000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2025-01-012025-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001785"
      unitRef="GBP">-19000</ifrs-full:DisposalsIntangibleAssetsAndGoodwill>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2025-01-012025-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001787"
      unitRef="GBP">-19000</ifrs-full:DisposalsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001789"
      unitRef="GBP">19023000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001791"
      unitRef="GBP">2291000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_ITAndWebsiteCostsMember_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001793"
      unitRef="GBP">69000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_GrossGrossGrossCarryingAmountMember"
      decimals="-3"
      id="Fact001795"
      unitRef="GBP">21383000</ifrs-full:IntangibleAssetsAndGoodwill>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2022-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001797"
      unitRef="GBP">13378000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001799"
      unitRef="GBP">2291000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2022-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001801"
      unitRef="GBP">104000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001803"
      unitRef="GBP">15773000</bdrx:AccumulatedAmortisationAndImpairment>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001809"
      unitRef="GBP">3000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001811"
      unitRef="GBP">3000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001821"
      unitRef="GBP">13378000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001823"
      unitRef="GBP">2291000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2023-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001825"
      unitRef="GBP">107000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001827"
      unitRef="GBP">15776000</bdrx:AccumulatedAmortisationAndImpairment>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001833"
      unitRef="GBP">2000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001835"
      unitRef="GBP">2000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <bdrx:Disposal
      contextRef="From2024-01-012024-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001841"
      unitRef="GBP">-22000</bdrx:Disposal>
    <bdrx:Disposal
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001843"
      unitRef="GBP">-22000</bdrx:Disposal>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001845"
      unitRef="GBP">13378000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001847"
      unitRef="GBP">2291000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2024-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001849"
      unitRef="GBP">87000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001851"
      unitRef="GBP">15756000</bdrx:AccumulatedAmortisationAndImpairment>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001857"
      unitRef="GBP">1000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001859"
      unitRef="GBP">1000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <bdrx:Disposal
      contextRef="From2025-01-012025-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001865"
      unitRef="GBP">-19000</bdrx:Disposal>
    <bdrx:Disposal
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001867"
      unitRef="GBP">-19000</bdrx:Disposal>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001869"
      unitRef="GBP">13378000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001871"
      unitRef="GBP">2291000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2025-12-31_custom_ITAndWebsiteCostsMember_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001873"
      unitRef="GBP">69000</bdrx:AccumulatedAmortisationAndImpairment>
    <bdrx:AccumulatedAmortisationAndImpairment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fact001875"
      unitRef="GBP">15738000</bdrx:AccumulatedAmortisationAndImpairment>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember"
      decimals="-3"
      id="Fact001877"
      unitRef="GBP">5645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001883"
      unitRef="GBP">5645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember"
      decimals="-3"
      id="Fact001885"
      unitRef="GBP">5645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_ITAndWebsiteCostsMember"
      decimals="-3"
      id="Fact001889"
      unitRef="GBP">1000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001891"
      unitRef="GBP">5646000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_IntangibleAssetsUnderDevelopmentMember"
      decimals="-3"
      id="Fact001893"
      unitRef="GBP">2938000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_ITAndWebsiteCostsMember"
      decimals="-3"
      id="Fact001897"
      unitRef="GBP">3000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001899"
      unitRef="GBP">2941000</ifrs-full:IntangibleAssetsAndGoodwill>
    <bdrx:DisclosureOffCondensedFinancialStatementsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001904">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOffCondensedFinancialStatementsTableTextBlock_pn3n3_zABhsTAnXqc4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Intangible assets (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_zQdGNuC25MD1" style="display: none"&gt;Schedule of condensed financial statements&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Carrying amount&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Remaining amortisation &lt;br/&gt; period&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; (years)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; (years)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; (years)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;MTX228 tolimidone acquired IPRD*&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zG3zUky8Fd47" title="Carrying amount"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zVPjyRakZTWb" title="Carrying amount"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX228TolimidoneAcquiredIPRDMember_fKg_____zOTq9yiWP7g4" title="Carrying amount"&gt;2,938&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;MTX230 eRapa acquired IPRD*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____zciRlDiibdse" title="Carrying amount"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____zfTtmNCNaEF6" title="Carrying amount"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--MTX230ERapaacquiredIPRDMember_fKg_____zjCVXI3rURuk" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1916"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: right"&gt;n/a&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td id="xdx_F0E_zBO0PvK6EGKe" style="width: 9pt; text-align: left"&gt;*&lt;/td&gt;&lt;td id="xdx_F10_zMESEH8Njh6g"&gt;asset is not yet in use and has not started amortising&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</bdrx:DisclosureOffCondensedFinancialStatementsTableTextBlock>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_MTX228TolimidoneAcquiredIPRDMember"
      decimals="-3"
      id="Fact001906"
      unitRef="GBP">2938000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_MTX228TolimidoneAcquiredIPRDMember"
      decimals="-3"
      id="Fact001908"
      unitRef="GBP">2938000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31_custom_MTX228TolimidoneAcquiredIPRDMember"
      decimals="-3"
      id="Fact001910"
      unitRef="GBP">2938000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_MTX230ERapaacquiredIPRDMember"
      decimals="-3"
      id="Fact001912"
      unitRef="GBP">2707000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_MTX230ERapaacquiredIPRDMember"
      decimals="-3"
      id="Fact001914"
      unitRef="GBP">2707000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001919">&lt;p id="xdx_806_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zrhJP1jCkuaf" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;12&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_826_zWPCkUpy0w6a"&gt;Subsidiaries&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The subsidiaries of the Company, all of which are
100% owned as at 31 December 2025, either directly or through subsidiaries where indicated, and have been included in these financial
statements in accordance with the details set out in the basis of preparation and basis of consolidation note 1, are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureOfSignificantInvestmentsInSubsidiariesTableExplanatory_pn3n3_zMxIn3pxetli" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse" summary="xdx: Disclosure - Subsidiaries (Details)"&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_zi3rd5qSjuD6" style="display: none"&gt;Schedule of subsidiaries&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 29%"&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 43%"&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;b&gt;Registered&lt;br/&gt;
Office&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 16%"&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;b&gt;Nature of&lt;br/&gt;
Business&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%"&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;b&gt;Notes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimited1Member" title="Name"&gt;Biodexa Australia PTY Limited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimited1Member" title="Registered office"&gt;c/o Prime Accounting &amp;amp; Business Advisory, HWT Towel Level 17, 40 City Road, Southbank, VIC, 3006, Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimited1Member" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_905_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimited1Member" title="Name"&gt;Biodexa Limited&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimited1Member_zfmuIiFO2gj6"&gt;&lt;span style="font-family: Times New Roman"&gt;1 Caspian Point, Caspian Way, Cardiff, &lt;br/&gt;
CF10 4DQ&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimited1Member" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember_zTsYR9NsRvfg" title="Name"&gt;Biodexa Ireland Limited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember" title="Registered office"&gt;First Floor, Riverside Two, 43-49 Sir John Rogerson's Quay, Dublin 2, Ireland, C02 KV60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember_zgo4A8j12dP2" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember" title="Name"&gt;Biodexa Pharmaceuticals (Wales) Limited&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember_zo4PMGXYk9zg"&gt;&lt;span style="font-family: Times New Roman"&gt;1 Caspian Point, Caspian Way, Cardiff, &lt;br/&gt;
CF10 4DQ&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember_zye8B8lCIN27" title="Name"&gt;Biodexa US, Inc&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember" title="Registered office"&gt;16601 Blanco Rd, Suite 120, San Antonio, Texas, 78232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember_zw7AOM8p9Zmb" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_900_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimited1Member" title="Name"&gt;Haaland UK Limited&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;
    &lt;p style="font: 10pt Times New Roman; margin: 0pt 7.1pt 0pt 0"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimited1Member" title="Registered office"&gt;1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimited1Member" title="Nature of Operation"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_908_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAG1Member_fKGEpIChiKQ_____zKCViO8n9Tii" title="Name"&gt;PharMida AG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAG1Member_fKGEpIChiKQ_____zU4FXahU3DR7" title="Registered office"&gt;c/o Kellerhals, Hirschg&#xe4;sslein 11, 4051 Basel, Switzerland&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAG1Member_fKGEpIChiKQ_____zDlvk7sRrbd7" title="Nature of Operation"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;(a) (b)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Notes:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td id="xdx_F00_ztgp4Z3Lrkg6" style="width: 18pt; text-align: left"&gt;(a)&lt;/td&gt;&lt;td id="xdx_F14_zWdRtd3yYP5f"&gt;Wholly owned subsidiary of Biodexa Limited.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td id="xdx_F01_z6cc4gaMRP4k" style="width: 18pt; text-align: left"&gt;(b)&lt;/td&gt;&lt;td id="xdx_F1D_zBA8GKMvgmsa"&gt;PharMida AG became dormant in January 2016. Proceedings to wind
up the company commenced in 2025.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <bdrx:DisclosureOfSignificantInvestmentsInSubsidiariesTableExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001921">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureOfSignificantInvestmentsInSubsidiariesTableExplanatory_pn3n3_zMxIn3pxetli" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse" summary="xdx: Disclosure - Subsidiaries (Details)"&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_zi3rd5qSjuD6" style="display: none"&gt;Schedule of subsidiaries&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 29%"&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 43%"&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;b&gt;Registered&lt;br/&gt;
Office&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 16%"&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;b&gt;Nature of&lt;br/&gt;
Business&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%"&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;b&gt;Notes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimited1Member" title="Name"&gt;Biodexa Australia PTY Limited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimited1Member" title="Registered office"&gt;c/o Prime Accounting &amp;amp; Business Advisory, HWT Towel Level 17, 40 City Road, Southbank, VIC, 3006, Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaAustraliaPTYLimited1Member" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_905_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimited1Member" title="Name"&gt;Biodexa Limited&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimited1Member_zfmuIiFO2gj6"&gt;&lt;span style="font-family: Times New Roman"&gt;1 Caspian Point, Caspian Way, Cardiff, &lt;br/&gt;
CF10 4DQ&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaLimited1Member" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember_zTsYR9NsRvfg" title="Name"&gt;Biodexa Ireland Limited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember" title="Registered office"&gt;First Floor, Riverside Two, 43-49 Sir John Rogerson's Quay, Dublin 2, Ireland, C02 KV60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaIrelandLimitedMember_zgo4A8j12dP2" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember" title="Name"&gt;Biodexa Pharmaceuticals (Wales) Limited&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember_zo4PMGXYk9zg"&gt;&lt;span style="font-family: Times New Roman"&gt;1 Caspian Point, Caspian Way, Cardiff, &lt;br/&gt;
CF10 4DQ&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember_zye8B8lCIN27" title="Name"&gt;Biodexa US, Inc&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember" title="Registered office"&gt;16601 Blanco Rd, Suite 120, San Antonio, Texas, 78232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BiodexaUSIncMember_zw7AOM8p9Zmb" title="Nature of Operation"&gt;Trading company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_900_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimited1Member" title="Name"&gt;Haaland UK Limited&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;
    &lt;p style="font: 10pt Times New Roman; margin: 0pt 7.1pt 0pt 0"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimited1Member" title="Registered office"&gt;1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--HaalandUKLimited1Member" title="Nature of Operation"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_908_eifrs-full--NameOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAG1Member_fKGEpIChiKQ_____zKCViO8n9Tii" title="Name"&gt;PharMida AG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAG1Member_fKGEpIChiKQ_____zU4FXahU3DR7" title="Registered office"&gt;c/o Kellerhals, Hirschg&#xe4;sslein 11, 4051 Basel, Switzerland&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PharMidaAG1Member_fKGEpIChiKQ_____zDlvk7sRrbd7" title="Nature of Operation"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman"&gt;(a) (b)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:DisclosureOfSignificantInvestmentsInSubsidiariesTableExplanatory>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaAustraliaPTYLimited1Member"
      id="Fact001923">Biodexa Australia PTY Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaAustraliaPTYLimited1Member"
      id="Fact001925">c/o Prime Accounting &amp; Business Advisory, HWT Towel Level 17, 40 City Road, Southbank, VIC, 3006, Australia</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaAustraliaPTYLimited1Member"
      id="Fact001927">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaLimited1Member"
      id="Fact001929">Biodexa Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaLimited1Member"
      id="Fact001930">1 Caspian Point, Caspian Way, Cardiff,
CF10 4DQ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaLimited1Member"
      id="Fact001932">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaIrelandLimitedMember"
      id="Fact001934">Biodexa Ireland Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaIrelandLimitedMember"
      id="Fact001936">First Floor, Riverside Two, 43-49 Sir John Rogerson's Quay, Dublin 2, Ireland, C02 KV60</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaIrelandLimitedMember"
      id="Fact001938">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember"
      id="Fact001940">Biodexa Pharmaceuticals (Wales) Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember"
      id="Fact001941">1 Caspian Point, Caspian Way, Cardiff,
CF10 4DQ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaPharmaceuticalsWalesLimitedFormerlyMidatechPharmaWalesLimitedMember"
      id="Fact001943">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaUSIncMember"
      id="Fact001945">Biodexa US, Inc</ifrs-full:NameOfSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_BiodexaUSIncMember"
      id="Fact001947">16601 Blanco Rd, Suite 120, San Antonio, Texas, 78232</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_BiodexaUSIncMember"
      id="Fact001949">Trading company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_HaalandUKLimited1Member"
      id="Fact001951">Haaland UK Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_HaalandUKLimited1Member"
      id="Fact001953">1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_HaalandUKLimited1Member"
      id="Fact001955">Dormant</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NameOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_PharMidaAG1Member"
      id="Fact001957">PharMida AG</ifrs-full:NameOfSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_PharMidaAG1Member"
      id="Fact001959">c/o Kellerhals, Hirschg&#xe4;sslein 11, 4051 Basel, Switzerland</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_PharMidaAG1Member"
      id="Fact001961">Dormant</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001965">&lt;p id="xdx_808_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_za67YVyFWkua" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt; text-align: left"&gt;13&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82C_zVecr97i5RBe"&gt;Trade and other receivables&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--DisclosureOfTradeAndOtherReceivableTableExplanatory_pn3n3_zpOQe44iAok9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Trade and other receivables (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B3_zQB5whnKBLvi" style="display: none"&gt;Schedule of trade and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20251231_z2oiUM9dTBj4" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20241231_zJ4Ka6q1q3l6" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20231231_zFmpghBebn5f" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--TradeReceivables_iI_pn3n3_maTAORz2OZ_zNJPHxyk2Mi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Trade receivables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;35&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;11&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1971"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--Prepayments_iI_pn3n3_maTAORz2OZ_zcv5cq76AhR6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Prepayments&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;3,687&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;6,426&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;355&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--OtherReceivables_iI_pn3n3_maTAORz2OZ_zGgI9QM67eDd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;64&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;131&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;282&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--TradeAndOtherReceivables_iTI_pn3n3_mtTAORz2OZ_zNYGly78xls1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total trade and other receivables&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;3,786&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;6,568&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;637&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherNoncurrentReceivables_iNI_pn3n3_zWnTt8yNbam3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Less: non-current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1985"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1986"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1987"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--TradeAndOtherCurrentReceivables_iI_pn3n3_zZD4poheRwIk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;3,786&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;6,568&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;637&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;The Group has applied the practical expedient permitted
by IFRS 15 to not disclose the transaction price allocated to performance obligations unsatisfied (or partially unsatisfied) as of the
end of the reporting period as contracts typically have an original expected duration of a year or less.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;Book values approximate to fair value at 31 December
2025, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;i&gt;Expected Credit Loss&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;Given the short-term nature of the
Group&#x2019;s trade receivables and accrued income, which are mainly due from large national or multinational companies, the Group's assessment
of expected credit losses includes provisions for specific clients and receivables where the contractual cash flow is deemed at risk.
Considerations include the current economic environment along with historical and forward-looking information. No assumptions or estimating
techniques are applied in considering these. Additional provisions are made based on the assessment of recoverability of aged receivables
over one year where sufficient evidence of recoverability is not evident.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;2025 and 2023 Trade and other receivables
did not contain any impaired asset. Trade and other receivables contained one impaired asset in 2024; this was recovered in 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;The maximum exposure to credit risk
at the consolidated statement of financial position date is the fair value of each class of receivable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: left"&gt;The Company recognises a default
on a financial asset when the counter party announces they have limited resources to satisfy the debt.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <bdrx:DisclosureOfTradeAndOtherReceivableTableExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001967">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--DisclosureOfTradeAndOtherReceivableTableExplanatory_pn3n3_zpOQe44iAok9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Trade and other receivables (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B3_zQB5whnKBLvi" style="display: none"&gt;Schedule of trade and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20251231_z2oiUM9dTBj4" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20241231_zJ4Ka6q1q3l6" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20231231_zFmpghBebn5f" style="color: #4D4D4C; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: #4D4D4C; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--TradeReceivables_iI_pn3n3_maTAORz2OZ_zNJPHxyk2Mi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Trade receivables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;35&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;11&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1971"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--Prepayments_iI_pn3n3_maTAORz2OZ_zcv5cq76AhR6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Prepayments&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;3,687&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;6,426&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;355&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--OtherReceivables_iI_pn3n3_maTAORz2OZ_zGgI9QM67eDd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;64&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;131&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;282&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--TradeAndOtherReceivables_iTI_pn3n3_mtTAORz2OZ_zNYGly78xls1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total trade and other receivables&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;3,786&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;6,568&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: right"&gt;637&lt;/td&gt;&lt;td style="color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherNoncurrentReceivables_iNI_pn3n3_zWnTt8yNbam3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Less: non-current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1985"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1986"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1987"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--TradeAndOtherCurrentReceivables_iI_pn3n3_zZD4poheRwIk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;3,786&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;6,568&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: right"&gt;637&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:DisclosureOfTradeAndOtherReceivableTableExplanatory>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001969"
      unitRef="GBP">35000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001970"
      unitRef="GBP">11000</ifrs-full:TradeReceivables>
    <ifrs-full:Prepayments
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001973"
      unitRef="GBP">3687000</ifrs-full:Prepayments>
    <ifrs-full:Prepayments
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001974"
      unitRef="GBP">6426000</ifrs-full:Prepayments>
    <ifrs-full:Prepayments
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001975"
      unitRef="GBP">355000</ifrs-full:Prepayments>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001977"
      unitRef="GBP">64000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001978"
      unitRef="GBP">131000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001979"
      unitRef="GBP">282000</ifrs-full:OtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001981"
      unitRef="GBP">3786000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001982"
      unitRef="GBP">6568000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001983"
      unitRef="GBP">637000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001989"
      unitRef="GBP">3786000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001990"
      unitRef="GBP">6568000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001991"
      unitRef="GBP">637000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001993">&lt;p id="xdx_807_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zYKupVmNZ6nc" style="font: 10pt Times New Roman; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;14&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82F_zPgOkfpmwgC7"&gt;Cash and cash equivalents and cash flow supporting notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Cash and cash equivalents for purposes of the consolidated statement
of cash flows comprises:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zgiheyFyGQSj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Cash and cash equivalents and cash flow supporting notes (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zU0cKGEj3DRg" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Cash at bank available on demand&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231_zDbi7RKy3SNa" title="Cash at bank available on demand"&gt;8,534&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231_zMOSPO3ZgnVj" title="Cash at bank available on demand"&gt;1,669&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231_zVeNBFBadQd4" title="Cash at bank available on demand"&gt;5,971&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zKXdcceIEs02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During 2025, 2024 and 2023, cash inflows arose from equity financing
transactions, included within financing activities on the face of the cash flow statement. As part of the equity transactions entered
in December 2025, July and May 2024 and December and May 2023 warrants to the value of &#xa3;5.0 million ( 2024: &#xa3;3.1 million;
2023: &#xa3;4.6 million) were issued as disclosed in note 19.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutShareIssuesNetOfCostsExplanatory_pn3n3_z3jiMnQXMEqh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Cash and cash equivalents and cash flow supporting notes (Details 1)"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left"&gt;&lt;span id="xdx_8B7_zS4gG9K5xsIk" style="display: none"&gt;Schedule of cash inflows from an equity financing transaction&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Gross proceeds&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--FundsRaisedOnPublicOffering_pn3n3_c20250101__20251231_z0OxVIQbjHYd" title="Gross proceeds"&gt;14,369&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FundsRaisedOnPublicOffering_pn3n3_c20240101__20241231_zLmrfclsKZz8" title="Gross proceeds"&gt;9,065&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FundsRaisedOnPublicOffering_pn3n3_c20230101__20231231_zu0TBKLEQkBf" title="Gross proceeds"&gt;12,084&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Transaction costs&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CostsOfRaisingFundsOnPublicOffering_pn3n3_c20250101__20251231_zfvPbAVquyY7" title="Transaction costs"&gt;(620&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)_&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CostsOfRaisingFundsOnPublicOffering_pn3n3_c20240101__20241231_zmj9ySiDJCe9" title="Transaction costs"&gt;(753&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--CostsOfRaisingFundsOnPublicOffering_pn3n3_c20230101__20231231_zSyND0Xw607d" title="Transaction costs"&gt;(1,657&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20250101__20251231_zCseohg4Fdb6" title="Proceeds from issuing shares"&gt;13,749&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20240101__20241231_z20R9xH1cA6c" title="Proceeds from issuing shares"&gt;8,312&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230101__20231231_zgtTHst963q6" title="Proceeds from issuing shares"&gt;10,427&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zblxYppSoake" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following changes in loans and borrowings arose as a result of
financing activities during the year:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory1_pn3n3_zolUCSc7wo5h" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Cash and cash equivalents and cash flow supporting notes (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zPor27idjmqe" style="display: none"&gt;Schedule of changes in bank loan liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Non-current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;At 1 January 2025&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zzFYySqSm5s" title="Beginning"&gt;1,424&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zr5nbrfaomA6" title="Beginning"&gt;1,530&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231_zWEDzhEo0U13" title="Beginning"&gt;2,954&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash flows&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zbaHhFf1n1El" title="Cash Flows"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2031"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zf8CSooIDrK1" title="Cash Flows"&gt;(1,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zwrvIduOfUNg" title="Cash Flows"&gt;(1,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Non-cashflows:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign exchange&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zQ7yp3oKjevd" title="Foreign Exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2037"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zkDM7B7NQoAg" title="Foreign Exchange"&gt;(132&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zWr6fqZuffE2" title="Foreign Exchange"&gt;(132&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zpiKb04Z0ilf" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;(779&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_z5cIdGqxvt04" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;779&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zCGBJnKMKFx8" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2047"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Transfer to share premium on exercise of warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zWIUNGAXLlc8" title="Transfer to share premium on exercise of warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2049"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zInZMvuE1tej" title="Transfer to share premium on exercise of warrants"&gt;(196&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20250101__20251231_zKiUo3Qpfaai" title="Transfer to share premium on exercise of warrants"&gt;(196&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantsIssued_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zW6ovqQImRol" title="Warrants issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2055"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WarrantsIssued_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_z2j1vrVNUtX5" title="Warrants issued"&gt;5,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--WarrantsIssued_pn3n3_c20250101__20251231_zuoRk2gt05gh" title="Warrants issued"&gt;5,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gain recognised in finance income within the consolidated statement of comprehensive income&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zZdogmLgKyLe" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2061"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zQmvqcfIiRW1" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(2,296&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20250101__20251231_zhaGqM7AUpOi" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(2,296&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Interest accruing in period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zW9oE0Y5MYZb" title="Interest accruing in period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2067"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zbm0P1qgMRnj" title="Interest accruing in period"&gt;229&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zL9G75yH84Dh" title="Interest accruing in period"&gt;229&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zIZ60TgVUzX9" title="Ending"&gt;645&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zEl0qNj4T1t" title="Ending"&gt;3,539&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20251231_zTSyvJF2mPFi" title="Ending"&gt;4,184&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: windowtext; font-weight: bold; text-align: right"&gt;Non-current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: windowtext; font-weight: bold; text-align: right"&gt;Current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: windowtext; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;At 1 January 2024&lt;/td&gt;&lt;td style="width: 1%; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: windowtext; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zvq0eJo3rWB5" title="Beginning"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: windowtext; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zosffrhdqERg" title="Beginning"&gt;4,329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: windowtext; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231_zNnBaUs88OA3" title="Beginning"&gt;4,624&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash flows&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zHDGGoBSv1Wd" title="Cash Flows"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2088"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zox9MXk78Ouk" title="Cash Flows"&gt;(460&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zhQEvlzfsYgb" title="Cash Flows"&gt;(460&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Non-cashflows:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign exchange&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zWWQEFq0YT86" title="Foreign Exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zyKKiT7LQPNb" title="Foreign Exchange"&gt;(26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z08gU0t6lHX7" title="Foreign Exchange"&gt;(26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loans and borrowings classified as non-current 31 December 2023 becoming current in 2024&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_907_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zvTv61vuJlYj" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;(412&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zmmji1R13V24" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;412&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_909_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zno13q2qsaO4" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2104"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred consideration on acquisition&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DeferredConsiderationOnAcquisition_iP3custom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zImhAUU0j2B2" title="Deferred consideration on acquisition"&gt;1,541&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_902_ecustom--DeferredConsiderationOnAcquisition_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zJZy0kkxq1m2" title="Deferred consideration on acquisition"&gt;456&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DeferredConsiderationOnAcquisition_pn3n3_c20240101__20241231_zUUnpEiAGPgk" title="Deferred consideration on acquisition"&gt;1,997&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Promissory note issued&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_905_ecustom--PromissoryNoteIssued_iP3custom--DeferredConsiderationOnAcquisition_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zqCS7If0FnE2" title="Promissory note issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2112"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_900_ecustom--PromissoryNoteIssued_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zJWHNQZdJL27" title="Promissory note issued"&gt;431&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_904_ecustom--PromissoryNoteIssued_pn3n3_c20240101__20241231_zJI1OKO6JxN5" title="Promissory note issued"&gt;431&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WarrantsIssued_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zCTzZQHTS82a" title="Warrants issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2118"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsIssued_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zY3BKBIMaZvj" title="Warrants issued"&gt;3,059&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_903_ecustom--WarrantsIssued_pn3n3_c20240101__20241231_zDXU570YXmjj" title="Warrants issued"&gt;3,059&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercise of warrants &#x2013; transfer to share premium&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExerciseOfWarrantsTransferToSharePremium_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zLrFTYr5UaEa" title="Exercise of warrants - transfer to share premium"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ExerciseOfWarrantsTransferToSharePremium_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zTxVrIIDSsOi" title="Exercise of warrants - transfer to share premium"&gt;(3,618&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ExerciseOfWarrantsTransferToSharePremium_pn3n3_c20240101__20241231_zjb4e5ImPnrb" title="Exercise of warrants - transfer to share premium"&gt;(3,618&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gain recognised in finance income within the consolidated statement of comprehensive income&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_906_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zodXw0l98Y1l" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2130"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zF82YdhENiik" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(3,218&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_904_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20240101__20241231_zheZsyoulZc3" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(3,218&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Interest accruing in period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zBtGDqbyodpa" title="Interest accruing in period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2136"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: right"&gt;&lt;span id="xdx_905_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zv2sMTk52f2f" title="Interest accruing in period"&gt;165&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z9f4K1vWH7yb" title="Interest accruing in period"&gt;165&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zVX0oCfDrHG3" title="Ending"&gt;1,424&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_ziVUi3gQ9T5h" title="Ending"&gt;1,530&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231_zqLOLg7p6Z8b" title="Ending"&gt;2,954&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Non-current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_ztSL0SM7Mspc" title="Beginning"&gt;463&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zHWCj7Imzdac" title="Beginning"&gt;246&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zWfxjYgE99ea" title="Beginning"&gt;709&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash flows&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zEmzSSPyZS4c" title="Cash Flows"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_z5laRo2wPifc" title="Cash Flows"&gt;(188&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_ziael6IjJt1g" title="Cash Flows"&gt;(188&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Non-cashflows:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loans and borrowings classified as non-current 31 December 2022 becoming current in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_ztLFpZLQFcGi" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;(168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zeiRu41ooy8c" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zCJ7llSJMfad" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2164"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--WarrantsIssued_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_z871WVC8t904" title="Warrants issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2166"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WarrantsIssued_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zWHSDFo9Mk99" title="Warrants issued"&gt;4,562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WarrantsIssued_pn3n3_c20230101__20231231_z7MCJXwA6Lzk" title="Warrants issued"&gt;4,562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gain recognised in finance income within the consolidated statement of comprehensive income&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zXGHS4zzGApb" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2172"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zu1LdUafAT19" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(487&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20230101__20231231_zjrPOScQmupa" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(487&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Interest accruing in period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zOZEJKw9eQKk" title="Interest accruing in period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2178"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zfCPKnHMrJta" title="Interest accruing in period"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z9Yt3kKIyCr3" title="Interest accruing in period"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zX3HOsYHbN5f" title="Ending"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zydAPSWM8RDb" title="Ending"&gt;4,329&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_ziWhwAPZKYFk" title="Ending"&gt;4,624&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zFq3r8xHHig6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <bdrx:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001995">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zgiheyFyGQSj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Cash and cash equivalents and cash flow supporting notes (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zU0cKGEj3DRg" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Cash at bank available on demand&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231_zDbi7RKy3SNa" title="Cash at bank available on demand"&gt;8,534&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231_zMOSPO3ZgnVj" title="Cash at bank available on demand"&gt;1,669&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231_zVeNBFBadQd4" title="Cash at bank available on demand"&gt;5,971&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001997"
      unitRef="GBP">8534000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001999"
      unitRef="GBP">1669000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002001"
      unitRef="GBP">5971000</ifrs-full:CashAndCashEquivalents>
    <bdrx:DisclosureOfDetailedInformationAboutShareIssuesNetOfCostsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002003">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutShareIssuesNetOfCostsExplanatory_pn3n3_z3jiMnQXMEqh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Cash and cash equivalents and cash flow supporting notes (Details 1)"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left"&gt;&lt;span id="xdx_8B7_zS4gG9K5xsIk" style="display: none"&gt;Schedule of cash inflows from an equity financing transaction&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Gross proceeds&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--FundsRaisedOnPublicOffering_pn3n3_c20250101__20251231_z0OxVIQbjHYd" title="Gross proceeds"&gt;14,369&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FundsRaisedOnPublicOffering_pn3n3_c20240101__20241231_zLmrfclsKZz8" title="Gross proceeds"&gt;9,065&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FundsRaisedOnPublicOffering_pn3n3_c20230101__20231231_zu0TBKLEQkBf" title="Gross proceeds"&gt;12,084&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Transaction costs&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CostsOfRaisingFundsOnPublicOffering_pn3n3_c20250101__20251231_zfvPbAVquyY7" title="Transaction costs"&gt;(620&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)_&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CostsOfRaisingFundsOnPublicOffering_pn3n3_c20240101__20241231_zmj9ySiDJCe9" title="Transaction costs"&gt;(753&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--CostsOfRaisingFundsOnPublicOffering_pn3n3_c20230101__20231231_zSyND0Xw607d" title="Transaction costs"&gt;(1,657&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20250101__20251231_zCseohg4Fdb6" title="Proceeds from issuing shares"&gt;13,749&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20240101__20241231_z20R9xH1cA6c" title="Proceeds from issuing shares"&gt;8,312&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230101__20231231_zgtTHst963q6" title="Proceeds from issuing shares"&gt;10,427&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfDetailedInformationAboutShareIssuesNetOfCostsExplanatory>
    <bdrx:FundsRaisedOnPublicOffering
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002005"
      unitRef="GBP">14369000</bdrx:FundsRaisedOnPublicOffering>
    <bdrx:FundsRaisedOnPublicOffering
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002007"
      unitRef="GBP">9065000</bdrx:FundsRaisedOnPublicOffering>
    <bdrx:FundsRaisedOnPublicOffering
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002009"
      unitRef="GBP">12084000</bdrx:FundsRaisedOnPublicOffering>
    <bdrx:CostsOfRaisingFundsOnPublicOffering
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002011"
      unitRef="GBP">-620000</bdrx:CostsOfRaisingFundsOnPublicOffering>
    <bdrx:CostsOfRaisingFundsOnPublicOffering
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002013"
      unitRef="GBP">-753000</bdrx:CostsOfRaisingFundsOnPublicOffering>
    <bdrx:CostsOfRaisingFundsOnPublicOffering
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002015"
      unitRef="GBP">-1657000</bdrx:CostsOfRaisingFundsOnPublicOffering>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002017"
      unitRef="GBP">13749000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002019"
      unitRef="GBP">8312000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002021"
      unitRef="GBP">10427000</ifrs-full:ProceedsFromIssuingShares>
    <bdrx:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory1 contextRef="From2025-01-01to2025-12-31" id="Fact002023">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory1_pn3n3_zolUCSc7wo5h" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Cash and cash equivalents and cash flow supporting notes (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zPor27idjmqe" style="display: none"&gt;Schedule of changes in bank loan liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Non-current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;At 1 January 2025&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zzFYySqSm5s" title="Beginning"&gt;1,424&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zr5nbrfaomA6" title="Beginning"&gt;1,530&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231_zWEDzhEo0U13" title="Beginning"&gt;2,954&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash flows&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zbaHhFf1n1El" title="Cash Flows"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2031"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zf8CSooIDrK1" title="Cash Flows"&gt;(1,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zwrvIduOfUNg" title="Cash Flows"&gt;(1,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Non-cashflows:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign exchange&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zQ7yp3oKjevd" title="Foreign Exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2037"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zkDM7B7NQoAg" title="Foreign Exchange"&gt;(132&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zWr6fqZuffE2" title="Foreign Exchange"&gt;(132&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zpiKb04Z0ilf" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;(779&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_z5cIdGqxvt04" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;779&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zCGBJnKMKFx8" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2047"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Transfer to share premium on exercise of warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zWIUNGAXLlc8" title="Transfer to share premium on exercise of warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2049"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zInZMvuE1tej" title="Transfer to share premium on exercise of warrants"&gt;(196&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20250101__20251231_zKiUo3Qpfaai" title="Transfer to share premium on exercise of warrants"&gt;(196&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantsIssued_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zW6ovqQImRol" title="Warrants issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2055"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WarrantsIssued_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_z2j1vrVNUtX5" title="Warrants issued"&gt;5,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--WarrantsIssued_pn3n3_c20250101__20251231_zuoRk2gt05gh" title="Warrants issued"&gt;5,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gain recognised in finance income within the consolidated statement of comprehensive income&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zZdogmLgKyLe" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2061"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zQmvqcfIiRW1" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(2,296&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20250101__20251231_zhaGqM7AUpOi" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(2,296&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Interest accruing in period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zW9oE0Y5MYZb" title="Interest accruing in period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2067"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zbm0P1qgMRnj" title="Interest accruing in period"&gt;229&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zL9G75yH84Dh" title="Interest accruing in period"&gt;229&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zIZ60TgVUzX9" title="Ending"&gt;645&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zEl0qNj4T1t" title="Ending"&gt;3,539&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20251231_zTSyvJF2mPFi" title="Ending"&gt;4,184&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: windowtext; font-weight: bold; text-align: right"&gt;Non-current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: windowtext; font-weight: bold; text-align: right"&gt;Current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: windowtext; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;At 1 January 2024&lt;/td&gt;&lt;td style="width: 1%; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: windowtext; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zvq0eJo3rWB5" title="Beginning"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: windowtext; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zosffrhdqERg" title="Beginning"&gt;4,329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: windowtext; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231_zNnBaUs88OA3" title="Beginning"&gt;4,624&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash flows&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zHDGGoBSv1Wd" title="Cash Flows"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2088"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zox9MXk78Ouk" title="Cash Flows"&gt;(460&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zhQEvlzfsYgb" title="Cash Flows"&gt;(460&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Non-cashflows:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign exchange&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zWWQEFq0YT86" title="Foreign Exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zyKKiT7LQPNb" title="Foreign Exchange"&gt;(26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z08gU0t6lHX7" title="Foreign Exchange"&gt;(26&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loans and borrowings classified as non-current 31 December 2023 becoming current in 2024&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_907_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zvTv61vuJlYj" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;(412&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zmmji1R13V24" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;412&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_909_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zno13q2qsaO4" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2104"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred consideration on acquisition&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DeferredConsiderationOnAcquisition_iP3custom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zImhAUU0j2B2" title="Deferred consideration on acquisition"&gt;1,541&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_902_ecustom--DeferredConsiderationOnAcquisition_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zJZy0kkxq1m2" title="Deferred consideration on acquisition"&gt;456&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DeferredConsiderationOnAcquisition_pn3n3_c20240101__20241231_zUUnpEiAGPgk" title="Deferred consideration on acquisition"&gt;1,997&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Promissory note issued&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_905_ecustom--PromissoryNoteIssued_iP3custom--DeferredConsiderationOnAcquisition_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zqCS7If0FnE2" title="Promissory note issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2112"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_900_ecustom--PromissoryNoteIssued_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zJWHNQZdJL27" title="Promissory note issued"&gt;431&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_904_ecustom--PromissoryNoteIssued_pn3n3_c20240101__20241231_zJI1OKO6JxN5" title="Promissory note issued"&gt;431&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WarrantsIssued_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zCTzZQHTS82a" title="Warrants issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2118"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsIssued_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zY3BKBIMaZvj" title="Warrants issued"&gt;3,059&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_903_ecustom--WarrantsIssued_pn3n3_c20240101__20241231_zDXU570YXmjj" title="Warrants issued"&gt;3,059&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercise of warrants &#x2013; transfer to share premium&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExerciseOfWarrantsTransferToSharePremium_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zLrFTYr5UaEa" title="Exercise of warrants - transfer to share premium"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ExerciseOfWarrantsTransferToSharePremium_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zTxVrIIDSsOi" title="Exercise of warrants - transfer to share premium"&gt;(3,618&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ExerciseOfWarrantsTransferToSharePremium_pn3n3_c20240101__20241231_zjb4e5ImPnrb" title="Exercise of warrants - transfer to share premium"&gt;(3,618&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gain recognised in finance income within the consolidated statement of comprehensive income&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_906_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zodXw0l98Y1l" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2130"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zF82YdhENiik" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(3,218&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: windowtext; text-align: right"&gt;&lt;span id="xdx_904_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20240101__20241231_zheZsyoulZc3" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(3,218&lt;/span&gt;&lt;/td&gt;&lt;td style="color: windowtext; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Interest accruing in period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zBtGDqbyodpa" title="Interest accruing in period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2136"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: right"&gt;&lt;span id="xdx_905_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zv2sMTk52f2f" title="Interest accruing in period"&gt;165&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z9f4K1vWH7yb" title="Interest accruing in period"&gt;165&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zVX0oCfDrHG3" title="Ending"&gt;1,424&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_ziVUi3gQ9T5h" title="Ending"&gt;1,530&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231_zqLOLg7p6Z8b" title="Ending"&gt;2,954&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: windowtext; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Non-current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Current &lt;br/&gt; liabilities&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Total&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;At 1 January 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_ztSL0SM7Mspc" title="Beginning"&gt;463&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zHWCj7Imzdac" title="Beginning"&gt;246&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zWfxjYgE99ea" title="Beginning"&gt;709&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash flows&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zEmzSSPyZS4c" title="Cash Flows"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_z5laRo2wPifc" title="Cash Flows"&gt;(188&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_ziael6IjJt1g" title="Cash Flows"&gt;(188&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Non-cashflows:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loans and borrowings classified as non-current 31 December 2022 becoming current in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_ztLFpZLQFcGi" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;(168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zeiRu41ooy8c" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zCJ7llSJMfad" title="Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2164"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--WarrantsIssued_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_z871WVC8t904" title="Warrants issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2166"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WarrantsIssued_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zWHSDFo9Mk99" title="Warrants issued"&gt;4,562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WarrantsIssued_pn3n3_c20230101__20231231_z7MCJXwA6Lzk" title="Warrants issued"&gt;4,562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gain recognised in finance income within the consolidated statement of comprehensive income&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zXGHS4zzGApb" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2172"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zu1LdUafAT19" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(487&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome_pn3n3_c20230101__20231231_zjrPOScQmupa" title="Gain recognised in finance income within the consolidated statement of comprehensive income"&gt;(487&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Interest accruing in period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zOZEJKw9eQKk" title="Interest accruing in period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2178"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zfCPKnHMrJta" title="Interest accruing in period"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z9Yt3kKIyCr3" title="Interest accruing in period"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LongtermBorrowingsMember_zX3HOsYHbN5f" title="Ending"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--ShorttermBorrowingsMember_zydAPSWM8RDb" title="Ending"&gt;4,329&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_ziWhwAPZKYFk" title="Ending"&gt;4,624&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory1>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002025"
      unitRef="GBP">1424000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002027"
      unitRef="GBP">1530000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002029"
      unitRef="GBP">2954000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002033"
      unitRef="GBP">-1399000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002035"
      unitRef="GBP">-1399000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002039"
      unitRef="GBP">-132000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002041"
      unitRef="GBP">-132000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002043"
      unitRef="GBP">-779000</bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002045"
      unitRef="GBP">779000</bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities>
    <bdrx:TransferToSharePremiumOnExerciseOfWarrants
      contextRef="From2025-01-012025-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002051"
      unitRef="GBP">-196000</bdrx:TransferToSharePremiumOnExerciseOfWarrants>
    <bdrx:TransferToSharePremiumOnExerciseOfWarrants
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002053"
      unitRef="GBP">-196000</bdrx:TransferToSharePremiumOnExerciseOfWarrants>
    <bdrx:WarrantsIssued
      contextRef="From2025-01-012025-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002057"
      unitRef="GBP">5024000</bdrx:WarrantsIssued>
    <bdrx:WarrantsIssued
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002059"
      unitRef="GBP">5024000</bdrx:WarrantsIssued>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002063"
      unitRef="GBP">-2296000</bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002065"
      unitRef="GBP">-2296000</bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002069"
      unitRef="GBP">229000</bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002071"
      unitRef="GBP">229000</bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2025-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002073"
      unitRef="GBP">645000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2025-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002075"
      unitRef="GBP">3539000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002077"
      unitRef="GBP">4184000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002082"
      unitRef="GBP">295000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002084"
      unitRef="GBP">4329000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002086"
      unitRef="GBP">4624000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002090"
      unitRef="GBP">-460000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002092"
      unitRef="GBP">-460000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002096"
      unitRef="GBP">-26000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002098"
      unitRef="GBP">-26000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002100"
      unitRef="GBP">-412000</bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002102"
      unitRef="GBP">412000</bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities>
    <bdrx:DeferredConsiderationOnAcquisition
      contextRef="From2024-01-012024-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002106"
      unitRef="GBP">1541000</bdrx:DeferredConsiderationOnAcquisition>
    <bdrx:DeferredConsiderationOnAcquisition
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002108"
      unitRef="GBP">456000</bdrx:DeferredConsiderationOnAcquisition>
    <bdrx:DeferredConsiderationOnAcquisition
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002110"
      unitRef="GBP">1997000</bdrx:DeferredConsiderationOnAcquisition>
    <bdrx:PromissoryNoteIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002114"
      unitRef="GBP">431000</bdrx:PromissoryNoteIssued>
    <bdrx:PromissoryNoteIssued
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002116"
      unitRef="GBP">431000</bdrx:PromissoryNoteIssued>
    <bdrx:WarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002120"
      unitRef="GBP">3059000</bdrx:WarrantsIssued>
    <bdrx:WarrantsIssued
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002122"
      unitRef="GBP">3059000</bdrx:WarrantsIssued>
    <bdrx:ExerciseOfWarrantsTransferToSharePremium
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002126"
      unitRef="GBP">-3618000</bdrx:ExerciseOfWarrantsTransferToSharePremium>
    <bdrx:ExerciseOfWarrantsTransferToSharePremium
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002128"
      unitRef="GBP">-3618000</bdrx:ExerciseOfWarrantsTransferToSharePremium>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002132"
      unitRef="GBP">-3218000</bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002134"
      unitRef="GBP">-3218000</bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002138"
      unitRef="GBP">165000</bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002140"
      unitRef="GBP">165000</bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002142"
      unitRef="GBP">1424000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002144"
      unitRef="GBP">1530000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002146"
      unitRef="GBP">2954000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002148"
      unitRef="GBP">463000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002150"
      unitRef="GBP">246000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002152"
      unitRef="GBP">709000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002156"
      unitRef="GBP">-188000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002158"
      unitRef="GBP">-188000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002160"
      unitRef="GBP">-168000</bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002162"
      unitRef="GBP">168000</bdrx:IncreaseThroughLoansAndBorrowingsLiabilitiesArisingFromFinancingActivities>
    <bdrx:WarrantsIssued
      contextRef="From2023-01-012023-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002168"
      unitRef="GBP">4562000</bdrx:WarrantsIssued>
    <bdrx:WarrantsIssued
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002170"
      unitRef="GBP">4562000</bdrx:WarrantsIssued>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002174"
      unitRef="GBP">-487000</bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome>
    <bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002176"
      unitRef="GBP">-487000</bdrx:GainRecognisedInFinanceIncomeWithinConsolidatedStatementOfComprehensiveIncome>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002180"
      unitRef="GBP">28000</bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities>
    <bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002182"
      unitRef="GBP">28000</bdrx:IncreaseThroughInterestAccruingInPeriodLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_ifrs-full_LongtermBorrowingsMember"
      decimals="-3"
      id="Fact002184"
      unitRef="GBP">295000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_ifrs-full_ShorttermBorrowingsMember"
      decimals="-3"
      id="Fact002186"
      unitRef="GBP">4329000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002188"
      unitRef="GBP">4624000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002190">&lt;p id="xdx_80F_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zIXepulTCNS9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;15&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82D_zyHWhYV2TxFg"&gt;Trade and other payables&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_pn3n3_zpYAxEG7KFr" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Trade and other payables (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; text-align: left"&gt;&lt;span id="xdx_8B5_z7HnuGzHvP29" style="display: none"&gt;Schedule of trade and other payables&lt;/span&gt;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20251231_zM0OEsejA6b4" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20241231_zxeadWDWGlb" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20231231_zMArZuZ4vkm9" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eifrs-full--TradeAndOtherCurrentPayablesAbstract_iB_zJ2RLopyYSGf" style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold"&gt;Current&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_i01I_pn3n3_maCFLzfyh_zltmEW4C1Eda" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; color: black; text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;97&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;707&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;314&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--OtherCurrentPayables_i01I_pn3n3_maCFLzfyh_zhbmHASzVNoc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; text-align: left"&gt;Other payables&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;17&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;6&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;7&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--AccrualsClassifiedAsCurrent_i01I_pn3n3_maCFLzfyh_zthh4mK651Mb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black"&gt;Accruals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;1,860&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;1,273&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;857&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--CurrentFinancialLiabilities_i01TI_pn3n3_mtCFLzfyh_maTAOPzN30_zLAsdx3l5X2g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; font-weight: bold; text-align: left"&gt;Total financial liabilities, excluding loans and borrowings, classified as financial liabilities measured at amortised cost&lt;/td&gt;&lt;td style="color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: right"&gt;1,974&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: right"&gt;1,986&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: right"&gt;1,178&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_i01I_pn3n3_maTAOPzN30_zzCdIEmJKEf3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: black; text-align: left"&gt;Tax and social security&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;45&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;50&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;62&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredIncome1_i01I_pn3n3_maTAOPzN30_zvO1MKaoSwb3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;Deferred revenue&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;571&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;1,468&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2220"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--TradeAndOtherPayables_i01TI_pn3n3_mtTAOPzN30_zevTtMcPYwb8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;Total trade and other payables&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: right"&gt;2,590&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: right"&gt;3,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: right"&gt;1,240&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Book values approximate to fair value at 31 December 2025, 2024 and
2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;All current trade and other payables are payable within 3 months of
the period end date shown above.&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <bdrx:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002192">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_pn3n3_zpYAxEG7KFr" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Trade and other payables (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; text-align: left"&gt;&lt;span id="xdx_8B5_z7HnuGzHvP29" style="display: none"&gt;Schedule of trade and other payables&lt;/span&gt;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20251231_zM0OEsejA6b4" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20241231_zxeadWDWGlb" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20231231_zMArZuZ4vkm9" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eifrs-full--TradeAndOtherCurrentPayablesAbstract_iB_zJ2RLopyYSGf" style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold"&gt;Current&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_i01I_pn3n3_maCFLzfyh_zltmEW4C1Eda" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; color: black; text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;97&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;707&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;314&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--OtherCurrentPayables_i01I_pn3n3_maCFLzfyh_zhbmHASzVNoc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; text-align: left"&gt;Other payables&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;17&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;6&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;7&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--AccrualsClassifiedAsCurrent_i01I_pn3n3_maCFLzfyh_zthh4mK651Mb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black"&gt;Accruals&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;1,860&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;1,273&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;857&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--CurrentFinancialLiabilities_i01TI_pn3n3_mtCFLzfyh_maTAOPzN30_zLAsdx3l5X2g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; font-weight: bold; text-align: left"&gt;Total financial liabilities, excluding loans and borrowings, classified as financial liabilities measured at amortised cost&lt;/td&gt;&lt;td style="color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: right"&gt;1,974&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: right"&gt;1,986&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: right"&gt;1,178&lt;/td&gt;&lt;td style="color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_i01I_pn3n3_maTAOPzN30_zzCdIEmJKEf3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: black; text-align: left"&gt;Tax and social security&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;45&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;50&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;62&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredIncome1_i01I_pn3n3_maTAOPzN30_zvO1MKaoSwb3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;Deferred revenue&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;571&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;1,468&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2220"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--TradeAndOtherPayables_i01TI_pn3n3_mtTAOPzN30_zevTtMcPYwb8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;Total trade and other payables&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: right"&gt;2,590&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: right"&gt;3,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: right"&gt;1,240&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002198"
      unitRef="GBP">97000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002199"
      unitRef="GBP">707000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002200"
      unitRef="GBP">314000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002202"
      unitRef="GBP">17000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002203"
      unitRef="GBP">6000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002204"
      unitRef="GBP">7000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:AccrualsClassifiedAsCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002206"
      unitRef="GBP">1860000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:AccrualsClassifiedAsCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002207"
      unitRef="GBP">1273000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:AccrualsClassifiedAsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002208"
      unitRef="GBP">857000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002210"
      unitRef="GBP">1974000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002211"
      unitRef="GBP">1986000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002212"
      unitRef="GBP">1178000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002214"
      unitRef="GBP">45000</ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002215"
      unitRef="GBP">50000</ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002216"
      unitRef="GBP">62000</ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <bdrx:DeferredIncome1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002218"
      unitRef="GBP">571000</bdrx:DeferredIncome1>
    <bdrx:DeferredIncome1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002219"
      unitRef="GBP">1468000</bdrx:DeferredIncome1>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002222"
      unitRef="GBP">2590000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002223"
      unitRef="GBP">3504000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002224"
      unitRef="GBP">1240000</ifrs-full:TradeAndOtherPayables>
    <bdrx:DeferredConsiderationTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact002226">&lt;p id="xdx_80B_ecustom--DeferredConsiderationTextBlock_zr09eWJRKjXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;16&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_829_zE0Fz15Zo4f3"&gt;Deferred consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ScheduleOfDeferredConsiderationTableTextBlock_pn3n3_zHDv4z8oUCP1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Deferred consideration (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zOnRD7kgZ2Tc" style="display: none"&gt;Schedule of deferred consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20251231_zelSKoh4oeEb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20241231_zjGHKLQCxHw1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20231231_z2JB2nUqtD91" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Current&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredConsiderationOpeningProvision_iI_pn3n3_zHC4sXDuOVXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Opening provision at 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,844&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2231"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2232"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredConsiderationOnAcquisitionOfLicence_iI_pn3n3_zpvSVvGJZVZd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;On acquisition of licence&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2234"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,997&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2236"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredConsiderationPayments_iI_pn3n3_zbA2KF0d4era" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Payments&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(689&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(274&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2240"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredConsiderationInterestExpense_iI_pn3n3_zGxb17KGxCR3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;159&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2244"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredConsiderationForeignExchange_iI_pn3n3_zSWHgjFIHh0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(106&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(23&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2248"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--DeferredConsideration_iI_pn3n3_c20251231_zCccHIAb8Mo1" title="Deferred consideration"&gt;1,208&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--DeferredConsideration_iI_pn3n3_c20241231_zVyQSyNlliRk" title="Deferred consideration"&gt;1,844&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DeferredConsideration_iI_pn3n3_c20231231_zwR7sAGntbOc" title="Deferred consideration"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2254"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeferredConsiderationNonCurrent_iI_pn3n3_zs42dZiLVoo3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Less: non-current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;645&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2258"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredConsiderationCurrent_iI_pn3n3_zeHuCGrKyizg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;563&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;538&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2262"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On 25 April 2024 the Company entered into a LCA
with Emtora, relating to the license of eRapa. Under the LCA the Company is obligated to make quarterly payments to Emtora of $&lt;span id="xdx_903_ecustom--QuarterlyPaymentObligation_pn3n3_dm_uUSD_c20250101__20251231__ifrs-full--BiologicalAssetsAxis__custom--EmtoraMember_zzqPfLl02NRc" title="Quarterly payments"&gt;0.25&lt;/span&gt; million
less 75% of any research sales by Emtora until the handover trigger event occurs. The obligation meets the definition of a financial liability
in accordance with IAS32 and is measured at fair value in accordance with IFRS9.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;This financial liability is measured on Level
3, the fair value is derived using a discounted cash flow approach. The discount rate applied to the obligation was 11.64% (2024: 11.64%).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--LiabilityIncreaseAndDecreaseDescription_c20250101__20251231_zDDjTgAP2sZf" title="Liability increase and decrease description"&gt;A 1% increase or decrease in the discount rate would
decrease or increase the liability by approximately &#xa3;0.13 million (2024: &#xa3;0.03 million) and &#xa3;0.01 million (2024: &#xa3;0.03
million), respectively.&lt;/span&gt; An increase in the liability would result in a loss in the revaluation of financial instruments, while a decrease
would result in a gain.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;There were no transfers between Level 1 and 2 in
the period.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

</bdrx:DeferredConsiderationTextBlock>
    <bdrx:ScheduleOfDeferredConsiderationTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact002228">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ScheduleOfDeferredConsiderationTableTextBlock_pn3n3_zHDv4z8oUCP1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Deferred consideration (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zOnRD7kgZ2Tc" style="display: none"&gt;Schedule of deferred consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20251231_zelSKoh4oeEb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20241231_zjGHKLQCxHw1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20231231_z2JB2nUqtD91" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Current&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredConsiderationOpeningProvision_iI_pn3n3_zHC4sXDuOVXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Opening provision at 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,844&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2231"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2232"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredConsiderationOnAcquisitionOfLicence_iI_pn3n3_zpvSVvGJZVZd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;On acquisition of licence&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2234"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,997&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2236"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredConsiderationPayments_iI_pn3n3_zbA2KF0d4era" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Payments&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(689&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(274&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2240"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredConsiderationInterestExpense_iI_pn3n3_zGxb17KGxCR3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;159&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2244"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredConsiderationForeignExchange_iI_pn3n3_zSWHgjFIHh0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(106&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(23&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2248"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--DeferredConsideration_iI_pn3n3_c20251231_zCccHIAb8Mo1" title="Deferred consideration"&gt;1,208&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--DeferredConsideration_iI_pn3n3_c20241231_zVyQSyNlliRk" title="Deferred consideration"&gt;1,844&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DeferredConsideration_iI_pn3n3_c20231231_zwR7sAGntbOc" title="Deferred consideration"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2254"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeferredConsiderationNonCurrent_iI_pn3n3_zs42dZiLVoo3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Less: non-current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;645&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2258"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredConsiderationCurrent_iI_pn3n3_zeHuCGrKyizg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;563&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;538&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2262"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:ScheduleOfDeferredConsiderationTableTextBlock>
    <bdrx:DeferredConsiderationOpeningProvision
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002230"
      unitRef="GBP">1844000</bdrx:DeferredConsiderationOpeningProvision>
    <bdrx:DeferredConsiderationOnAcquisitionOfLicence
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002235"
      unitRef="GBP">1997000</bdrx:DeferredConsiderationOnAcquisitionOfLicence>
    <bdrx:DeferredConsiderationPayments
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002238"
      unitRef="GBP">-689000</bdrx:DeferredConsiderationPayments>
    <bdrx:DeferredConsiderationPayments
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002239"
      unitRef="GBP">-274000</bdrx:DeferredConsiderationPayments>
    <bdrx:DeferredConsiderationInterestExpense
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002242"
      unitRef="GBP">159000</bdrx:DeferredConsiderationInterestExpense>
    <bdrx:DeferredConsiderationInterestExpense
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002243"
      unitRef="GBP">144000</bdrx:DeferredConsiderationInterestExpense>
    <bdrx:DeferredConsiderationForeignExchange
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002246"
      unitRef="GBP">-106000</bdrx:DeferredConsiderationForeignExchange>
    <bdrx:DeferredConsiderationForeignExchange
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002247"
      unitRef="GBP">-23000</bdrx:DeferredConsiderationForeignExchange>
    <bdrx:DeferredConsideration
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002250"
      unitRef="GBP">1208000</bdrx:DeferredConsideration>
    <bdrx:DeferredConsideration
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002252"
      unitRef="GBP">1844000</bdrx:DeferredConsideration>
    <bdrx:DeferredConsiderationNonCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002256"
      unitRef="GBP">645000</bdrx:DeferredConsiderationNonCurrent>
    <bdrx:DeferredConsiderationNonCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002257"
      unitRef="GBP">1306000</bdrx:DeferredConsiderationNonCurrent>
    <bdrx:DeferredConsiderationCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002260"
      unitRef="GBP">563000</bdrx:DeferredConsiderationCurrent>
    <bdrx:DeferredConsiderationCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002261"
      unitRef="GBP">538000</bdrx:DeferredConsiderationCurrent>
    <bdrx:QuarterlyPaymentObligation
      contextRef="From2025-01-012025-12-31_custom_EmtoraMember"
      decimals="-3"
      id="Fact002264"
      unitRef="USD">250000</bdrx:QuarterlyPaymentObligation>
    <bdrx:LiabilityIncreaseAndDecreaseDescription contextRef="From2025-01-01to2025-12-31" id="Fact002266">A 1% increase or decrease in the discount rate would
decrease or increase the liability by approximately &#xa3;0.13 million (2024: &#xa3;0.03 million) and &#xa3;0.01 million (2024: &#xa3;0.03
million), respectively.</bdrx:LiabilityIncreaseAndDecreaseDescription>
    <ifrs-full:DisclosureOfBorrowingsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002269">&lt;p id="xdx_800_eifrs-full--DisclosureOfBorrowingsExplanatory_zkLAFzIuNYvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;17&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_827_zCEWY9Nj6Lig"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfDetailedInformationBorrowingsExplanatory_pn3n3_zXReDEsp3aEd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Borrowings (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; text-align: left"&gt;&lt;span id="xdx_8B5_zT0D6s3C6AVb" style="display: none"&gt;Schedule of borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold"&gt;Current&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; color: black; text-align: left"&gt;Promissory note&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zGptjgfI3I5h" title="Current borriwings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2273"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zF4orDgR1FV" title="Current borriwings"&gt;430&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_z0ZU8dmLsgre" title="Current borriwings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2277"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_z8Mt7o9xkns5" title="Current borriwings"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zRTyP3c7hmR4" title="Current borriwings"&gt;179&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zkBCvFgUg0Jc" title="Current borriwings"&gt;169&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20251231_zJ3e8nlu36ng" title="Current borriwings"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20241231_zFFuFSwaCzkl" title="Current borriwings"&gt;609&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20231231_znelwC4pUksd" title="Current borriwings"&gt;169&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; font-weight: bold"&gt;Non-current&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LongtermBorrowings_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_z3CtUTre8Tl7" title="Non current borriwings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2291"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--LongtermBorrowings_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zWVK5tl8cff2" title="Non current borriwings"&gt;118&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LongtermBorrowings_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zHMBXxjEzu2h" title="Non current borriwings"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--LongtermBorrowings_iI_pn3n3_c20251231_zXJoHovALZzj" title="Non current borriwings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2297"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--LongtermBorrowings_iI_pn3n3_c20241231_zpeBtBe7VCE3" title="Non current borriwings"&gt;118&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--LongtermBorrowings_iI_pn3n3_c20231231_zrZtK368qq98" title="Non current borriwings"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Book values approximate to fair value at 31 December 2025, 2024 and
2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Promissory note&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;In December 2024 the Company issued
a Promissory Note to C/M Capital Master Fund, LP in the aggregate principal amount of $600,000 at a 10% original issue discount. The Note
is an unsecured obligation of the Company and bears interest at an annual rate of 5%, which may be increased under certain circumstances,
and has a maturity date of one year from the Issuance Date. The Note includes a monthly repayment schedule, with the entire principal
amount of the Note, plus accrued and unpaid interest, due and payable by the Company on the date that is twelve months from the Issuance
Date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Company received $540,000 pursuant
to the Promissory Note on 24 December 2024. The note was repaid in full during 2025.&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfBorrowingsExplanatory>
    <bdrx:DisclosureOfDetailedInformationBorrowingsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002271">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfDetailedInformationBorrowingsExplanatory_pn3n3_zXReDEsp3aEd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Borrowings (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; text-align: left"&gt;&lt;span id="xdx_8B5_zT0D6s3C6AVb" style="display: none"&gt;Schedule of borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; font-weight: bold"&gt;Current&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; color: black; text-align: left"&gt;Promissory note&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zGptjgfI3I5h" title="Current borriwings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2273"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zF4orDgR1FV" title="Current borriwings"&gt;430&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_z0ZU8dmLsgre" title="Current borriwings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2277"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_z8Mt7o9xkns5" title="Current borriwings"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zRTyP3c7hmR4" title="Current borriwings"&gt;179&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zkBCvFgUg0Jc" title="Current borriwings"&gt;169&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20251231_zJ3e8nlu36ng" title="Current borriwings"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20241231_zFFuFSwaCzkl" title="Current borriwings"&gt;609&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn3n3_c20231231_znelwC4pUksd" title="Current borriwings"&gt;169&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: black; font-weight: bold"&gt;Non-current&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LongtermBorrowings_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_z3CtUTre8Tl7" title="Non current borriwings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2291"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--LongtermBorrowings_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zWVK5tl8cff2" title="Non current borriwings"&gt;118&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LongtermBorrowings_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zHMBXxjEzu2h" title="Non current borriwings"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--LongtermBorrowings_iI_pn3n3_c20251231_zXJoHovALZzj" title="Non current borriwings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2297"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--LongtermBorrowings_iI_pn3n3_c20241231_zpeBtBe7VCE3" title="Non current borriwings"&gt;118&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--LongtermBorrowings_iI_pn3n3_c20231231_zrZtK368qq98" title="Non current borriwings"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:DisclosureOfDetailedInformationBorrowingsExplanatory>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2024-12-31_custom_PromissoryNoteMember"
      decimals="-3"
      id="Fact002275"
      unitRef="GBP">430000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2025-12-31_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact002279"
      unitRef="GBP">61000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2024-12-31_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact002281"
      unitRef="GBP">179000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2023-12-31_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact002283"
      unitRef="GBP">169000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002285"
      unitRef="GBP">61000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002287"
      unitRef="GBP">609000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002289"
      unitRef="GBP">169000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2024-12-31_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact002293"
      unitRef="GBP">118000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2023-12-31_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact002295"
      unitRef="GBP">295000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002299"
      unitRef="GBP">118000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002301"
      unitRef="GBP">295000</ifrs-full:LongtermBorrowings>
    <bdrx:ProvisionsTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact002304">&lt;p id="xdx_807_ecustom--ProvisionsTextBlock_zOzftS9qqBS" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;18&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_820_zQvE3JR2qJZ4"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--DisclosureOfDetailedInformationProvisionExplanatory_pn3n3_zvFQRZwQxlMb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Provisions (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BD_zhvT3yCCK3od" style="display: none"&gt;Schedule of provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Opening provision at 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Provision_iS_pn3n3_c20250101__20251231_z02MfTFefeXi" title="Opening provision at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2308"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Provision_iS_pn3n3_c20240101__20241231_zSAyv9eqcuwj" title="Opening provision at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2310"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Provision_iS_pn3n3_c20230101__20231231_zLT37LbfZAe6" title="Opening provision at beginning"&gt;207&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Utilisation of provision&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--UtilisationOfProvision_pn3n3_c20250101__20251231_zSFKxsfNTN4b" title="Utilisation of provision"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2314"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--UtilisationOfProvision_pn3n3_c20240101__20241231_zQcOj31Wuks9" title="Utilisation of provision"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2316"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--UtilisationOfProvision_pn3n3_c20230101__20231231_zAMaFCUbqh13" title="Utilisation of provision"&gt;(207&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Provision recognised in the year&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AdjustmentsForProvisions1_pn3n3_c20250101__20251231_zsMNQM6BKqU3" title="Provision recognised in the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2320"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--AdjustmentsForProvisions1_pn3n3_c20240101__20241231_zaoj1bwxuk4l" title="Provision recognised in the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2322"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AdjustmentsForProvisions1_pn3n3_c20230101__20231231_zTxmUKaRTKIe" title="Provision recognised in the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2324"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;At 31 December&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Provision_iE_pn3n3_c20250101__20251231_zSmF1aB5NzTj" title="Opening provision at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2326"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--Provision_iE_pn3n3_c20240101__20241231_zAqM8FuJHP66" title="Opening provision at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2328"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--Provision_iE_pn3n3_c20230101__20231231_zv09lKwQEHIl" title="Opening provision at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2330"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Less: non-current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NoncurrentProvisions1_pn3n3_c20250101__20251231_z5gW1N2zU2Kh" title="Less: non-current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2332"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NoncurrentProvisions1_pn3n3_c20240101__20241231_zOI3Da5WmVcb" title="Less: non-current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2334"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NoncurrentProvisions1_pn3n3_c20230101__20231231_zPpPPaMBIZO8" title="Less: non-current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2336"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--CurrentProvisions_iI_pn3n3_c20251231_zHrH2kM2LX7h" title="Current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2338"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--CurrentProvisions_iI_pn3n3_c20251231_zHP6MZflhHve" title="Current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2340"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CurrentProvisions_iI_pn3n3_c20221231_zdUn5tRYBx7h" title="Current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2342"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</bdrx:ProvisionsTextBlock>
    <bdrx:DisclosureOfDetailedInformationProvisionExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002306">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--DisclosureOfDetailedInformationProvisionExplanatory_pn3n3_zvFQRZwQxlMb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Provisions (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BD_zhvT3yCCK3od" style="display: none"&gt;Schedule of provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Opening provision at 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Provision_iS_pn3n3_c20250101__20251231_z02MfTFefeXi" title="Opening provision at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2308"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Provision_iS_pn3n3_c20240101__20241231_zSAyv9eqcuwj" title="Opening provision at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2310"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Provision_iS_pn3n3_c20230101__20231231_zLT37LbfZAe6" title="Opening provision at beginning"&gt;207&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Utilisation of provision&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--UtilisationOfProvision_pn3n3_c20250101__20251231_zSFKxsfNTN4b" title="Utilisation of provision"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2314"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--UtilisationOfProvision_pn3n3_c20240101__20241231_zQcOj31Wuks9" title="Utilisation of provision"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2316"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--UtilisationOfProvision_pn3n3_c20230101__20231231_zAMaFCUbqh13" title="Utilisation of provision"&gt;(207&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Provision recognised in the year&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AdjustmentsForProvisions1_pn3n3_c20250101__20251231_zsMNQM6BKqU3" title="Provision recognised in the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2320"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--AdjustmentsForProvisions1_pn3n3_c20240101__20241231_zaoj1bwxuk4l" title="Provision recognised in the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2322"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AdjustmentsForProvisions1_pn3n3_c20230101__20231231_zTxmUKaRTKIe" title="Provision recognised in the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2324"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;At 31 December&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Provision_iE_pn3n3_c20250101__20251231_zSmF1aB5NzTj" title="Opening provision at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2326"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--Provision_iE_pn3n3_c20240101__20241231_zAqM8FuJHP66" title="Opening provision at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2328"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--Provision_iE_pn3n3_c20230101__20231231_zv09lKwQEHIl" title="Opening provision at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2330"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Less: non-current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NoncurrentProvisions1_pn3n3_c20250101__20251231_z5gW1N2zU2Kh" title="Less: non-current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2332"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NoncurrentProvisions1_pn3n3_c20240101__20241231_zOI3Da5WmVcb" title="Less: non-current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2334"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NoncurrentProvisions1_pn3n3_c20230101__20231231_zPpPPaMBIZO8" title="Less: non-current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2336"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Current portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--CurrentProvisions_iI_pn3n3_c20251231_zHrH2kM2LX7h" title="Current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2338"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--CurrentProvisions_iI_pn3n3_c20251231_zHP6MZflhHve" title="Current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2340"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CurrentProvisions_iI_pn3n3_c20221231_zdUn5tRYBx7h" title="Current portion"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2342"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:DisclosureOfDetailedInformationProvisionExplanatory>
    <bdrx:Provision
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002312"
      unitRef="GBP">207000</bdrx:Provision>
    <bdrx:UtilisationOfProvision
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002318"
      unitRef="GBP">-207000</bdrx:UtilisationOfProvision>
    <bdrx:DisclosureOfDerivativeFinancialLiabilityCurrentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002345">&lt;p id="xdx_807_ecustom--DisclosureOfDerivativeFinancialLiabilityCurrentExplanatory_z6iKa9Fj9lNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;19&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82B_zNf4rX2foFx2"&gt;Derivative financial
liability &#x2013; current&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eifrs-full--MaturityAnalysisForDerivativeFinancialLiabilities_pn3n3_zLWAcu5ciIS2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Derivative financial liability - current (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zKLIJ6H9jw35" style="display: none"&gt;Schedule of derivative financial liability&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;Equity settled derivative financial liability&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;At 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CurrentDerivativeFinancialLiabilities_iS_pn3n3_c20250101__20251231_zUSxaRQNGVg7" title="Balance at beginning"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--CurrentDerivativeFinancialLiabilities_iS_pn3n3_c20240101__20241231_zaYWyvn6ksZi" title="Balance at beginning"&gt;4,160&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentDerivativeFinancialLiabilities_iS_pn3n3_c20230101__20231231_zoZxxecB0Seg" title="Balance at beginning"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WarrantsIssued_pn3n3_c20250101__20251231_zEFAjzCiPqI" title="Warrants issued"&gt;5,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsIssued_pn3n3_c20240101__20241231_zUvY6ykrS4Ma" title="Warrants issued"&gt;3,059&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsIssued_pn3n3_c20230101__20231231_zbcwWGmPL8h3" title="Warrants issued"&gt;4,562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Transfer to share premium on exercise of warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20250101__20251231_zqkNBxWR8yI5" title="Transfer to share premium on exercise of warrants"&gt;(196&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20240101__20241231_zifKSr0RIdwg" title="Transfer to share premium on exercise of warrants"&gt;(3,618&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20230101__20231231_z5MNCVyLYzta" title="Transfer to share premium on exercise of warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2365"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--GainLossOfEquitySettledDerivativeFinancialLiability_pn3n3_c20250101__20251231_zMGByjrktSAb" title="Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income"&gt;(2,296&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--GainLossOfEquitySettledDerivativeFinancialLiability_pn3n3_c20240101__20241231_zEYomCa4O383" title="Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income"&gt;(3,218&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--GainLossOfEquitySettledDerivativeFinancialLiability_pn3n3_c20230101__20231231_zhd7gX5D2QO8" title="Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income"&gt;(487&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentDerivativeFinancialLiabilities_iE_pn3n3_c20250101__20251231_zsqQLVnybWq4" title="Balance at ending"&gt;2,915&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentDerivativeFinancialLiabilities_iE_pn3n3_c20240101__20241231_zfYlf2iFCVva" title="Balance at ending"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CurrentDerivativeFinancialLiabilities_iE_pn3n3_c20230101__20231231_zw35gZYNrmD3" title="Balance at ending"&gt;4,160&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Equity settled derivative financial liability is a liability that is
not to be settled for cash.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company issues warrants in the ADSs of the Company as part of registered
direct offerings and private placements in the US. The number of ADSs to be issued when exercised is fixed, however the exercise price
is denominated in US Dollars being different to the functional currency of the Company. Therefore, the warrants are classified as equity
settled derivative financial liabilities recognised at fair value through the profit and loss account (&#x2018;FVTPL&#x2019;). The financial
liability is valued using the Black-Scholes model in 2024 and 2023. Financial liabilities at FVTPL are stated at fair value, with any
gains or losses arising on re-measurement recognised in profit or loss. The net gain or loss recognised in profit or loss incorporates
any interest paid on the financial liability and is included in the &#x2018;finance income&#x2019; or &#x2018;finance expense&#x2019; lines
item in the income statement. A key input in the valuation of the instrument is the Company share price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Details of the warrants are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;December 2025 warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In December 2025 the Company issued &lt;span id="xdx_90E_ecustom--NumberOfWarrantsIssued_pid_c20251201__20251231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesLADSwarrantsMember_zp63wEP93fkb" title="Number of warrants issued"&gt;6,097,562&lt;/span&gt; Series L ADS warrants
as part of the Registered Offering in the US.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;July 2024 warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In July 2024 the Company issued &lt;span id="xdx_904_ecustom--NumberOfWarrantsIssued_pid_c20240701__20240731__ifrs-full--ComponentsOfEquityAxis__custom--SeriesJADSWarrantsMember_z6MOMuI4Twuk" title="Number of warrants issued"&gt;21,315&lt;/span&gt; Series J ADS Warrants and &lt;span id="xdx_90B_ecustom--NumberOfWarrantsIssued_pid_c20240701__20240731__ifrs-full--ComponentsOfEquityAxis__custom--SeriesKWarrantsMember_zPhc0KL8jWC9" title="Number of warrants issued"&gt;21,315&lt;/span&gt;
Series K warrants as part of the Registered Direct Offering and Concurrent Private Placement in the US. The Series K warrants expired
on 22 July 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;May 2024 warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In May 2024 the Company issued &lt;span id="xdx_90E_ecustom--NumberOfWarrantsIssued_pid_c20240501__20240531__ifrs-full--ComponentsOfEquityAxis__custom--SeriesGADSWarrantsMember_zWPiymYEt4l3" title="Number of warrants issued"&gt;9,434&lt;/span&gt; Series G ADS Warrants and &lt;span id="xdx_908_ecustom--NumberOfWarrantsIssued_pid_c20240501__20240531__ifrs-full--ComponentsOfEquityAxis__custom--SeriesHWarrantsMember_zdXiIUDQLyn7" title="Number of warrants issued"&gt;14,780&lt;/span&gt;
Series H warrants as part of the Warrant Inducement in the US. The Series H warrants expired on 22 May 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;December 2023 warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In December 2023 the Company issued &lt;span id="xdx_907_ecustom--NumberOfWarrantsIssued_pid_c20231201__20231231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesEADSWarrantsMember_zrCdhflQzekb" title="Number of warrants issued"&gt;11,998&lt;/span&gt; Series E ADS Warrants and
&lt;span id="xdx_908_ecustom--NumberOfWarrantsIssued_pid_c20231201__20231231__ifrs-full--ComponentsOfEquityAxis__custom--SeriesFADSWarrantsMember_zykGujIL4o6l" title="Number of warrants issued"&gt;11,998&lt;/span&gt; Series F ADS Warrants as part of the Registered Offering in the US. The Series F warrants expired on 23 December 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;May 2023 warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In June 2023 the Company issued &lt;span id="xdx_909_ecustom--NumberOfWarrantsIssued_pid_c20230601__20230630__ifrs-full--ComponentsOfEquityAxis__custom--SeriesDADSWarrantsMember_z4xwRg9Aqbta" title="Number of warrants issued"&gt;1,098&lt;/span&gt; Series D ADS Warrants as part
of a registered direct offering and private placement in the US after securing shareholder approval.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;May 2020 warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In May 2020 the Company issued &lt;span id="xdx_906_ecustom--NumberOfWarrantsIssued_pid_c20200501__20200531__ifrs-full--ComponentsOfEquityAxis__custom--SeriesADSWarrantsMember_zZSx7JvEBiUk" title="Number of warrants issued"&gt;2&lt;/span&gt; ADS warrants as part of a registered
direct offering in the US. The warrants expired on 20 November 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;October 2019 warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In October 2019 the Company issued &lt;span id="xdx_906_ecustom--NumberOfWarrantsIssued_pid_c20191001__20191031__ifrs-full--ComponentsOfEquityAxis__custom--SeriesADSWarrantsMember_zfiz1pd44wBd" title="Number of warrants issued"&gt;1 &lt;/span&gt;ADS warrants as part of a registered
direct offering in the US. The warrants expired on 23 June 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 9pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt; font-weight: normal"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt; font-weight: normal"&gt;Number and original price of warrants have been adjusted to reflect
the share consolidation and ratio change of ADS&#x2019;s to ordinary shares that occurred on 24 March 2023 and the ratio change of ADS&#x2019;s
to ordinary shares on 5 July 2023, 4 October 2024 and 31 July 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;DARA warrants and share options&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group also assumed fully vested warrants and share options on the
acquisition of DARA Biosciences, Inc. (which took place in 2015). The number of ordinary shares to be issued when exercised is fixed,
however the exercise prices are denominated in US Dollars. The warrants are classified equity settled derivative financial liabilities
and accounted for in the same way as those detailed above. The financial liability is valued using the Black-Scholes option pricing model.
All warrants and options have lapsed as at 31 December 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table details the outstanding warrants over ADSs and
ordinary shares as at 31 December and also the movement in the year:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eifrs-full--DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_pn3n3_zkub3lZ7cNF9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Derivative financial liability - current (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold; text-align: justify"&gt;&lt;span id="xdx_8BA_zWm0kruSSWfg" style="display: none"&gt;Schedule of warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 31 &lt;br/&gt; December &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 31 &lt;br/&gt; December &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 31 &lt;br/&gt; December &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 31 &lt;br/&gt; December &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: justify"&gt;ADSs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify; width: 16%"&gt;December 2025 grant&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zLMc57J4KbVh" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2404"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zSQHWEssrXm7" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2406"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zz8wOEYb9jW1" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2408"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zR0OSC2P64v3" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2410"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zREhfMew5mnb" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2412"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zKhxKYiGP658" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2414"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zV2EMz5tfbI3" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2416"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zcNDFYvkpBC4" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2418"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zAORQXlfA6L6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2420"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zcuB44waLyK4" title="Granted"&gt;6,097,562&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zbu6HT1MsAHd" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zKBv9gPmqmj" title="Number of shares outstanding at end"&gt;6,097,562&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;July 2024 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_z4OGyUIcQAhi" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2428"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zREdOgpVKnj1" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2430"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zWomYbb1fDS" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2432"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zshGrw0zYyRi" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2434"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_z28Pq65ens6f" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2436"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zkqAUm74EZva" title="Granted"&gt;42,630&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_z8mblt67IPO8" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2440"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zXDAMBpX7Jkc" title="Number of shares outstanding at beginning"&gt;42,630&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_z5AG7g7xwIoj" title="Lapsed"&gt;(8,594&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zHvh3lxlcgY6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2446"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zLZBMz0eTeB2" title="Exercised"&gt;(17,018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zvCHRhnyJBr" title="Number of shares outstanding at end"&gt;17,018&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;May 2024 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zTRCRQKAVt1d" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2452"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zbffoAlAK5k5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2454"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zpoIuDMNiCUc" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2456"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zfz8oR1jO6gk" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2458"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zmiuHNLQNcpb" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2460"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zdMMdHlL4v06" title="Granted"&gt;24,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_z1swoXrT5QU7" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2464"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zPIbXgSo09z3" title="Number of shares outstanding at beginning"&gt;24,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zF2H9l6BQ8Dk" title="Lapsed"&gt;(6,695&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zFm0TOF2ejZj" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2470"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zcIQIdjn2kah" title="Exercised"&gt;(8,085&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_ztu64w6HSkn7" title="Number of shares outstanding at end"&gt;9,434&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;December 2023 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zqDRdzZ5CVT9" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2476"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_z4F6wehElB3f" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2478"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zF9BVDJKFu28" title="Granted"&gt;23,996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zJhmFR2fPhmd" title="Number of shares outstanding at beginning"&gt;23,996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zEzPiTVHZ99a" title="Lapsed"&gt;(1,602&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zaMbOlrVMT9a" title="Exercised"&gt;(17,129&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zCE7KXgXpUn3" title="Number of shares outstanding at beginning"&gt;5,265&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zqfQlczzehZ7" title="Lapsed"&gt;(4,753&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zLAuRGEZq723" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2492"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_z6YdNQXQ9xAj" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2494"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zT0iw6bs8jgb" title="Number of shares outstanding at end"&gt;512&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;May 2023 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zjqRBIW78nMb" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2498"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zd0amQ7dyPR8" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2500"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zPjA54wr6Hy2" title="Granted"&gt;1,098&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zFY4iePKeVQc" title="Number of shares outstanding at beginning"&gt;1,098&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zihHNTG5tjIi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2506"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zYtD59txfF3l" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2508"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_z2vmwny7Mmf1" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2510"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_z3z5s0tCWkGd" title="Number of shares outstanding at beginning"&gt;1,098&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_z8qVSKijvNa3" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2514"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zxqVxJJ616Bk" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2516"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_z0A8i8170h3h" title="Number of shares outstanding at end"&gt;1,098&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;May 2020 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zp3gsEvdEvIk" title="Number of shares outstanding at beginning"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zyr34XJFunXi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2522"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zub9ggIvS0ba" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2524"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zqFTsNQLeFyb" title="Number of shares outstanding at beginning"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zLSSy3SQ5ipj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2528"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zHFl902eVDm2" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2530"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesExercised_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_pd" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2532"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Warrants_iS_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zXZ2pMLzTAf4" title="Number of shares outstanding at beginning"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zEGJVHOqi6O9" title="Lapsed"&gt;(2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zqbaIMejb3c3" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2538"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zzIhrO6OmNNe" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2540"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zo4bAyAvekIi" title="Number of shares outstanding at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2542"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;October 2019 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zKeqU6ygoV1h" title="Number of shares outstanding at beginning"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zNZclyDx2K61" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2546"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zvqRz0XcUqQ6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2548"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zVLPaZJ41479" title="Number of shares outstanding at beginning"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zdfeThwu3zS4" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2552"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zQmeVPCifHNh" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2554"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zrLGBPzwRaY5" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2556"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zytXBlu8Od49" title="Number of shares outstanding at beginning"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zQsodCDK3DYf" title="Lapsed"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zi6aHoGeI3S4" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2562"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zfHUzcaRFIci" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2564"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zgQ1swvr3QQ4" title="Number of shares outstanding at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2566"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: justify"&gt;Ordinary shares&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;Dara warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zt19x43FYBB8" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2568"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zsNYQCkmkQXk" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2570"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zpaYbsUrTUX9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2572"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zF543rvvqdLh" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2574"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zZ26aCgm0Ah6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2576"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zIiHlSeLdG26" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2578"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zFIj7SbrGTDa" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2580"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zsSG160q0Qcc" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2582"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zXQD9taDUZ3l" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2584"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zEhvjZt6bD8g" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2586"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zV2gCsIY68ih" title="Number of shares outstanding at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2588"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;Dara options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_z7bmaoO54QG3" title="Number of shares outstanding at beginning"&gt;138&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zwFvtuP7bDcd" title="Lapsed"&gt;(10&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zsQolqyqefr9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2594"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zRSITTulG6Xj" title="Number of shares outstanding at beginning"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zYJHziyuvl21" title="Lapsed"&gt;(29&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zsWbctXK3QN9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2600"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zfv7tDoWztL" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zx9S3ezNvaNa" title="Number of shares outstanding at beginning"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zch5AwLhvdHh" title="Lapsed"&gt;(99&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zkCwyRY8Cu44" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2608"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zmIT4lgI4El" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2610"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zjwQRo663Px1" title="Number of shares outstanding at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2612"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 9pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt; font-weight: normal"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt; font-weight: normal"&gt;Number and original price of warrants have been adjusted to reflect
the share consolidation and ratio change of ADS&#x2019;s to ordinary shares that occurred on 24 March 2023 and the ratio change of ADS&#x2019;s
to ordinary shares on 5 July 2023, 4 October 2024 and 31 July 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zPJk2gSj5NF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</bdrx:DisclosureOfDerivativeFinancialLiabilityCurrentExplanatory>
    <ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities contextRef="From2025-01-01to2025-12-31" id="Fact002347">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eifrs-full--MaturityAnalysisForDerivativeFinancialLiabilities_pn3n3_zLWAcu5ciIS2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Derivative financial liability - current (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zKLIJ6H9jw35" style="display: none"&gt;Schedule of derivative financial liability&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;Equity settled derivative financial liability&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;At 1 January&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CurrentDerivativeFinancialLiabilities_iS_pn3n3_c20250101__20251231_zUSxaRQNGVg7" title="Balance at beginning"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--CurrentDerivativeFinancialLiabilities_iS_pn3n3_c20240101__20241231_zaYWyvn6ksZi" title="Balance at beginning"&gt;4,160&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentDerivativeFinancialLiabilities_iS_pn3n3_c20230101__20231231_zoZxxecB0Seg" title="Balance at beginning"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WarrantsIssued_pn3n3_c20250101__20251231_zEFAjzCiPqI" title="Warrants issued"&gt;5,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsIssued_pn3n3_c20240101__20241231_zUvY6ykrS4Ma" title="Warrants issued"&gt;3,059&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsIssued_pn3n3_c20230101__20231231_zbcwWGmPL8h3" title="Warrants issued"&gt;4,562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Transfer to share premium on exercise of warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20250101__20251231_zqkNBxWR8yI5" title="Transfer to share premium on exercise of warrants"&gt;(196&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20240101__20241231_zifKSr0RIdwg" title="Transfer to share premium on exercise of warrants"&gt;(3,618&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--TransferToSharePremiumOnExerciseOfWarrants_pn3n3_c20230101__20231231_z5MNCVyLYzta" title="Transfer to share premium on exercise of warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2365"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--GainLossOfEquitySettledDerivativeFinancialLiability_pn3n3_c20250101__20251231_zMGByjrktSAb" title="Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income"&gt;(2,296&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--GainLossOfEquitySettledDerivativeFinancialLiability_pn3n3_c20240101__20241231_zEYomCa4O383" title="Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income"&gt;(3,218&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--GainLossOfEquitySettledDerivativeFinancialLiability_pn3n3_c20230101__20231231_zhd7gX5D2QO8" title="Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income"&gt;(487&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;At 31 December&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentDerivativeFinancialLiabilities_iE_pn3n3_c20250101__20251231_zsqQLVnybWq4" title="Balance at ending"&gt;2,915&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CurrentDerivativeFinancialLiabilities_iE_pn3n3_c20240101__20241231_zfYlf2iFCVva" title="Balance at ending"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--CurrentDerivativeFinancialLiabilities_iE_pn3n3_c20230101__20231231_zw35gZYNrmD3" title="Balance at ending"&gt;4,160&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002349"
      unitRef="GBP">383000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002351"
      unitRef="GBP">4160000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002353"
      unitRef="GBP">85000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <bdrx:WarrantsIssued
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002355"
      unitRef="GBP">5024000</bdrx:WarrantsIssued>
    <bdrx:WarrantsIssued
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002357"
      unitRef="GBP">3059000</bdrx:WarrantsIssued>
    <bdrx:WarrantsIssued
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002359"
      unitRef="GBP">4562000</bdrx:WarrantsIssued>
    <bdrx:TransferToSharePremiumOnExerciseOfWarrants
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002361"
      unitRef="GBP">-196000</bdrx:TransferToSharePremiumOnExerciseOfWarrants>
    <bdrx:TransferToSharePremiumOnExerciseOfWarrants
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002363"
      unitRef="GBP">-3618000</bdrx:TransferToSharePremiumOnExerciseOfWarrants>
    <bdrx:GainLossOfEquitySettledDerivativeFinancialLiability
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002367"
      unitRef="GBP">-2296000</bdrx:GainLossOfEquitySettledDerivativeFinancialLiability>
    <bdrx:GainLossOfEquitySettledDerivativeFinancialLiability
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002369"
      unitRef="GBP">-3218000</bdrx:GainLossOfEquitySettledDerivativeFinancialLiability>
    <bdrx:GainLossOfEquitySettledDerivativeFinancialLiability
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002371"
      unitRef="GBP">-487000</bdrx:GainLossOfEquitySettledDerivativeFinancialLiability>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002373"
      unitRef="GBP">2915000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002375"
      unitRef="GBP">383000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002377"
      unitRef="GBP">4160000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2025-12-012025-12-31_custom_SeriesLADSwarrantsMember"
      decimals="INF"
      id="Fact002379"
      unitRef="Shares">6097562</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2024-07-012024-07-31_custom_SeriesJADSWarrantsMember"
      decimals="INF"
      id="Fact002381"
      unitRef="Shares">21315</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2024-07-012024-07-31_custom_SeriesKWarrantsMember"
      decimals="INF"
      id="Fact002383"
      unitRef="Shares">21315</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2024-05-012024-05-31_custom_SeriesGADSWarrantsMember"
      decimals="INF"
      id="Fact002385"
      unitRef="Shares">9434</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2024-05-012024-05-31_custom_SeriesHWarrantsMember"
      decimals="INF"
      id="Fact002387"
      unitRef="Shares">14780</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2023-12-012023-12-31_custom_SeriesEADSWarrantsMember"
      decimals="INF"
      id="Fact002389"
      unitRef="Shares">11998</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2023-12-012023-12-31_custom_SeriesFADSWarrantsMember"
      decimals="INF"
      id="Fact002391"
      unitRef="Shares">11998</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2023-06-012023-06-30_custom_SeriesDADSWarrantsMember"
      decimals="INF"
      id="Fact002393"
      unitRef="Shares">1098</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2020-05-012020-05-31_custom_SeriesADSWarrantsMember"
      decimals="INF"
      id="Fact002395"
      unitRef="Shares">2</bdrx:NumberOfWarrantsIssued>
    <bdrx:NumberOfWarrantsIssued
      contextRef="From2019-10-012019-10-31_custom_SeriesADSWarrantsMember"
      decimals="INF"
      id="Fact002397"
      unitRef="Shares">1</bdrx:NumberOfWarrantsIssued>
    <ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002402">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eifrs-full--DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_pn3n3_zkub3lZ7cNF9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Derivative financial liability - current (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold; text-align: justify"&gt;&lt;span id="xdx_8BA_zWm0kruSSWfg" style="display: none"&gt;Schedule of warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 31 &lt;br/&gt; December &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 31 &lt;br/&gt; December &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 31 &lt;br/&gt; December &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 31 &lt;br/&gt; December &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: justify"&gt;ADSs&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify; width: 16%"&gt;December 2025 grant&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zLMc57J4KbVh" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2404"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zSQHWEssrXm7" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2406"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zz8wOEYb9jW1" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2408"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zR0OSC2P64v3" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2410"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zREhfMew5mnb" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2412"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zKhxKYiGP658" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2414"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zV2EMz5tfbI3" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2416"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zcNDFYvkpBC4" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2418"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zAORQXlfA6L6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2420"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zcuB44waLyK4" title="Granted"&gt;6,097,562&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zbu6HT1MsAHd" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantOneMember_zKBv9gPmqmj" title="Number of shares outstanding at end"&gt;6,097,562&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;July 2024 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_z4OGyUIcQAhi" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2428"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zREdOgpVKnj1" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2430"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zWomYbb1fDS" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2432"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zshGrw0zYyRi" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2434"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_z28Pq65ens6f" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2436"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zkqAUm74EZva" title="Granted"&gt;42,630&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_z8mblt67IPO8" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2440"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zXDAMBpX7Jkc" title="Number of shares outstanding at beginning"&gt;42,630&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_z5AG7g7xwIoj" title="Lapsed"&gt;(8,594&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zHvh3lxlcgY6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2446"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zLZBMz0eTeB2" title="Exercised"&gt;(17,018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantTwoMember_zvCHRhnyJBr" title="Number of shares outstanding at end"&gt;17,018&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;May 2024 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zTRCRQKAVt1d" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2452"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zbffoAlAK5k5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2454"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zpoIuDMNiCUc" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2456"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zfz8oR1jO6gk" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2458"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zmiuHNLQNcpb" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2460"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zdMMdHlL4v06" title="Granted"&gt;24,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_z1swoXrT5QU7" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2464"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zPIbXgSo09z3" title="Number of shares outstanding at beginning"&gt;24,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zF2H9l6BQ8Dk" title="Lapsed"&gt;(6,695&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zFm0TOF2ejZj" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2470"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_zcIQIdjn2kah" title="Exercised"&gt;(8,085&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantThreeMember_ztu64w6HSkn7" title="Number of shares outstanding at end"&gt;9,434&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;December 2023 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zqDRdzZ5CVT9" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2476"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_z4F6wehElB3f" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2478"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zF9BVDJKFu28" title="Granted"&gt;23,996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zJhmFR2fPhmd" title="Number of shares outstanding at beginning"&gt;23,996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zEzPiTVHZ99a" title="Lapsed"&gt;(1,602&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zaMbOlrVMT9a" title="Exercised"&gt;(17,129&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zCE7KXgXpUn3" title="Number of shares outstanding at beginning"&gt;5,265&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zqfQlczzehZ7" title="Lapsed"&gt;(4,753&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zLAuRGEZq723" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2492"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_z6YdNQXQ9xAj" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2494"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFourMember_zT0iw6bs8jgb" title="Number of shares outstanding at end"&gt;512&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;May 2023 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zjqRBIW78nMb" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2498"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zd0amQ7dyPR8" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2500"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zPjA54wr6Hy2" title="Granted"&gt;1,098&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zFY4iePKeVQc" title="Number of shares outstanding at beginning"&gt;1,098&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zihHNTG5tjIi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2506"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zYtD59txfF3l" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2508"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_z2vmwny7Mmf1" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2510"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_z3z5s0tCWkGd" title="Number of shares outstanding at beginning"&gt;1,098&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_z8qVSKijvNa3" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2514"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_zxqVxJJ616Bk" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2516"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantFiveMember_z0A8i8170h3h" title="Number of shares outstanding at end"&gt;1,098&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;May 2020 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zp3gsEvdEvIk" title="Number of shares outstanding at beginning"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zyr34XJFunXi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2522"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zub9ggIvS0ba" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2524"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zqFTsNQLeFyb" title="Number of shares outstanding at beginning"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zLSSy3SQ5ipj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2528"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zHFl902eVDm2" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2530"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesExercised_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_pd" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2532"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Warrants_iS_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zXZ2pMLzTAf4" title="Number of shares outstanding at beginning"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zEGJVHOqi6O9" title="Lapsed"&gt;(2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zqbaIMejb3c3" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2538"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zzIhrO6OmNNe" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2540"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSixMember_zo4bAyAvekIi" title="Number of shares outstanding at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2542"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;October 2019 grant&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zKeqU6ygoV1h" title="Number of shares outstanding at beginning"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zNZclyDx2K61" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2546"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zvqRz0XcUqQ6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2548"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zVLPaZJ41479" title="Number of shares outstanding at beginning"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zdfeThwu3zS4" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2552"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zQmeVPCifHNh" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2554"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zrLGBPzwRaY5" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2556"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zytXBlu8Od49" title="Number of shares outstanding at beginning"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zQsodCDK3DYf" title="Lapsed"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zi6aHoGeI3S4" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2562"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zfHUzcaRFIci" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2564"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--WarrantSevenMember_zgQ1swvr3QQ4" title="Number of shares outstanding at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2566"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: justify"&gt;Ordinary shares&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;Dara warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zt19x43FYBB8" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2568"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zsNYQCkmkQXk" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2570"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zpaYbsUrTUX9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2572"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zF543rvvqdLh" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2574"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zZ26aCgm0Ah6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2576"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zIiHlSeLdG26" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2578"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zFIj7SbrGTDa" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2580"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zsSG160q0Qcc" title="Number of shares outstanding at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2582"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zXQD9taDUZ3l" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2584"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zEhvjZt6bD8g" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2586"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAWarrantsMember_zV2gCsIY68ih" title="Number of shares outstanding at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2588"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; text-align: justify"&gt;Dara options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Warrants_iS_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_z7bmaoO54QG3" title="Number of shares outstanding at beginning"&gt;138&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesLapsed_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zwFvtuP7bDcd" title="Lapsed"&gt;(10&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfSharesOutstandingGranted_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zsQolqyqefr9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2594"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Warrants_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zRSITTulG6Xj" title="Number of shares outstanding at beginning"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--SharesLapsed_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zYJHziyuvl21" title="Lapsed"&gt;(29&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--NumberOfSharesOutstandingGranted_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zsWbctXK3QN9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2600"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharesExercised_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zfv7tDoWztL" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Warrants_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zx9S3ezNvaNa" title="Number of shares outstanding at beginning"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--SharesLapsed_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zch5AwLhvdHh" title="Lapsed"&gt;(99&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--NumberOfSharesOutstandingGranted_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zkCwyRY8Cu44" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2608"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SharesExercised_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zmIT4lgI4El" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2610"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Warrants_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--DARAOptionsMember_zjwQRo663Px1" title="Number of shares outstanding at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2612"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 9pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt; font-weight: normal"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt; font-weight: normal"&gt;Number and original price of warrants have been adjusted to reflect
the share consolidation and ratio change of ADS&#x2019;s to ordinary shares that occurred on 24 March 2023 and the ratio change of ADS&#x2019;s
to ordinary shares on 5 July 2023, 4 October 2024 and 31 July 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2025-01-012025-12-31_custom_WarrantOneMember"
      decimals="INF"
      id="Fact002422"
      unitRef="Shares">6097562</bdrx:NumberOfSharesOutstandingGranted>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_WarrantOneMember"
      decimals="INF"
      id="Fact002426"
      unitRef="Shares">6097562</bdrx:Warrants>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2024-01-012024-12-31_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact002438"
      unitRef="Shares">42630</bdrx:NumberOfSharesOutstandingGranted>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact002442"
      unitRef="Shares">42630</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2025-01-012025-12-31_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact002444"
      unitRef="Shares">-8594</bdrx:SharesLapsed>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact002448"
      unitRef="Shares">-17018</bdrx:SharesExercised>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact002450"
      unitRef="Shares">17018</bdrx:Warrants>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2024-01-012024-12-31_custom_WarrantThreeMember"
      decimals="INF"
      id="Fact002462"
      unitRef="Shares">24214</bdrx:NumberOfSharesOutstandingGranted>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_WarrantThreeMember"
      decimals="INF"
      id="Fact002466"
      unitRef="Shares">24214</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2025-01-012025-12-31_custom_WarrantThreeMember"
      decimals="INF"
      id="Fact002468"
      unitRef="Shares">-6695</bdrx:SharesLapsed>
    <bdrx:SharesExercised
      contextRef="From2025-01-012025-12-31_custom_WarrantThreeMember"
      decimals="INF"
      id="Fact002472"
      unitRef="Shares">-8085</bdrx:SharesExercised>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_WarrantThreeMember"
      decimals="INF"
      id="Fact002474"
      unitRef="Shares">9434</bdrx:Warrants>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_WarrantFourMember"
      decimals="INF"
      id="Fact002480"
      unitRef="Shares">23996</bdrx:NumberOfSharesOutstandingGranted>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_WarrantFourMember"
      decimals="INF"
      id="Fact002482"
      unitRef="Shares">23996</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_WarrantFourMember"
      decimals="INF"
      id="Fact002484"
      unitRef="Shares">-1602</bdrx:SharesLapsed>
    <bdrx:SharesExercised
      contextRef="From2024-01-012024-12-31_custom_WarrantFourMember"
      decimals="INF"
      id="Fact002486"
      unitRef="Shares">-17129</bdrx:SharesExercised>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_WarrantFourMember"
      decimals="INF"
      id="Fact002488"
      unitRef="Shares">5265</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2025-01-012025-12-31_custom_WarrantFourMember"
      decimals="INF"
      id="Fact002490"
      unitRef="Shares">-4753</bdrx:SharesLapsed>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_WarrantFourMember"
      decimals="INF"
      id="Fact002496"
      unitRef="Shares">512</bdrx:Warrants>
    <bdrx:NumberOfSharesOutstandingGranted
      contextRef="From2023-01-012023-12-31_custom_WarrantFiveMember"
      decimals="INF"
      id="Fact002502"
      unitRef="Shares">1098</bdrx:NumberOfSharesOutstandingGranted>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_WarrantFiveMember"
      decimals="INF"
      id="Fact002504"
      unitRef="Shares">1098</bdrx:Warrants>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_WarrantFiveMember"
      decimals="INF"
      id="Fact002512"
      unitRef="Shares">1098</bdrx:Warrants>
    <bdrx:Warrants
      contextRef="AsOf2025-12-31_custom_WarrantFiveMember"
      decimals="INF"
      id="Fact002518"
      unitRef="Shares">1098</bdrx:Warrants>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_WarrantSixMember"
      decimals="INF"
      id="Fact002520"
      unitRef="Shares">2</bdrx:Warrants>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_WarrantSixMember"
      decimals="INF"
      id="Fact002526"
      unitRef="Shares">2</bdrx:Warrants>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_WarrantSixMember"
      decimals="-3"
      id="Fact002534"
      unitRef="Shares">2000</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2025-01-012025-12-31_custom_WarrantSixMember"
      decimals="INF"
      id="Fact002536"
      unitRef="Shares">-2</bdrx:SharesLapsed>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_WarrantSevenMember"
      decimals="INF"
      id="Fact002544"
      unitRef="Shares">1</bdrx:Warrants>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_WarrantSevenMember"
      decimals="INF"
      id="Fact002550"
      unitRef="Shares">1</bdrx:Warrants>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_WarrantSevenMember"
      decimals="INF"
      id="Fact002558"
      unitRef="Shares">1</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2025-01-012025-12-31_custom_WarrantSevenMember"
      decimals="INF"
      id="Fact002560"
      unitRef="Shares">-1</bdrx:SharesLapsed>
    <bdrx:Warrants
      contextRef="AsOf2022-12-31_custom_DARAOptionsMember"
      decimals="INF"
      id="Fact002590"
      unitRef="Shares">138</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2023-01-012023-12-31_custom_DARAOptionsMember"
      decimals="INF"
      id="Fact002592"
      unitRef="Shares">-10</bdrx:SharesLapsed>
    <bdrx:Warrants
      contextRef="AsOf2023-12-31_custom_DARAOptionsMember"
      decimals="INF"
      id="Fact002596"
      unitRef="Shares">128</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2024-01-012024-12-31_custom_DARAOptionsMember"
      decimals="INF"
      id="Fact002598"
      unitRef="Shares">-29</bdrx:SharesLapsed>
    <bdrx:Warrants
      contextRef="AsOf2024-12-31_custom_DARAOptionsMember"
      decimals="INF"
      id="Fact002604"
      unitRef="Shares">99</bdrx:Warrants>
    <bdrx:SharesLapsed
      contextRef="From2025-01-012025-12-31_custom_DARAOptionsMember"
      decimals="INF"
      id="Fact002606"
      unitRef="Shares">-99</bdrx:SharesLapsed>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002614">&lt;p id="xdx_80B_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_z4GHpufJaJzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;20&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82C_zFkyPYadWnZg"&gt;Financial instruments
&#x2013; risk management&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group is exposed through its operations to the following financial
risks:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Credit risk&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Foreign exchange risk&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Liquidity risk&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;This note describes the Group&#x2019;s policies and processes for managing
those risks. The policy for managing these risks is reviewed and agreed with the Board, however it has delegated the authority for designing
and operating processes that ensure the effective management of the risks to the Group&#x2019;s management.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Principal financial instruments&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The principal financial instruments used by the Group, from which financial
instrument risk arises, are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Trade and other receivables&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Cash and cash equivalents&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Trade and other payables&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Accruals&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Deferred considerations&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Loans and borrowings&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Derivative financial liability&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;A summary of the financial instruments held by category is provided
below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financial assets &#x2013; amortised cost&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eifrs-full--DisclosureOfFairValueOfFinancialInstrumentsExplanatory_pn3n3_zYxLl6teJn" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Financial instruments - risk management (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_z3XeYdAiKv12" style="display: none"&gt;Schedule of consolidated derivative financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20251231_zAsBEEYkSmb9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20241231_zHrYF5hJPFee" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20231231_z83xi6mYgXmf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--CashAndCashEquivalents_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;8,534&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,669&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,971&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--CurrentTradeReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade receivables&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2624"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--OtherReceivables1_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;64&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;131&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;282&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--FinancialAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total financial assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,633&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,811&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,253&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financial liabilities &#x2013; amortised cost&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;97&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;707&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--OtherCurrentPayables_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other payables&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--Accruals_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Accruals&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,273&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredConsideration_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred consideration&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,844&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2648"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--Borrowings1_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Borrowings&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;61&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;727&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;464&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinancialLiabilitiesAtAmortisedCost_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total financial liabilities &#x2013; amortised cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,243&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,557&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,642&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financial liabilities &#x2013; fair value through profit and loss
&#x2013; current&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Equity settled derivative financial liability&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;2,915&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;383&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;4,160&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zhHegTLITnjj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Fair value hierarchy &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group uses the following hierarchy for determining and disclosing
the fair value of financial instruments by valuation technique:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Level 1: quoted (unadjusted) prices in active markets for identical assets and liabilities;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly
or indirectly; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Level 3: techniques which use inputs that have a significant effect on the recorded fair value that are not based on observable market
data.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The fair value of the Group&#x2019;s derivative financial liability
is measured on a recurring basis. The following table gives information about how the fair value of this financial liability is determined,
additional disclosure is given in note 19:&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfConsolidatedFinancialAssetsAndLiabilitiesValuedAtFairValueExplanatory_pn3n3_zIzfKJCcZ2Vg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments - risk management (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;span id="xdx_8B4_ztkmByDfqkcj" style="display: none"&gt;Schedule of consolidated financial assets and liabilities at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Financial &lt;br/&gt; liabilities&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair value as &lt;br/&gt; at &lt;br/&gt; 31/12/2025&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair &lt;br/&gt; value &lt;br/&gt; hierarchy&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; white-space: nowrap; font-weight: bold"&gt;Valuation &lt;br/&gt; technique(s)&lt;br/&gt; and key input(s)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Significant unobservable input(s)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Relationship of &lt;br/&gt; unobservable inputs to &lt;br/&gt; fair value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series L warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 11%; text-align: left"&gt;&#xa3;&lt;span id="xdx_90E_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember_zANRsiEsWw49" title="Equity settled derivative financial liability"&gt;2,914,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 8%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; width: 13%; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 32%; text-align: left"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Volatility rate of 110.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 20%; text-align: left"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.97 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.73% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember_zciiXiDLETQc" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series J warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_909_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember_zNask9FYj2Y4" title="Equity settled derivative financial liability"&gt;1,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Volatility rate of 115.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_905_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 3.56 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.60% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember_zNPvsvJXKIh8" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series G warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_90D_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_z4c46oqytjFf" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2701"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Volatility rate of 115.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 3.39 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_906_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.59% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_zRZlDK6HrQG1" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series E warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_902_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_z3RebuobSiXc" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2716"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Volatility rate of 115.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 2.98 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_907_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.55% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_zZaYTCRLr7Ud" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series D warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_90A_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_zSEdJGVyst9g" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2731"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Volatility rate of 120.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 2.47 years determined using the remaining life of the share options.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_901_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.51% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_zBllAigNYRXl" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;span id="xdx_904_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231_zMRspwD8g6B" title="Equity settled derivative financial liability"&gt;2,915,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Financial &lt;br/&gt; liabilities&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair value as &lt;br/&gt; at &lt;br/&gt; 31/12/2024&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair &lt;br/&gt; value &lt;br/&gt; hierarchy&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left; white-space: nowrap; font-weight: bold"&gt;Valuation &lt;br/&gt; technique(s)&lt;br/&gt; and key input(s)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left; font-weight: bold"&gt;Significant unobservable input(s)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Relationship of &lt;br/&gt; unobservable inputs to &lt;br/&gt; fair value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Equity settled financial derivative liability &#x2013; Series K warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; white-space: nowrap"&gt;&#xa3; &lt;span id="xdx_90E_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember_zOQddKl3s5b7" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2751"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; white-space: nowrap"&gt;Level 3&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left; white-space: nowrap"&gt;&lt;p id="xdx_980_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember_zvA8EEfmXiV4" style="margin-top: 0; margin-bottom: 0" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes&lt;br/&gt;Model&lt;/p&gt;
                                                      &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Volatility rate of 75.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.51 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.24% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the risk-free rate the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series J warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 11%; text-align: left"&gt;&#xa3;&lt;span id="xdx_90E_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember_zOxDpPdc0QCk" title="Equity settled derivative financial liability"&gt;231,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 8%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; width: 13%; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 32%; text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Volatility rate of 100.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 20%; text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_907_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.56 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.36% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember_zxMNfBJLQ7S1" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series H warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_906_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_z5IPp4oi9m6i" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2782"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Volatility rate of 75.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.39 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.29% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_zQGCZWBkAR82" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series G warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_907_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_z71tMnG5p262" title="Equity settled derivative financial liability"&gt;102,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Volatility rate of 105.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_905_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.39 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_901_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_902_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.35% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_zqZRqqxWIdM2" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 15%"&gt;Equity settled financial derivative liability &#x2013; Series E warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 11%"&gt;&#xa3;&lt;span id="xdx_90F_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_z27SfCYcU7pd" title="Equity settled derivative financial liability"&gt;47,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left; width: 13%"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 32%"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Volatility rate of 105.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 20%"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 3.98 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.32% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_zndXeGMRFbm9" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series D warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_901_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember_z6qcm5Sr8oN2" title="Equity settled derivative financial liability"&gt;2,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Significant unobservable input(s)"&gt;Volatility rate of 110.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 3.47 years determined using the remaining life of the share options.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.30% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember_zjiWp73jezva" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; May 2020 warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_908_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember_zlL1nTfQO7v5" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2843"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Significant unobservable input(s)"&gt;Volatility rate of 100.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.89 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.18% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember_zTRHdFvkUDb1" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; October 2019 warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_909_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember_z6mDSfbubUTb" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2858"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Significant unobservable input(s)"&gt;Volatility rate of 80.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.48 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.24% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember_zPeue9IWGRe2" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;span id="xdx_904_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231_z6u0ziGWtTGb" title="Equity settled derivative financial liability"&gt;383,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Financial &lt;br/&gt; liabilities&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair value as &lt;br/&gt; at &lt;br/&gt; 31/12/2023&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair &lt;br/&gt; value &lt;br/&gt; hierarchy&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; white-space: nowrap; font-weight: bold"&gt;Valuation &lt;br/&gt; technique(s)&lt;br/&gt; and key input(s)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Significant unobservable input(s)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Relationship of &lt;br/&gt; unobservable inputs to &lt;br/&gt; fair value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series E warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 11%; text-align: left"&gt;&#xa3;&lt;span id="xdx_90D_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember_zQoxKhRRdEu9" title="Equity settled derivative financial liability"&gt;2,592,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 8%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; width: 13%; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 32%; text-align: left"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Significant unobservable input(s)"&gt;Volatility rate of 90.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 20%; text-align: left"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.98 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.79% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember_zMYQfGlUVUqk" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series F warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_907_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember_z34vnHRRTPJd" title="Equity settled derivative financial liability"&gt;1,444,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Significant unobservable input(s)"&gt;Volatility rate of 95.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.98 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_901_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.84% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember_zdTIzZErVSi" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series D warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_906_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_z9Ah05coLJbe" title="Equity settled derivative financial liability"&gt;124,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Volatility rate of 95.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.40 years determined using the remaining life of the share options.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_902_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.93% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_z6VqjOwoovHj" style="text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; May 2020 warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_907_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_zYGcLHizHmo4" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2924"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Volatility rate of 100.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_907_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 1.88 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.23% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_zG640Gov9TD5" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; October 2019 warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_90B_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_zNlesinfd1L6" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2939"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Volatility rate of 100.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 1.50 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.51% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_z1LX4aEwdBB2" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;span id="xdx_901_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231_zADu6nyGNZ4l" title="Equity settled derivative financial liability"&gt;4,160,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zGzXPlXyrEIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Changing the unobservable risk-free rate input to the valuation model
by 10% higher while all other variables were held constant, would not impact the carrying amount of warrants (2024: nil; 2023: nil).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;There were no transfers between Level 1 and 2 in the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The financial liability measured at fair value at 31 December 2025
on Level 3 fair value measurement represents consideration relating to warrants issued in December 2025, July 2024, May 2024, December
2023 and May 2023 as part of Registered Direct offerings and private placement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Credit risk &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group is exposed to credit risk from amounts due from collaborative
partners and from cash and cash equivalents and deposits with banks and financial institutions. The risk from collaborative partners is
deemed to be low. For banks and financial institutions, only independently rated parties with high credit status are accepted. The Group
does not enter into derivatives to manage credit risk. The gross carrying amount of a financial asset is written off (either partially
or in full) to the extent that there is no realistic prospect of recovery.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The total exposure to credit risk of the Group is equal to the total
value of the financial assets held at each year end as noted above.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Foreign exchange risk &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The group operates internationally although its operations are based
in the United Kingdom. The group incorporated subsidiaries in the United Sate of America and the Republic of Ireland during the year,
there were minimal transactions in these entities during 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The group assets and liabilities are predominately denominated in Pounds
Sterling and US Dollar. The Group retains cash balances in US Dollars as a hedge against these liabilities. The assets and liabilities
associated with the Joint Arrangement with Emtora, as disclosed in note 1, are held in US dollars as the majority of operations under
the arrangement are undertaken in the US.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The group is exposed to foreign exchange risk arising from exposure
to various currencies primarily the US Dollar and Euro.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The table below shows analysis of the Pounds Sterling equivalent of
year-end cash and cash equivalent balances by&#160;currency:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfForeignExchangeRiskExplanatory_pn3n3_zoKXTaLW4RTe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Financial instruments - risk management (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zrDALJrfG3Eh" style="display: none"&gt;Schedule of foreign exchange risk&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash and cash equivalents:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Pounds Sterling&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--GBP_z2nQUApYqeO7" title="Cash and cash equivalents"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--GBP_zU2WfPujWxc5" title="Cash and cash equivalents"&gt;212&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--GBP_zSRu4j0zZi67" title="Cash and cash equivalents"&gt;2,244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;US Dollar&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--USD_z9kcSMj74qOj" title="Cash and cash equivalents"&gt;8,436&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--USD_zAYjVALsK74a" title="Cash and cash equivalents"&gt;1,457&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--USD_zxPWn04TOAn6" title="Cash and cash equivalents"&gt;3,727&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Other&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__srt--OtherCurrencyMember_zsmyqNmHnV53" title="Cash and cash equivalents"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__srt--OtherCurrencyMember_zB9peqSVc1Na" title="Cash and cash equivalents"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2979"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__srt--OtherCurrencyMember_z2Ju3hRxtENf" title="Cash and cash equivalents"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2981"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231_zkTaPuUHsEXe" title="Cash and cash equivalents"&gt;8,534&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231_zx4NzWeBh5U9" title="Cash and cash equivalents"&gt;1,669&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231_znymrN8rpMbg" title="Cash and cash equivalents"&gt;5,971&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zTIyqHLdTpr6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Foreign exchange risk also arises when individual Group entities enter
into transactions denominated in a currency other than their functional currency, the Group&#x2019;s transactions outside the UK to the
US and Europe drive foreign exchange movements where suppliers invoice in currency other than sterling. The Group does retain some cash
balances in US Dollars from its US Dollar denominated equity raises to reduce the foreign exchange exposure on US$ denominated suppliers
related to its NASDAQ listing and US based clinical trial. All other assets and/or consumables that are purchased in foreign currencies,
such currency is purchased immediately upon invoice. These transactions are not hedged because the cost of doing so is disproportionate
to the risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Foreign currency sensitivity analysis&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The most significant currencies in which the Group transacts, other
than Pounds Sterling, are the US Dollar and the Euro. The Group also trades in other currencies in small amounts as necessary.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table details the Group&#x2019;s sensitivity to a 10%
change in year-end exchange rates, which the Group feels is the maximum likely change in rate based upon recent currency movements, in
the key foreign currency exchange rates against Pounds Sterling:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfForeignCurrencyExchangeRatesExplanatory_pn3n3_zzBBan3THny2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Financial instruments - risk management (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zBDG45QOOj2k" style="display: none"&gt;Schedule of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Year ended 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;US Dollar&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Euro&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Other&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Loss before tax&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zGdJrFFtxEZ1" title="Loss before tax"&gt;1,068&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zUK4RrxYr3w2" title="Loss before tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2993"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_z7DC9OeorBo3" title="Loss before tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2995"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total equity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zg27OF1AGoy5" title="Total equity"&gt;1,068&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zyjMkFqsR4Xc" title="Total equity"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2999"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_zqspeVg6IzXg" title="Total equity"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3001"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Year ended 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;US Dollar&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Euro&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Other&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Loss before tax&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zdjdWBQPROke" title="Loss before tax"&gt;146&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zgBUHvCeW4Xi" title="Loss before tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3005"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_zMXnBD912lLh" title="Loss before tax"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total equity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zIuLtpMN7TR8" title="Total equity"&gt;146&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zO9j08M6dqBf" title="Total equity"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3011"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_zKrPZlCmgFjb" title="Total equity"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Year ended 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;US Dollar&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Euro&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Other&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Loss before tax&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zVeeGZIBDOfi" title="Loss before tax"&gt;373&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zGfEauGRGnLf" title="Loss before tax"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_z5wgTLSvACHi" title="Loss before tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3019"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total equity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zXMErVV4B5ze" title="Total equity"&gt;373&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_znZWkraeksY6" title="Total equity"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_z8Uwg5lyLqX2" title="Total equity"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3025"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zHQ3pcS7JkNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Liquidity risk &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Liquidity risk arises from the Group&#x2019;s management of working
capital. It is the risk that the Group will encounter difficulty in meeting its financial obligations as they fall due. It is the Group&#x2019;s
aim to settle balances as they become&#160;due.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During 2025 the Company utilised its Equity Line of Credit (&#x201c;ELOC&#x201d;)
to raise gross proceeds of $&lt;span id="xdx_901_ecustom--ProceedsFromEquityLineOfCredit_pn3n3_dm_uUSD_c20250101__20251231_zlSjNubCNw14" title="Proceeds from Equity Line of Credit"&gt;8.92&lt;/span&gt; million before expenses. In May 2025, the Company completed a Warrant Inducement which raised &#xa3;&lt;span id="xdx_90F_ecustom--WarrantInducementValue_pn3p0_c20250501__20250531_zJHb75i8sc4g" title="Warrant Inducement"&gt;47,000&lt;/span&gt;.
In December 2025, the Company completed a Registered Offering in the US which raised $&lt;span id="xdx_900_ecustom--ProceedsFromRegisteredOffering_pn3n3_dm_uUSD_c20251201__20251231_zboHEcnWZWLe" title="Proceeds from registered offering"&gt;10&lt;/span&gt; million before expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In December 2024 the Company issued a Promissory Note as detailed in
Note 17 for the principle amount of $&lt;span id="xdx_909_ecustom--PrincipleAmount_iI_pn3p0_uUSD_c20251231_zGnChQZQ4caf" title="Principle amount"&gt;600,000&lt;/span&gt;. The Company received $&lt;span id="xdx_904_ecustom--ProceedsFromNote_pn3p0_uUSD_c20241201__20241231_zurfUMyO0tdi" title="Proceeds from note"&gt;540,000&lt;/span&gt; on 24 December 2024 as the note was issued at a 10% discount.
The Promissory Note was repaid in full during 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In May 2024, the Company completed a Warrant Inducement which raised
&#xa3;&lt;span id="xdx_90F_ecustom--WarrantInducementValue_pn3n3_dm_c20240501__20240531_zCw3XUhMw1ji" title="Warrant Inducement"&gt;4.8 &lt;/span&gt;million before expenses. In July 2024, the Company completed a Registered Direct Offering in the US which raised &#xa3;&lt;span id="xdx_900_ecustom--ProceedsFromRegisteredOffering_pn3n3_dm_c20240701__20240731_zLB1IihGVjTi" title="Proceeds from registered offering"&gt;3.9&lt;/span&gt;
million before expenses. During the year warrants previously issued were exercised resulting in the Company receiving &#xa3;&lt;span id="xdx_90D_ecustom--ProceedsFromWarrantsExercised_pn3n3_dm_c20250101__20251231_zciMTDOw4vVe" title="Proceeds from warrants exercised"&gt;0.4&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In February 2023, the Company completed a Private Placement in the
US which raised &#xa3;&lt;span id="xdx_904_ecustom--ProceedsFromPrivatePlacement_pn3n3_dm_c20230201__20230228_zR6PzVhKI8rb" title="Proceeds from private placement"&gt;5.0 &lt;/span&gt;million before expenses. In May 2023, the Company completed a Registered Direct Offering in the US which raised
&#xa3;&lt;span id="xdx_90C_ecustom--ProceedsFromRegisteredOffering_pn3n3_dm_c20230501__20230531_zrx4Y3Pw7qoc" title="Proceeds from registered offering"&gt;2.7 &lt;/span&gt;million before expenses. In December 2023, the Company completed a Registered Offering in the US which raised &#xa3;&lt;span id="xdx_902_ecustom--ProceedsFromRegisteredOffering_pn3n3_dm_c20231201__20231231_z15qtWT8Yc8e" title="Proceeds from registered offering"&gt;4.4 &lt;/span&gt;million
before expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Directors have prepared cash flow forecasts and considered the
cash flow requirement for the Group for the next three years including the period 12 months from the date of approval of the consolidated
financial statements. These forecasts show that further financing will be required before Q4 2025 assuming, inter alia, that certain development
programs and other operating activities continue as currently planned.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Pursuant to its $35 million Equity Line of Credit, or ELOC, as described
above, the Company may direct C/M to purchase ADSs (subject to certain limitations) and receive proceeds in accordance with a formula
price for up to 36 months from the Commencement Date. There is no guarantee that the Company will be able to use the ELOC or raise from
other financing to the extent necessary to finance the Company&#x2019;s operations. As at 31 December 2025 $26.08 million remains undrawn
from the ELOC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In the Directors&#x2019; opinion, the environment for financing of small
and micro-cap biotech companies remains challenging. While this may present acquisition and/or merger opportunities with other companies
with limited or no access to financing, as noted above, any attendant financings by Biodexa are likely to be dilutive. The Directors continue
to evaluate financing options, including those connected to acquisitions and/or mergers, potentially available to the Group. Any alternatives
considered are contingent upon the agreement of counterparties and accordingly, there can be no assurance that any alternative courses
of action to finance the Company would be successful.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;This requirement for additional financing in the short term represents
a material uncertainty that may cast significant doubt upon the Group and Parent Company&#x2019;s ability to continue as a going concern.
Should it become evident in the future that there are no realistic financing options available to the Company which are actionable before
its cash resources run out then the Company will no longer be a going concern. In such circumstances, we would no longer be able to prepare
financial statements under paragraph 25 of IAS 1. Instead, the financial statements would be prepared on a liquidation basis and assets
would be stated at net realizable value and all liabilities would be accelerated to current liabilities.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table sets out the contractual maturities (representing
undiscounted contractual cash-flows) of financial&#160;liabilities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfMaturitiesOfFinancialInstrumentsExplanatory_pn3n3_zi3161v2nJq1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Financial instruments - risk management (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zp6TXH0Pxrlj" style="display: none"&gt;Schedule of contractual maturities of financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Up to 3&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 3 and 12&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 1 and 2&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 2 and 5&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Over&lt;br/&gt; 5&#160;years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zWxh8Oemat9i" title="Total"&gt;1,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zslL4NKv0Mxg" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3060"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_znYSIu5lsCTi" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3062"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zL7xF4m7N1P" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3064"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_ziIQWB4nMBHj" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3066"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred considerations&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zghTpiBDZh84" title="Total"&gt;166&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zn8NcVdKshv3" title="Total"&gt;497&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_z3ARhngQ8kXh" title="Total"&gt;662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zWX8CYZ3AFNk" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3074"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zCWFjLrTLWjg" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3076"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Promissory note&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_z7i25Zh6Besf" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3078"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zpThBWsHnPRd" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3080"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zkyqMVs8ItAg" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3082"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zyOi8w187vT1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3084"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zfiUDb03jKx5" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3086"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zSoeuC3CzoGd" title="Total"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_z45JIw66Bfx1" title="Total"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zGEt0OnRaWq9" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3092"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zmxw0NJXlbrl" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3094"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember_zbdam8WmweOh" title="Total"&gt;2,188&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember_zfenHQu9lVt" title="Total"&gt;513&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zeBEpsZ3JMad" title="Total"&gt;662&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember_zzAR32WAN9G1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3102"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__ifrs-full--LiquidityRiskMember_z54FN8mdE0qc" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3104"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Up to 3&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 3 and 12&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 1 and 2&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 2 and 5&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Over&lt;br/&gt; 5&#160;years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zttfHZ1BPWNj" title="Total"&gt;1,986&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zTg9XzSAhEvb" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3108"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zwTdPypM3amh" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3110"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zyDqhsVhDhA5" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3112"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zIS1b6rDkZT" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3114"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred considerations&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zlTthlE68mMf" title="Total"&gt;178&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_z8eJIFQmfrIa" title="Total"&gt;533&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zzxadtujp7Tf" title="Total"&gt;711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zmDsPmvyHE13" title="Total"&gt;711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_z0ad1ohRdRT5" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3124"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Promissory note&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zmyrjrTXgQgl" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3126"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_z6JTQjvBqCoe" title="Total"&gt;479&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zpD5Qye13bod" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3130"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_ze6thaumP2Ta" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3132"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zz5QKlTRzglb" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3134"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zSR4NisdHpA9" title="Total"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zz2ybVGPWy2e" title="Total"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zeEiSs3I6XU3" title="Total"&gt;111&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zT5GErXNsZqh" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3142"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zNqwvXBoQXS2" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3144"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember_z6cYCwAUaZ4f" title="Total"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember_zBpEhpunDwPj" title="Total"&gt;1,154&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_ztgNlVpIkux4" title="Total"&gt;822&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember_zVYMfi6sVf9" title="Total"&gt;711&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__ifrs-full--LiquidityRiskMember_zTex0j1rUGI8" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3154"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Up to 3&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 3 and 12&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 1 and 2&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 2 and 5&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Over&lt;br/&gt; 5&#160;years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zsmhRGYk1ZQj" title="Total"&gt;1,178&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zGVjkvV8RgP1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3158"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zDgHvUaZ15q8" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3160"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zhqHswx8BSSj" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3162"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zAQ0cTaoeYCj" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3164"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zarWPhpaMMxh" title="Total"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zuDq7TnXFrc" title="Total"&gt;141&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zFT8C0u6x5g2" title="Total"&gt;189&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zbsjn5Z1Zel1" title="Total"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zrnroLrPxh93" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3174"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_z8fW0PSgII7c" title="Total"&gt;1,225&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_z0H486kkcwG8" title="Total"&gt;141&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_zjoSwmhZpgvf" title="Total"&gt;189&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_zyko1pz7s9X" title="Total"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_zp5s5xo2Ncp6" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3184"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p id="xdx_8A3_zJLfBHQt5KG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;More details with regard to the line items above are included in the
respective notes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Trade and other payables
                                            &#x2013; &lt;b&gt;note 15&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Deferred consideration
                                            &#x2013; &lt;b&gt;note 16&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Borrowings &#x2013; &lt;b&gt;note
                                            17&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Capital risk management &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group monitors capital which comprises all components of equity
(i.e. share capital, share premium, foreign exchange reserve and accumulated deficit).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group&#x2019;s objectives when maintaining capital are:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;to safeguard the entity&#x2019;s ability to continue as a going concern; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;to have sufficient resource to take development projects forward towards commercialisation.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group continues to incur substantial operating expenses. Until
the Group generates positive net cash inflows from the commercialisation of its products it remains dependent upon additional funding
through the injection of equity capital and government funding. The Group may not be able to generate positive net cash inflows in the
future or to attract such additional required funding at all, or on suitable terms. In such circumstances the development programmes may
be delayed or cancelled, and business operations cut back.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group seeks to reduce this risk by keeping a tight control on expenditure,
avoiding long term supplier contracts (other than clinical trials), prioritising development spend on products closest to potential revenue
generation, obtaining government grants (where applicable), maintaining a focussed portfolio of products under development and keeping
shareholders informed of progress.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;There have been no changes to the Group&#x2019;s processes for managing
capital risk since the previous year.&lt;/p&gt;

</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002616">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eifrs-full--DisclosureOfFairValueOfFinancialInstrumentsExplanatory_pn3n3_zYxLl6teJn" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Financial instruments - risk management (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_z3XeYdAiKv12" style="display: none"&gt;Schedule of consolidated derivative financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20251231_zAsBEEYkSmb9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20241231_zHrYF5hJPFee" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20231231_z83xi6mYgXmf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--CashAndCashEquivalents_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;8,534&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,669&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,971&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--CurrentTradeReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade receivables&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2624"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--OtherReceivables1_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;64&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;131&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;282&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--FinancialAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total financial assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,633&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,811&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,253&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financial liabilities &#x2013; amortised cost&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;97&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;707&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--OtherCurrentPayables_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other payables&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--Accruals_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Accruals&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,273&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredConsideration_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred consideration&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,844&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2648"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--Borrowings1_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Borrowings&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;61&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;727&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;464&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinancialLiabilitiesAtAmortisedCost_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total financial liabilities &#x2013; amortised cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,243&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,557&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,642&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financial liabilities &#x2013; fair value through profit and loss
&#x2013; current&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Equity settled derivative financial liability&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;2,915&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;383&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;4,160&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002618"
      unitRef="GBP">8534000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002619"
      unitRef="GBP">1669000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002620"
      unitRef="GBP">5971000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002622"
      unitRef="GBP">35000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002623"
      unitRef="GBP">11000</ifrs-full:CurrentTradeReceivables>
    <bdrx:OtherReceivables1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002626"
      unitRef="GBP">64000</bdrx:OtherReceivables1>
    <bdrx:OtherReceivables1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002627"
      unitRef="GBP">131000</bdrx:OtherReceivables1>
    <bdrx:OtherReceivables1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002628"
      unitRef="GBP">282000</bdrx:OtherReceivables1>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002630"
      unitRef="GBP">8633000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002631"
      unitRef="GBP">1811000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002632"
      unitRef="GBP">6253000</ifrs-full:FinancialAssets>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002634"
      unitRef="GBP">97000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002635"
      unitRef="GBP">707000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002636"
      unitRef="GBP">314000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002638"
      unitRef="GBP">17000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002639"
      unitRef="GBP">6000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002640"
      unitRef="GBP">7000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:Accruals
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002642"
      unitRef="GBP">1860000</ifrs-full:Accruals>
    <ifrs-full:Accruals
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002643"
      unitRef="GBP">1273000</ifrs-full:Accruals>
    <ifrs-full:Accruals
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002644"
      unitRef="GBP">857000</ifrs-full:Accruals>
    <bdrx:DeferredConsideration
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002646"
      unitRef="GBP">1208000</bdrx:DeferredConsideration>
    <bdrx:DeferredConsideration
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002647"
      unitRef="GBP">1844000</bdrx:DeferredConsideration>
    <bdrx:Borrowings1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002650"
      unitRef="GBP">61000</bdrx:Borrowings1>
    <bdrx:Borrowings1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002651"
      unitRef="GBP">727000</bdrx:Borrowings1>
    <bdrx:Borrowings1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002652"
      unitRef="GBP">464000</bdrx:Borrowings1>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002654"
      unitRef="GBP">3243000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002655"
      unitRef="GBP">4557000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002656"
      unitRef="GBP">1642000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002658"
      unitRef="GBP">2915000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002659"
      unitRef="GBP">383000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002660"
      unitRef="GBP">4160000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <bdrx:DisclosureOfConsolidatedFinancialAssetsAndLiabilitiesValuedAtFairValueExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002669">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfConsolidatedFinancialAssetsAndLiabilitiesValuedAtFairValueExplanatory_pn3n3_zIzfKJCcZ2Vg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments - risk management (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;span id="xdx_8B4_ztkmByDfqkcj" style="display: none"&gt;Schedule of consolidated financial assets and liabilities at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Financial &lt;br/&gt; liabilities&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair value as &lt;br/&gt; at &lt;br/&gt; 31/12/2025&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair &lt;br/&gt; value &lt;br/&gt; hierarchy&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; white-space: nowrap; font-weight: bold"&gt;Valuation &lt;br/&gt; technique(s)&lt;br/&gt; and key input(s)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Significant unobservable input(s)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Relationship of &lt;br/&gt; unobservable inputs to &lt;br/&gt; fair value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series L warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 11%; text-align: left"&gt;&#xa3;&lt;span id="xdx_90E_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember_zANRsiEsWw49" title="Equity settled derivative financial liability"&gt;2,914,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 8%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; width: 13%; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 32%; text-align: left"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Volatility rate of 110.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 20%; text-align: left"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.97 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.73% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember_zciiXiDLETQc" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series J warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_909_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember_zNask9FYj2Y4" title="Equity settled derivative financial liability"&gt;1,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Volatility rate of 115.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_905_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 3.56 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.60% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember_zNPvsvJXKIh8" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series G warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_90D_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_z4c46oqytjFf" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2701"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Volatility rate of 115.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 3.39 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_906_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.59% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_zRZlDK6HrQG1" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series E warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_902_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_z3RebuobSiXc" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2716"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Volatility rate of 115.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 2.98 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_907_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.55% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_zZaYTCRLr7Ud" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series D warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_90A_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_zSEdJGVyst9g" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2731"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Volatility rate of 120.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 2.47 years determined using the remaining life of the share options.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_901_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.51% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_zBllAigNYRXl" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;span id="xdx_904_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20251231_zMRspwD8g6B" title="Equity settled derivative financial liability"&gt;2,915,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Financial &lt;br/&gt; liabilities&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair value as &lt;br/&gt; at &lt;br/&gt; 31/12/2024&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair &lt;br/&gt; value &lt;br/&gt; hierarchy&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left; white-space: nowrap; font-weight: bold"&gt;Valuation &lt;br/&gt; technique(s)&lt;br/&gt; and key input(s)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left; font-weight: bold"&gt;Significant unobservable input(s)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Relationship of &lt;br/&gt; unobservable inputs to &lt;br/&gt; fair value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Equity settled financial derivative liability &#x2013; Series K warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; white-space: nowrap"&gt;&#xa3; &lt;span id="xdx_90E_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember_zOQddKl3s5b7" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2751"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; white-space: nowrap"&gt;Level 3&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left; white-space: nowrap"&gt;&lt;p id="xdx_980_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember_zvA8EEfmXiV4" style="margin-top: 0; margin-bottom: 0" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes&lt;br/&gt;Model&lt;/p&gt;
                                                      &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Volatility rate of 75.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.51 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.24% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the risk-free rate the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series J warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 11%; text-align: left"&gt;&#xa3;&lt;span id="xdx_90E_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember_zOxDpPdc0QCk" title="Equity settled derivative financial liability"&gt;231,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 8%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; width: 13%; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 32%; text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Volatility rate of 100.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 20%; text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_907_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.56 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.36% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelOneMember_zxMNfBJLQ7S1" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series H warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_906_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_z5IPp4oi9m6i" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2782"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Volatility rate of 75.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.39 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.29% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_zQGCZWBkAR82" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series G warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_907_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_z71tMnG5p262" title="Equity settled derivative financial liability"&gt;102,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Volatility rate of 105.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_905_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.39 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_901_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_902_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.35% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_zqZRqqxWIdM2" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 15%"&gt;Equity settled financial derivative liability &#x2013; Series E warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 11%"&gt;&#xa3;&lt;span id="xdx_90F_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_z27SfCYcU7pd" title="Equity settled derivative financial liability"&gt;47,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left; width: 13%"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 32%"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Volatility rate of 105.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 20%"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 3.98 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.32% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_zndXeGMRFbm9" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series D warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_901_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember_z6qcm5Sr8oN2" title="Equity settled derivative financial liability"&gt;2,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Significant unobservable input(s)"&gt;Volatility rate of 110.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 3.47 years determined using the remaining life of the share options.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.30% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFiveMember_zjiWp73jezva" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; May 2020 warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_908_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember_zlL1nTfQO7v5" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2843"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Significant unobservable input(s)"&gt;Volatility rate of 100.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.89 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.18% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSixMember_zTRHdFvkUDb1" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; October 2019 warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_909_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember_z6mDSfbubUTb" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2858"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Significant unobservable input(s)"&gt;Volatility rate of 80.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.48 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.24% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelSevenMember_zPeue9IWGRe2" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;span id="xdx_904_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20241231_z6u0ziGWtTGb" title="Equity settled derivative financial liability"&gt;383,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Financial &lt;br/&gt; liabilities&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair value as &lt;br/&gt; at &lt;br/&gt; 31/12/2023&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Fair &lt;br/&gt; value &lt;br/&gt; hierarchy&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt; white-space: nowrap; font-weight: bold"&gt;Valuation &lt;br/&gt; technique(s)&lt;br/&gt; and key input(s)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Significant unobservable input(s)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Relationship of &lt;br/&gt; unobservable inputs to &lt;br/&gt; fair value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series E warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 11%; text-align: left"&gt;&#xa3;&lt;span id="xdx_90D_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember_zQoxKhRRdEu9" title="Equity settled derivative financial liability"&gt;2,592,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 8%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; width: 13%; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                             &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 32%; text-align: left"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Significant unobservable input(s)"&gt;Volatility rate of 90.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 20%; text-align: left"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 0.98 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.79% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelMember_zMYQfGlUVUqk" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series F warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_907_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember_z34vnHRRTPJd" title="Equity settled derivative financial liability"&gt;1,444,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Significant unobservable input(s)"&gt;Volatility rate of 95.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.98 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_901_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.84% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--MonteCarloSimulationModelOneMember_zdTIzZErVSi" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; Series D warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_906_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_z9Ah05coLJbe" title="Equity settled derivative financial liability"&gt;124,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Volatility rate of 95.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 4.40 years determined using the remaining life of the share options.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_902_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 3.93% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelTwoMember_z6VqjOwoovHj" style="text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; May 2020 warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_907_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_zYGcLHizHmo4" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2924"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Volatility rate of 100.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_907_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 1.88 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.23% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelThreeMember_zG640Gov9TD5" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equity settled financial derivative liability &#x2013; October 2019 warrants&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#xa3;&lt;span id="xdx_90B_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_zNlesinfd1L6" title="Equity settled derivative financial liability"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2939"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Valuation technique (s) and key input(s)"&gt;Black-Scholes Model&lt;/span&gt;&lt;/p&gt;
                                 &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfInputsUsedInFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Volatility rate of 100.0% determined using historical volatility of comparable companies.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfReasonsForFairValueMeasurementAssets_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The higher the volatility the higher the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_908_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Expected life between a range of 0.1 and 1.50 years determined using the remaining life of the warrant.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets1_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Relationship of unobservable inputs to fair value"&gt;The shorter the expected life the lower the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfInputsUsedInFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember" title="Significant unobservable input(s)"&gt;Risk-free rate of 4.51% determined using the expected life assumptions.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DescriptionOfReasonsForFairValueMeasurementAssets2_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--BlackScholesOptionPricingModelFourMember_z1LX4aEwdBB2" style="vertical-align: top; text-align: left"&gt;The higher the risk-free rate &lt;br/&gt; the higher the fair value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;span id="xdx_901_ecustom--CurrentDerivativeFinancialLiabilities1_iI_pn3p0_c20231231_zADu6nyGNZ4l" title="Equity settled derivative financial liability"&gt;4,160,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfConsolidatedFinancialAssetsAndLiabilitiesValuedAtFairValueExplanatory>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      decimals="-3"
      id="Fact002671"
      unitRef="GBP">2914000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002673">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002675">Volatility rate of 110.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002677">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002679">Expected life between a range of 0.1 and 4.97 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002681">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002683">Risk-free rate of 3.73% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002684">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      decimals="-3"
      id="Fact002686"
      unitRef="GBP">1000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002688">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002690">Volatility rate of 115.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002692">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002694">Expected life between a range of 0.1 and 3.56 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002696">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002698">Risk-free rate of 3.60% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002699">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002703">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002705">Volatility rate of 115.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002707">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002709">Expected life between a range of 0.1 and 3.39 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002711">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002713">Risk-free rate of 3.59% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002714">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002718">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002720">Volatility rate of 115.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002722">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002724">Expected life between a range of 0.1 and 2.98 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002726">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002728">Risk-free rate of 3.55% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002729">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002733">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002735">Volatility rate of 120.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002737">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002739">Expected life between a range of 0.1 and 2.47 years determined using the remaining life of the share options.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002741">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002743">Risk-free rate of 3.51% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002744">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002746"
      unitRef="GBP">2915000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002753">Black-ScholesModel</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002755">Volatility rate of 75.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002757">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002759">Expected life between a range of 0.1 and 0.51 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002761">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002763">Risk-free rate of 4.24% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelMember"
      id="Fact002765">The higher the risk-free rate the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      decimals="-3"
      id="Fact002767"
      unitRef="GBP">231000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002769">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002771">Volatility rate of 100.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002773">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002775">Expected life between a range of 0.1 and 4.56 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002777">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002779">Risk-free rate of 4.36% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelOneMember"
      id="Fact002780">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002784">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002786">Volatility rate of 75.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002788">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002790">Expected life between a range of 0.1 and 0.39 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002792">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002794">Risk-free rate of 4.29% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002795">The higher the risk-free rate the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      decimals="-3"
      id="Fact002797"
      unitRef="GBP">102000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002799">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002801">Volatility rate of 105.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002803">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002805">Expected life between a range of 0.1 and 4.39 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002807">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002809">Risk-free rate of 4.35% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002810">The higher the risk-free rate the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      decimals="-3"
      id="Fact002813"
      unitRef="GBP">47000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002815">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002817">Volatility rate of 105.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002819">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002821">Expected life between a range of 0.1 and 3.98 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002823">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002825">Risk-free rate of 4.32% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002826">The higher the risk-free rate the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember"
      decimals="-3"
      id="Fact002828"
      unitRef="GBP">2000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember"
      id="Fact002830">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember"
      id="Fact002832">Volatility rate of 110.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember"
      id="Fact002834">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember"
      id="Fact002836">Expected life between a range of 0.1 and 3.47 years determined using the remaining life of the share options.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember"
      id="Fact002838">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember"
      id="Fact002840">Risk-free rate of 4.30% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFiveMember"
      id="Fact002841">The higher the risk-free rate the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember"
      id="Fact002845">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember"
      id="Fact002847">Volatility rate of 100.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember"
      id="Fact002849">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember"
      id="Fact002851">Expected life between a range of 0.1 and 0.89 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember"
      id="Fact002853">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember"
      id="Fact002855">Risk-free rate of 4.18% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSixMember"
      id="Fact002856">The higher the risk-free rate the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember"
      id="Fact002860">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember"
      id="Fact002862">Volatility rate of 80.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember"
      id="Fact002864">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember"
      id="Fact002866">Expected life between a range of 0.1 and 0.48 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember"
      id="Fact002868">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember"
      id="Fact002870">Risk-free rate of 4.24% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelSevenMember"
      id="Fact002871">The higher the risk-free rate the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002873"
      unitRef="GBP">383000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember"
      decimals="-3"
      id="Fact002879"
      unitRef="GBP">2592000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember"
      id="Fact002881">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember"
      id="Fact002883">Volatility rate of 90.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember"
      id="Fact002885">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember"
      id="Fact002887">Expected life between a range of 0.1 and 0.98 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember"
      id="Fact002889">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember"
      id="Fact002891">Risk-free rate of 4.79% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelMember"
      id="Fact002892">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember"
      decimals="-3"
      id="Fact002894"
      unitRef="GBP">1444000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember"
      id="Fact002896">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember"
      id="Fact002898">Volatility rate of 95.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember"
      id="Fact002900">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember"
      id="Fact002902">Expected life between a range of 0.1 and 4.98 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember"
      id="Fact002904">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember"
      id="Fact002906">Risk-free rate of 3.84% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_MonteCarloSimulationModelOneMember"
      id="Fact002907">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      decimals="-3"
      id="Fact002909"
      unitRef="GBP">124000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002911">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002913">Volatility rate of 95.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002915">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002917">Expected life between a range of 0.1 and 4.40 years determined using the remaining life of the share options.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002919">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002921">Risk-free rate of 3.93% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelTwoMember"
      id="Fact002922">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002926">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002928">Volatility rate of 100.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002930">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002932">Expected life between a range of 0.1 and 1.88 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002934">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002936">Risk-free rate of 4.23% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelThreeMember"
      id="Fact002937">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002941">Black-Scholes Model</ifrs-full:DescriptionOfValuationTechniquesUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002943">Volatility rate of 100.0% determined using historical volatility of comparable companies.</ifrs-full:DescriptionOfInputsUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002945">The higher the volatility the higher the fair value.</ifrs-full:DescriptionOfReasonsForFairValueMeasurementAssets>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002947">Expected life between a range of 0.1 and 1.50 years determined using the remaining life of the warrant.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets1>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002949">The shorter the expected life the lower the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets1>
    <bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002951">Risk-free rate of 4.51% determined using the expected life assumptions.</bdrx:DescriptionOfInputsUsedInFairValueMeasurementAssets2>
    <bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2
      contextRef="From2023-01-012023-12-31_ifrs-full_Level3OfFairValueHierarchyMember_custom_BlackScholesOptionPricingModelFourMember"
      id="Fact002952">The higher the risk-free rate  the higher the fair value.</bdrx:DescriptionOfReasonsForFairValueMeasurementAssets2>
    <bdrx:CurrentDerivativeFinancialLiabilities1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002954"
      unitRef="GBP">4160000</bdrx:CurrentDerivativeFinancialLiabilities1>
    <bdrx:DisclosureOfForeignExchangeRiskExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002963">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfForeignExchangeRiskExplanatory_pn3n3_zoKXTaLW4RTe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Financial instruments - risk management (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zrDALJrfG3Eh" style="display: none"&gt;Schedule of foreign exchange risk&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash and cash equivalents:&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Pounds Sterling&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--GBP_z2nQUApYqeO7" title="Cash and cash equivalents"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--GBP_zU2WfPujWxc5" title="Cash and cash equivalents"&gt;212&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--GBP_zSRu4j0zZi67" title="Cash and cash equivalents"&gt;2,244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;US Dollar&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--USD_z9kcSMj74qOj" title="Cash and cash equivalents"&gt;8,436&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--USD_zAYjVALsK74a" title="Cash and cash equivalents"&gt;1,457&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__currency--USD_zxPWn04TOAn6" title="Cash and cash equivalents"&gt;3,727&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Other&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__srt--OtherCurrencyMember_zsmyqNmHnV53" title="Cash and cash equivalents"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__srt--OtherCurrencyMember_zB9peqSVc1Na" title="Cash and cash equivalents"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2979"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskMember__srt--CurrencyAxis__srt--OtherCurrencyMember_z2Ju3hRxtENf" title="Cash and cash equivalents"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2981"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231_zkTaPuUHsEXe" title="Cash and cash equivalents"&gt;8,534&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231_zx4NzWeBh5U9" title="Cash and cash equivalents"&gt;1,669&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20231231_znymrN8rpMbg" title="Cash and cash equivalents"&gt;5,971&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfForeignExchangeRiskExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_ForeignExchangeRiskMember_currency_GBP"
      decimals="-3"
      id="Fact002965"
      unitRef="GBP">97000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_ForeignExchangeRiskMember_currency_GBP"
      decimals="-3"
      id="Fact002967"
      unitRef="GBP">212000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31_custom_ForeignExchangeRiskMember_currency_GBP"
      decimals="-3"
      id="Fact002969"
      unitRef="GBP">2244000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_ForeignExchangeRiskMember_currency_USD"
      decimals="-3"
      id="Fact002971"
      unitRef="GBP">8436000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_ForeignExchangeRiskMember_currency_USD"
      decimals="-3"
      id="Fact002973"
      unitRef="GBP">1457000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31_custom_ForeignExchangeRiskMember_currency_USD"
      decimals="-3"
      id="Fact002975"
      unitRef="GBP">3727000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_ForeignExchangeRiskMember_srt_OtherCurrencyMember"
      decimals="-3"
      id="Fact002977"
      unitRef="GBP">1000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002983"
      unitRef="GBP">8534000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002985"
      unitRef="GBP">1669000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002987"
      unitRef="GBP">5971000</ifrs-full:CashAndCashEquivalents>
    <bdrx:DisclosureOfForeignCurrencyExchangeRatesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002989">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfForeignCurrencyExchangeRatesExplanatory_pn3n3_zzBBan3THny2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Financial instruments - risk management (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zBDG45QOOj2k" style="display: none"&gt;Schedule of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Year ended 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;US Dollar&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Euro&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Other&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Loss before tax&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zGdJrFFtxEZ1" title="Loss before tax"&gt;1,068&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zUK4RrxYr3w2" title="Loss before tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2993"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_z7DC9OeorBo3" title="Loss before tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2995"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total equity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zg27OF1AGoy5" title="Total equity"&gt;1,068&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zyjMkFqsR4Xc" title="Total equity"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2999"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_zqspeVg6IzXg" title="Total equity"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3001"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Year ended 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;US Dollar&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Euro&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Other&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Loss before tax&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zdjdWBQPROke" title="Loss before tax"&gt;146&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zgBUHvCeW4Xi" title="Loss before tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3005"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_zMXnBD912lLh" title="Loss before tax"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total equity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zIuLtpMN7TR8" title="Total equity"&gt;146&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zO9j08M6dqBf" title="Total equity"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3011"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_zKrPZlCmgFjb" title="Total equity"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Year ended 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;US Dollar&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Euro&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Other&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 55%; text-align: left"&gt;Loss before tax&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zVeeGZIBDOfi" title="Loss before tax"&gt;373&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_zGfEauGRGnLf" title="Loss before tax"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_z5wgTLSvACHi" title="Loss before tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3019"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Total equity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--USD_zXMErVV4B5ze" title="Total equity"&gt;373&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__currency--EUR_znZWkraeksY6" title="Total equity"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencySensitivityAnalysisMember__srt--CurrencyAxis__custom--OtherMember_z8Uwg5lyLqX2" title="Total equity"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3025"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfForeignCurrencyExchangeRatesExplanatory>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD"
      decimals="-3"
      id="Fact002991"
      unitRef="GBP">1068000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD"
      decimals="-3"
      id="Fact002997"
      unitRef="GBP">1068000</ifrs-full:Equity>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD"
      decimals="-3"
      id="Fact003003"
      unitRef="GBP">146000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember"
      decimals="-3"
      id="Fact003007"
      unitRef="GBP">-1000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD"
      decimals="-3"
      id="Fact003009"
      unitRef="GBP">146000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_ForeignCurrencySensitivityAnalysisMember_custom_OtherMember"
      decimals="-3"
      id="Fact003013"
      unitRef="GBP">-1000</ifrs-full:Equity>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD"
      decimals="-3"
      id="Fact003015"
      unitRef="GBP">373000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR"
      decimals="-3"
      id="Fact003017"
      unitRef="GBP">2000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_USD"
      decimals="-3"
      id="Fact003021"
      unitRef="GBP">373000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_custom_ForeignCurrencySensitivityAnalysisMember_currency_EUR"
      decimals="-3"
      id="Fact003023"
      unitRef="GBP">2000</ifrs-full:Equity>
    <bdrx:ProceedsFromEquityLineOfCredit
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003030"
      unitRef="USD">8920000</bdrx:ProceedsFromEquityLineOfCredit>
    <bdrx:WarrantInducementValue
      contextRef="From2025-05-012025-05-31"
      decimals="-3"
      id="Fact003032"
      unitRef="GBP">47000</bdrx:WarrantInducementValue>
    <bdrx:ProceedsFromRegisteredOffering
      contextRef="From2025-12-012025-12-31"
      decimals="-3"
      id="Fact003034"
      unitRef="USD">10000000</bdrx:ProceedsFromRegisteredOffering>
    <bdrx:PrincipleAmount
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003036"
      unitRef="USD">600000</bdrx:PrincipleAmount>
    <bdrx:ProceedsFromNote
      contextRef="From2024-12-012024-12-31"
      decimals="-3"
      id="Fact003038"
      unitRef="USD">540000</bdrx:ProceedsFromNote>
    <bdrx:WarrantInducementValue
      contextRef="From2024-05-012024-05-31"
      decimals="-3"
      id="Fact003040"
      unitRef="GBP">4800000</bdrx:WarrantInducementValue>
    <bdrx:ProceedsFromRegisteredOffering
      contextRef="From2024-07-012024-07-31"
      decimals="-3"
      id="Fact003042"
      unitRef="GBP">3900000</bdrx:ProceedsFromRegisteredOffering>
    <bdrx:ProceedsFromWarrantsExercised
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003044"
      unitRef="GBP">400000</bdrx:ProceedsFromWarrantsExercised>
    <bdrx:ProceedsFromPrivatePlacement
      contextRef="From2023-02-012023-02-28"
      decimals="-3"
      id="Fact003046"
      unitRef="GBP">5000000.0</bdrx:ProceedsFromPrivatePlacement>
    <bdrx:ProceedsFromRegisteredOffering
      contextRef="From2023-05-012023-05-31"
      decimals="-3"
      id="Fact003048"
      unitRef="GBP">2700000</bdrx:ProceedsFromRegisteredOffering>
    <bdrx:ProceedsFromRegisteredOffering
      contextRef="From2023-12-012023-12-31"
      decimals="-3"
      id="Fact003050"
      unitRef="GBP">4400000</bdrx:ProceedsFromRegisteredOffering>
    <bdrx:DisclosureOfMaturitiesOfFinancialInstrumentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003056">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfMaturitiesOfFinancialInstrumentsExplanatory_pn3n3_zi3161v2nJq1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Financial instruments - risk management (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zp6TXH0Pxrlj" style="display: none"&gt;Schedule of contractual maturities of financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Up to 3&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 3 and 12&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 1 and 2&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 2 and 5&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Over&lt;br/&gt; 5&#160;years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zWxh8Oemat9i" title="Total"&gt;1,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zslL4NKv0Mxg" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3060"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_znYSIu5lsCTi" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3062"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zL7xF4m7N1P" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3064"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_ziIQWB4nMBHj" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3066"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred considerations&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zghTpiBDZh84" title="Total"&gt;166&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zn8NcVdKshv3" title="Total"&gt;497&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_z3ARhngQ8kXh" title="Total"&gt;662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zWX8CYZ3AFNk" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3074"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zCWFjLrTLWjg" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3076"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Promissory note&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_z7i25Zh6Besf" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3078"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zpThBWsHnPRd" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3080"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zkyqMVs8ItAg" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3082"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zyOi8w187vT1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3084"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zfiUDb03jKx5" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3086"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zSoeuC3CzoGd" title="Total"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_z45JIw66Bfx1" title="Total"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zGEt0OnRaWq9" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3092"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zmxw0NJXlbrl" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3094"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember_zbdam8WmweOh" title="Total"&gt;2,188&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember_zfenHQu9lVt" title="Total"&gt;513&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zeBEpsZ3JMad" title="Total"&gt;662&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember_zzAR32WAN9G1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3102"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__ifrs-full--LiquidityRiskMember_z54FN8mdE0qc" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3104"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Up to 3&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 3 and 12&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 1 and 2&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 2 and 5&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Over&lt;br/&gt; 5&#160;years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zttfHZ1BPWNj" title="Total"&gt;1,986&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zTg9XzSAhEvb" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3108"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zwTdPypM3amh" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3110"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zyDqhsVhDhA5" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3112"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zIS1b6rDkZT" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3114"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred considerations&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zlTthlE68mMf" title="Total"&gt;178&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_z8eJIFQmfrIa" title="Total"&gt;533&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zzxadtujp7Tf" title="Total"&gt;711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_zmDsPmvyHE13" title="Total"&gt;711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredConsiderationsMember_z0ad1ohRdRT5" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3124"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Promissory note&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zmyrjrTXgQgl" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3126"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_z6JTQjvBqCoe" title="Total"&gt;479&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zpD5Qye13bod" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3130"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_ze6thaumP2Ta" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3132"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--PromissoryNoteMember_zz5QKlTRzglb" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3134"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zSR4NisdHpA9" title="Total"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zz2ybVGPWy2e" title="Total"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zeEiSs3I6XU3" title="Total"&gt;111&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zT5GErXNsZqh" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3142"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zNqwvXBoQXS2" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3144"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember_z6cYCwAUaZ4f" title="Total"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember_zBpEhpunDwPj" title="Total"&gt;1,154&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_ztgNlVpIkux4" title="Total"&gt;822&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember_zVYMfi6sVf9" title="Total"&gt;711&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__ifrs-full--LiquidityRiskMember_zTex0j1rUGI8" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3154"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Up to 3&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 3 and 12&lt;br/&gt; months&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 1 and 2&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Between&lt;br/&gt; 2 and 5&lt;br/&gt; years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Over&lt;br/&gt; 5&#160;years&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zsmhRGYk1ZQj" title="Total"&gt;1,178&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zGVjkvV8RgP1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3158"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zDgHvUaZ15q8" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3160"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zhqHswx8BSSj" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3162"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradeAndOtherPayablesMember_zAQ0cTaoeYCj" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3164"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zarWPhpaMMxh" title="Total"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zuDq7TnXFrc" title="Total"&gt;141&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zFT8C0u6x5g2" title="Total"&gt;189&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zbsjn5Z1Zel1" title="Total"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinanceLeaseMember_zrnroLrPxh93" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3174"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanThreeMonthsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_z8fW0PSgII7c" title="Total"&gt;1,225&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_z0H486kkcwG8" title="Total"&gt;141&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_zjoSwmhZpgvf" title="Total"&gt;189&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_zyko1pz7s9X" title="Total"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GovernmentAndResearchLoansMember_zp5s5xo2Ncp6" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3184"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

</bdrx:DisclosureOfMaturitiesOfFinancialInstrumentsExplanatory>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003058"
      unitRef="GBP">1974000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_DeferredConsiderationsMember"
      decimals="-3"
      id="Fact003068"
      unitRef="GBP">166000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_DeferredConsiderationsMember"
      decimals="-3"
      id="Fact003070"
      unitRef="GBP">497000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_DeferredConsiderationsMember"
      decimals="-3"
      id="Fact003072"
      unitRef="GBP">662000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003088"
      unitRef="GBP">48000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003090"
      unitRef="GBP">16000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember"
      decimals="-3"
      id="Fact003096"
      unitRef="GBP">2188000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember"
      decimals="-3"
      id="Fact003098"
      unitRef="GBP">513000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fact003100"
      unitRef="GBP">662000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003106"
      unitRef="GBP">1986000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_DeferredConsiderationsMember"
      decimals="-3"
      id="Fact003116"
      unitRef="GBP">178000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_DeferredConsiderationsMember"
      decimals="-3"
      id="Fact003118"
      unitRef="GBP">533000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_DeferredConsiderationsMember"
      decimals="-3"
      id="Fact003120"
      unitRef="GBP">711000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_DeferredConsiderationsMember"
      decimals="-3"
      id="Fact003122"
      unitRef="GBP">711000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_PromissoryNoteMember"
      decimals="-3"
      id="Fact003128"
      unitRef="GBP">479000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003136"
      unitRef="GBP">47000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003138"
      unitRef="GBP">142000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003140"
      unitRef="GBP">111000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember"
      decimals="-3"
      id="Fact003146"
      unitRef="GBP">2211000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember"
      decimals="-3"
      id="Fact003148"
      unitRef="GBP">1154000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fact003150"
      unitRef="GBP">822000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fact003152"
      unitRef="GBP">711000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_TradeAndOtherPayablesMember"
      decimals="-3"
      id="Fact003156"
      unitRef="GBP">1178000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003166"
      unitRef="GBP">47000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003168"
      unitRef="GBP">141000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003170"
      unitRef="GBP">189000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_FinanceLeaseMember"
      decimals="-3"
      id="Fact003172"
      unitRef="GBP">112000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_NotLaterThanThreeMonthsMember_custom_GovernmentAndResearchLoansMember"
      decimals="-3"
      id="Fact003176"
      unitRef="GBP">1225000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_custom_GovernmentAndResearchLoansMember"
      decimals="-3"
      id="Fact003178"
      unitRef="GBP">141000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_custom_GovernmentAndResearchLoansMember"
      decimals="-3"
      id="Fact003180"
      unitRef="GBP">189000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember_custom_GovernmentAndResearchLoansMember"
      decimals="-3"
      id="Fact003182"
      unitRef="GBP">112000</ifrs-full:FinancialLiabilities>
    <bdrx:DisclosureOfDeferredTaxeExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003190">&lt;p id="xdx_803_ecustom--DisclosureOfDeferredTaxeExplanatory_zrVxxxBliMC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;21&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82B_zjiyi520y2e"&gt;Deferred tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Deferred tax is calculated in full on temporary differences under the
liability method using tax rates applicable in the tax jurisdictions where the tax asset or liability would arise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The movement on the deferred tax account in 2025 is &#xa3;nil (2024:
&#xa3;nil, 2023: &#xa3;nil) as the net credit arising on the amortisation of intangible assets and other timing differences has been
matched by a reduction in the deferred tax asset recognised on the losses offsetting the liability remaining.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Unused tax losses carried forward, subject to agreement with local
tax authorities, were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_pn3n3_zoPejXGu2Zpb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Deferred tax (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zbcyhIa8Ygi7" style="display: none"&gt;Schedule of unused tax losses carried forward&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Gross losses&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Potential &lt;br/&gt; deferred tax &lt;br/&gt; asset&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 69%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;31 December 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zyne3c3VEOPe" title="Gross losses"&gt;82,168&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231_zpX2vEWCSc1d" title="Potential deferred tax asset"&gt;20,542&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31 December 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zhYh90SAIGZ6" title="Gross losses"&gt;79,740&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20241231_zdnYSNx4zfug" title="Potential deferred tax asset"&gt;19,935&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31 December 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20231231_ziyLVpQCof7" title="Gross losses"&gt;75,530&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20231231_z79hujN0OySb" title="Potential deferred tax asset"&gt;18,947&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The potential deferred tax asset of &#xa3;&lt;span id="xdx_90A_eifrs-full--NetDeferredTaxAssets_iI_pn3n3_dm_c20251231_zYaQo7s1Jh6f" title="Net deferred tax assets"&gt;20.5&lt;/span&gt; million (2024: &#xa3;&lt;span id="xdx_90F_eifrs-full--NetDeferredTaxAssets_iI_pn3n3_dm_c20241231_z4GLfeY14eWj" title="Net deferred tax assets"&gt;19.9&lt;/span&gt;
million, 2023: &#xa3;&lt;span id="xdx_90E_eifrs-full--NetDeferredTaxAssets_iI_pn3n3_dm_c20231231_zWSfLmaq74e6" title="Net deferred tax assets"&gt;18.9 &lt;/span&gt;million) has not been provided in these accounts due to uncertainty as to whether the asset would be recovered.
The losses have arisen as a result of accumulated trading losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_901_ecustom--DescriptionOfDeferredTaxAsset_c20250101__20251231_zGYAIdbdKMZa" title="Description of deferred tax asset"&gt;Deferred tax asset balances disclosed as at 31 December 2025 have been
calculated at 25%. The main rate of corporation tax increased to 25% from 1 April 2023.&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</bdrx:DisclosureOfDeferredTaxeExplanatory>
    <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003192">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_pn3n3_zoPejXGu2Zpb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Deferred tax (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zbcyhIa8Ygi7" style="display: none"&gt;Schedule of unused tax losses carried forward&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Gross losses&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Potential &lt;br/&gt; deferred tax &lt;br/&gt; asset&lt;br/&gt; &#xa3;&#x2019;000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 69%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;31 December 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zyne3c3VEOPe" title="Gross losses"&gt;82,168&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231_zpX2vEWCSc1d" title="Potential deferred tax asset"&gt;20,542&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31 December 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zhYh90SAIGZ6" title="Gross losses"&gt;79,740&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20241231_zdnYSNx4zfug" title="Potential deferred tax asset"&gt;19,935&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31 December 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20231231_ziyLVpQCof7" title="Gross losses"&gt;75,530&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20231231_z79hujN0OySb" title="Potential deferred tax asset"&gt;18,947&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003194"
      unitRef="GBP">82168000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003196"
      unitRef="GBP">20542000</ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003198"
      unitRef="GBP">79740000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003200"
      unitRef="GBP">19935000</ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003202"
      unitRef="GBP">75530000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003204"
      unitRef="GBP">18947000</ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003206"
      unitRef="GBP">20500000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003208"
      unitRef="GBP">19900000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003210"
      unitRef="GBP">18900000</ifrs-full:NetDeferredTaxAssets>
    <bdrx:DescriptionOfDeferredTaxAsset contextRef="From2025-01-01to2025-12-31" id="Fact003212">Deferred tax asset balances disclosed as at 31 December 2025 have been
calculated at 25%. The main rate of corporation tax increased to 25% from 1 April 2023.</bdrx:DescriptionOfDeferredTaxAsset>
    <ifrs-full:DisclosureOfIssuedCapitalExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003215">&lt;p id="xdx_806_eifrs-full--DisclosureOfIssuedCapitalExplanatory_zub0p2Sl4Z5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;22&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82D_zJuJ5n33HfG5"&gt;Share capital&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfIssuedCapital1Explanatory_pn3n3_z5WMpQziexPc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share capital (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B4_zmAn0A1pqgC6" style="display: none"&gt;Schedule of detailed information about share capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Authorised, allotted and fully paid &#x2013; classified as equity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;At 31 December&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%"&gt;Ordinary shares of &#xa3;0.000001 each&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zKlGMw0HWNY5" title="Number"&gt;225,817,808,922&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_pp0p" title="Total"&gt;225,818&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z4ZXnDfBj0Ei" title="Number"&gt;6,685,918,922&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_pp0p" title="Total"&gt;334,296&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zrBNADg0wB9c" title="Number"&gt;1,189,577,722&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_pp0p" title="Total"&gt;1,189,578&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#x2018;A&#x2019; Deferred shares of &#xa3;1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zjpEzS9cxnMe" title="Number"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_pp0p" title="Total"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zi77Xj5IBas4" title="Number"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_pp0p" title="Total"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zC2zCUQEAYZf" title="Number"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_pp0p" title="Total"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#x2018;B&#x2019; Deferred shares of &#xa3;0.001 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zx74FGoN12U6" title="Number"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_pp0p" title="Total"&gt;4,063,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_z9yVwKW9Bto8" title="Number"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_pp0p" title="Total"&gt;4,063,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zCXO4OICltW3" title="Number"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_pp0p" title="Total"&gt;4,063,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#x2018;C&#x2019; Deferred shares of &#xa3;0.00005 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_z6DpOMz3cRWf" title="Number"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_pp0p" title="Total"&gt;6,327,370&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zRpaMJBnxagf" title="Number"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_pp0p" title="Total"&gt;6,327,370&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_z50CpFAoxLo9" title="Number"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3263"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_pp0p" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3265"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#x2018;D&#x2019; Deferred shares of &#xa3;0.000001 each&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zM1QXLn3rJb6" title="Number"&gt;2,482,747,137,178&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_pp0p" title="Total"&gt;2,482,747&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zQduqmEV6nL6" title="Number"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3271"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_pp0p" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3273"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zl2LHSGSYi0g" title="Number"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3275"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_pp0p" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3277"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValueOfShares_c20251231_pp0p" title="Total"&gt;14,099,257&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValueOfShares_c20241231_pp0p" title="Total"&gt;11,724,988&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ValueOfShares_c20231231_pp0p" title="Total"&gt;6,252,900&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zph9l327XM52" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;At a General Meeting on 11 June 2025, shareholders approved the subdivision
and redesignation of the Company&#x2019;s Issued Ordinary Shares of &#xa3;0.00005 each into to one Ordinary Share of &#xa3;0.000001 each
and 49 &#x2018;D&#x2019; Deferred Shares of &#xa3;0.000001 each. The &#x2018;D&#x2019; Deferred Shares have limited rights and are effectively
valueless.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On 31 July 2025 the Company effected a ratio change in the number of
Ordinary Shares represented by ADSs from 10,000 Ordinary Shares per ADS to 100,000 Ordinary Shares per ADS.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the year the Company issued the following warrants over ADSs,
and these were recognised in the warrant reserve until exercise:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfWarrantReserveRecognizedTableTextBlock_pn3n3_zXyTFVbw3Eb6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Share capital (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zsPvyPBUkl64" style="display: none"&gt;Schedule of warrant reserve recognize&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Pre-Funded &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As at 1 January 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zlIhwCTMvRR6" title="Beginning balance, shares"&gt;1,773&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued:&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 2025 Registered Offering&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--RegisteredDirectOffering_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zEVNc91d2jMf" title="December 2025 Registered Offering"&gt;2,891,781&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Exercised_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_z6CuOQlILkk5" title="Exercised"&gt;(1,419,391&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lapsed&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Lapsed_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zPazQK5Ni247" title="Lapsed"&gt;(33&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;As at 31 December 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zy18TNPaYGW" title="Ending balance, shares"&gt;1,474,130&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Numbers of warrants and related exercise prices are after the impact
of the ADS ratio changes on 31 July 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In accordance with the Articles of Association for the Company adopted
on 11 June 2025, the share capital of the Company consists of an unlimited number of ordinary shares of nominal value &#xa3;0.000001
each. Ordinary and deferred shares were recorded as equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Rights attaching to the shares following the incorporation of
Biodexa Pharmaceuticals plc&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Shares classified as equity&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The holders of ordinary shares in the capital of the Company have the
following rights:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(a)&#x2002;to receive notice of, to attend and to vote at all general
meetings of the Company, in which case shareholders shall have one vote for each share of which he is the holder; and,&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(b)&#x2002;to receive such dividend as is declared by the Board on each
share held.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The holders of both classes of deferred shares in the capital of the
Company:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(a)&#x2002;shall not be entitled to receive notice of or to attend or
speak at any general meeting of the Company or to vote on any resolution to be proposed at any general meeting of the Company; and&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(b)&#x2002;shall not be entitled to receive any dividend or other distribution
of out of the profits of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In the event of a distribution of assets, the deferred shareholders
shall receive the nominal amount paid up on such share after the holder of each ordinary share shall have received (in cash or specie)
the amount paid up or credited as paid up on such ordinary share together with an additional payment of &#xa3;100 per share. The Company
has the authority to purchase the deferred shares and may require the holder of the deferred shares to sell them for a price not exceeding
1p for all the deferred shares.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfOrdinaryAndDeferredShares_pn3n3_zelS4eq6x4Il" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share capital (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B9_zcJbtwBR6789" style="display: none"&gt;Schedule of ordinary and deferred shares&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Ordinary Shares&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;&#x2018;A&#x2019; Deferred &lt;br/&gt; Shares&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;&#x2018;B&#x2019; Deferred &lt;br/&gt; Shares&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;&#x2018;C&#x2019; Deferred &lt;br/&gt; Shares&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;&#x2018;D&#x2019; Deferred &lt;br/&gt; Share Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Nominal value &#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 20%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;At 1 January 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 12%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zXKMAEuwxXfh" title="Beginning balance, shares"&gt;5,417,137&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zJt1FtkDL7ce" title="Beginning balance, shares"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValueOfSharesIssued_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zuKpPQySuG95" title="Beginning balance, amount"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15 February 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Private Placement*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zA9gvyJtaeO6" title="Private Placements"&gt;98,387,275&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_fKg_____zBi08ADw9oGl" title="Private Placements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3315"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_fKg_____znyAervmKuIa" title="Private Placements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3317"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_fKg_____zbv7PZ2VygW9" title="Private Placements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3319"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_fKg_____zKnxZNafZjpj" title="Private Placements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3321"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConsiderationForPrivatePlacements_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zVkrf16BjMx6" title="Consideration for Private Placements"&gt;98&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26 May 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Registered Direct Offering*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zApUmLiQY81e" title="Registered Direct Offering"&gt;276,697,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_fKg_____zAzAq9Rf3rSj" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3327"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_fKg_____zz4m8Rx1NeTa" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3329"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_fKg_____zC0rvbBofJog" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3331"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_fKg_____zCVTT5B8kV1e" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3333"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ConsiderationForRegisteredDirectOffering_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zjMFdz7hNppf" title="Consideration for Registered Direct Offering"&gt;277&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14 June 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Share sub-division and &lt;br/&gt;re-designation&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareSubdivisionAndRedesignation_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_ztzLonsHZRpb" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3337"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareSubdivisionAndRedesignation_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_z8bnXRIC1SXk" title="Share sub-division and re-designation"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareSubdivisionAndRedesignation_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zwAaSHTg1WO5" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3341"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareSubdivisionAndRedesignation_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zTqfiGiHf7D" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3343"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21 December 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Shares issued on purchase &lt;br/&gt;Intangible asset (see note 11)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zm47Sblo1hug" title="Shares issued on purchase Intangible asset"&gt;323,684,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_z59wG0TyLzl3" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3347"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zBObRyeWH3Ag" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3349"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zSjTR3bhv1Fa" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3351"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zUE66auW9V56" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3353"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ConsiderationForSharesIssuedOnPurchaseIntangibleAsset_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z6TqN6YvKx2a" title="Consideration for Shares issued on purchase Intangible asset"&gt;324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21 December 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Registered Offering&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zsadnaDtgcRh" title="Registered Offering"&gt;485,391,200&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_ze6AM7RrwdC" title="Registered Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3359"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zElBvS02rrN3" title="Registered Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3361"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zBDgA3F7EVp8" title="Registered Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3363"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zttzuMXVSUl" title="Registered Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3365"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ConsiderationForRegisteredOffering_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zoVtk69acAH5" title="Consideration for Registered Offering"&gt;485&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;At 31 December 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zOoD05NhtC5j" title="Beginning balance, shares"&gt;1,189,577,722&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zsdP16kv0IP5" title="Beginning balance, shares"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zUFc556Qnjkl" title="Beginning balance, shares"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValueOfSharesIssued_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_znnytUvYhEm" title="Beginning balance, amount"&gt;1,189&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25 April 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Shares issued on purchase &lt;br/&gt;Intangible asset (see note 11)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zkl8R2WOdNhd" title="Shares issued on purchase Intangible asset"&gt;151,265,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zswWWdwCI6fj" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3379"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zPBt3Z8kYTm1" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3381"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_za0g7zSxIuTk" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3383"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zYha6HMtSuG2" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3385"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ConsiderationForSharesIssuedOnPurchaseIntangibleAsset_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zo6LLdllQQ7k" title="Consideration for Shares issued on purchase Intangible asset"&gt;151&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22 May 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Warrant inducement&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z3zvnHFB49sf" title="Warrant inducement"&gt;1,614,435,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_ztEvLJxv0uCf" title="Warrant inducement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3391"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_z8xqxetnQOM" title="Warrant inducement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3393"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zJkbwj6B77kj" title="Warrant inducement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3395"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zTljnP1hBtm6" title="Warrant inducement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3397"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConsiderationForSharesIssuedOnWarrantInducement_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zFXN7RBG310g" title="Consideration for shares issued on warrant inducement"&gt;1,614&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22 July 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Registered Direct Offering&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zwdxee3vxcj9" title="Registered Direct Offering"&gt;2,129,516,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_z3BM4WMfTC4g" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3403"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zvpVlSMtUqO9" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3405"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zsPeElfnQoJ3" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3407"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_z9uQrykCw7Gl" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3409"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ConsiderationForRegisteredDirectOffering_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z647xbN2jVNf" title="Consideration for Registered Direct Offering"&gt;2,130&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February - October 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;Exercise pre-funded warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zgRJMEivDom9" title="Exercise pre-funded warrants"&gt;1,502,426,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_z6i9VEwKgVSa" title="Exercise pre-funded warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3415"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zE1UugGZjJl" title="Exercise pre-funded warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3417"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zVS9U3w7JIo1" title="Exercise pre-funded warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3419"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zYEZ3i0tGC4" title="Exercise pre-funded warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3421"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ConsiderationExercisePrefundedWarrants_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJQFqEpcVite" title="Consideration exercise pre-funded warrants"&gt;1,502&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February - May 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Exercise Series E &amp;amp; Series F warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zBZ5E4wUDWj9" title="Exercise Series E &amp;amp; Series F warrants"&gt;98,697,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zPD1Jv58k6Ze" title="Exercise Series E &amp;amp; Series F warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3427"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_z4gfVREGGINd" title="Exercise Series E &amp;amp; Series F warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3429"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zIyvkcH83PO" title="Exercise Series E &amp;amp; Series F warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3431"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zd690HLe9D93" title="Exercise Series E &amp;amp; Series F warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3433"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ConsiderationExerciseSeriesESeriesFWarrants_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zg53ZgUvTuw4" title="Consideration exercise series E &amp;amp; series F warrants"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22 November 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Share sub-division and &lt;br/&gt;re-designation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareSubdivisionAndRedesignation_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zK2z8FdW1Ki3" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3437"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareSubdivisionAndRedesignation_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zAlolynL1vL1" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3439"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareSubdivisionAndRedesignation_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zs6EWebsWJH1" title="Share sub-division and re-designation"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareSubdivisionAndRedesignation_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_z5ZIKMYmWH44" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3443"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;At 31 December 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJLMIWOIqNnl" title="Beginning balance, shares"&gt;6,685,918,922&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zPDB8rMNsYie" title="Beginning balance, shares"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zAyQDqm3H0yi" title="Beginning balance, shares"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zRpmQYRWE9hk" title="Beginning balance, shares"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValueOfSharesIssued_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zpveSzfH4fN4" title="Beginning balance, amount"&gt;6,685&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15 May 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Warrant inducement&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WarrantInducement_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zEVEVJqEa9df" title="Warrant inducement"&gt;2,004,330,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ConsiderationForSharesIssuedOnWarrantInducement_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zPCf5W1ZNopb" title="Consideration for shares issued on warrant inducement"&gt;2,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11 June 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Share sub-division and &lt;br/&gt;re-designation&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareSubdivisionAndRedesignation_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_z0EKrH1mImW2" title="Share sub-division and re-designation"&gt;2,482,747,137,178&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Shares issued under ELOC&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesIssuedUnderEloc_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z8zkE5PoO769" title="Shares issued under ELOC"&gt;59,488,460,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConsiderationForSharesIssuedUnderEloc_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zWaM0hLVRcF" title="Consideration for Shares issued under ELOC"&gt;59,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19 December 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Registered Offering&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RegisteredOffering_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zhv9rtzpqffb" title="Registered Offering"&gt;157,639,100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConsiderationForRegisteredOffering_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z0eznBJxmhl4" title="Consideration for Registered Offering"&gt;157,639&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;At 31 December 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_za1Dpcn67o34" title="Ending balance, shares"&gt;225,817,808,922&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zG4wV7Yv7nmb" title="Ending balance, shares"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zbNDAi42byZ4" title="Ending balance, shares"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zbCy2FJfZbO4" title="Ending balance, shares"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zzmVTv3byYH2" title="Ending balance, shares"&gt;2,482,747,137,178&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 9pt; font-size: 10pt; font-weight: bold"&gt;&lt;span id="xdx_F05_zKDAc0JwoK9k" style="font-size: 10pt; font-weight: normal"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span id="xdx_F14_zd8zYwbq6Mu3" style="font-size: 10pt; font-weight: normal"&gt;Number of shares issued includes exercise of pre-funded warrants and Series A, Series B and Series C warrants that were exercisable on an &#x2018;alternative cashless basis&#x2019;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A0_zg9AVzFEZYmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIssuedCapitalExplanatory>
    <bdrx:DisclosureOfIssuedCapital1Explanatory contextRef="From2025-01-01to2025-12-31" id="Fact003217">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfIssuedCapital1Explanatory_pn3n3_z5WMpQziexPc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share capital (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B4_zmAn0A1pqgC6" style="display: none"&gt;Schedule of detailed information about share capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"&gt;Authorised, allotted and fully paid &#x2013; classified as equity&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2025&lt;br/&gt; &#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2024&lt;br/&gt; &#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;2023&#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;At 31 December&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%"&gt;Ordinary shares of &#xa3;0.000001 each&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zKlGMw0HWNY5" title="Number"&gt;225,817,808,922&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_pp0p" title="Total"&gt;225,818&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z4ZXnDfBj0Ei" title="Number"&gt;6,685,918,922&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_pp0p" title="Total"&gt;334,296&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zrBNADg0wB9c" title="Number"&gt;1,189,577,722&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_pp0p" title="Total"&gt;1,189,578&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#x2018;A&#x2019; Deferred shares of &#xa3;1 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zjpEzS9cxnMe" title="Number"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_pp0p" title="Total"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zi77Xj5IBas4" title="Number"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_pp0p" title="Total"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zC2zCUQEAYZf" title="Number"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_pp0p" title="Total"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#x2018;B&#x2019; Deferred shares of &#xa3;0.001 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zx74FGoN12U6" title="Number"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_pp0p" title="Total"&gt;4,063,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_z9yVwKW9Bto8" title="Number"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_pp0p" title="Total"&gt;4,063,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zCXO4OICltW3" title="Number"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_pp0p" title="Total"&gt;4,063,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#x2018;C&#x2019; Deferred shares of &#xa3;0.00005 each&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_z6DpOMz3cRWf" title="Number"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_pp0p" title="Total"&gt;6,327,370&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zRpaMJBnxagf" title="Number"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_pp0p" title="Total"&gt;6,327,370&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_z50CpFAoxLo9" title="Number"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3263"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_pp0p" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3265"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#x2018;D&#x2019; Deferred shares of &#xa3;0.000001 each&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zM1QXLn3rJb6" title="Number"&gt;2,482,747,137,178&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ValueOfShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_pp0p" title="Total"&gt;2,482,747&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zQduqmEV6nL6" title="Number"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3271"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValueOfShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_pp0p" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3273"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zl2LHSGSYi0g" title="Number"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3275"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValueOfShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_pp0p" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3277"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValueOfShares_c20251231_pp0p" title="Total"&gt;14,099,257&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValueOfShares_c20241231_pp0p" title="Total"&gt;11,724,988&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ValueOfShares_c20231231_pp0p" title="Total"&gt;6,252,900&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:DisclosureOfIssuedCapital1Explanatory>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003219"
      unitRef="Shares">225817808922</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="0"
      id="Fact003221"
      unitRef="GBP">225818</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003223"
      unitRef="Shares">6685918922</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="0"
      id="Fact003225"
      unitRef="GBP">334296</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003227"
      unitRef="Shares">1189577722</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="0"
      id="Fact003229"
      unitRef="GBP">1189578</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_custom_ADeferredSharesMember"
      decimals="INF"
      id="Fact003231"
      unitRef="Shares">1000001</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2025-12-31_custom_ADeferredSharesMember"
      decimals="0"
      id="Fact003233"
      unitRef="GBP">1000001</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_custom_ADeferredSharesMember"
      decimals="INF"
      id="Fact003235"
      unitRef="Shares">1000001</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2024-12-31_custom_ADeferredSharesMember"
      decimals="0"
      id="Fact003237"
      unitRef="GBP">1000001</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2023-12-31_custom_ADeferredSharesMember"
      decimals="INF"
      id="Fact003239"
      unitRef="Shares">1000001</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2023-12-31_custom_ADeferredSharesMember"
      decimals="0"
      id="Fact003241"
      unitRef="GBP">1000001</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_custom_BDeferredSharesMember"
      decimals="INF"
      id="Fact003243"
      unitRef="Shares">4063321418</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2025-12-31_custom_BDeferredSharesMember"
      decimals="0"
      id="Fact003245"
      unitRef="GBP">4063321</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_custom_BDeferredSharesMember"
      decimals="INF"
      id="Fact003247"
      unitRef="Shares">4063321418</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2024-12-31_custom_BDeferredSharesMember"
      decimals="0"
      id="Fact003249"
      unitRef="GBP">4063321</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2023-12-31_custom_BDeferredSharesMember"
      decimals="INF"
      id="Fact003251"
      unitRef="Shares">4063321418</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2023-12-31_custom_BDeferredSharesMember"
      decimals="0"
      id="Fact003253"
      unitRef="GBP">4063321</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_custom_CDeferredSharesMember"
      decimals="INF"
      id="Fact003255"
      unitRef="Shares">126547389518</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2025-12-31_custom_CDeferredSharesMember"
      decimals="0"
      id="Fact003257"
      unitRef="GBP">6327370</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31_custom_CDeferredSharesMember"
      decimals="INF"
      id="Fact003259"
      unitRef="Shares">126547389518</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2024-12-31_custom_CDeferredSharesMember"
      decimals="0"
      id="Fact003261"
      unitRef="GBP">6327370</bdrx:ValueOfShares>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2025-12-31_custom_DDeferredSharesMember"
      decimals="INF"
      id="Fact003267"
      unitRef="Shares">2482747137178</ifrs-full:NumberOfSharesAuthorised>
    <bdrx:ValueOfShares
      contextRef="AsOf2025-12-31_custom_DDeferredSharesMember"
      decimals="0"
      id="Fact003269"
      unitRef="GBP">2482747</bdrx:ValueOfShares>
    <bdrx:ValueOfShares
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003279"
      unitRef="GBP">14099257</bdrx:ValueOfShares>
    <bdrx:ValueOfShares
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact003281"
      unitRef="GBP">11724988</bdrx:ValueOfShares>
    <bdrx:ValueOfShares
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003283"
      unitRef="GBP">6252900</bdrx:ValueOfShares>
    <bdrx:ScheduleOfWarrantReserveRecognizedTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003289">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfWarrantReserveRecognizedTableTextBlock_pn3n3_zXyTFVbw3Eb6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Share capital (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zsPvyPBUkl64" style="display: none"&gt;Schedule of warrant reserve recognize&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Pre-Funded &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As at 1 January 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zlIhwCTMvRR6" title="Beginning balance, shares"&gt;1,773&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued:&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 2025 Registered Offering&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--RegisteredDirectOffering_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zEVNc91d2jMf" title="December 2025 Registered Offering"&gt;2,891,781&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Exercised_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_z6CuOQlILkk5" title="Exercised"&gt;(1,419,391&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lapsed&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Lapsed_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zPazQK5Ni247" title="Lapsed"&gt;(33&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;As at 31 December 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zy18TNPaYGW" title="Ending balance, shares"&gt;1,474,130&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:ScheduleOfWarrantReserveRecognizedTableTextBlock>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2024-12-31_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact003291"
      unitRef="Shares">1773</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:RegisteredDirectOffering
      contextRef="From2025-01-012025-12-31_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact003293"
      unitRef="Shares">2891781</bdrx:RegisteredDirectOffering>
    <bdrx:Exercised
      contextRef="From2025-01-012025-12-31_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact003295"
      unitRef="Shares">-1419391</bdrx:Exercised>
    <bdrx:Lapsed
      contextRef="From2025-01-012025-12-31_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact003297"
      unitRef="Shares">-33</bdrx:Lapsed>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2025-12-31_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact003299"
      unitRef="Shares">1474130</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:DisclosureOfOrdinaryAndDeferredShares contextRef="From2025-01-01to2025-12-31" id="Fact003305">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfOrdinaryAndDeferredShares_pn3n3_zelS4eq6x4Il" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share capital (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B9_zcJbtwBR6789" style="display: none"&gt;Schedule of ordinary and deferred shares&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #4D4D4C"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Ordinary Shares&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;&#x2018;A&#x2019; Deferred &lt;br/&gt; Shares&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;&#x2018;B&#x2019; Deferred &lt;br/&gt; Shares&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;&#x2018;C&#x2019; Deferred &lt;br/&gt; Shares&lt;br/&gt; Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;&#x2018;D&#x2019; Deferred &lt;br/&gt; Share Number&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Nominal value &#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 20%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;At 1 January 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 12%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zXKMAEuwxXfh" title="Beginning balance, shares"&gt;5,417,137&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zJt1FtkDL7ce" title="Beginning balance, shares"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 8%; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValueOfSharesIssued_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zuKpPQySuG95" title="Beginning balance, amount"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15 February 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Private Placement*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zA9gvyJtaeO6" title="Private Placements"&gt;98,387,275&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_fKg_____zBi08ADw9oGl" title="Private Placements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3315"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_fKg_____znyAervmKuIa" title="Private Placements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3317"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_fKg_____zbv7PZ2VygW9" title="Private Placements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3319"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--PrivatePlacements_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_fKg_____zKnxZNafZjpj" title="Private Placements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3321"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConsiderationForPrivatePlacements_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zVkrf16BjMx6" title="Consideration for Private Placements"&gt;98&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26 May 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Registered Direct Offering*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zApUmLiQY81e" title="Registered Direct Offering"&gt;276,697,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_fKg_____zAzAq9Rf3rSj" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3327"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_fKg_____zz4m8Rx1NeTa" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3329"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_fKg_____zC0rvbBofJog" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3331"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RegisteredDirectOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_fKg_____zCVTT5B8kV1e" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3333"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ConsiderationForRegisteredDirectOffering_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_fKg_____zjMFdz7hNppf" title="Consideration for Registered Direct Offering"&gt;277&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14 June 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Share sub-division and &lt;br/&gt;re-designation&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareSubdivisionAndRedesignation_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_ztzLonsHZRpb" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3337"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareSubdivisionAndRedesignation_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_z8bnXRIC1SXk" title="Share sub-division and re-designation"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareSubdivisionAndRedesignation_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zwAaSHTg1WO5" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3341"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareSubdivisionAndRedesignation_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zTqfiGiHf7D" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3343"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21 December 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Shares issued on purchase &lt;br/&gt;Intangible asset (see note 11)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zm47Sblo1hug" title="Shares issued on purchase Intangible asset"&gt;323,684,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_z59wG0TyLzl3" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3347"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zBObRyeWH3Ag" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3349"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zSjTR3bhv1Fa" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3351"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zUE66auW9V56" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3353"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ConsiderationForSharesIssuedOnPurchaseIntangibleAsset_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z6TqN6YvKx2a" title="Consideration for Shares issued on purchase Intangible asset"&gt;324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21 December 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Registered Offering&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zsadnaDtgcRh" title="Registered Offering"&gt;485,391,200&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_ze6AM7RrwdC" title="Registered Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3359"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zElBvS02rrN3" title="Registered Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3361"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zBDgA3F7EVp8" title="Registered Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3363"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RegisteredOffering_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zttzuMXVSUl" title="Registered Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3365"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ConsiderationForRegisteredOffering_pn3n3_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zoVtk69acAH5" title="Consideration for Registered Offering"&gt;485&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;At 31 December 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zOoD05NhtC5j" title="Beginning balance, shares"&gt;1,189,577,722&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zsdP16kv0IP5" title="Beginning balance, shares"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zUFc556Qnjkl" title="Beginning balance, shares"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValueOfSharesIssued_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_znnytUvYhEm" title="Beginning balance, amount"&gt;1,189&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25 April 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Shares issued on purchase &lt;br/&gt;Intangible asset (see note 11)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zkl8R2WOdNhd" title="Shares issued on purchase Intangible asset"&gt;151,265,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zswWWdwCI6fj" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3379"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zPBt3Z8kYTm1" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3381"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_za0g7zSxIuTk" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3383"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--SharesIssuedOnPurchaseIntangibleAsset_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zYha6HMtSuG2" title="Shares issued on purchase Intangible asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3385"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ConsiderationForSharesIssuedOnPurchaseIntangibleAsset_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zo6LLdllQQ7k" title="Consideration for Shares issued on purchase Intangible asset"&gt;151&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22 May 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Warrant inducement&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z3zvnHFB49sf" title="Warrant inducement"&gt;1,614,435,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_ztEvLJxv0uCf" title="Warrant inducement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3391"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_z8xqxetnQOM" title="Warrant inducement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3393"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zJkbwj6B77kj" title="Warrant inducement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3395"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantInducement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zTljnP1hBtm6" title="Warrant inducement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3397"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConsiderationForSharesIssuedOnWarrantInducement_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zFXN7RBG310g" title="Consideration for shares issued on warrant inducement"&gt;1,614&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22 July 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Registered Direct Offering&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zwdxee3vxcj9" title="Registered Direct Offering"&gt;2,129,516,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_z3BM4WMfTC4g" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3403"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zvpVlSMtUqO9" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3405"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zsPeElfnQoJ3" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3407"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RegisteredDirectOffering_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_z9uQrykCw7Gl" title="Registered Direct Offering"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3409"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ConsiderationForRegisteredDirectOffering_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z647xbN2jVNf" title="Consideration for Registered Direct Offering"&gt;2,130&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February - October 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;Exercise pre-funded warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zgRJMEivDom9" title="Exercise pre-funded warrants"&gt;1,502,426,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_z6i9VEwKgVSa" title="Exercise pre-funded warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3415"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zE1UugGZjJl" title="Exercise pre-funded warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3417"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zVS9U3w7JIo1" title="Exercise pre-funded warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3419"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ExercisePrefundedWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zYEZ3i0tGC4" title="Exercise pre-funded warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3421"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ConsiderationExercisePrefundedWarrants_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJQFqEpcVite" title="Consideration exercise pre-funded warrants"&gt;1,502&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February - May 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Exercise Series E &amp;amp; Series F warrants&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zBZ5E4wUDWj9" title="Exercise Series E &amp;amp; Series F warrants"&gt;98,697,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zPD1Jv58k6Ze" title="Exercise Series E &amp;amp; Series F warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3427"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_z4gfVREGGINd" title="Exercise Series E &amp;amp; Series F warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3429"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zIyvkcH83PO" title="Exercise Series E &amp;amp; Series F warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3431"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExerciseSeriesESeriesFWarrants_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zd690HLe9D93" title="Exercise Series E &amp;amp; Series F warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3433"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ConsiderationExerciseSeriesESeriesFWarrants_pn3n3_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zg53ZgUvTuw4" title="Consideration exercise series E &amp;amp; series F warrants"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22 November 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Share sub-division and &lt;br/&gt;re-designation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareSubdivisionAndRedesignation_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zK2z8FdW1Ki3" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3437"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareSubdivisionAndRedesignation_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zAlolynL1vL1" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3439"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareSubdivisionAndRedesignation_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zs6EWebsWJH1" title="Share sub-division and re-designation"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareSubdivisionAndRedesignation_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_z5ZIKMYmWH44" title="Share sub-division and re-designation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3443"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;At 31 December 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJLMIWOIqNnl" title="Beginning balance, shares"&gt;6,685,918,922&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zPDB8rMNsYie" title="Beginning balance, shares"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zAyQDqm3H0yi" title="Beginning balance, shares"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareIssuedForConsideration_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zRpmQYRWE9hk" title="Beginning balance, shares"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValueOfSharesIssued_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zpveSzfH4fN4" title="Beginning balance, amount"&gt;6,685&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15 May 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Warrant inducement&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WarrantInducement_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zEVEVJqEa9df" title="Warrant inducement"&gt;2,004,330,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ConsiderationForSharesIssuedOnWarrantInducement_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zPCf5W1ZNopb" title="Consideration for shares issued on warrant inducement"&gt;2,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11 June 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Share sub-division and &lt;br/&gt;re-designation&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareSubdivisionAndRedesignation_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_z0EKrH1mImW2" title="Share sub-division and re-designation"&gt;2,482,747,137,178&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Shares issued under ELOC&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharesIssuedUnderEloc_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z8zkE5PoO769" title="Shares issued under ELOC"&gt;59,488,460,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConsiderationForSharesIssuedUnderEloc_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zWaM0hLVRcF" title="Consideration for Shares issued under ELOC"&gt;59,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19 December 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Registered Offering&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RegisteredOffering_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zhv9rtzpqffb" title="Registered Offering"&gt;157,639,100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConsiderationForRegisteredOffering_pn3n3_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z0eznBJxmhl4" title="Consideration for Registered Offering"&gt;157,639&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;At 31 December 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_za1Dpcn67o34" title="Ending balance, shares"&gt;225,817,808,922&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ADeferredSharesMember_zG4wV7Yv7nmb" title="Ending balance, shares"&gt;1,000,001&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--BDeferredSharesMember_zbNDAi42byZ4" title="Ending balance, shares"&gt;4,063,321,418&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--CDeferredSharesMember_zbCy2FJfZbO4" title="Ending balance, shares"&gt;126,547,389,518&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShareIssuedForConsideration_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--DDeferredSharesMember_zzmVTv3byYH2" title="Ending balance, shares"&gt;2,482,747,137,178&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 9pt; font-size: 10pt; font-weight: bold"&gt;&lt;span id="xdx_F05_zKDAc0JwoK9k" style="font-size: 10pt; font-weight: normal"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span id="xdx_F14_zd8zYwbq6Mu3" style="font-size: 10pt; font-weight: normal"&gt;Number of shares issued includes exercise of pre-funded warrants and Series A, Series B and Series C warrants that were exercisable on an &#x2018;alternative cashless basis&#x2019;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;/span&gt;&lt;/p&gt;

</bdrx:DisclosureOfOrdinaryAndDeferredShares>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2022-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003307"
      unitRef="Shares">5417137</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2022-12-31_custom_ADeferredSharesMember"
      decimals="INF"
      id="Fact003309"
      unitRef="Shares">1000001</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:ValueOfSharesIssued
      contextRef="AsOf2022-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003311"
      unitRef="GBP">5000</bdrx:ValueOfSharesIssued>
    <bdrx:PrivatePlacements
      contextRef="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003313"
      unitRef="Shares">98387275</bdrx:PrivatePlacements>
    <bdrx:ConsiderationForPrivatePlacements
      contextRef="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003323"
      unitRef="GBP">98000</bdrx:ConsiderationForPrivatePlacements>
    <bdrx:RegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003325"
      unitRef="Shares">276697310</bdrx:RegisteredDirectOffering>
    <bdrx:ConsiderationForRegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003335"
      unitRef="GBP">277000</bdrx:ConsiderationForRegisteredDirectOffering>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2023-01-012023-12-31_custom_BDeferredSharesMember"
      decimals="INF"
      id="Fact003339"
      unitRef="Shares">4063321418</bdrx:ShareSubdivisionAndRedesignation>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003345"
      unitRef="Shares">323684800</bdrx:SharesIssuedOnPurchaseIntangibleAsset>
    <bdrx:ConsiderationForSharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003355"
      unitRef="GBP">324000</bdrx:ConsiderationForSharesIssuedOnPurchaseIntangibleAsset>
    <bdrx:RegisteredOffering
      contextRef="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003357"
      unitRef="Shares">485391200</bdrx:RegisteredOffering>
    <bdrx:ConsiderationForRegisteredOffering
      contextRef="From2023-01-012023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003367"
      unitRef="GBP">485000</bdrx:ConsiderationForRegisteredOffering>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003369"
      unitRef="Shares">1189577722</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2024-12-31_custom_ADeferredSharesMember"
      decimals="INF"
      id="Fact003371"
      unitRef="Shares">1000001</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2023-12-31_custom_BDeferredSharesMember"
      decimals="INF"
      id="Fact003373"
      unitRef="Shares">4063321418</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:ValueOfSharesIssued
      contextRef="AsOf2023-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003375"
      unitRef="GBP">1189000</bdrx:ValueOfSharesIssued>
    <bdrx:SharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003377"
      unitRef="Shares">151265200</bdrx:SharesIssuedOnPurchaseIntangibleAsset>
    <bdrx:ConsiderationForSharesIssuedOnPurchaseIntangibleAsset
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003387"
      unitRef="GBP">151000</bdrx:ConsiderationForSharesIssuedOnPurchaseIntangibleAsset>
    <bdrx:WarrantInducement
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003389"
      unitRef="Shares">1614435600</bdrx:WarrantInducement>
    <bdrx:ConsiderationForSharesIssuedOnWarrantInducement
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003399"
      unitRef="GBP">1614000</bdrx:ConsiderationForSharesIssuedOnWarrantInducement>
    <bdrx:RegisteredDirectOffering
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003401"
      unitRef="Shares">2129516800</bdrx:RegisteredDirectOffering>
    <bdrx:ConsiderationForRegisteredDirectOffering
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003411"
      unitRef="GBP">2130000</bdrx:ConsiderationForRegisteredDirectOffering>
    <bdrx:ExercisePrefundedWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003413"
      unitRef="Shares">1502426000</bdrx:ExercisePrefundedWarrants>
    <bdrx:ConsiderationExercisePrefundedWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003423"
      unitRef="GBP">1502000</bdrx:ConsiderationExercisePrefundedWarrants>
    <bdrx:ExerciseSeriesESeriesFWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003425"
      unitRef="Shares">98697600</bdrx:ExerciseSeriesESeriesFWarrants>
    <bdrx:ConsiderationExerciseSeriesESeriesFWarrants
      contextRef="From2024-01-012024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003435"
      unitRef="GBP">99000</bdrx:ConsiderationExerciseSeriesESeriesFWarrants>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2024-01-012024-12-31_custom_CDeferredSharesMember"
      decimals="INF"
      id="Fact003441"
      unitRef="Shares">126547389518</bdrx:ShareSubdivisionAndRedesignation>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003445"
      unitRef="Shares">6685918922</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2024-12-31_custom_ADeferredSharesMember"
      decimals="INF"
      id="Fact003447"
      unitRef="Shares">1000001</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2024-12-31_custom_BDeferredSharesMember"
      decimals="INF"
      id="Fact003449"
      unitRef="Shares">4063321418</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2024-12-31_custom_CDeferredSharesMember"
      decimals="INF"
      id="Fact003451"
      unitRef="Shares">126547389518</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:ValueOfSharesIssued
      contextRef="AsOf2024-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003453"
      unitRef="GBP">6685000</bdrx:ValueOfSharesIssued>
    <bdrx:WarrantInducement
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003455"
      unitRef="Shares">2004330000</bdrx:WarrantInducement>
    <bdrx:ConsiderationForSharesIssuedOnWarrantInducement
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003457"
      unitRef="GBP">2004000</bdrx:ConsiderationForSharesIssuedOnWarrantInducement>
    <bdrx:ShareSubdivisionAndRedesignation
      contextRef="From2025-01-012025-12-31_custom_DDeferredSharesMember"
      decimals="INF"
      id="Fact003459"
      unitRef="Shares">2482747137178</bdrx:ShareSubdivisionAndRedesignation>
    <bdrx:SharesIssuedUnderEloc
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003461"
      unitRef="Shares">59488460000</bdrx:SharesIssuedUnderEloc>
    <bdrx:ConsiderationForSharesIssuedUnderEloc
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003463"
      unitRef="GBP">59488000</bdrx:ConsiderationForSharesIssuedUnderEloc>
    <bdrx:RegisteredOffering
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003465"
      unitRef="Shares">157639100000</bdrx:RegisteredOffering>
    <bdrx:ConsiderationForRegisteredOffering
      contextRef="From2025-01-012025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="-3"
      id="Fact003467"
      unitRef="GBP">157639000</bdrx:ConsiderationForRegisteredOffering>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2025-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact003469"
      unitRef="Shares">225817808922</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2025-12-31_custom_ADeferredSharesMember"
      decimals="INF"
      id="Fact003471"
      unitRef="Shares">1000001</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2025-12-31_custom_BDeferredSharesMember"
      decimals="INF"
      id="Fact003473"
      unitRef="Shares">4063321418</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2025-12-31_custom_CDeferredSharesMember"
      decimals="INF"
      id="Fact003475"
      unitRef="Shares">126547389518</bdrx:NumberOfShareIssuedForConsideration>
    <bdrx:NumberOfShareIssuedForConsideration
      contextRef="AsOf2025-12-31_custom_DDeferredSharesMember"
      decimals="INF"
      id="Fact003477"
      unitRef="Shares">2482747137178</bdrx:NumberOfShareIssuedForConsideration>
    <ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003480">&lt;p id="xdx_804_eifrs-full--DisclosureOfReservesAndOtherEquityInterestExplanatory_zDq5FSPGxYOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;23&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82B_zKKc9UWimHXf"&gt;Reserves&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following describes the nature and purpose of each reserve within
equity:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfReservesAndOtherEquityInterest1Explanatory_pn3n3_zd5EvrFMfEqh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Reserves (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B4_zh06dnPbGYT3" style="display: none"&gt;Schedule of reserves&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 29%; font-weight: bold"&gt;Reserve&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 71%; font-weight: bold; text-align: left"&gt;Description and purpose&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share capital&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--ShareCapitalMember" title="Description of nature and purpose of reserves within equity"&gt;Nominal value of subscribed share capital&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Share premium&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember" style="text-align: left" title="Description of nature and purpose of reserves within equity"&gt;Amount subscribed for share capital in excess of nominal value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Merger reserve&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--ReserveForMergerMember" style="text-align: left" title="Description of nature and purpose of reserves within equity"&gt;Represents the difference between the fair value and nominal value of shares issued on the acquisition of subsidiary companies where the Company has elected to take advantage of merger accounting.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign exchange reserve&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfExchangeDifferencesOnTranslationMember" style="text-align: left" title="Description of nature and purpose of reserves within equity"&gt;Gains/losses arising on retranslating the net assets of overseas operations into sterling&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;Warrant reserve&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember" style="text-align: left" title="Description of nature and purpose of reserves within equity"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.1pt 0pt 0"&gt;Represents the following:&lt;/p&gt;

   &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in; background-color: transparent"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;the fair value of warrants denominated in &#xa3; at the date of grant. The number and price are fixed at the date of grant. The warrants expired in November 2025.&lt;/span&gt;&lt;/p&gt;
  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in; background-color: transparent"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;the fair value of pre-funded warrants granted. The pre-funded warrants do not have an expiry date.&lt;/span&gt;&lt;/p&gt;
  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in; background-color: transparent"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The fair value of Series C warrants denominated in US$ at the date of grant but allow for the warrants to be exercised on an alternative cashless basis effectively allowing the holders to exercise for nil consideration. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Accumulated deficit&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--RetainedEarningsMember" style="border-bottom: Black 1pt solid; text-align: left" title="Description of nature and purpose of reserves within equity"&gt;All other net gains and losses and transactions with owners (e.g., dividends) not recognised elsewhere.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory>
    <bdrx:DisclosureOfReservesAndOtherEquityInterest1Explanatory contextRef="From2025-01-01to2025-12-31" id="Fact003482">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfReservesAndOtherEquityInterest1Explanatory_pn3n3_zd5EvrFMfEqh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Reserves (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B4_zh06dnPbGYT3" style="display: none"&gt;Schedule of reserves&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 29%; font-weight: bold"&gt;Reserve&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 71%; font-weight: bold; text-align: left"&gt;Description and purpose&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share capital&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--ShareCapitalMember" title="Description of nature and purpose of reserves within equity"&gt;Nominal value of subscribed share capital&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Share premium&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember" style="text-align: left" title="Description of nature and purpose of reserves within equity"&gt;Amount subscribed for share capital in excess of nominal value.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Merger reserve&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--ReserveForMergerMember" style="text-align: left" title="Description of nature and purpose of reserves within equity"&gt;Represents the difference between the fair value and nominal value of shares issued on the acquisition of subsidiary companies where the Company has elected to take advantage of merger accounting.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign exchange reserve&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfExchangeDifferencesOnTranslationMember" style="text-align: left" title="Description of nature and purpose of reserves within equity"&gt;Gains/losses arising on retranslating the net assets of overseas operations into sterling&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;Warrant reserve&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember" style="text-align: left" title="Description of nature and purpose of reserves within equity"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.1pt 0pt 0"&gt;Represents the following:&lt;/p&gt;

   &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in; background-color: transparent"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;the fair value of warrants denominated in &#xa3; at the date of grant. The number and price are fixed at the date of grant. The warrants expired in November 2025.&lt;/span&gt;&lt;/p&gt;
  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in; background-color: transparent"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;the fair value of pre-funded warrants granted. The pre-funded warrants do not have an expiry date.&lt;/span&gt;&lt;/p&gt;
  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in; background-color: transparent"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The fair value of Series C warrants denominated in US$ at the date of grant but allow for the warrants to be exercised on an alternative cashless basis effectively allowing the holders to exercise for nil consideration. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Accumulated deficit&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--DescriptionOfNatureAndPurposeOfReservesWithinEquity_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--RetainedEarningsMember" style="border-bottom: Black 1pt solid; text-align: left" title="Description of nature and purpose of reserves within equity"&gt;All other net gains and losses and transactions with owners (e.g., dividends) not recognised elsewhere.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bdrx:DisclosureOfReservesAndOtherEquityInterest1Explanatory>
    <ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember"
      id="Fact003484">Nominal value of subscribed share capital</ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity>
    <ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember"
      id="Fact003486">Amount subscribed for share capital in excess of nominal value.</ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity>
    <ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity
      contextRef="From2025-01-012025-12-31_custom_ReserveForMergerMember"
      id="Fact003488">Represents the difference between the fair value and nominal value of shares issued on the acquisition of subsidiary companies where the Company has elected to take advantage of merger accounting.</ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity>
    <ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="Fact003490">Gains/losses arising on retranslating the net assets of overseas operations into sterling</ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity>
    <ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantReserveMember"
      id="Fact003492">Represents the following:

   &#xb7;&#160;&#160;&#160;&#160;&#160;the fair value of warrants denominated in &#xa3; at the date of grant. The number and price are fixed at the date of grant. The warrants expired in November 2025.
  &#xb7;&#160;&#160;&#160;&#160;&#160;the fair value of pre-funded warrants granted. The pre-funded warrants do not have an expiry date.
  &#xb7;&#160;&#160;&#160;&#160;&#160;The fair value of Series C warrants denominated in US$ at the date of grant but allow for the warrants to be exercised on an alternative cashless basis effectively allowing the holders to exercise for nil consideration. </ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity>
    <ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="Fact003494">All other net gains and losses and transactions with owners (e.g., dividends) not recognised elsewhere.</ifrs-full:DescriptionOfNatureAndPurposeOfReservesWithinEquity>
    <bdrx:DisclosureOfRetirementBenefitsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003496">&lt;p id="xdx_804_ecustom--DisclosureOfRetirementBenefitsExplanatory_zGUfJSme53Zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;24&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_826_z5CZvsg8Cqp1"&gt;Retirement
benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group operates a defined contribution pension scheme for the benefit
of its employees. The assets of the scheme are administered by trustees in funds independent from those of the Group. The annual charge
for the year was &#xa3;&lt;span id="xdx_90D_ecustom--RetirementBenefits_pn3n3_c20250101__20251231_zIjE26h0AOO9" title="Retirement benefits"&gt;69,000&lt;/span&gt; (2024: &#xa3;&lt;span id="xdx_90D_ecustom--RetirementBenefits_pn3n3_c20240101__20241231_zERKbUEXNmy9" title="Retirement benefits"&gt;67,000&lt;/span&gt;)&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

</bdrx:DisclosureOfRetirementBenefitsExplanatory>
    <bdrx:RetirementBenefits
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003498"
      unitRef="GBP">69000000</bdrx:RetirementBenefits>
    <bdrx:RetirementBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003500"
      unitRef="GBP">67000000</bdrx:RetirementBenefits>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003504">&lt;p id="xdx_80B_eifrs-full--DisclosureOfSharebasedPaymentArrangementsExplanatory_zJzvHeWcO2Ji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;25&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_823_zWO5v0b5kDw9"&gt;Share-based payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Share Options&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group has issued options over ordinary shares under the 2014 Biodexa
Pharmaceuticals PLC Enterprise Management Incentive Scheme and unapproved share options awarded to non-UK staff and Directors. In addition,
certain share options originally issued over shares in Biodexa Limited under the Biodexa Limited 2008 unapproved share option scheme or
Biodexa Limited 2013 approved Enterprise Incentive scheme were reissued in 2015 over shares in Biodexa Pharmaceuticals PLC under the 2014
Biodexa Pharmaceuticals PLC Enterprise Management Incentive Scheme, all remaining re-issued share options lapsed during 2024. Exercise
of an option is subject to continued employment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;At a General Meeting on 11 June 2024, shareholders approved a share
sub-division and re-designation of the Company&#x2019;s Ordinary Shares. As a result, the par value of the Ordinary Shares was changed
from &#xa3;0.00005 per share to &#xa3;0.000001 per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Details of all share options granted under the Schemes are set out
below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_pn3n3_z49vmWO3FgLf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span id="xdx_8B8_zrb8mx8sLpB" style="display: none"&gt;Details of all share options granted under the schemes are set out below&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member" title="Grant date"&gt;19 December 2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_zbN88qOs2wl7" title="Beginning of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_zQhC6DHIX9n" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3512"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_z0fz94rvrLO1" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3514"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_ziuWzM3OIVQe" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3516"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_zpOXXr2Qy7Rl" title="Ending of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_zta3k91Wcy9d" title="Exercise Price"&gt;484.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member" title="Grant date"&gt;15 December 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_z7wgxhCtf752" title="Beginning of the year"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_z90yeT8EJQ5c" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3526"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_zIfLbr55Ts0e" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3528"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_z0WuaO9ZUM6e" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3530"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_zZjlT2EZ2KV1" title="Ending of the year"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_zUZdz2ogfRM6" title="Exercise Price"&gt;184.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member" title="Grant date"&gt;24 April 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zGeRcZBbLBu2" title="Beginning of the year"&gt;237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zJSDkuSExQw9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3540"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zi0eyM5EDpk5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3542"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_ztnJRI1TxOG3" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3544"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zCAGHWX0nAxd" title="Ending of the year"&gt;237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zJFErEIESOsl" title="Exercise Price"&gt;29.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member" title="Grant date"&gt;2 October 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zWX1kMhJ8m8f" title="Beginning of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zXhp6nzLcSsi" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3554"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zKvKLZYyavmj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3556"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zaHnPYEuvlcb" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3558"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zv5MbfVONSxe" title="Ending of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zf5Lw9odFN1" title="Exercise Price"&gt;21.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member" title="Grant date"&gt;17 April 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zzG1LRxBGqAb" title="Beginning of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zvhZ8vSMpQDc" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3568"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zGvos3B0dwLh" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3570"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zB6g6uRV0hP2" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3572"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_z4T9nP7IJXI7" title="Ending of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zqwH0Wp7tbT6" title="Exercise Price"&gt;4.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member" title="Grant date"&gt;17 June 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zYMjEpkdwKq9" title="Beginning of the year"&gt;26,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zIlu0BOddF97" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3582"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zoUYF0BeO23c" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3584"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zBf8xM1HSlP5" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3586"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zX051MFzSWji" title="Ending of the year"&gt;26,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zFxQx02nOF7h" title="Exercise Price"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member" title="Grant date"&gt;15 July 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_z9cpZeG3NxYk" title="Beginning of the year"&gt;40,850&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_zz637PaJ3atd" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3596"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_zPlAV7J3NMy9" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3598"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_z0atGuIbidJl" title="Forfeited"&gt;(600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_zDHDEjgnDZKl" title="Ending of the year"&gt;40,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_zx1J0YKB9Emh" title="Exercise Price"&gt;5.55&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member" title="Grant date"&gt;1 September 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zRlGiX2RB6Mf" title="Beginning of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zf2EaoHRBHz7" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3610"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_z13camsTAnv5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3612"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zuZKuBZU2VS5" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3614"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zOudwqUOSBK1" title="Ending of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zrNIVWGJE76l" title="Exercise Price"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member" title="Grant date"&gt;7 February 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zWv0oNgPA6N4" title="Beginning of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zosQi9PTPlC6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3624"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zU1v8kDtR22l" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3626"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zFZ4LEzqIPRf" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3628"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zkK4OG7RIHkh" title="Ending of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zk3JeLKQgoZ5" title="Exercise Price"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member" title="Grant date"&gt;23 January 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zY27MP7upPTg" title="Beginning of the year"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zuIOx6gg7ZB4" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3638"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zKXcVsl9anuj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3640"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zqdjkIXu17x" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3642"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zQ0XuTER7XXg" title="Ending of the year"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zL3AgWraMevf" title="Exercise Price"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member" title="Grant date"&gt;10 February 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_zAhlhAcUZ12j" title="Beginning of the year"&gt;98,808,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_z6L3ubmgbzSj" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3652"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_zHFBsBJZp9De" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3654"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_z5ooqliSguBc" title="Forfeited"&gt;(15,752,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_zBZmFHsxfzH6" title="Ending of the year"&gt;83,056,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_zWBftx9r7Ymk" title="Exercise Price"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member" title="Grant date"&gt;10 July 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_z5HH6ZfAbVLj" title="Beginning of the year"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_zvY0KGuBO5pi" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3666"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_z9JeNEPcm86h" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3668"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_z2ramydvnuh4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3670"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_zJdLQWjee7Zg" title="Ending of the year"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_zW7LTl7hoV51" title="Exercise Price"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231_zlK2pRBQDNg" title="Beginning of the year"&gt;328,823,388&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231_zsI4i9ghOQOc" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3678"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231_zWhMpp1rFR0f" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3680"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231_zkAPbBUxfuR3" title="Forfeited"&gt;(15,752,600&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231_zJDnJRit1Ku7" title="Ending of the year"&gt;313,070,788&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Options exercisable at 31 December 2025&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20251231_zCYB1q8gTz5h" title="Options exercisable"&gt;137,022,409&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_c20251231_zyaXUs94xMmg" title="Weighted average exercise price of outstanding options"&gt;0.005&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20250101__20251231_z1dfk4XXmuo2" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3690"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20250101__20251231_ztzJsHP2oRij" title="Weighted average exercise price of options lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3692"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20250101__20251231_zb9T6STdBrzl" title="Weighted average exercise price of options forfeited"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_c20250101__20251231_zK8X63EQkAR7" title="Weighted average exercise price of options granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3696"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20250101__20251231_zDYOfDtzEiLg" title="Weighted average remaining contractual life of outstanding options"&gt;8.2&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member" title="Grant date"&gt;30 June 2014&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zk2kMErcQ659" title="Beginning of the year"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zUxG8krHcMRj" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3708"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zyfhmELHVpvi" title="Lapsed"&gt;(25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zjjuAYa3SUVd" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3712"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zOtQggBZ6J8i" title="Ending of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3714"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zK2RyyzDyHCl" title="Exercise Price"&gt;30.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member" title="Grant date"&gt;19 December 2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zQbzpiefxTH6" title="Beginning of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zJ0LVile6Fb4" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3722"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zXQTVkrWqMX3" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3724"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zB4jkyM2nb9a" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3726"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zDct60lDrGfa" title="Ending of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zrlNfK87Y8B" title="Exercise Price"&gt;484.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member" title="Grant date"&gt;15 December 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zATUdYL9MrJi" title="Beginning of the year"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zjoQ0MfFhii2" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3736"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zGACczqCx6j9" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3738"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zJV1psxgwx17" title="Forfeited"&gt;(2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zHKmNkRw9P9i" title="Ending of the year"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_z70xbR3Gi4Rb" title="Exercise Price"&gt;184.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member" title="Grant date"&gt;24 April 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_z2c9yxDTKpQb" title="Beginning of the year"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_zYTZ2BC7M3Fh" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3750"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_zUsHPgs4FMWe" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3752"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_zXUV3fc29ly3" title="Forfeited"&gt;(75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_znXzpruxlFZ" title="Ending of the year"&gt;237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_zp6OrZb11wxa" title="Exercise Price"&gt;29.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member" title="Grant date"&gt;2 October 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zZewl6K4yHJ9" title="Beginning of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zhOK9eJfWpvj" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3764"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zIEvf3ZPIeLc" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3766"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zJXRPF0JNJHg" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3768"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zwQCYgjfI301" title="Ending of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zlf0R8xhdeC7" title="Exercise Price"&gt;21.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member" title="Grant date"&gt;17 April 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zdxFw0LU1gR3" title="Beginning of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zKOCGH7PZj63" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3778"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zfGf7DXAvB5j" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3780"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zyfxTGj3O7o9" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3782"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_z7rduPmD13Of" title="Ending of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zas2Yxme5gpg" title="Exercise Price"&gt;4.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member" title="Grant date"&gt;17 June 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_zrfLdQ0IU1m8" title="Beginning of the year"&gt;27,350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_zOemolHey055" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3792"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_zBDVPQ7KwfHf" title="Forfeited"&gt;(900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_zIGKVsC4TVbc" title="Ending of the year"&gt;26,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_z5FtgqMHvzz2" title="Exercise Price"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member" title="Grant date"&gt;15 July 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zA6D25ZHY32f" title="Beginning of the year"&gt;58,850&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zibpRDUSIxDg" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3804"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_z0TwxfKEAyu6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3806"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zYAreEkGAvde" title="Forfeited"&gt;(18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zuNQmmok3wfe" title="Ending of the year"&gt;40,850&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zyoJ68xf8FY5" title="Exercise Price"&gt;5.55&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member" title="Grant date"&gt;1 September 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member_zXpMO17Xujk6" title="Beginning of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member_zwfywjBtLFT1" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3818"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member_zD1H6gVC4W06" title="Ending of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member_zxUJ1IKCsXx7" title="Exercise Price"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member" title="Grant date"&gt;7 February 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zaOG8W2Hf1wg" title="Beginning of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zXzSF6Twr1Ib" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3828"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zEdE6Pfpghmc" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3830"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zjqlTpEBOSYc" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3832"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zG7Y84yFmEu3" title="Ending of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zlnckM1liuxh" title="Exercise Price"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member" title="Grant date"&gt;23 January 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_zblMmLomxlFl" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3840"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_ziaZSlsbsJAg" title="Granted"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_zWL4jL500QBj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3844"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_z3tjdWEzAWZb" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3846"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_z3K4oSYNYzSb" title="Ending of the year"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_zp57X6MuZSCk" title="Exercise Price"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member" title="Grant date"&gt;10 February 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_z88ZGMl0fCvk" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3854"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_zqNiD2o2lHS1" title="Granted"&gt;130,313,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_zAsa3yJL9zSg" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3858"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_zBZ34f2a18Eb" title="Forfeited"&gt;(31,504,400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_z11YlgnBeMUj" title="Ending of the year"&gt;98,808,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_z2TnYCs3Dcph" title="Exercise Price"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member" title="Grant date"&gt;10 July 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_z2PE56Zpiloc" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3868"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_zuNl5n3UUFO5" title="Granted"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_zUPjPEwefSD" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3872"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_z858E506eWz9" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3874"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_zYunzicSd2M4" title="Ending of the year"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_zAJULEUqjz36" title="Exercise Price"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231_ztVva0hgofQ6" title="Beginning of the year"&gt;111,590&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231_zWynEWLHNb3d" title="Granted"&gt;360,235,200&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231_zZSWe58WVeU8" title="Lapsed"&gt;(25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231_zpaLd0Pd7Hsl" title="Forfeited"&gt;(31,523,377&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231_zkSzBsRkwNu4" title="Ending of the year"&gt;328,823,388&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Options exercisable at 31 December 2024&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20241231_zj3x4YZzleU1" title="Options exercisable"&gt;82,874&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_c20241231_zdImKyY5z0R2" title="Weighted average exercise price of outstanding options"&gt;0.005&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20240101__20241231_zJKz6iuHNy6b" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3894"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20240101__20241231_zqxddUkcJJji" title="Weighted average exercise price of options lapsed"&gt;30.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20240101__20241231_zoMwYASrVKAe" title="Weighted average exercise price of options forfeited"&gt;0.006&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_c20240101__20241231_zOegbRBT2Haa" title="Weighted average exercise price of options granted"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;span id="xdx_902_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20240101__20241231_zsz2lFzwFRxk" title="Weighted average remaining contractual life of outstanding options"&gt;9.2&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zqwIeEoLiDTf" title="Grant date"&gt;30 June 2014&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zqueiV27F8vl" title="Beginning of the year"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zLh55bwrAGoh" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3912"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_z6PXTTgElDK" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3914"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zq8aVHvuNo09" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3916"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_z4pUpzvnYmCl" title="Ending of the year"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zy3xSmYNwIY2" title="Exercise Price"&gt;30.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zRG16MEO3416" title="Grant date"&gt;19 December 2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_z8ZwD3FiXgW1" title="Beginning of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zf2zfe3IhG1g" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3926"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zFDYKX9cjEi9" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3928"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zRCRfi05cxVk" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3930"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zK7nbNrJ2R6" title="Ending of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zah1TpVutkAj" title="Exercise Price"&gt;484.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zKoLamC2AhS7" title="Grant date"&gt;15 December 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_z781GM4jzvvi" title="Beginning of the year"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zne2mjQTOAWf" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3940"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zrSAybzclRe" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3942"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_z3qbdnyTDqb5" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3944"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zBd28aUNNcs2" title="Ending of the year"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zBcruMeIowlh" title="Exercise Price"&gt;184.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zzHRZ9mJLUx2" title="Grant date"&gt;24 April 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zrgBwVx2rylf" title="Beginning of the year"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_z3zEArl96Vt6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3954"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_z0Nv36sw3nla" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3956"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zr8iscppbbo4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3958"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zi5MEtu7KG2d" title="Ending of the year"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zubQWidTljWg" title="Exercise Price"&gt;29.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zROi07MAxcZf" title="Grant date"&gt;2 October 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zPP7EmdEAw0h" title="Beginning of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zQTotLivp4Jd" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3968"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zSPQ90uMIFg4" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3970"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zcN931ld9KV4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3972"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zwZyXuZpFrgl" title="Ending of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zE47rwidGw0j" title="Exercise Price"&gt;21.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zq9LhoDGUtNf" title="Grant date"&gt;17 April 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zRuvIuHeuCoc" title="Beginning of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zPA6zCvt9wf1" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3982"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_z5ezBOTlgbm5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3984"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zUqdW5aRPD95" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3986"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zSbr9UthwXEa" title="Ending of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zjFF6eOqKtMh" title="Exercise Price"&gt;4.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zbHMwMaYe256" title="Grant date"&gt;17 June 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_z8sCUATxrTr4" title="Beginning of the year"&gt;33,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zlrryEdBX22d" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3996"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zHyDAEdHM1X3" title="Lapsed"&gt;(6,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zt9TzweYB50a" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4000"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zTe7RrhaOca2" title="Ending of the year"&gt;27,350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zqdC1sRnfku7" title="Exercise Price"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zDqXDVvpioag" title="Grant date"&gt;15 July 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zBHWFumSm1z3" title="Beginning of the year"&gt;64,350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_z5z3JgEKBTPb" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4010"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_z4mMKm7lBAyj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4012"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zfNSTnnEjvy5" title="Forfeited"&gt;(5,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zIleCjs6dte6" title="Ending of the year"&gt;58,850&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zhKtrvKISoh" title="Exercise Price"&gt;5.55&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zTV7hV3g3va3" title="Grant date"&gt;2 August 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zl39kCrEzYil" title="Beginning of the year"&gt;2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zBG3nqyr81jh" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4024"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_znFa3hNfFVR5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4026"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zTa9Vd4TOZGa" title="Forfeited"&gt;(2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zB6swd0AqISg" title="Ending of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4030"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zxviJ2N9Bsvd" title="Exercise Price"&gt;5.30&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_z4q0XubFBqM7" title="Grant date"&gt;1 September 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_zjl8qgfePgxa" title="Beginning of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_z6v9DJhmg9M9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4038"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_z15vTbRi5Yxk" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4040"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_zSveSX7fAXh9" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4042"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_zP8LvOqteCo9" title="Ending of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_znzqXYHYQBV4" title="Exercise Price"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member" title="Grant date"&gt;7 February 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zUPwvsGURk6a" title="Beginning of the year"&gt;18,750&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zr6M8T4P0MS9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4052"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zQ8dFLTOOgoi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4054"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zdN0CxRdVaWf" title="Forfeited"&gt;(6,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_z6jbfBp6mlU" title="Ending of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zlzOjy3oL5Al" title="Exercise Price"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member" title="Grant date"&gt;12 August 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_z2THwdnfwRjh" title="Beginning of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zX8nmaP0c5F4" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4066"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zjrUEsIbiFY6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4068"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zSZxcHE2v49f" title="Forfeited"&gt;(12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zB3cMdgEppwb" title="Ending of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4072"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zMVZJBLAFdR5" title="Exercise Price"&gt;2.10&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231_zoZXXnDyh3q2" title="Beginning of the year"&gt;144,590&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231_zNv1FF8xM3nf" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4078"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231_zEYIWLMoCVil" title="Lapsed"&gt;(6,250&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231_z29MZodnU1Le" title="Forfeited"&gt;(26,750&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231_zM539i6bByRb" title="Ending of the year"&gt;111,590&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Options exercisable at 31 December 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20231231_zzAlJrDAWGi3" title="Options exercisable"&gt;75,720&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_c20231231_z2WZFgJJDZ57" title="Weighted average exercise price of outstanding options"&gt;5.241&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20230101__20231231_zMCg1VZGqQL8" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4090"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20230101__20231231_zD8iL2NGKN7b" title="Weighted average exercise price of options lapsed"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20230101__20231231_zI1Vec4jLVPg" title="Weighted average exercise price of options forfeited"&gt;3.33&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_c20230101__20231231_zNsFwqIDK9z9" title="Weighted average exercise price of options granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4096"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20230101__20231231_zpcEvnnewzHk" title="Weighted average remaining contractual life of outstanding options"&gt;7.3&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AA_zeUOQECitlci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following information is relevant in the determination of the fair
value of options granted during the year 2024 under the equity share based remuneration schemes operated by the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_pn3n3_zRgUBhUpV72g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zEviKTCnFNY6" style="display: none"&gt;Schedule of fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;January 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;February 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;July 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%"&gt;Number of options&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20240131_zwpJypEH80kk" title="Number of options"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240201__20240229_zDWzlTRbhIU2" title="Number of options"&gt;130,313,200&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240701__20240731_z18ZpCRK7vI5" title="Number of options"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Option pricing models used&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240101__20240131" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240201__20240229" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240701__20240731" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20240101__20240131_zN6miT1Vq157" title="Share price"&gt;1.90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20240201__20240229_zLNYOE7bnJgh" title="Share price"&gt;1.310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_c20240701__20240731_zy142fWDtls6" title="Share price"&gt;0.00139&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price of options issued in year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ExercisePriceOfOptionsIssuedInYear_pid_uUSDPShares_c20240101__20240131_z0JbHg5JQkZi" title="Exercise price of options issued in year"&gt;1.90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ExercisePriceOfOptionsIssuedInYear_pid_uUSDPShares_c20240201__20240229_zTuLOI2Ejt22" title="Exercise price of options issued in year"&gt;1.310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExercisePriceOfOptionsIssuedInYear_pid_c20240701__20240731_zg6SrlAcC8pg" title="Exercise price of options issued in year"&gt;0.00259&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contractual life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ContractualLifeTerm_dtY_c20240101__20240131_zIC8IpWbKJyf" title="Contractual life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ContractualLifeTerm_dtY_c20240201__20240229_zVNu4sLsgxl7" title="Contractual life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ContractualLifeTerm_dtY_c20240701__20240731_ztuJHRQrXof4" title="Contractual life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ExpectedLifeTerm_dtY_c20240101__20240131_z5Auar4mg8j8" title="Expected life"&gt;4&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ExpectedLifeTerm_dtY_c20240201__20240229_zlS2HV6TN0o9" title="Expected life"&gt;4&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeTerm_dtY_c20240701__20240731_zqAH1J5MQdBd" title="Expected life"&gt;4&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240101__20240131_fKio___zVNosSXRdRtg" title="Volatility"&gt;100.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240201__20240229_fKio___zdXbl0QtrXG9" title="Volatility"&gt;100.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240701__20240731_fKio___zuOSbLOF7fE" title="Volatility"&gt;110.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240101__20240131_zUrlwYElV855" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240201__20240229_z3YdjFrfbpX6" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240701__20240731_zxB8FD7ma8Uc" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Risk free rate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240101__20240131_zehryT9afNpk" title="Risk free rate"&gt;4.110&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240201__20240229_zL2sHWJulNpf" title="Risk free rate"&gt;4.195&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240701__20240731_zBUoDTEQ58Dj" title="Risk free rate"&gt;4.025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The share price used in the determination of the fair value of the
options granted in 2024 was the share price on the date of grant.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F00_zpTlXwjbBmNe" style="width: 3%; font-size: 10pt"&gt;**&lt;/td&gt;
    &lt;td id="xdx_F15_zTninv6sKbpc" style="width: 97%; font-size: 10pt"&gt;Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a four-year period.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zJzZdLcVpX3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Share Incentive Plan&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In April 2017 the Group set up the Biodexa Pharmaceuticals Share Incentive
Plan (MPSIP). Under the BPSIP, Group employees and Directors can acquire ordinary shares in the Company via a salary sacrifice arrangement.
Biodexa grants matching shares for every share bought. In order to retain these shares, scheme participants must remain employed by the
Group for three years from the date of acquisition. All shares purchased by the BPSIP are held by an Employee Benefit Trust that is not
under the control of Biodexa. Shares must be left in the plan for 5 years to qualify for full income tax and NIC relief.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On 24 April 2023 the Company terminated the Trust and requested the
Trustees distribute the assets of the Trust to the relevant Group employees.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1F3A5D"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Warrants issued in lieu of fees&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1F3A5D"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company issues warrants over ADSs to certain its brokers in lieu
of broker fees connected to the equity transactions in the year. The warrants are accounted for as share based payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfWarrantsAccountedForShareBasedPaymentsTableTextBlock_pn3n3_zOhTdPrKR9h8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span id="xdx_8B8_zpYrIwxtJfB9" style="display: none"&gt;Schedule of warrants are accounted for as share based payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price per ADS&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member" title="Grant date"&gt;24 March 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z1dFs6cTTKw" title="Beginning of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zmXNlAf6ESF" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4169"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zvtymAV6EkWi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4171"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zUFzbPKy9Nyl" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4173"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zgoEpVtZvrn1" title="Ending of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zn33DWkakLG1" title="Exercise Price"&gt;58,000.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member" title="Grant date"&gt;14 June 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zZ51XNOYgIS" title="Beginning of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zGMPnAVc8pvc" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4183"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zwUNtIWkk6Ef" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4185"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zrWK1nmlEaKd" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4187"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zJJhJVufCxP3" title="Ending of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zXNY1WuVE1wb" title="Exercise Price"&gt;3,750.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member" title="Grant date"&gt;21 December 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zKk3LwIcHaW" title="Beginning of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zwk4T0JjG0u6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4197"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_z3WTqpSFWe52" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4199"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zoHSBQEKV9hi" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4201"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zNwYdk7fzilf" title="Ending of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zXAQ667BzVo7" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member" title="Grant date"&gt;24 May 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zoyRC3LotDT6" title="Beginning of the year"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_z6xno5VTF4N3" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4211"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zWvlqQpLLaYg" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4213"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_z3NZecWLBLy7" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4215"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zEKNm2wzNJQ9" title="Ending of the year"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zgSSxnpeP40d" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member" title="Grant date"&gt;22 July 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zABwFJizZEfa" title="Beginning of the year"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zpC6b0MsrmKl" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4225"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zg4W1i4qGt79" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4227"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zrefQ8mHm3Nf" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4229"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zh1HeZxQYkJ1" title="Ending of the year"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zejP1v5TKvOh" title="Exercise Price"&gt;312.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member" title="Grant date"&gt;19 December 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zZB6doZIKHEc" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4237"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zdByzACfv6rd" title="Granted"&gt;152,439&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zrEgIbDUprj1" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4241"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zLdoYHp6UEz8" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4243"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zezgsKcebuRd" title="Ending of the year"&gt;152,439&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zNym7Vi8irw4" title="Exercise Price"&gt;3.28&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zIpH9y0Hjuc2" title="Beginning of the year"&gt;2,024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_za7e3ErAkY1e" title="Granted"&gt;152,439&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z5szDuFDamVh" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4253"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zIuPEKZDGYk" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4255"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zPirWB6IOARd" title="Ending of the year"&gt;154,463&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Warrants exercisable at 31 December 2025&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--WarrantsExercisable_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z6iXtVZZn8m9" title="Warrants exercisable"&gt;154,463&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_uUSDPShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zKw3pPIRSITa" title="Weighted average exercise price of outstanding options"&gt;12.458&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_znMk1hEZiaYa" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4263"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zoOpdvFhop7d" title="Weighted average exercise price of options lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4265"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zUigoBw0xi6h" title="Weighted average exercise price of options forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4267"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_uUSDPShares_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zDOF8v9Qx1Y5" title="Weighted average exercise price of options granted"&gt;3.28&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zEjX30adpnKf" title="Weighted average remaining contractual life of outstanding options"&gt;4.9&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price per ADS&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member" title="Grant date"&gt;24 March 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z66JapzaT1rl" title="Beginning of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z01QZMi3yJ99" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4281"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zBPItBK53Bjh" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4283"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z49potcROtz1" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4285"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z4enhXpyD6mf" title="Ending of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z1yLtebGCnJ9" title="Exercise Price"&gt;58,000.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member" title="Grant date"&gt;14 June 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zXpBUCbyEhv7" title="Beginning of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zU3s51g7jq2a" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4295"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_z95cR9TZdbpc" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4297"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zImBOhaixhF8" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4299"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zZxn32CGwZfd" title="Ending of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zJqNF92l3VO9" title="Exercise Price"&gt;3,750.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member" title="Grant date"&gt;21 December 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zqKpc0E6RfS7" title="Beginning of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_z0Bj8xRauAQ8" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4309"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zLYmtpW7qMQ6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4311"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zuTByhcUQFok" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4313"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zdrgonY0yFRa" title="Ending of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zUoInHhDUSRb" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member" title="Grant date"&gt;24 May 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zCUyvKO6aWPd" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4321"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zxy8uJ74HJRd" title="Granted"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zobbjETEkcR2" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4325"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zjUnZm5mBOHd" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4327"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zeWrVGN8Z57l" title="Ending of the year"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zt87t1urc8oh" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member" title="Grant date"&gt;22 July 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zzWDToanAVh5" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4335"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zunv61ZoTZO5" title="Granted"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zxwSBnT36AXc" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4339"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zG6bkQnlpSI4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4341"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zUbnDJGM3nO" title="Ending of the year"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_z5u9f9ZDHMXl" title="Exercise Price"&gt;312.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zSUvxFGxxSCa" title="Beginning of the year"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zZlqnp80mZfk" title="Granted"&gt;1,495&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zaJcheu02dak" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4351"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zajjkEe6vx33" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4353"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zvCxNyJb7sM3" title="Ending of the year"&gt;2,024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Warrants exercisable at 31 December 2024&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--WarrantsExercisable_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zaOOANlAf1r9" title="Warrants exercisable"&gt;2,024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_uUSDPShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zQoGfVzZ6yF1" title="Weighted average exercise price of outstanding options"&gt;703.28&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zwHyY7s1t784" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4361"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_znGIRhq1uLm5" title="Weighted average exercise price of options lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4363"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zESeuQrwTLt1" title="Weighted average exercise price of options forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4365"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_uUSDPShares_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zHRmykbZrKc8" title="Weighted average exercise price of options granted"&gt;447.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zHKsE1X8did9" title="Weighted average remaining contractual life of outstanding options"&gt;2.2&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price per ADS&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member" title="Grant date"&gt;24 March 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zcyJX4Z4Krsl" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4373"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zVJbaXt72gkb" title="Granted"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zYz4b4hR4xHi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4377"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z13bQDyRf40h" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4379"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zIBhoDTIaBj" title="Ending of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zYx5fWK83MV8" title="Exercise Price"&gt;58,000.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member" title="Grant date"&gt;14 June 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zjUS1GkmREv8" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4387"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zkrC9CbdbzNb" title="Granted"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zYG4dmjD7AT5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4391"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_ztmRqwqweVLh" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4393"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zIvz96Wo3hR4" title="Ending of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zkH828u3aNYh" title="Exercise Price"&gt;3,750.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member" title="Grant date"&gt;21 December 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zspRMdQRXjCi" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4401"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zxZIt07MCCrk" title="Granted"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zGUhXNbMwwT5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4405"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_z902dSMCLQY7" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4407"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zIIm89n04DBd" title="Ending of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_z5hrfaNDTCT3" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zKyQWTtNkj9c" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4413"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z3BllmM3PEcf" title="Granted"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zI8wDw975bid" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4417"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zUQy5erBSVi4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4419"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zqavpUAA53c9" title="Ending of the year"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Warrants exercisable at 31 December 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WarrantsExercisable_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z0RxuVNQLurl" title="Warrants exercisable"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_znrj405VWnA9" title="Weighted average exercise price of outstanding options"&gt;1,427.22&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z77Vzl1AYZk2" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4427"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z292WnVfuxi" title="Weighted average exercise price of options lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4429"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z68SnApYxKt6" title="Weighted average exercise price of options forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4431"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_uUSDPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z26gRJ866cLg" title="Weighted average exercise price of options granted"&gt;1,427.22&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_ztQ69nhPtMR5" title="Weighted average remaining contractual life of outstanding options"&gt;2.2&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_8AA_zKXMKC106eQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following information is relevant in the determination of the fair
value of warrants granted during the year 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfFairValueOfWarrantsGrantedTableTextBlock_pn3n3_zgNqcFoh2ED3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zfIG0cPYtRae" style="display: none"&gt;Schedule of fair value of warrants granted&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%; text-align: left"&gt;Number of ADS warrants granted&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfAdsWarrantsGranted_pid_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z0G77dDhlDPf" title="Number of ADS warrants granted"&gt;152,439&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Option pricing models used&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z8wBlgPyOhxe" title="Share price"&gt;3.640&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price of warrants issued in year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zg59vANr0ZBf" title="Exercise price of warrants issued in year"&gt;3.280&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contractual life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ContractualLifeTerm_dtY_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zvgVEew5EDmc" title="Contractual life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ExpectedLifeTerm_dtY_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zFinQ3y6kAr2" title="Expected life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zejPbHEbuVP" title="Volatility"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zFttCNz4EhB3" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Risk free rate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zWn9yS7Ug3ue" title="Risk free rate"&gt;3.70&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="color: windowtext"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="color: windowtext"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4D4D4C"&gt;&lt;span style="color: windowtext"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 3%"&gt;*&lt;/td&gt;
    &lt;td style="width: 97%"&gt;The share price used in the determination of the fair value of the ADS warrants granted in 2025 was the ADS price on the date of grant.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;**&lt;/td&gt;
    &lt;td&gt;Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a three-year period.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4D4D4C"&gt;&lt;span style="color: windowtext"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4D4D4C"&gt;&lt;span style="color: windowtext"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4D4D4C"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following information is relevant in the determination of the fair
value of warrants granted during the year 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;May 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;July 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Number of ADS warrants granted&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NumberOfAdsWarrantsGranted_pid_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zvVUjobLVCK2" title="Number of ADS warrants granted"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfAdsWarrantsGranted_pid_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zZjUddhiCq9g" title="Number of ADS warrants granted"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Option pricing models used&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zrYXYG8o1dWg" title="Share price"&gt;325.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z90rS1dqONDl" title="Share price"&gt;198.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price of warrants issued in year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zxV4XFhdkf2d" title="Exercise price of warrants issued in year"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zumsX52dfAhh" title="Exercise price of warrants issued in year"&gt;312.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contractual life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ContractualLifeTerm_dtY_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z0itbPlIpy9k" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ContractualLifeTerm_dtY_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zoXJGH531ay1" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ExpectedLifeTerm_dtY_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zqfZFlN08gnl" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeTerm_dtY_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zsLsiCBwUjmb" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zylVCFhZQ7J6" title="Volatility"&gt;115&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___z2DNIyWAWVMk" title="Volatility"&gt;115&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zTDxbkmIClvh" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zrLvYFe3pBp3" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Risk free rate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zqeE3BKN2dmi" title="Risk free rate"&gt;4.71&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zmGY5QEkdWHa" title="Risk free rate"&gt;4.29&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 3%"&gt;*&lt;/td&gt;
    &lt;td style="width: 97%"&gt;The share price used in the determination of the fair value of the ADS warrants granted in 2024 was the ADS price on the date of grant.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;**&lt;/td&gt;
    &lt;td&gt;Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a three-year period.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following information is relevant in the determination of the fair
value of warrants granted during the year 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;March 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;June 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Number of ADS warrants granted&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--NumberOfAdsWarrantsGranted_pid_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zV46pOwdkKyg" title="Number of ADS warrants granted"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfAdsWarrantsGranted_pid_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zIBcua0vINGa" title="Number of ADS warrants granted"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfAdsWarrantsGranted_pid_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z3NkEZAFwAE7" title="Number of ADS warrants granted"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Option pricing models used&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKg_____zkvmtbwxsUOa" title="Share price"&gt;50,400.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKg_____zLOwTTfCfpVi" title="Share price"&gt;2,635.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zz74Ll4W7xb9" title="Share price"&gt;632.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price of warrants issued in year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zthBsrnRFP67" title="Exercise price of warrants issued in year"&gt;58,000.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zCOABAJkDmI7" title="Exercise price of warrants issued in year"&gt;3,750.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z5MEv8W2tSi7" title="Exercise price of warrants issued in year"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contractual life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ContractualLifeTerm_dtY_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z2xchWFSCNtd" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ContractualLifeTerm_dtY_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zgjfUH36cac9" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ContractualLifeTerm_dtY_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zgmlZrJ5LCCb" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ExpectedLifeTerm_dtY_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zMfRexcgfgjk" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ExpectedLifeTerm_dtY_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zLJrKPmhzXI8" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExpectedLifeTerm_dtY_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zxngVeZGwcWh" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zZAlRH9LR1Q3" title="Volatility"&gt;75.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zM1T4DWOC4Bk" title="Volatility"&gt;80.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zYc4DtNHebN7" title="Volatility"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zqPrPzjgS6yg" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zkmrPG863twd" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zfFfkMXrhbWe" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Risk free rate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zzYV2IVzFxMe" title="Risk free rate"&gt;4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_ztUFuzYfViL6" title="Risk free rate"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zMynoEg874Yc" title="Risk free rate"&gt;4.06&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zXTNaYpifmQl" style="width: 3%"&gt;*&lt;/td&gt;
    &lt;td id="xdx_F14_zegciKYtVFfg" style="width: 97%"&gt;The share price used in the determination of the fair value of the ADS warrants granted in 2023 was the ADS price on the date of grant.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F04_zxocdOHOgu6e"&gt;**&lt;/td&gt;
    &lt;td id="xdx_F1B_zcYFBLvmf1H9"&gt;Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a three-year period.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_ztEXbSE9m098" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;Number and original price of warrants have been adjusted
to reflect the ratio change of ADS&#x2019;s to ordinary shares that occurred on 5 July 2023, 4 October 2024 and 31 July 2025.&lt;br/&gt;
&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003506">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_pn3n3_z49vmWO3FgLf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span id="xdx_8B8_zrb8mx8sLpB" style="display: none"&gt;Details of all share options granted under the schemes are set out below&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member" title="Grant date"&gt;19 December 2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_zbN88qOs2wl7" title="Beginning of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_zQhC6DHIX9n" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3512"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_z0fz94rvrLO1" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3514"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_ziuWzM3OIVQe" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3516"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_zpOXXr2Qy7Rl" title="Ending of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant1Member_zta3k91Wcy9d" title="Exercise Price"&gt;484.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member" title="Grant date"&gt;15 December 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_z7wgxhCtf752" title="Beginning of the year"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_z90yeT8EJQ5c" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3526"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_zIfLbr55Ts0e" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3528"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_z0WuaO9ZUM6e" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3530"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_zZjlT2EZ2KV1" title="Ending of the year"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant2Member_zUZdz2ogfRM6" title="Exercise Price"&gt;184.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member" title="Grant date"&gt;24 April 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zGeRcZBbLBu2" title="Beginning of the year"&gt;237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zJSDkuSExQw9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3540"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zi0eyM5EDpk5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3542"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_ztnJRI1TxOG3" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3544"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zCAGHWX0nAxd" title="Ending of the year"&gt;237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant3Member_zJFErEIESOsl" title="Exercise Price"&gt;29.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member" title="Grant date"&gt;2 October 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zWX1kMhJ8m8f" title="Beginning of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zXhp6nzLcSsi" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3554"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zKvKLZYyavmj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3556"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zaHnPYEuvlcb" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3558"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zv5MbfVONSxe" title="Ending of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant4Member_zf5Lw9odFN1" title="Exercise Price"&gt;21.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member" title="Grant date"&gt;17 April 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zzG1LRxBGqAb" title="Beginning of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zvhZ8vSMpQDc" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3568"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zGvos3B0dwLh" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3570"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zB6g6uRV0hP2" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3572"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_z4T9nP7IJXI7" title="Ending of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant5Member_zqwH0Wp7tbT6" title="Exercise Price"&gt;4.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member" title="Grant date"&gt;17 June 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zYMjEpkdwKq9" title="Beginning of the year"&gt;26,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zIlu0BOddF97" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3582"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zoUYF0BeO23c" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3584"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zBf8xM1HSlP5" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3586"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zX051MFzSWji" title="Ending of the year"&gt;26,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant6Member_zFxQx02nOF7h" title="Exercise Price"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member" title="Grant date"&gt;15 July 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_z9cpZeG3NxYk" title="Beginning of the year"&gt;40,850&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_zz637PaJ3atd" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3596"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_zPlAV7J3NMy9" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3598"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_z0atGuIbidJl" title="Forfeited"&gt;(600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_zDHDEjgnDZKl" title="Ending of the year"&gt;40,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant7Member_zx1J0YKB9Emh" title="Exercise Price"&gt;5.55&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member" title="Grant date"&gt;1 September 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zRlGiX2RB6Mf" title="Beginning of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zf2EaoHRBHz7" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3610"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_z13camsTAnv5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3612"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zuZKuBZU2VS5" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3614"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zOudwqUOSBK1" title="Ending of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant8Member_zrNIVWGJE76l" title="Exercise Price"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member" title="Grant date"&gt;7 February 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zWv0oNgPA6N4" title="Beginning of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zosQi9PTPlC6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3624"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zU1v8kDtR22l" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3626"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zFZ4LEzqIPRf" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3628"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zkK4OG7RIHkh" title="Ending of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant9Member_zk3JeLKQgoZ5" title="Exercise Price"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member" title="Grant date"&gt;23 January 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zY27MP7upPTg" title="Beginning of the year"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zuIOx6gg7ZB4" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3638"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zKXcVsl9anuj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3640"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zqdjkIXu17x" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3642"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zQ0XuTER7XXg" title="Ending of the year"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant10Member_zL3AgWraMevf" title="Exercise Price"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member" title="Grant date"&gt;10 February 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_zAhlhAcUZ12j" title="Beginning of the year"&gt;98,808,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_z6L3ubmgbzSj" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3652"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_zHFBsBJZp9De" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3654"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_z5ooqliSguBc" title="Forfeited"&gt;(15,752,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_zBZmFHsxfzH6" title="Ending of the year"&gt;83,056,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant11Member_zWBftx9r7Ymk" title="Exercise Price"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member" title="Grant date"&gt;10 July 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_z5HH6ZfAbVLj" title="Beginning of the year"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_zvY0KGuBO5pi" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3666"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_z9JeNEPcm86h" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3668"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_z2ramydvnuh4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3670"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_zJdLQWjee7Zg" title="Ending of the year"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--Grant12Member_zW7LTl7hoV51" title="Exercise Price"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231_zlK2pRBQDNg" title="Beginning of the year"&gt;328,823,388&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231_zsI4i9ghOQOc" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3678"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231_zWhMpp1rFR0f" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3680"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231_zkAPbBUxfuR3" title="Forfeited"&gt;(15,752,600&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231_zJDnJRit1Ku7" title="Ending of the year"&gt;313,070,788&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Options exercisable at 31 December 2025&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20251231_zCYB1q8gTz5h" title="Options exercisable"&gt;137,022,409&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_c20251231_zyaXUs94xMmg" title="Weighted average exercise price of outstanding options"&gt;0.005&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20250101__20251231_z1dfk4XXmuo2" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3690"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20250101__20251231_ztzJsHP2oRij" title="Weighted average exercise price of options lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3692"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20250101__20251231_zb9T6STdBrzl" title="Weighted average exercise price of options forfeited"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_c20250101__20251231_zK8X63EQkAR7" title="Weighted average exercise price of options granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3696"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20250101__20251231_zDYOfDtzEiLg" title="Weighted average remaining contractual life of outstanding options"&gt;8.2&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; color: #00A3DB; text-indent: -27pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member" title="Grant date"&gt;30 June 2014&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zk2kMErcQ659" title="Beginning of the year"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zUxG8krHcMRj" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3708"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zyfhmELHVpvi" title="Lapsed"&gt;(25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zjjuAYa3SUVd" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3712"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zOtQggBZ6J8i" title="Ending of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3714"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant13Member_zK2RyyzDyHCl" title="Exercise Price"&gt;30.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member" title="Grant date"&gt;19 December 2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zQbzpiefxTH6" title="Beginning of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zJ0LVile6Fb4" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3722"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zXQTVkrWqMX3" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3724"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zB4jkyM2nb9a" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3726"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zDct60lDrGfa" title="Ending of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant14Member_zrlNfK87Y8B" title="Exercise Price"&gt;484.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member" title="Grant date"&gt;15 December 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zATUdYL9MrJi" title="Beginning of the year"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zjoQ0MfFhii2" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3736"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zGACczqCx6j9" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3738"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zJV1psxgwx17" title="Forfeited"&gt;(2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_zHKmNkRw9P9i" title="Ending of the year"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant15Member_z70xbR3Gi4Rb" title="Exercise Price"&gt;184.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member" title="Grant date"&gt;24 April 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_z2c9yxDTKpQb" title="Beginning of the year"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_zYTZ2BC7M3Fh" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3750"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_zUsHPgs4FMWe" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3752"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_zXUV3fc29ly3" title="Forfeited"&gt;(75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_znXzpruxlFZ" title="Ending of the year"&gt;237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant16Member_zp6OrZb11wxa" title="Exercise Price"&gt;29.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member" title="Grant date"&gt;2 October 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zZewl6K4yHJ9" title="Beginning of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zhOK9eJfWpvj" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3764"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zIEvf3ZPIeLc" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3766"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zJXRPF0JNJHg" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3768"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zwQCYgjfI301" title="Ending of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant17Member_zlf0R8xhdeC7" title="Exercise Price"&gt;21.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member" title="Grant date"&gt;17 April 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zdxFw0LU1gR3" title="Beginning of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zKOCGH7PZj63" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3778"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zfGf7DXAvB5j" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3780"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zyfxTGj3O7o9" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3782"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_z7rduPmD13Of" title="Ending of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant18Member_zas2Yxme5gpg" title="Exercise Price"&gt;4.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member" title="Grant date"&gt;17 June 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_zrfLdQ0IU1m8" title="Beginning of the year"&gt;27,350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_zOemolHey055" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3792"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_zBDVPQ7KwfHf" title="Forfeited"&gt;(900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_zIGKVsC4TVbc" title="Ending of the year"&gt;26,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant19Member_z5FtgqMHvzz2" title="Exercise Price"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member" title="Grant date"&gt;15 July 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zA6D25ZHY32f" title="Beginning of the year"&gt;58,850&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zibpRDUSIxDg" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3804"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_z0TwxfKEAyu6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3806"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zYAreEkGAvde" title="Forfeited"&gt;(18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zuNQmmok3wfe" title="Ending of the year"&gt;40,850&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant20Member_zyoJ68xf8FY5" title="Exercise Price"&gt;5.55&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member" title="Grant date"&gt;1 September 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member_zXpMO17Xujk6" title="Beginning of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member_zwfywjBtLFT1" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3818"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member_zD1H6gVC4W06" title="Ending of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant21Member_zxUJ1IKCsXx7" title="Exercise Price"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member" title="Grant date"&gt;7 February 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zaOG8W2Hf1wg" title="Beginning of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zXzSF6Twr1Ib" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3828"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zEdE6Pfpghmc" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3830"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zjqlTpEBOSYc" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3832"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zG7Y84yFmEu3" title="Ending of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant22Member_zlnckM1liuxh" title="Exercise Price"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member" title="Grant date"&gt;23 January 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_zblMmLomxlFl" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3840"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_ziaZSlsbsJAg" title="Granted"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_zWL4jL500QBj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3844"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_z3tjdWEzAWZb" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3846"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_z3K4oSYNYzSb" title="Ending of the year"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant23Member_zp57X6MuZSCk" title="Exercise Price"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member" title="Grant date"&gt;10 February 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_z88ZGMl0fCvk" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3854"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_zqNiD2o2lHS1" title="Granted"&gt;130,313,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_zAsa3yJL9zSg" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3858"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_zBZ34f2a18Eb" title="Forfeited"&gt;(31,504,400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_z11YlgnBeMUj" title="Ending of the year"&gt;98,808,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant24Member_z2TnYCs3Dcph" title="Exercise Price"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member" title="Grant date"&gt;10 July 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_z2PE56Zpiloc" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3868"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_zuNl5n3UUFO5" title="Granted"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_zUPjPEwefSD" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3872"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_z858E506eWz9" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3874"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_zYunzicSd2M4" title="Ending of the year"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--Grant25Member_zAJULEUqjz36" title="Exercise Price"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231_ztVva0hgofQ6" title="Beginning of the year"&gt;111,590&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231_zWynEWLHNb3d" title="Granted"&gt;360,235,200&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231_zZSWe58WVeU8" title="Lapsed"&gt;(25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231_zpaLd0Pd7Hsl" title="Forfeited"&gt;(31,523,377&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231_zkSzBsRkwNu4" title="Ending of the year"&gt;328,823,388&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Options exercisable at 31 December 2024&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20241231_zj3x4YZzleU1" title="Options exercisable"&gt;82,874&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_c20241231_zdImKyY5z0R2" title="Weighted average exercise price of outstanding options"&gt;0.005&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20240101__20241231_zJKz6iuHNy6b" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3894"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20240101__20241231_zqxddUkcJJji" title="Weighted average exercise price of options lapsed"&gt;30.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20240101__20241231_zoMwYASrVKAe" title="Weighted average exercise price of options forfeited"&gt;0.006&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_c20240101__20241231_zOegbRBT2Haa" title="Weighted average exercise price of options granted"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;span id="xdx_902_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20240101__20241231_zsz2lFzwFRxk" title="Weighted average remaining contractual life of outstanding options"&gt;9.2&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zqwIeEoLiDTf" title="Grant date"&gt;30 June 2014&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zqueiV27F8vl" title="Beginning of the year"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zLh55bwrAGoh" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3912"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_z6PXTTgElDK" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3914"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zq8aVHvuNo09" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3916"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_z4pUpzvnYmCl" title="Ending of the year"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant26Member_zy3xSmYNwIY2" title="Exercise Price"&gt;30.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zRG16MEO3416" title="Grant date"&gt;19 December 2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_z8ZwD3FiXgW1" title="Beginning of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zf2zfe3IhG1g" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3926"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zFDYKX9cjEi9" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3928"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zRCRfi05cxVk" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3930"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zK7nbNrJ2R6" title="Ending of the year"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant27Member_zah1TpVutkAj" title="Exercise Price"&gt;484.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zKoLamC2AhS7" title="Grant date"&gt;15 December 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_z781GM4jzvvi" title="Beginning of the year"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zne2mjQTOAWf" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3940"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zrSAybzclRe" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3942"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_z3qbdnyTDqb5" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3944"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zBd28aUNNcs2" title="Ending of the year"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant28Member_zBcruMeIowlh" title="Exercise Price"&gt;184.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zzHRZ9mJLUx2" title="Grant date"&gt;24 April 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zrgBwVx2rylf" title="Beginning of the year"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_z3zEArl96Vt6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3954"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_z0Nv36sw3nla" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3956"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zr8iscppbbo4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3958"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zi5MEtu7KG2d" title="Ending of the year"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant29Member_zubQWidTljWg" title="Exercise Price"&gt;29.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zROi07MAxcZf" title="Grant date"&gt;2 October 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zPP7EmdEAw0h" title="Beginning of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zQTotLivp4Jd" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3968"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zSPQ90uMIFg4" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3970"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zcN931ld9KV4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3972"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zwZyXuZpFrgl" title="Ending of the year"&gt;1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant30Member_zE47rwidGw0j" title="Exercise Price"&gt;21.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zq9LhoDGUtNf" title="Grant date"&gt;17 April 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zRuvIuHeuCoc" title="Beginning of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zPA6zCvt9wf1" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3982"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_z5ezBOTlgbm5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3984"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zUqdW5aRPD95" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3986"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zSbr9UthwXEa" title="Ending of the year"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant31Member_zjFF6eOqKtMh" title="Exercise Price"&gt;4.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zbHMwMaYe256" title="Grant date"&gt;17 June 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_z8sCUATxrTr4" title="Beginning of the year"&gt;33,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zlrryEdBX22d" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3996"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zHyDAEdHM1X3" title="Lapsed"&gt;(6,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zt9TzweYB50a" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4000"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zTe7RrhaOca2" title="Ending of the year"&gt;27,350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant32Member_zqdC1sRnfku7" title="Exercise Price"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zDqXDVvpioag" title="Grant date"&gt;15 July 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zBHWFumSm1z3" title="Beginning of the year"&gt;64,350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_z5z3JgEKBTPb" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4010"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_z4mMKm7lBAyj" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4012"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zfNSTnnEjvy5" title="Forfeited"&gt;(5,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zIleCjs6dte6" title="Ending of the year"&gt;58,850&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant33Member_zhKtrvKISoh" title="Exercise Price"&gt;5.55&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zTV7hV3g3va3" title="Grant date"&gt;2 August 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zl39kCrEzYil" title="Beginning of the year"&gt;2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zBG3nqyr81jh" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4024"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_znFa3hNfFVR5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4026"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zTa9Vd4TOZGa" title="Forfeited"&gt;(2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zB6swd0AqISg" title="Ending of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4030"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant34Member_zxviJ2N9Bsvd" title="Exercise Price"&gt;5.30&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_z4q0XubFBqM7" title="Grant date"&gt;1 September 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_zjl8qgfePgxa" title="Beginning of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_z6v9DJhmg9M9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4038"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_z15vTbRi5Yxk" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4040"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_zSveSX7fAXh9" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4042"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_zP8LvOqteCo9" title="Ending of the year"&gt;6,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant35Member_znzqXYHYQBV4" title="Exercise Price"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member" title="Grant date"&gt;7 February 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zUPwvsGURk6a" title="Beginning of the year"&gt;18,750&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zr6M8T4P0MS9" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4052"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zQ8dFLTOOgoi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4054"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zdN0CxRdVaWf" title="Forfeited"&gt;(6,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_z6jbfBp6mlU" title="Ending of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant36Member_zlzOjy3oL5Al" title="Exercise Price"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member" title="Grant date"&gt;12 August 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_z2THwdnfwRjh" title="Beginning of the year"&gt;12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zX8nmaP0c5F4" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4066"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zjrUEsIbiFY6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4068"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zSZxcHE2v49f" title="Forfeited"&gt;(12,500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zB3cMdgEppwb" title="Ending of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4072"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--Grant37Member_zMVZJBLAFdR5" title="Exercise Price"&gt;2.10&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231_zoZXXnDyh3q2" title="Beginning of the year"&gt;144,590&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231_zNv1FF8xM3nf" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4078"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231_zEYIWLMoCVil" title="Lapsed"&gt;(6,250&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231_z29MZodnU1Le" title="Forfeited"&gt;(26,750&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231_zM539i6bByRb" title="Ending of the year"&gt;111,590&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Options exercisable at 31 December 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20231231_zzAlJrDAWGi3" title="Options exercisable"&gt;75,720&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_c20231231_z2WZFgJJDZ57" title="Weighted average exercise price of outstanding options"&gt;5.241&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20230101__20231231_zMCg1VZGqQL8" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4090"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20230101__20231231_zD8iL2NGKN7b" title="Weighted average exercise price of options lapsed"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20230101__20231231_zI1Vec4jLVPg" title="Weighted average exercise price of options forfeited"&gt;3.33&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_c20230101__20231231_zNsFwqIDK9z9" title="Weighted average exercise price of options granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4096"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20230101__20231231_zpcEvnnewzHk" title="Weighted average remaining contractual life of outstanding options"&gt;7.3&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant1Member"
      id="Fact003508">19 December 2016</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant1Member"
      decimals="INF"
      id="Fact003510"
      unitRef="N">13</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant1Member"
      decimals="INF"
      id="Fact003518"
      unitRef="N">13</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant1Member"
      decimals="INF"
      id="Fact003520"
      unitRef="GBPPShares">484.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant2Member"
      id="Fact003522">15 December 2017</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant2Member"
      decimals="INF"
      id="Fact003524"
      unitRef="N">38</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant2Member"
      decimals="INF"
      id="Fact003532"
      unitRef="N">38</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant2Member"
      decimals="INF"
      id="Fact003534"
      unitRef="GBPPShares">184.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant3Member"
      id="Fact003536">24 April 2019</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant3Member"
      decimals="INF"
      id="Fact003538"
      unitRef="N">237</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant3Member"
      decimals="INF"
      id="Fact003546"
      unitRef="N">237</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant3Member"
      decimals="INF"
      id="Fact003548"
      unitRef="GBPPShares">29.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant4Member"
      id="Fact003550">2 October 2019</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant4Member"
      decimals="INF"
      id="Fact003552"
      unitRef="N">1500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant4Member"
      decimals="INF"
      id="Fact003560"
      unitRef="N">1500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant4Member"
      decimals="INF"
      id="Fact003562"
      unitRef="GBPPShares">21.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant5Member"
      id="Fact003564">17 April 2020</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant5Member"
      decimals="INF"
      id="Fact003566"
      unitRef="N">5000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant5Member"
      decimals="INF"
      id="Fact003574"
      unitRef="N">5000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant5Member"
      decimals="INF"
      id="Fact003576"
      unitRef="GBPPShares">4.80</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant6Member"
      id="Fact003578">17 June 2020</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant6Member"
      decimals="INF"
      id="Fact003580"
      unitRef="N">26450</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant6Member"
      decimals="INF"
      id="Fact003588"
      unitRef="N">26450</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant6Member"
      decimals="INF"
      id="Fact003590"
      unitRef="GBPPShares">4.04</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant7Member"
      id="Fact003592">15 July 2021</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant7Member"
      decimals="INF"
      id="Fact003594"
      unitRef="N">40850</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant7Member"
      decimals="INF"
      id="Fact003600"
      unitRef="N">-600</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant7Member"
      decimals="INF"
      id="Fact003602"
      unitRef="N">40250</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant7Member"
      decimals="INF"
      id="Fact003604"
      unitRef="GBPPShares">5.55</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant8Member"
      id="Fact003606">1 September 2021</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant8Member"
      decimals="INF"
      id="Fact003608"
      unitRef="N">6000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant8Member"
      decimals="INF"
      id="Fact003616"
      unitRef="N">6000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant8Member"
      decimals="INF"
      id="Fact003618"
      unitRef="GBPPShares">5.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant9Member"
      id="Fact003620">7 February 2022</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant9Member"
      decimals="INF"
      id="Fact003622"
      unitRef="N">12500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant9Member"
      decimals="INF"
      id="Fact003630"
      unitRef="N">12500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant9Member"
      decimals="INF"
      id="Fact003632"
      unitRef="GBPPShares">3.05</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant10Member"
      id="Fact003634">23 January 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant10Member"
      decimals="INF"
      id="Fact003636"
      unitRef="N">144000000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant10Member"
      decimals="INF"
      id="Fact003644"
      unitRef="N">144000000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant10Member"
      decimals="INF"
      id="Fact003646"
      unitRef="GBPPShares">0.004</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant11Member"
      id="Fact003648">10 February 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant11Member"
      decimals="INF"
      id="Fact003650"
      unitRef="N">98808800</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_Grant11Member"
      decimals="INF"
      id="Fact003656"
      unitRef="N">-15752000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant11Member"
      decimals="INF"
      id="Fact003658"
      unitRef="N">83056800</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant11Member"
      decimals="INF"
      id="Fact003660"
      unitRef="GBPPShares">0.003</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_Grant12Member"
      id="Fact003662">10 July 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant12Member"
      decimals="INF"
      id="Fact003664"
      unitRef="N">85922000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_Grant12Member"
      decimals="INF"
      id="Fact003672"
      unitRef="N">85922000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_Grant12Member"
      decimals="INF"
      id="Fact003674"
      unitRef="GBPPShares">0.003</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact003676"
      unitRef="N">328823388</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003682"
      unitRef="N">-15752600</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003684"
      unitRef="N">313070788</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003686"
      unitRef="N">137022409</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003688"
      unitRef="GBPPShares">0.005</bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003694"
      unitRef="GBPPShares">0.003</bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited>
    <bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1 contextRef="From2025-01-01to2025-12-31" id="Fact003698">P8Y2M12D</bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant13Member"
      id="Fact003704">30 June 2014</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant13Member"
      decimals="INF"
      id="Fact003706"
      unitRef="N">25</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant13Member"
      decimals="INF"
      id="Fact003710"
      unitRef="N">-25</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant13Member"
      decimals="INF"
      id="Fact003716"
      unitRef="GBPPShares">30.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant14Member"
      id="Fact003718">19 December 2016</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant14Member"
      decimals="INF"
      id="Fact003720"
      unitRef="N">13</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant14Member"
      decimals="INF"
      id="Fact003728"
      unitRef="N">13</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant14Member"
      decimals="INF"
      id="Fact003730"
      unitRef="GBPPShares">484.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant15Member"
      id="Fact003732">15 December 2017</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant15Member"
      decimals="INF"
      id="Fact003734"
      unitRef="N">40</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant15Member"
      decimals="INF"
      id="Fact003740"
      unitRef="N">-2</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant15Member"
      decimals="INF"
      id="Fact003742"
      unitRef="N">38</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant15Member"
      decimals="INF"
      id="Fact003744"
      unitRef="GBPPShares">184.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant16Member"
      id="Fact003746">24 April 2019</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant16Member"
      decimals="INF"
      id="Fact003748"
      unitRef="N">312</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant16Member"
      decimals="INF"
      id="Fact003754"
      unitRef="N">-75</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant16Member"
      decimals="INF"
      id="Fact003756"
      unitRef="N">237</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant16Member"
      decimals="INF"
      id="Fact003758"
      unitRef="GBPPShares">29.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant17Member"
      id="Fact003760">2 October 2019</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant17Member"
      decimals="INF"
      id="Fact003762"
      unitRef="N">1500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant17Member"
      decimals="INF"
      id="Fact003770"
      unitRef="N">1500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant17Member"
      decimals="INF"
      id="Fact003772"
      unitRef="GBPPShares">21.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant18Member"
      id="Fact003774">17 April 2020</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant18Member"
      decimals="INF"
      id="Fact003776"
      unitRef="N">5000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant18Member"
      decimals="INF"
      id="Fact003784"
      unitRef="N">5000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant18Member"
      decimals="INF"
      id="Fact003786"
      unitRef="GBPPShares">4.80</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant19Member"
      id="Fact003788">17 June 2020</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant19Member"
      decimals="INF"
      id="Fact003790"
      unitRef="N">27350</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant19Member"
      decimals="INF"
      id="Fact003794"
      unitRef="N">-900</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant19Member"
      decimals="INF"
      id="Fact003796"
      unitRef="N">26450</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant19Member"
      decimals="INF"
      id="Fact003798"
      unitRef="GBPPShares">4.04</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant20Member"
      id="Fact003800">15 July 2021</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant20Member"
      decimals="INF"
      id="Fact003802"
      unitRef="N">58850</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant20Member"
      decimals="INF"
      id="Fact003808"
      unitRef="N">-18000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant20Member"
      decimals="INF"
      id="Fact003810"
      unitRef="N">40850</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant20Member"
      decimals="INF"
      id="Fact003812"
      unitRef="GBPPShares">5.55</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant21Member"
      id="Fact003814">1 September 2021</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant21Member"
      decimals="INF"
      id="Fact003816"
      unitRef="N">6000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant21Member"
      decimals="INF"
      id="Fact003820"
      unitRef="N">6000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant21Member"
      decimals="INF"
      id="Fact003822"
      unitRef="GBPPShares">5.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant22Member"
      id="Fact003824">7 February 2022</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant22Member"
      decimals="INF"
      id="Fact003826"
      unitRef="N">12500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant22Member"
      decimals="INF"
      id="Fact003834"
      unitRef="N">12500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant22Member"
      decimals="INF"
      id="Fact003836"
      unitRef="GBPPShares">3.05</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant23Member"
      id="Fact003838">23 January 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant23Member"
      decimals="INF"
      id="Fact003842"
      unitRef="N">144000000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant23Member"
      decimals="INF"
      id="Fact003848"
      unitRef="N">144000000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant23Member"
      decimals="INF"
      id="Fact003850"
      unitRef="GBPPShares">0.004</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant24Member"
      id="Fact003852">10 February 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant24Member"
      decimals="INF"
      id="Fact003856"
      unitRef="N">130313200</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant24Member"
      decimals="INF"
      id="Fact003860"
      unitRef="N">-31504400</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant24Member"
      decimals="INF"
      id="Fact003862"
      unitRef="N">98808800</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant24Member"
      decimals="INF"
      id="Fact003864"
      unitRef="GBPPShares">0.003</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_Grant25Member"
      id="Fact003866">10 July 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_Grant25Member"
      decimals="INF"
      id="Fact003870"
      unitRef="N">85922000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_Grant25Member"
      decimals="INF"
      id="Fact003876"
      unitRef="N">85922000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_Grant25Member"
      decimals="INF"
      id="Fact003878"
      unitRef="GBPPShares">0.003</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact003880"
      unitRef="N">111590</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003882"
      unitRef="N">360235200</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003884"
      unitRef="N">-25</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003886"
      unitRef="N">-31523377</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact003888"
      unitRef="N">328823388</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact003890"
      unitRef="N">82874</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact003892"
      unitRef="GBPPShares">0.005</bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsLapsed
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003896"
      unitRef="GBPPShares">30.00</bdrx:WeightedAverageExercisePriceOfShareOptionsLapsed>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003898"
      unitRef="GBPPShares">0.006</bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsGranted
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003900"
      unitRef="GBPPShares">0.003</bdrx:WeightedAverageExercisePriceOfShareOptionsGranted>
    <bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1 contextRef="From2024-01-012024-12-31" id="Fact003902">P9Y2M12D</bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant26Member"
      id="Fact003908">30 June 2014</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant26Member"
      decimals="INF"
      id="Fact003910"
      unitRef="N">25</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant26Member"
      decimals="INF"
      id="Fact003918"
      unitRef="N">25</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant26Member"
      decimals="INF"
      id="Fact003920"
      unitRef="GBPPShares">30.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant27Member"
      id="Fact003922">19 December 2016</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant27Member"
      decimals="INF"
      id="Fact003924"
      unitRef="N">13</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant27Member"
      decimals="INF"
      id="Fact003932"
      unitRef="N">13</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant27Member"
      decimals="INF"
      id="Fact003934"
      unitRef="GBPPShares">484.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant28Member"
      id="Fact003936">15 December 2017</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant28Member"
      decimals="INF"
      id="Fact003938"
      unitRef="N">40</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant28Member"
      decimals="INF"
      id="Fact003946"
      unitRef="N">40</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant28Member"
      decimals="INF"
      id="Fact003948"
      unitRef="GBPPShares">184.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant29Member"
      id="Fact003950">24 April 2019</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant29Member"
      decimals="INF"
      id="Fact003952"
      unitRef="N">312</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant29Member"
      decimals="INF"
      id="Fact003960"
      unitRef="N">312</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant29Member"
      decimals="INF"
      id="Fact003962"
      unitRef="GBPPShares">29.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant30Member"
      id="Fact003964">2 October 2019</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant30Member"
      decimals="INF"
      id="Fact003966"
      unitRef="N">1500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant30Member"
      decimals="INF"
      id="Fact003974"
      unitRef="N">1500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant30Member"
      decimals="INF"
      id="Fact003976"
      unitRef="GBPPShares">21.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant31Member"
      id="Fact003978">17 April 2020</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant31Member"
      decimals="INF"
      id="Fact003980"
      unitRef="N">5000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant31Member"
      decimals="INF"
      id="Fact003988"
      unitRef="N">5000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant31Member"
      decimals="INF"
      id="Fact003990"
      unitRef="GBPPShares">4.80</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant32Member"
      id="Fact003992">17 June 2020</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant32Member"
      decimals="INF"
      id="Fact003994"
      unitRef="N">33600</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant32Member"
      decimals="INF"
      id="Fact003998"
      unitRef="N">-6250</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant32Member"
      decimals="INF"
      id="Fact004002"
      unitRef="N">27350</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant32Member"
      decimals="INF"
      id="Fact004004"
      unitRef="GBPPShares">4.04</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant33Member"
      id="Fact004006">15 July 2021</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant33Member"
      decimals="INF"
      id="Fact004008"
      unitRef="N">64350</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant33Member"
      decimals="INF"
      id="Fact004014"
      unitRef="N">-5500</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant33Member"
      decimals="INF"
      id="Fact004016"
      unitRef="N">58850</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant33Member"
      decimals="INF"
      id="Fact004018"
      unitRef="GBPPShares">5.55</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant34Member"
      id="Fact004020">2 August 2021</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant34Member"
      decimals="INF"
      id="Fact004022"
      unitRef="N">2500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant34Member"
      decimals="INF"
      id="Fact004028"
      unitRef="N">-2500</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant34Member"
      decimals="INF"
      id="Fact004032"
      unitRef="GBPPShares">5.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant35Member"
      id="Fact004034">1 September 2021</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant35Member"
      decimals="INF"
      id="Fact004036"
      unitRef="N">6000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant35Member"
      decimals="INF"
      id="Fact004044"
      unitRef="N">6000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant35Member"
      decimals="INF"
      id="Fact004046"
      unitRef="GBPPShares">5.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant36Member"
      id="Fact004048">7 February 2022</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant36Member"
      decimals="INF"
      id="Fact004050"
      unitRef="N">18750</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant36Member"
      decimals="INF"
      id="Fact004056"
      unitRef="N">-6250</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_Grant36Member"
      decimals="INF"
      id="Fact004058"
      unitRef="N">12500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant36Member"
      decimals="INF"
      id="Fact004060"
      unitRef="GBPPShares">3.05</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_Grant37Member"
      id="Fact004062">12 August 2022</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_Grant37Member"
      decimals="INF"
      id="Fact004064"
      unitRef="N">12500</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_Grant37Member"
      decimals="INF"
      id="Fact004070"
      unitRef="N">-12500</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_Grant37Member"
      decimals="INF"
      id="Fact004074"
      unitRef="GBPPShares">2.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004076"
      unitRef="N">144590</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004080"
      unitRef="N">-6250</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004082"
      unitRef="N">-26750</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004084"
      unitRef="N">111590</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004086"
      unitRef="N">75720</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004088"
      unitRef="GBPPShares">5.241</bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsLapsed
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004092"
      unitRef="GBPPShares">4.04</bdrx:WeightedAverageExercisePriceOfShareOptionsLapsed>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004094"
      unitRef="GBPPShares">3.33</bdrx:WeightedAverageExercisePriceOfShareOptionsForfeited>
    <bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1 contextRef="From2023-01-012023-12-31" id="Fact004098">P7Y3M18D</bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004103">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_pn3n3_zRgUBhUpV72g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zEviKTCnFNY6" style="display: none"&gt;Schedule of fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;January 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;February 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;July 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%"&gt;Number of options&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20240131_zwpJypEH80kk" title="Number of options"&gt;144,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240201__20240229_zDWzlTRbhIU2" title="Number of options"&gt;130,313,200&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240701__20240731_z18ZpCRK7vI5" title="Number of options"&gt;85,922,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Option pricing models used&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240101__20240131" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240201__20240229" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240701__20240731" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20240101__20240131_zN6miT1Vq157" title="Share price"&gt;1.90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20240201__20240229_zLNYOE7bnJgh" title="Share price"&gt;1.310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_c20240701__20240731_zy142fWDtls6" title="Share price"&gt;0.00139&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price of options issued in year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ExercisePriceOfOptionsIssuedInYear_pid_uUSDPShares_c20240101__20240131_z0JbHg5JQkZi" title="Exercise price of options issued in year"&gt;1.90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ExercisePriceOfOptionsIssuedInYear_pid_uUSDPShares_c20240201__20240229_zTuLOI2Ejt22" title="Exercise price of options issued in year"&gt;1.310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#xa3;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExercisePriceOfOptionsIssuedInYear_pid_c20240701__20240731_zg6SrlAcC8pg" title="Exercise price of options issued in year"&gt;0.00259&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contractual life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ContractualLifeTerm_dtY_c20240101__20240131_zIC8IpWbKJyf" title="Contractual life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ContractualLifeTerm_dtY_c20240201__20240229_zVNu4sLsgxl7" title="Contractual life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ContractualLifeTerm_dtY_c20240701__20240731_ztuJHRQrXof4" title="Contractual life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ExpectedLifeTerm_dtY_c20240101__20240131_z5Auar4mg8j8" title="Expected life"&gt;4&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ExpectedLifeTerm_dtY_c20240201__20240229_zlS2HV6TN0o9" title="Expected life"&gt;4&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeTerm_dtY_c20240701__20240731_zqAH1J5MQdBd" title="Expected life"&gt;4&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240101__20240131_fKio___zVNosSXRdRtg" title="Volatility"&gt;100.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240201__20240229_fKio___zdXbl0QtrXG9" title="Volatility"&gt;100.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240701__20240731_fKio___zuOSbLOF7fE" title="Volatility"&gt;110.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240101__20240131_zUrlwYElV855" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240201__20240229_z3YdjFrfbpX6" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240701__20240731_zxB8FD7ma8Uc" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Risk free rate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240101__20240131_zehryT9afNpk" title="Risk free rate"&gt;4.110&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240201__20240229_zL2sHWJulNpf" title="Risk free rate"&gt;4.195&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240701__20240731_zBUoDTEQ58Dj" title="Risk free rate"&gt;4.025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The share price used in the determination of the fair value of the
options granted in 2024 was the share price on the date of grant.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F00_zpTlXwjbBmNe" style="width: 3%; font-size: 10pt"&gt;**&lt;/td&gt;
    &lt;td id="xdx_F15_zTninv6sKbpc" style="width: 97%; font-size: 10pt"&gt;Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a four-year period.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-01-31"
      decimals="INF"
      id="Fact004105"
      unitRef="N">144000000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-02-012024-02-29"
      decimals="INF"
      id="Fact004107"
      unitRef="N">130313200</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-07-012024-07-31"
      decimals="INF"
      id="Fact004109"
      unitRef="N">85922000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2024-01-012024-01-31" id="Fact004111">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2024-02-012024-02-29" id="Fact004113">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2024-07-012024-07-31" id="Fact004115">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2024-01-012024-01-31"
      decimals="INF"
      id="Fact004117"
      unitRef="USDPShares">1.90</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2024-02-012024-02-29"
      decimals="INF"
      id="Fact004119"
      unitRef="USDPShares">1.310</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2024-07-012024-07-31"
      decimals="INF"
      id="Fact004121"
      unitRef="N">0.00139</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:ExercisePriceOfOptionsIssuedInYear
      contextRef="From2024-01-012024-01-31"
      decimals="INF"
      id="Fact004123"
      unitRef="USDPShares">1.90</bdrx:ExercisePriceOfOptionsIssuedInYear>
    <bdrx:ExercisePriceOfOptionsIssuedInYear
      contextRef="From2024-02-012024-02-29"
      decimals="INF"
      id="Fact004125"
      unitRef="USDPShares">1.310</bdrx:ExercisePriceOfOptionsIssuedInYear>
    <bdrx:ExercisePriceOfOptionsIssuedInYear
      contextRef="From2024-07-012024-07-31"
      decimals="INF"
      id="Fact004127"
      unitRef="GBPPShares">0.00259</bdrx:ExercisePriceOfOptionsIssuedInYear>
    <bdrx:ContractualLifeTerm contextRef="From2024-01-012024-01-31" id="Fact004129">P10Y</bdrx:ContractualLifeTerm>
    <bdrx:ContractualLifeTerm contextRef="From2024-02-012024-02-29" id="Fact004131">P10Y</bdrx:ContractualLifeTerm>
    <bdrx:ContractualLifeTerm contextRef="From2024-07-012024-07-31" id="Fact004133">P10Y</bdrx:ContractualLifeTerm>
    <bdrx:ExpectedLifeTerm contextRef="From2024-01-012024-01-31" id="Fact004135">P4Y</bdrx:ExpectedLifeTerm>
    <bdrx:ExpectedLifeTerm contextRef="From2024-02-012024-02-29" id="Fact004137">P4Y</bdrx:ExpectedLifeTerm>
    <bdrx:ExpectedLifeTerm contextRef="From2024-07-012024-07-31" id="Fact004139">P4Y</bdrx:ExpectedLifeTerm>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-01-31"
      decimals="INF"
      id="Fact004141"
      unitRef="Pure">1.000</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-02-012024-02-29"
      decimals="INF"
      id="Fact004143"
      unitRef="Pure">1.000</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-07-012024-07-31"
      decimals="INF"
      id="Fact004145"
      unitRef="Pure">1.100</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-01-012024-01-31"
      decimals="INF"
      id="Fact004147"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-02-012024-02-29"
      decimals="INF"
      id="Fact004149"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-07-012024-07-31"
      decimals="INF"
      id="Fact004151"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-01-012024-01-31"
      decimals="INF"
      id="Fact004153"
      unitRef="Pure">0.04110</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-02-012024-02-29"
      decimals="INF"
      id="Fact004155"
      unitRef="Pure">0.04195</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-07-012024-07-31"
      decimals="INF"
      id="Fact004157"
      unitRef="Pure">0.04025</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <bdrx:ScheduleOfWarrantsAccountedForShareBasedPaymentsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact004163">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfWarrantsAccountedForShareBasedPaymentsTableTextBlock_pn3n3_zOhTdPrKR9h8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span id="xdx_8B8_zpYrIwxtJfB9" style="display: none"&gt;Schedule of warrants are accounted for as share based payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price per ADS&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member" title="Grant date"&gt;24 March 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z1dFs6cTTKw" title="Beginning of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zmXNlAf6ESF" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4169"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zvtymAV6EkWi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4171"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zUFzbPKy9Nyl" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4173"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zgoEpVtZvrn1" title="Ending of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zn33DWkakLG1" title="Exercise Price"&gt;58,000.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member" title="Grant date"&gt;14 June 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zZ51XNOYgIS" title="Beginning of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zGMPnAVc8pvc" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4183"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zwUNtIWkk6Ef" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4185"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zrWK1nmlEaKd" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4187"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zJJhJVufCxP3" title="Ending of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zXNY1WuVE1wb" title="Exercise Price"&gt;3,750.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member" title="Grant date"&gt;21 December 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zKk3LwIcHaW" title="Beginning of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zwk4T0JjG0u6" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4197"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_z3WTqpSFWe52" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4199"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zoHSBQEKV9hi" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4201"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zNwYdk7fzilf" title="Ending of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zXAQ667BzVo7" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member" title="Grant date"&gt;24 May 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zoyRC3LotDT6" title="Beginning of the year"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_z6xno5VTF4N3" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4211"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zWvlqQpLLaYg" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4213"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_z3NZecWLBLy7" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4215"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zEKNm2wzNJQ9" title="Ending of the year"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zgSSxnpeP40d" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member" title="Grant date"&gt;22 July 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zABwFJizZEfa" title="Beginning of the year"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zpC6b0MsrmKl" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4225"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zg4W1i4qGt79" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4227"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zrefQ8mHm3Nf" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4229"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zh1HeZxQYkJ1" title="Ending of the year"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zejP1v5TKvOh" title="Exercise Price"&gt;312.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OutstandingGrantedOptionsGrantDate_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member" title="Grant date"&gt;19 December 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zZB6doZIKHEc" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4237"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zdByzACfv6rd" title="Granted"&gt;152,439&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zrEgIbDUprj1" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4241"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zLdoYHp6UEz8" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4243"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zezgsKcebuRd" title="Ending of the year"&gt;152,439&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20250101__20251231__custom--DateOfGrantAxis__custom--WarrantsGrant6Member_zNym7Vi8irw4" title="Exercise Price"&gt;3.28&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zIpH9y0Hjuc2" title="Beginning of the year"&gt;2,024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_za7e3ErAkY1e" title="Granted"&gt;152,439&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z5szDuFDamVh" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4253"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zIuPEKZDGYk" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4255"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zPirWB6IOARd" title="Ending of the year"&gt;154,463&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Warrants exercisable at 31 December 2025&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--WarrantsExercisable_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z6iXtVZZn8m9" title="Warrants exercisable"&gt;154,463&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_uUSDPShares_c20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zKw3pPIRSITa" title="Weighted average exercise price of outstanding options"&gt;12.458&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_znMk1hEZiaYa" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4263"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zoOpdvFhop7d" title="Weighted average exercise price of options lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4265"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zUigoBw0xi6h" title="Weighted average exercise price of options forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4267"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2025&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_uUSDPShares_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zDOF8v9Qx1Y5" title="Weighted average exercise price of options granted"&gt;3.28&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20250101__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zEjX30adpnKf" title="Weighted average remaining contractual life of outstanding options"&gt;4.9&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price per ADS&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member" title="Grant date"&gt;24 March 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z66JapzaT1rl" title="Beginning of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z01QZMi3yJ99" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4281"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zBPItBK53Bjh" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4283"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z49potcROtz1" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4285"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z4enhXpyD6mf" title="Ending of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z1yLtebGCnJ9" title="Exercise Price"&gt;58,000.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member" title="Grant date"&gt;14 June 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zXpBUCbyEhv7" title="Beginning of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zU3s51g7jq2a" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4295"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_z95cR9TZdbpc" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4297"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zImBOhaixhF8" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4299"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zZxn32CGwZfd" title="Ending of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zJqNF92l3VO9" title="Exercise Price"&gt;3,750.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member" title="Grant date"&gt;21 December 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zqKpc0E6RfS7" title="Beginning of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_z0Bj8xRauAQ8" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4309"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zLYmtpW7qMQ6" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4311"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zuTByhcUQFok" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4313"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zdrgonY0yFRa" title="Ending of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zUoInHhDUSRb" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member" title="Grant date"&gt;24 May 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zCUyvKO6aWPd" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4321"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zxy8uJ74HJRd" title="Granted"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zobbjETEkcR2" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4325"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zjUnZm5mBOHd" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4327"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zeWrVGN8Z57l" title="Ending of the year"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant4Member_zt87t1urc8oh" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OutstandingGrantedOptionsGrantDate_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member" title="Grant date"&gt;22 July 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zzWDToanAVh5" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4335"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zunv61ZoTZO5" title="Granted"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zxwSBnT36AXc" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4339"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zG6bkQnlpSI4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4341"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_zUbnDJGM3nO" title="Ending of the year"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20240101__20241231__custom--DateOfGrantAxis__custom--WarrantsGrant5Member_z5u9f9ZDHMXl" title="Exercise Price"&gt;312.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zSUvxFGxxSCa" title="Beginning of the year"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zZlqnp80mZfk" title="Granted"&gt;1,495&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zaJcheu02dak" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4351"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zajjkEe6vx33" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4353"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zvCxNyJb7sM3" title="Ending of the year"&gt;2,024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Warrants exercisable at 31 December 2024&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--WarrantsExercisable_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zaOOANlAf1r9" title="Warrants exercisable"&gt;2,024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_uUSDPShares_c20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zQoGfVzZ6yF1" title="Weighted average exercise price of outstanding options"&gt;703.28&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zwHyY7s1t784" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4361"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_znGIRhq1uLm5" title="Weighted average exercise price of options lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4363"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zESeuQrwTLt1" title="Weighted average exercise price of options forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4365"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2024&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_uUSDPShares_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zHRmykbZrKc8" title="Weighted average exercise price of options granted"&gt;447.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20240101__20241231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zHKsE1X8did9" title="Weighted average remaining contractual life of outstanding options"&gt;2.2&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At 1 January &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Granted in 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Lapsed in 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Forfeited in &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;At &lt;br/&gt; 31 December &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; Price per ADS&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member" title="Grant date"&gt;24 March 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zcyJX4Z4Krsl" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4373"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zVJbaXt72gkb" title="Granted"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zYz4b4hR4xHi" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4377"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_z13bQDyRf40h" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4379"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zIBhoDTIaBj" title="Ending of the year"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant1Member_zYx5fWK83MV8" title="Exercise Price"&gt;58,000.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member" title="Grant date"&gt;14 June 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zjUS1GkmREv8" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4387"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zkrC9CbdbzNb" title="Granted"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zYG4dmjD7AT5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4391"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_ztmRqwqweVLh" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4393"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zIvz96Wo3hR4" title="Ending of the year"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant2Member_zkH828u3aNYh" title="Exercise Price"&gt;3,750.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OutstandingGrantedOptionsGrantDate_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member" title="Grant date"&gt;21 December 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zspRMdQRXjCi" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4401"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zxZIt07MCCrk" title="Granted"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zGUhXNbMwwT5" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4405"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_z902dSMCLQY7" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4407"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_zIIm89n04DBd" title="Ending of the year"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20231231__custom--DateOfGrantAxis__custom--WarrantsGrant3Member_z5hrfaNDTCT3" title="Exercise Price"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zKyQWTtNkj9c" title="Beginning of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4413"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z3BllmM3PEcf" title="Granted"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zI8wDw975bid" title="Lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4417"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zUQy5erBSVi4" title="Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4419"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zqavpUAA53c9" title="Ending of the year"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Warrants exercisable at 31 December 2023&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WarrantsExercisable_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z0RxuVNQLurl" title="Warrants exercisable"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding options at 31 December 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstanding_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_znrj405VWnA9" title="Weighted average exercise price of outstanding options"&gt;1,427.22&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options exercised in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageExercisePriceOfOptionsExercised_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z77Vzl1AYZk2" title="Weighted average exercise price of options exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4427"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options lapsed in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageExercisePriceOfShareOptionsLapsed_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z292WnVfuxi" title="Weighted average exercise price of options lapsed"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4429"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average exercise price of options forfeited in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeited_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z68SnApYxKt6" title="Weighted average exercise price of options forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4431"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of options granted in 2023&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageExercisePriceOfShareOptionsGranted_pid_uUSDPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z26gRJ866cLg" title="Weighted average exercise price of options granted"&gt;1,427.22&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Weighted average remaining contractual life of outstanding options at 31 December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1_dtY_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_ztQ69nhPtMR5" title="Weighted average remaining contractual life of outstanding options"&gt;2.2&lt;/span&gt; years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

</bdrx:ScheduleOfWarrantsAccountedForShareBasedPaymentsTableTextBlock>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant1Member"
      id="Fact004165">24 March 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004167"
      unitRef="N">5</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004175"
      unitRef="N">5</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004177"
      unitRef="USDPShares">58000.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant2Member"
      id="Fact004179">14 June 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004181"
      unitRef="N">44</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004189"
      unitRef="N">44</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004191"
      unitRef="USDPShares">3750.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant3Member"
      id="Fact004193">21 December 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004195"
      unitRef="N">480</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004203"
      unitRef="N">480</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004205"
      unitRef="USDPShares">625.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant4Member"
      id="Fact004207">24 May 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant4Member"
      decimals="INF"
      id="Fact004209"
      unitRef="N">644</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_WarrantsGrant4Member"
      decimals="INF"
      id="Fact004217"
      unitRef="N">644</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant4Member"
      decimals="INF"
      id="Fact004219"
      unitRef="USDPShares">625.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant5Member"
      id="Fact004221">22 July 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant5Member"
      decimals="INF"
      id="Fact004223"
      unitRef="N">851</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_WarrantsGrant5Member"
      decimals="INF"
      id="Fact004231"
      unitRef="N">851</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant5Member"
      decimals="INF"
      id="Fact004233"
      unitRef="USDPShares">312.50</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant6Member"
      id="Fact004235">19 December 2025</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant6Member"
      decimals="INF"
      id="Fact004239"
      unitRef="N">152439</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_WarrantsGrant6Member"
      decimals="INF"
      id="Fact004245"
      unitRef="N">152439</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_custom_WarrantsGrant6Member"
      decimals="INF"
      id="Fact004247"
      unitRef="USDPShares">3.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004249"
      unitRef="N">2024</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004251"
      unitRef="N">152439</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004257"
      unitRef="N">154463</ifrs-full:NumberOfOutstandingShareOptions>
    <bdrx:WarrantsExercisable
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004259"
      unitRef="Shares">154463</bdrx:WarrantsExercisable>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004261"
      unitRef="USDPShares">12.458</bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsGranted
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004269"
      unitRef="USDPShares">3.28</bdrx:WeightedAverageExercisePriceOfShareOptionsGranted>
    <bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1
      contextRef="From2025-01-012025-12-31_ifrs-full_WarrantsMember"
      id="Fact004271">P4Y10M24D</bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant1Member"
      id="Fact004277">24 March 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004279"
      unitRef="N">5</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004287"
      unitRef="N">5</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004289"
      unitRef="USDPShares">58000.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant2Member"
      id="Fact004291">14 June 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004293"
      unitRef="N">44</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004301"
      unitRef="N">44</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004303"
      unitRef="USDPShares">3750.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant3Member"
      id="Fact004305">21 December 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004307"
      unitRef="N">480</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004315"
      unitRef="N">480</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004317"
      unitRef="USDPShares">625.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant4Member"
      id="Fact004319">24 May 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant4Member"
      decimals="INF"
      id="Fact004323"
      unitRef="N">644</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant4Member"
      decimals="INF"
      id="Fact004329"
      unitRef="N">644</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant4Member"
      decimals="INF"
      id="Fact004331"
      unitRef="USDPShares">625.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant5Member"
      id="Fact004333">22 July 2024</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant5Member"
      decimals="INF"
      id="Fact004337"
      unitRef="N">851</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_WarrantsGrant5Member"
      decimals="INF"
      id="Fact004343"
      unitRef="N">851</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_WarrantsGrant5Member"
      decimals="INF"
      id="Fact004345"
      unitRef="USDPShares">312.50</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004347"
      unitRef="N">529</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004349"
      unitRef="N">1495</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004355"
      unitRef="N">2024</ifrs-full:NumberOfOutstandingShareOptions>
    <bdrx:WarrantsExercisable
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004357"
      unitRef="Shares">2024</bdrx:WarrantsExercisable>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004359"
      unitRef="USDPShares">703.28</bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsGranted
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004367"
      unitRef="USDPShares">447.12</bdrx:WeightedAverageExercisePriceOfShareOptionsGranted>
    <bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1
      contextRef="From2024-01-012024-12-31_ifrs-full_WarrantsMember"
      id="Fact004369">P2Y2M12D</bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant1Member"
      id="Fact004371">24 March 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004375"
      unitRef="N">5</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004381"
      unitRef="N">5</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant1Member"
      decimals="INF"
      id="Fact004383"
      unitRef="USDPShares">58000.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant2Member"
      id="Fact004385">14 June 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004389"
      unitRef="N">44</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004395"
      unitRef="N">44</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant2Member"
      decimals="INF"
      id="Fact004397"
      unitRef="USDPShares">3750.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <bdrx:OutstandingGrantedOptionsGrantDate
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant3Member"
      id="Fact004399">21 December 2023</bdrx:OutstandingGrantedOptionsGrantDate>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004403"
      unitRef="N">480</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004409"
      unitRef="N">480</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_custom_WarrantsGrant3Member"
      decimals="INF"
      id="Fact004411"
      unitRef="USDPShares">625.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004415"
      unitRef="N">529</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004421"
      unitRef="N">529</ifrs-full:NumberOfOutstandingShareOptions>
    <bdrx:WarrantsExercisable
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004423"
      unitRef="Shares">529</bdrx:WarrantsExercisable>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding
      contextRef="AsOf2023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004425"
      unitRef="USDPShares">1427.22</bdrx:WeightedAverageExercisePriceOfShareOptionsOutstanding>
    <bdrx:WeightedAverageExercisePriceOfShareOptionsGranted
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004433"
      unitRef="USDPShares">1427.22</bdrx:WeightedAverageExercisePriceOfShareOptionsGranted>
    <bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1
      contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember"
      id="Fact004435">P2Y2M12D</bdrx:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions1>
    <bdrx:ScheduleOfFairValueOfWarrantsGrantedTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact004440">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfFairValueOfWarrantsGrantedTableTextBlock_pn3n3_zgNqcFoh2ED3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Share-based payments (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zfIG0cPYtRae" style="display: none"&gt;Schedule of fair value of warrants granted&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;December 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%; text-align: left"&gt;Number of ADS warrants granted&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfAdsWarrantsGranted_pid_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z0G77dDhlDPf" title="Number of ADS warrants granted"&gt;152,439&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Option pricing models used&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z8wBlgPyOhxe" title="Share price"&gt;3.640&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price of warrants issued in year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zg59vANr0ZBf" title="Exercise price of warrants issued in year"&gt;3.280&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contractual life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ContractualLifeTerm_dtY_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zvgVEew5EDmc" title="Contractual life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ExpectedLifeTerm_dtY_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zFinQ3y6kAr2" title="Expected life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zejPbHEbuVP" title="Volatility"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zFttCNz4EhB3" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Risk free rate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20251201__20251231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zWn9yS7Ug3ue" title="Risk free rate"&gt;3.70&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="color: windowtext"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="color: windowtext"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4D4D4C"&gt;&lt;span style="color: windowtext"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 3%"&gt;*&lt;/td&gt;
    &lt;td style="width: 97%"&gt;The share price used in the determination of the fair value of the ADS warrants granted in 2025 was the ADS price on the date of grant.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;**&lt;/td&gt;
    &lt;td&gt;Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a three-year period.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4D4D4C"&gt;&lt;span style="color: windowtext"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4D4D4C"&gt;&lt;span style="color: windowtext"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4D4D4C"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following information is relevant in the determination of the fair
value of warrants granted during the year 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;May 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;July 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Number of ADS warrants granted&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NumberOfAdsWarrantsGranted_pid_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zvVUjobLVCK2" title="Number of ADS warrants granted"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfAdsWarrantsGranted_pid_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zZjUddhiCq9g" title="Number of ADS warrants granted"&gt;851&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Option pricing models used&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zrYXYG8o1dWg" title="Share price"&gt;325.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z90rS1dqONDl" title="Share price"&gt;198.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price of warrants issued in year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zxV4XFhdkf2d" title="Exercise price of warrants issued in year"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zumsX52dfAhh" title="Exercise price of warrants issued in year"&gt;312.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contractual life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ContractualLifeTerm_dtY_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z0itbPlIpy9k" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ContractualLifeTerm_dtY_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zoXJGH531ay1" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ExpectedLifeTerm_dtY_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zqfZFlN08gnl" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeTerm_dtY_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zsLsiCBwUjmb" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zylVCFhZQ7J6" title="Volatility"&gt;115&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___z2DNIyWAWVMk" title="Volatility"&gt;115&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zTDxbkmIClvh" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zrLvYFe3pBp3" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Risk free rate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240501__20240531__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zqeE3BKN2dmi" title="Risk free rate"&gt;4.71&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20240701__20240731__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zmGY5QEkdWHa" title="Risk free rate"&gt;4.29&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 3%"&gt;*&lt;/td&gt;
    &lt;td style="width: 97%"&gt;The share price used in the determination of the fair value of the ADS warrants granted in 2024 was the ADS price on the date of grant.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;**&lt;/td&gt;
    &lt;td&gt;Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a three-year period.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following information is relevant in the determination of the fair
value of warrants granted during the year 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;March 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;June 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: right"&gt;December 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Number of ADS warrants granted&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--NumberOfAdsWarrantsGranted_pid_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zV46pOwdkKyg" title="Number of ADS warrants granted"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfAdsWarrantsGranted_pid_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zIBcua0vINGa" title="Number of ADS warrants granted"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfAdsWarrantsGranted_pid_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z3NkEZAFwAE7" title="Number of ADS warrants granted"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Option pricing models used&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember" title="Option pricing models used"&gt;Black-Scholes&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKg_____zkvmtbwxsUOa" title="Share price"&gt;50,400.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKg_____zLOwTTfCfpVi" title="Share price"&gt;2,635.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;*&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageSharePriceShareOptionsGranted1_pid_uUSDPShares_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zz74Ll4W7xb9" title="Share price"&gt;632.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price of warrants issued in year&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zthBsrnRFP67" title="Exercise price of warrants issued in year"&gt;58,000.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zCOABAJkDmI7" title="Exercise price of warrants issued in year"&gt;3,750.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ExercisePriceOfWarrantsIssuedInYear_pid_uUSDPShares_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z5MEv8W2tSi7" title="Exercise price of warrants issued in year"&gt;625.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contractual life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ContractualLifeTerm_dtY_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_z2xchWFSCNtd" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ContractualLifeTerm_dtY_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zgjfUH36cac9" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ContractualLifeTerm_dtY_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zgmlZrJ5LCCb" title="Contractual life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ExpectedLifeTerm_dtY_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zMfRexcgfgjk" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ExpectedLifeTerm_dtY_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zLJrKPmhzXI8" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExpectedLifeTerm_dtY_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zxngVeZGwcWh" title="Expected life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zZAlRH9LR1Q3" title="Volatility"&gt;75.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zM1T4DWOC4Bk" title="Volatility"&gt;80.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_fKio___zYc4DtNHebN7" title="Volatility"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%**&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zqPrPzjgS6yg" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zkmrPG863twd" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: #4D4D4C"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zfFfkMXrhbWe" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Risk free rate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230301__20230331__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zzYV2IVzFxMe" title="Risk free rate"&gt;4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230601__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_ztUFuzYfViL6" title="Risk free rate"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231201__20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--WarrantsMember_zMynoEg874Yc" title="Risk free rate"&gt;4.06&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zXTNaYpifmQl" style="width: 3%"&gt;*&lt;/td&gt;
    &lt;td id="xdx_F14_zegciKYtVFfg" style="width: 97%"&gt;The share price used in the determination of the fair value of the ADS warrants granted in 2023 was the ADS price on the date of grant.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F04_zxocdOHOgu6e"&gt;**&lt;/td&gt;
    &lt;td id="xdx_F1B_zcYFBLvmf1H9"&gt;Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a three-year period.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</bdrx:ScheduleOfFairValueOfWarrantsGrantedTableTextBlock>
    <bdrx:NumberOfAdsWarrantsGranted
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004442"
      unitRef="Shares">152439</bdrx:NumberOfAdsWarrantsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      id="Fact004444">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004446"
      unitRef="USDPShares">3.640</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:ExercisePriceOfWarrantsIssuedInYear
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004448"
      unitRef="USDPShares">3.280</bdrx:ExercisePriceOfWarrantsIssuedInYear>
    <bdrx:ContractualLifeTerm
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      id="Fact004450">P5Y</bdrx:ContractualLifeTerm>
    <bdrx:ExpectedLifeTerm
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      id="Fact004452">P5Y</bdrx:ExpectedLifeTerm>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004454"
      unitRef="Pure">1.10</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004456"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-12-012025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004458"
      unitRef="Pure">0.0370</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <bdrx:NumberOfAdsWarrantsGranted
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004460"
      unitRef="Shares">644</bdrx:NumberOfAdsWarrantsGranted>
    <bdrx:NumberOfAdsWarrantsGranted
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004462"
      unitRef="Shares">851</bdrx:NumberOfAdsWarrantsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      id="Fact004464">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      id="Fact004466">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004468"
      unitRef="USDPShares">325.00</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004470"
      unitRef="USDPShares">198.50</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:ExercisePriceOfWarrantsIssuedInYear
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004472"
      unitRef="USDPShares">625.00</bdrx:ExercisePriceOfWarrantsIssuedInYear>
    <bdrx:ExercisePriceOfWarrantsIssuedInYear
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004474"
      unitRef="USDPShares">312.50</bdrx:ExercisePriceOfWarrantsIssuedInYear>
    <bdrx:ContractualLifeTerm
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      id="Fact004476">P3Y</bdrx:ContractualLifeTerm>
    <bdrx:ContractualLifeTerm
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      id="Fact004478">P3Y</bdrx:ContractualLifeTerm>
    <bdrx:ExpectedLifeTerm
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      id="Fact004480">P3Y</bdrx:ExpectedLifeTerm>
    <bdrx:ExpectedLifeTerm
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      id="Fact004482">P3Y</bdrx:ExpectedLifeTerm>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004484"
      unitRef="Pure">1.15</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004486"
      unitRef="Pure">1.15</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004488"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004490"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-05-012024-05-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004492"
      unitRef="Pure">0.0471</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-07-012024-07-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004494"
      unitRef="Pure">0.0429</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <bdrx:NumberOfAdsWarrantsGranted
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004499"
      unitRef="Shares">5</bdrx:NumberOfAdsWarrantsGranted>
    <bdrx:NumberOfAdsWarrantsGranted
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004501"
      unitRef="Shares">44</bdrx:NumberOfAdsWarrantsGranted>
    <bdrx:NumberOfAdsWarrantsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004503"
      unitRef="Shares">480</bdrx:NumberOfAdsWarrantsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      id="Fact004505">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      id="Fact004507">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      id="Fact004509">Black-Scholes</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004511"
      unitRef="USDPShares">50400.00</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004513"
      unitRef="USDPShares">2635.00</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:WeightedAverageSharePriceShareOptionsGranted1
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004515"
      unitRef="USDPShares">632.50</bdrx:WeightedAverageSharePriceShareOptionsGranted1>
    <bdrx:ExercisePriceOfWarrantsIssuedInYear
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004517"
      unitRef="USDPShares">58000.00</bdrx:ExercisePriceOfWarrantsIssuedInYear>
    <bdrx:ExercisePriceOfWarrantsIssuedInYear
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004519"
      unitRef="USDPShares">3750.00</bdrx:ExercisePriceOfWarrantsIssuedInYear>
    <bdrx:ExercisePriceOfWarrantsIssuedInYear
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004521"
      unitRef="USDPShares">625.00</bdrx:ExercisePriceOfWarrantsIssuedInYear>
    <bdrx:ContractualLifeTerm
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      id="Fact004523">P3Y</bdrx:ContractualLifeTerm>
    <bdrx:ContractualLifeTerm
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      id="Fact004525">P3Y</bdrx:ContractualLifeTerm>
    <bdrx:ContractualLifeTerm
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      id="Fact004527">P3Y</bdrx:ContractualLifeTerm>
    <bdrx:ExpectedLifeTerm
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      id="Fact004529">P3Y</bdrx:ExpectedLifeTerm>
    <bdrx:ExpectedLifeTerm
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      id="Fact004531">P3Y</bdrx:ExpectedLifeTerm>
    <bdrx:ExpectedLifeTerm
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      id="Fact004533">P3Y</bdrx:ExpectedLifeTerm>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004535"
      unitRef="Pure">0.7500</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004537"
      unitRef="Pure">0.8000</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004539"
      unitRef="Pure">0.60</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004541"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004543"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004545"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-03-012023-03-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004547"
      unitRef="Pure">0.0435</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-06-012023-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004549"
      unitRef="Pure">0.0404</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact004551"
      unitRef="Pure">0.0406</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <bdrx:DisclosureOfCapitalCommitmentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004556">&lt;p id="xdx_80D_ecustom--DisclosureOfCapitalCommitmentsExplanatory_z8W0f6AZoRI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;26&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82B_z4xj0oB9DDyg"&gt;Capital commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Group had no capital commitments at 31 December 2025, 31 December
2024 and 31 December 2023.&lt;/p&gt;

</bdrx:DisclosureOfCapitalCommitmentsExplanatory>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004558">&lt;p id="xdx_803_eifrs-full--DisclosureOfRelatedPartyExplanatory_z8AiXtos0pVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;27&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82A_zZwYsXh7vxxb"&gt;Related party transactions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;There were no related party transactions in the current or prior periods
other than Directors&#x2019; remuneration.&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfContingentLiabilitiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004560">&lt;p id="xdx_80B_eifrs-full--DisclosureOfContingentLiabilitiesExplanatory_zPjBF0DikQ33" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;28&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_zLiQr1M6Sx6b"&gt;Contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;The Company entered into an Arrangement
Agreement with Bioasis on 13 December 2022 as amended on 18 December 2022. Under the agreement the Company agreed to acquire the entire
issued share capital of Bioasis for consideration of, in aggregate, approximately C$&lt;span id="xdx_900_ecustom--AggregateConsideration_iI_pn3n3_dm_uUSD_c20221218_zSSg5IpfMUmc" title="Aggregate consideration"&gt;7.4&lt;/span&gt; million (c&#xa3;4.4 million). The agreement was
subject to shareholder approval. On January 23, 2023 at the General Meeting to approve the Arrangement Agreement none of the special resolutions
were passed and, accordingly, the acquisition of Bioasis did not proceed. Under the agreement the Company agreed to reimburse Bioasis
US$&lt;span id="xdx_905_ecustom--RequestedForReimbursement_iI_pn3p0_uUSD_c20230123_z5jgPS5IAuAd" title="Requested for reimbursement"&gt;225,000&lt;/span&gt; for expenses relating to the transaction should the Company&#x2019;s shareholders not approve the transaction. On March 3, 2023
the Company advised Bioasis that it would offset this liability against the $500,000 loan it advanced to them during December 2022 and
January 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: normal"&gt;As at 31 December 2023 the Company
had a contingent liability of $&lt;span id="xdx_90E_ecustom--ContingentLiability_iI_pn3d_uUSD_c20231231_z7rvBzBUZJG7" title="Contingent liability"&gt;225,000&lt;/span&gt; in relation to this potential liability. As at 31 December 2025 and 31 December 2024 the Company
no longer believes it has a contingent liability.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfContingentLiabilitiesExplanatory>
    <bdrx:AggregateConsideration
      contextRef="AsOf2022-12-18"
      decimals="-3"
      id="Fact004562"
      unitRef="USD">7400000</bdrx:AggregateConsideration>
    <bdrx:RequestedForReimbursement
      contextRef="AsOf2023-01-23"
      decimals="-3"
      id="Fact004564"
      unitRef="USD">225000</bdrx:RequestedForReimbursement>
    <bdrx:ContingentLiability
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004566"
      unitRef="USD">225000</bdrx:ContingentLiability>
    <bdrx:DisclosureOfUltimateControllingPartyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004568">&lt;p id="xdx_80A_ecustom--DisclosureOfUltimateControllingPartyExplanatory_zFGJEdS4imDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;29&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_820_ziarfWqq4YOd"&gt;Ultimate controlling party&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Directors do not consider that there is an ultimate controlling
party.&lt;/p&gt;

</bdrx:DisclosureOfUltimateControllingPartyExplanatory>
    <bdrx:DisclosurePostBalanceSheetEventsTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact004570">&lt;p id="xdx_80F_ecustom--DisclosurePostBalanceSheetEventsTextBlock_zzlTLF9nWkjk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27pt"&gt;30&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_z53Ji9bjNusf"&gt;Post Balance Sheet Events&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 4, 2026, the Company announced that
it had entered into a license and collaboration agreement (the &#x201c;License Agreement&#x201d;) with Otsuka Pharmaceutical Co., Ltd. (&#x201c;Otsuka&#x201d;),
pursuant to which Otsuka granted the Company an exclusive, worldwide (excluding Japan) license (the &#x201c;Licensed Territory&#x201d;)
to develop manufacture and commercialize OPB-171755, to be designated MTX240 (&#x201c;MTX240&#x201d;), a Phase 1-ready molecular glue therapeutic
candidate, for all human therapeutic uses. The Company intends to initially develop MTX240 for the treatment of gastrointestinal stromal
tumors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to the License Agreement, the Company
will be responsible for all development, manufacturing and commercialization activities for MTX240 in the Licensed Territory, and Otsuka
will retain all rights to MTX240 in Japan. As consideration for the license, the Company made an upfront payment to Otsuka, and Otsuka
is eligible to receive one-time development and regulatory milestones, as well as tiered royalties in the mid-single digits on the net
sales of licensed products. The Company is also obligated to pay Otsuka a percentage of any sublicense income it receives, subject to
certain exceptions.&lt;/p&gt;

</bdrx:DisclosurePostBalanceSheetEventsTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000812"
          xlink:label="Fact000812"
          xlink:type="locator"/>
        <link:footnote id="Footnote000823" xlink:label="Footnote000823" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">prepayment reflects only the escrow account balance</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000812"
          xlink:to="Footnote000823"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000814"
          xlink:label="Fact000814"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000814"
          xlink:to="Footnote000823"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000912"
          xlink:label="Fact000912"
          xlink:type="locator"/>
        <link:footnote id="Footnote001917" xlink:label="Footnote001917" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">asset is not yet in use and has not started amortising</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000912"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000914"
          xlink:label="Fact000914"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000914"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000916"
          xlink:label="Fact000916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000916"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000918"
          xlink:label="Fact000918"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000918"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000920"
          xlink:label="Fact000920"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000920"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001906"
          xlink:label="Fact001906"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001906"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001908"
          xlink:label="Fact001908"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001908"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001910"
          xlink:label="Fact001910"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001910"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001912"
          xlink:label="Fact001912"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001912"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001914"
          xlink:label="Fact001914"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001914"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1916"
          xlink:label="xdx2ixbrl1916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1916"
          xlink:to="Footnote001917"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001957"
          xlink:label="Fact001957"
          xlink:type="locator"/>
        <link:footnote id="Footnote001962" xlink:label="Footnote001962" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Wholly owned subsidiary of Biodexa Limited.</link:footnote>
        <link:footnote id="Footnote001963" xlink:label="Footnote001963" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">PharMida AG became dormant in January 2016. Proceedings to wind
up the company commenced in 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001957"
          xlink:to="Footnote001962"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001957"
          xlink:to="Footnote001963"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001959"
          xlink:label="Fact001959"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001959"
          xlink:to="Footnote001962"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001959"
          xlink:to="Footnote001963"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001961"
          xlink:label="Fact001961"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001961"
          xlink:to="Footnote001962"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001961"
          xlink:to="Footnote001963"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003313"
          xlink:label="Fact003313"
          xlink:type="locator"/>
        <link:footnote id="Footnote003478" xlink:label="Footnote003478" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Number of shares issued includes exercise of pre-funded warrants and Series A, Series B and Series C warrants that were exercisable on an &#x2018;alternative cashless basis&#x2019;.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003313"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3315"
          xlink:label="xdx2ixbrl3315"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3315"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3317"
          xlink:label="xdx2ixbrl3317"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3317"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3319"
          xlink:label="xdx2ixbrl3319"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3319"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3321"
          xlink:label="xdx2ixbrl3321"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3321"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003323"
          xlink:label="Fact003323"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003323"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003325"
          xlink:label="Fact003325"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003325"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3327"
          xlink:label="xdx2ixbrl3327"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3327"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3329"
          xlink:label="xdx2ixbrl3329"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3329"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3331"
          xlink:label="xdx2ixbrl3331"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3331"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3333"
          xlink:label="xdx2ixbrl3333"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3333"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003335"
          xlink:label="Fact003335"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003335"
          xlink:to="Footnote003478"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004141"
          xlink:label="Fact004141"
          xlink:type="locator"/>
        <link:footnote id="Footnote004158" xlink:label="Footnote004158" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a four-year period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004141"
          xlink:to="Footnote004158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004143"
          xlink:label="Fact004143"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004143"
          xlink:to="Footnote004158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004145"
          xlink:label="Fact004145"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004145"
          xlink:to="Footnote004158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004511"
          xlink:label="Fact004511"
          xlink:type="locator"/>
        <link:footnote id="Footnote004552" xlink:label="Footnote004552" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The share price used in the determination of the fair value of the ADS warrants granted in 2023 was the ADS price on the date of grant.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004511"
          xlink:to="Footnote004552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004513"
          xlink:label="Fact004513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004513"
          xlink:to="Footnote004552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004454"
          xlink:label="Fact004454"
          xlink:type="locator"/>
        <link:footnote id="Footnote004553" xlink:label="Footnote004553" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Volatility was calculated with reference to the historic share price volatility of comparable companies measured over a three-year period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004454"
          xlink:to="Footnote004553"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004484"
          xlink:label="Fact004484"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004484"
          xlink:to="Footnote004553"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004486"
          xlink:label="Fact004486"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004486"
          xlink:to="Footnote004553"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004535"
          xlink:label="Fact004535"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004535"
          xlink:to="Footnote004553"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004537"
          xlink:label="Fact004537"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004537"
          xlink:to="Footnote004553"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004539"
          xlink:label="Fact004539"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004539"
          xlink:to="Footnote004553"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
